WASM 2013 Valencia Final Program 1

S Abstra Re

_________________________________________________________________

World Congress on Sleep Medicine__________________________________________________________________

September 28 - October 2, 2013 • Valencia, Spain

wasmcongress.com

5th

World Association of Sleep Medicine I Spanish Sleep Society

Presidents’ Welcome

Dear Colleagues and Friends,

On behalf of the World Association of Sleep Medicine (WASM) and the Spanish Sleep Society(SES), we are delighted to welcome you to our joint congress: the 5th World Congress on SleepMedicine and the 22nd Annual Congress of the Spanish Sleep Society in Valencia, Spain, fromSeptember 28th to October 2nd, 2013. The congress provides an international discussion forumof sleep professionals from the entire world. It focuses particularly on the interdisciplinarycharacter of our field. Sleep clinicians, technologists, trainees, educators and scientists fromaround the world will meet here to advance knowledge on sleep science, sleep in public health,sleep health and the sleep-wake disorders, their diagnosis and treatments. We seek to maximizelearning both from formal presentations by the leading experts in their fields and from informaldiscussion groups emphasizing opportunities for your participation. The social events and theMediterranean magic of Valencia also support productive professional and personal interactions.The global character and reach of WASM in collaboration with the knowledge of the localSpanish Sleep Society brings the best of sleep medicine to Valencia.

Your involvement in this congress will be greatly valued. You may learn and also shareknowledge and skills that will advance sleep health around the world.

We hope that you’ll enjoy the science, learning, collegiality and social events at our world sleepconference in this lively city with great history, architecture, art and music. Sunny weathermatching the warm Spanish hospitality is nearly guaranteed. Welcome to Valencia! Warm Greetings,

Claudia Trenkwalder, MD Diego Garcia-Borreguero, MD, PhDProf. of Neurology, Director of the Sleep Research InstituteUniv. Goettingen/Kassel, Germany Madrid, SpainPresident PresidentWorld Association of Sleep Medicine Sociedad Española de Sueño

1

WASM Mission Statement

e fundamental mission of the WASM is to advance sleep health worldwide. WASM will fulfill this mission bypromoting and encouraging education, research and patient care throughout the world, particularly in those partsof the world where the practice of sleep medicine is less developed. WASM will act as a bridge between differentsleep societies and cultures, supporting and encouraging worldwide exchange of clinical information and scientificstudies related to sleep medicine. WASM will seek to encourage development and exchange of information forworld-wide and regional standards of practice for sleep medicine.

Because sleep health will be advanced by information, WASM will strive to advance knowledge about sleep and itsdisorders amongst both healthcare workers and the general public. is will include both education about themeans to “healthy sleep” as well as awareness of the adverse consequences of sleep dysfunction on the quality oflife and the health of an individual. To address the concerns of specific areas of the world, WASM will provide aforum for discussion and consideration of issues of relevance to particular regions and cultures.

To achieve these goals, WASM will act in several directions including but not limited to: WASM will shareinformation both through its scientific congresses and by organization of intercontinental and regional educationalcourses, symposia and workshops.

• WASM will encourage international and regional collaborative research, keeping in mind that the customs, cultures and priorities for sleep medicine may vary among different continents of the world.

• WASM will help develop national and regional sleep organizations where none exist.

• WASM will participate in preparation of reviews, guidelines, and standards emphasizing preventive measures for the practicing sleep specialists and taking into consideration regional customs, cultures and habits.

• WASM will collaborate with lay and professional sleep organizations in order to disseminate information about sleep health to the public and the profession.

• WASM will encourage collaboration between sleep clinicians and basic scientists to bring sleep medicine from the bench to the bedside, promoting sleep medicine around the globe. In particular WASM will encourage development of clinical methods appropriate for regional conditions and cultures.

• WASM will be open to establishing closer relationships with individuals and regional associations by offering memberships at a modest cost, taking into consideration local economic issues.

• WASM will maintain an official journal available at a modest fee to its members that will focus on the full range of sleep medicine around the world.

• WASM provides an International Sleep Specialist Board Examination in collaboration with local societies and issues a certification of expertise to individuals who qualify and/or pass the test.

2

Table of Contents

Committees ....................................................................................................4 - 5

WASM Board of Officers, Past Presidents, Staff ..............................................7

General Information......................................................................................8 - 10

Tourism and Hotels .....................................................................................11 - 12

Keynote Speakers and Wayne Hening Lecture ................................................13

Program at a Glance ...................................................................................14 - 17

Saturday Programs ....................................................................................20 - 25

Sunday Programs.......................................................................................26 - 36

Monday Programs ......................................................................................37 - 70

Tuesday Programs......................................................................................71 - 96

Wednesday Programs...............................................................................97 - 114

Poster Presentations................................................................................115 - 151

Floor Plan and Exhibition Floor Plan...................................................18 and 154

Sponsors ............................................................................................................155

Commercial Companies and Exhibitors...................................................156 -161

3

5th World Congress on Sleep Medicine Committees

Program Organizing CommitteeRichard Allen, co-chairJavier Puertas Cuesta, co-chairDiego Garcia BorregueroChristian GuilleminaultMax HirshkowitzCharles MorinAllan O’BryanVirend SomersClaudia Trenkwalder

Technologist CommitteeMaxime ElbazSimone de Lacy

Course CommitteeJosep MontserratRobert omas

Organizing SecretariatsWorld Association of Sleep Medicine Foundation3270 19th St. NW • Suite 109Rochester, MN 55901 USA

Honorary CommitteePresident:S.M. Don Juan Carlos I, King of Spain

Members:M. H. Sr. Don Alberto Fabra,President of Valencia Regional GovernmentExcma. Sra. Doña Ana Mato,Minister of Health of SpainExcma. Sra. Doña Rita Barberá,Mayor of Valencia CityH. Sr. Don Manuel Llombart,Vice-Minister of Health of Valencia Regional GovernmentIlmo Sr Don Alfonso Rus,President, Diputación of ValenciaExcmo. y Magfco. Sr. Don Esteban Morcillo,President of University of ValenciaExcmo. y Magfco. Sr. Don Jose Alfredo Peris,President of Catholic University of ValenciaExcmo. Sr. Don Santiago Grisolia,Secretary of Valencia Foundation for Advanced Research

Monica AndersenIsabelle ArnulfNajib AyasMichel BilliardBjorn BjorvatnDiane BoivinDouglas BradleyOliviero BruniMichael CheeRon ChervinYong-Won ChoSudhansu ChokrovertyKimberly CoteAntonio CulebrasYves DauvilliersValerie Cochen De CockJoseph De KoninckLuis de LeceaColin EspieLuigi Ferini-StrambiRaffaele FerriArturo GarayNadia Gosselin

Leja Dolenz GroseljReut GruberChristian GuilleminaultFang HanJan HednerRaphael HeinzerMax HirshkowitzBirgit HoglSeung Chul HongSeung Bong HongMagda HornyakYu-Shu HuangPoul JennumSharon KeenanJun KohyamaP. Vijaya KrishnanGert LammersDamien LegerLena LeissnerGeraldo Lorenzi-FilhoPierre-Hervé LuppiGeert MayerJacques Montplaisir

Charles MorinSona NevsimalovaF. Javier NietoJudith OwensTeresa PaivaSylvia PaezLiborio ParrinoMarkku PartinenRafael PelayoThomas PenzelPierre PhilipClaudio PodestaDalva PoyaresM. Antonia Quera-SalvaDaniel RodensteinLeon RosenthalCharles SamuelsJulia SantinToshiaki ShiomiGarima ShuklaMichael SmithKarel SonkaEva Svanborg

Nana TachibanaMehdi TaftiRobert ThomasEus Van SomerenClaudia TrenkwalderMarco VenegasMaria Pia VillaShelly WeissYun Kwok WingJuliane WinkelmannPhilis ZeeMarco Zucconi

WASM International Scientific Committee

4

National Scientific CommitteeFerran BarbéAntonio BenetóAntonio Bové-RibéFrancesca CañellasTeresa CanetPilar Cuartero-RiosIsabel De AndrésLuis Dominguez-OrtegaJoaquin Durán-CantollaEduard EstivillEnrique Fernández-JuliánDiego Garcia BorregueroSandra Giménez-BadiaEnriqueta Gómez-SiuranaNicolás González-MangadoAlex Iranzo

Jorge Iriarte-FrancoJuan Antonio MadridMiguel Angel Martínez-GarcíaJuan Fernando MasaMilagros Merino-AndreuJosep M. MontserratGonzalo Pin-ArboledasInmaculada PitarchFernando PrietoOdile RomeroTeresa SagalésMª Montserrat Sánchez-OrtuñoOscar Sans-CapdevilaJoan SantamariaJoaquin Terán

5

Conselleria de Sanitat Ajuntament de Valencia

Dirección General del Tráfico Diputación de Valencia

Sociedad Española de Neumología yCirugía Torácica (SEPAR)

Sociedad Española de OR y PatologíaCervico-facial (SEORL PCF)

Universitat de Valéncia Universidad Católica de Valencia

Hospital Universitario de la Ribera

The World Association of Sleep Medicine and theSpanish Sleep Society would like to thank the followinginstitutions, scientific societies and universities for theirsupport of the 5th World Congress on Sleep Medicine.

6

WASM Committees Chair and Co-Chairs

WASM Officers

PresidentClaudia Trenkwalder (Germany)

President-ElectRichard Allen (USA)

Past PresidentsChristian Guilleminault (USA)Markku Partinen (Finland)

Founding PresidentSudhansu Chokroverty (USA)

SecretaryMax Hirshkowitz (USA)

Assistant SecretaryCarlos Schenck (USA)

TreasurerBirgit Högl (Austria)

Assistant TreasurerAlex Iranzo (Spain)

Members at-Large

EuropeLuigi Ferini-Strambi (Italy) Markku Partinen (Finland)

North AmericaCharles Atwood (USA)Charles Morin (Canada)Robert Thomas (USA)

South AmericaSergio Tufik (Brazil)

AfricaLamia Afifi (Egypt)

AsiaSuresh Kumar (India)Nana Tachibana (Japan)

Australia-OceaniaKaren Waters (Australia)

Executive CommitteeClaudia Trenkwalder, PresidentRichard Allen, President-electMax Hirshkowitz, SecretaryBirgit Högl, TreasurerChristian Guilleminault, Past-President

Valencia 2013 CommitteeRichard AllenDiego Garcia-BorregueroJavier Puertas

World Sleep Day ® CommitteeAntonio CulebrasLiborio Parrino

Education CommitteeMax Hirshkowitz Birgit HöglSharon Keenan

Bylaws CommitteeChristian Guilleminault

Membership CommitteeLuigi Ferini-StrambiClaudia Trenkwalder

Scientific Affairs CommitteeSonia Ancoli-IsraelKingman Strohl

Nominating Committee Christian Guilleminault

Awards Committee Antonio CulebrasManvir Bhatia

Publication CommitteeChristian Guilleminault

World Association of Sleep Medicine

Paracelsus-Elena-KlinikKlinikstrasse 1634128 Kassel, GermanyCarmen Castells, WASM Administrative Secretaryemail: [email protected]

3270 19th Street NW, Suite 109Rochester, MN 55901 (U.S.A.)Allan O’Bryan, WASM Executive DirectorBryan Weiss, WASM Associate Directoremail: [email protected] • wasmonline.org

7

LocationPalacio de Congresos ValenciaAvda. Cortes Valencianas, nº 6046015 Valencia (Spain)Tel.: +34 96 317 94 00Fax: +34 96 317 94 01www.palcongres-vlc.com

On-site Registration HoursFriday, September 27, 2013: 7:00pm – 9:00pm*Saturday, September 28, 2013: 7:00am – 9:00pmSunday, September 29, 2013: 7:00am – 9:00pmMonday, September 30, 2013: 7:00am – 9:00pmTuesday, October 1, 2013: 7:00am – 9:00pmWednesday, October 2, 2013: 7:00am – 7:00pm*Registration on Friday is only for course attendees.

Registration materials (including badges, final programs,tickets, etc.) will be provided at the registrationcounter located in the Palacio de Congresos Valenciaconvention center.

Tickets are required for entry for Saturday and Sunday’spre-congress courses, Monday and Tuesday’s discussionsymposia, and Monday’s presidential dinner. Ticketscan be purchased online at www.wasmonline.org or atthe registration desk.

Guest PassesA registered attendee may elect to buy a guest pass at cost ofUS$100. Guest passes allow entrance to the exhibit hall,opening and closing cermonies, and industry sponsoredevents only. Guests are not permitted to attend any of thegeneral scientific sessions or ticketed sessions.

Badge IdentificationAll congress participants and guests must wear a WASMcongress badge. Badges allow entrance to the scientificsessions and access to the convention center. Yourcooperation with this policy is appreciated. Recycleyour badge holder after the congress by dropping it offat the registration desk area. Replacement badges canbe obtained at the registration desk for a fee.

Exhibits and Exhibiting HoursThe 5th World Congress on Sleep Medicine provides anopportunity for commercial companies to network,educate, and provide information about sleep relatedproducts and services. Exhibiting is open during thefollowing hours:

Monday, September 30, 2013: 11:00AM to 5:00PMTuesday, October 1, 2013: 11:00AM to 5:00PMWednesday, October 2, 2013: 11:00AM to 5:00PM

The exhibition areas will be closed and monitored bysecurity before 11:00AM and after 5:00PM. Exhibitorpersonnel are allowed in their booths one hour prior andone hour after exhibition times. We require that allexhibit booths be staffed only during the exhibit hours.

Speaker Ready Room Presenting speakers can use the Speaker Ready Room,located across from the registration desk (room #13),to upload their PowerPoint presentations, test software,and make changes and adjustments to their presentations.Speakers are required to upload their presentation in thespeaker ready room 12 hours prior to their session. Atechnician will be available to assist as needed.Speaker Ready Room hours are:

Friday, September 27, 2013: 7:00pm – 9:00pmSaturday, September 28, 2013: 7:00am – 5:00pmSunday, September 29, 2013: 7:00am – 5:00pmMonday, September 30, 2013: 7:00am – 9:00pmTuesday, October 1, 2013: 7:00am – 9:00pmWednesday, October 2, 2013: 7:00am – 1:00pm

Press RoomMembers of the press are encouraged to utilize theSpeaker Ready Room to work on their stories, internetaccess, and other resources that are needed.

WASM Membership BoothWASM membership records may be reviewed andpurchased at the WASM Booth #2. Details aboutWASM membership can be directed to registrationor WASM booth staff.

Recording Device PolicyNo recording devices, audio or visual, may be usedduring scientific sessions and congressactivities. Duplication, distribution, or excerpting of thisprogram, without the express written permissionof Mayo Clinic and the World Association of SleepMedicine, is strictly prohibited.

All of the proceedings of this program, including thepresentation of scientific papers, are intended forlimited publication only, and all property rights in thematerial presented, including common-law copyright,are expressly reserved by the Faculty, World Associationof Sleep Medicine, and/or Mayo Clinic. No statementof presentation made is to be regarded as dedicated tothe public domain. Any sound reproduction, transcriptor other use of the material presented at this CMEactivity without the permission of the World Associationof Sleep Medicine and Mayo Clinic is prohibited to thefull extent of common-law copyright in such material.

General Information

8

Cameras and recording devices are not allowed to be usedin the scientific meeting rooms at any time. Violation ofthis rule could result in removal from the WASM 5th

World Congress on Sleep Medicine congress and Palaciode Congresos Valencia convention center along with theconfiscation of the film and/or recording device.

Electronic DevicesPlease turn all electronic devices (cellular telephones,pagers, etc.) to silent mode. As a courtesy to thepresenters and other participants, phone calls shouldbe taken outside of the scientific sessions.

SeatingScientific session are filled on a first-come, first servedbasis. WASM along with the Program Committeereviewed the scientific sessions to anticipate demandto match the room size with expected seating. Occasionally, a talk will have higher demand thanexpected. Seating limits are strictly enforced by thePalacio de Congresos Valencia convention center andCity of Valencia. We encourage delegates to arriveearly for best possible seating.

Abstract SupplementAbstracts from the 5th World Congress on Sleep Medicineare published in an online abstract supplement of thejournal Sleep Medicine. To view a PDF of the abstracts,please visit: www.wasmcongress.com/abstracts/.

Continuing Medicine Education

Continuing Medical Education (CME) Credit forPhysicians Accreditation Statement

WASM 5th World Congresson Sleep Medicine congressactivities have been plannedand implemented in accordancewith the Essential Areas and policiesof the Accreditation Council for

Continuing Medical Education (ACCME) through thejoint sponsorship of Mayo Clinic College of Medicineand the World Association of Sleep Medicine. MayoClinic College of Medicine is accredited by the ACCMEto provide continuing medical education for physicians. The World Association of Sleep Medicine designatesthis live educational activity for a maximum of 43.5AMA PRA Category 1 Credits™. Physicians shouldclaim only the credit commensurate with the extentof their participation in the activity. The maximumnumber of credits that can be earned for thepre-congress courses is 16. The maximum numberof credits that can be earned for the congress is 27.5.

CME is awarded for pre-congress courses, keynotelectures, symposia sessions, oral presentations, discussionsymposium, and technologist workshops. A CME fee ofUS$10 is payable online at www.wasmonline.org or atthe registration desk to obtain CME documentation.

CME Record of AttendanceA CME Record of Attendance is provided to attendeeswho have paid the $10 CME fee at on-site registration.The Record of Attendance allows attendees to calculatetheir own credits of participation in the educational activity.

The total number of credits participants can earn per dayis noted on the Record of Attendance form. Below eachday is a line to record the actual number of credits duringwhich you participated in the educational activity. It isrecommended that you record your actual credits daily asyou proceed through the CME activity.

Upon conclusion of the CME activity, please total thenumber of credits you have recorded on the top half of theform, sign it, and return it to the registration desk.

The bottom half of the form represents your Record ofAttendance, which you must retain for your records.Please make sure the number of credits claimed in bothsections coincide. No other documentation isprovided to you after this CME activity.

The CME Record of Attendance can be used forrequesting credits in accordance with state licensingboards, specialty societies, or other professional associations.Please note this CME Record of Attendance is differentthan the WASM Congress Certificate which all attendeesreceive in their registration packet.

CME Activity Evaluation

The overall CME activity evaluation will be emailedfollowing the activity to the email address that wasprovided when you registered. The CME activityevaluation is brief and will only take a few minutesto complete.

Faculty evaluation forms will be provided electronicallyvia email to registrants. Completed faculty evaluationforms should be completed online at the conclusion ofthe CME activity and within one week of the congress. Your feedback is very important to us and will be usedfor planning future programs, as well as identifyingfaculty strengths and opportunity for growth.

General Information

9

Opening Ceremony

Join us for the Opening Ceremony of the 5th WorldCongress on Sleep Medicine!

Sunday, September 29, 20137:00pm to 10:00pmPalau de les Arts Reina Sofia (www.lesarts.com)

The Opening Ceremony will take place at the Palaude les Arts, a world class venue in the City of Arts andSciences. Enjoy a selection of Opera arias and Zarzuelaoffered by Centro de Perfeccionamiento 'PlácidoDomingo' de Valencia.

Awards will be presented to the following individualsand sleep societies:

Christian Guilleminault Award:Diego Robles Mazzotti (Brazil)Prevalence and correlates for sleep complaints in olderadults in low and middle income countries: a 10/66Dementia Research Group study

Lugaresi Award:Paresh Zanzmera (India)Effect of successful epilepsy surgery on subjective andobjective sleep parameters – a prospective study

World Sleep Day – Distinguished Activities Awards:2012 György G. Németh (Hungary) 2012 Spanish Sleep Society – Teresa Canet (Spain)2013 Portuguese Sleep Association -2013 Marta Gonçalves (Portugal)2013 Bolivian Society of Internal Medicine,2013 chapter La Paz - Ximena Alvarado (Bolivia)2013 CENC – Sleep Medicine Center and2013 Professor Teresa Paiva (Portugal)

Young Investigators:Yo-El Ju (USA)Lena Tholfsen (Norway)Jason Valerio (Canada)Nicholas-Tiberio Economou (Greece)Alia Mansour (Egypt)Claudio Liguori (Italy)Preeti Devnani (India)

Chilean Sleep Society Abstract Awards:Andrea ZunigaMaria Jose Elso

After the music and awards program we will retireoutside to network while enjoying wine, appetizers andfireworks. More than 20 gourmet tapas appetizers andSpanish red and white wine and other beverages will beavailable as well. The cost of this event is included inyour registration.

Transportation will be provided from the congressvenue area to the Palau de les Arts. Buses will runfrom 5:00pm to 7:00pm and return from 10:00pmto 11:00pm.

Presidents’ Dinner and Reception

Monday, September 30, 20138:30pm to 11:00pmBalneario Las Arenas Resort

Come enjoy the beautiful beach view, gourmet cuisineand the classical Spanish guitar music and Spanishconcert of Ricardo Ramirez-Aranda.

The cost of this event is $150.

Transportation will be provided from the conventioncenter to the Palau de les Arts. Buses will run from8:10pm to 8:40pm and return when the dinner isconcluded.

Closing Ceremony

Wednesday, October 2, 20137:00pm to 7:45pmAuditorium 1

Join us for a final presentation as we acknowledge thehard work of the 2013 Program Committee and listento a special presentation from the 2015 ProgramCommittee co-chairs. Information will be sharedabout the 6th World Congress on Sleep Medicine heldMarch 21-25, 2015 in Seoul, Korea. Afterwards, joinus for a toast and a last chance to say good-bye toyour colleagues.

General Information

10

Discovering Valencia is a true pleasure for the senses. The legacy left by the cultures and civilizations which havereached these shores in the past still remains alive in the city’s monuments and streets, not to mention in itspeople’s hearts. Valencia is a city that never sleeps. It has a rich cultural life with festivals, concerts, shows andexhibitions year round. You may experience the Valencian culture by joining one of the following tour optionspresented by Kenes.

For more information please visit the Kenes booth in the registration area. Kenes is the official organizer of local toursfor the 5th World Congress on Sleep Medicine. You may also send an email to [email protected] or visit www.wasmcongress.com.

Tourism and Hotels

11

Option A:Old Town of Valenciaand Oceanografico

9:30am to 5:00pm50 €

Option B:Albufera Natural Park,Fallero Museum andPort America’s Cupand F1 Street Circuit

9:30am to 5:00pm35 €

Option C:Requena, Wine withD.O. and the WineRoute

10:00am to 5:00pm 45 €

Option D:Alboraya Horchatawith D.O. and LladróPorcelein Factory

9:30am to 1:30pm35 €

CME Registration RequiredPlease complete the following steps to receive CME credit:

1. Purchase the $10 CME fee at www.wasmonline.org or at registration desk.

2. Obtain the CME Record of Attendance at registration desk.

3. Turn in CME Record of Attendance once completed to registration desk or2. email to [email protected] by October 3, 2013.

4. Complete the faculty, session, and congress evaluations. Evaluations will be2. collected electronically and sent via e-mail each day.

For more information please visit the Kenes booth in the registration area. Kenes is the official organizer of thehotel accommodations for the 5th World Congress on Sleep Medicine. You may also send an email [email protected] or visit www.wasmcongress.com.

Map of Valencia

Hotels

12

Balneario Las Arenas ResortC/ Eugenia Viñes, 22-24en.hotel-lasarenas.com

The Westin ValenciaAmadeo de Saboya 16www.westinvalencia.com/en

MELIÄ Valencia Palacio de CongresosAvenida Cortes Valencianas 52www.melia.com

Eurostars Gran ValenciaVALLE DE AYORA No. 3www.eurostarsgranvalencia.com

Sercotel Sorolla PalaceAvda. de las Cortes Valencianas, 58en.hotelsorollapalace.com

NH CenterRicardo Micó, 1.46009 Valenciawww.nh-hotels.com

Ibis ValenciaCalle Valle de Ayora, 5www.ibis.com

NH Jardines del TuriaPintor Velázquez s/n. 46100 Burjasotwww.nh-hotels.com

Hotel Vora FiraCullera 67www.hotelvorafira.es

Keynote Speakers

Virend Somers, MD, PhD (USA)Mayo ClinicSleep, Death and the HeartMonday, September 30, 2013 • 9:00am - 10:00am • Auditorium 1

Göran Hajak, MD, PhD (Germany) University of Erlangen, Social Foundation Bamberg

Emerging Treatments for InsomniaMonday, September 30, 2013 • 3:30pm - 4:30pm • Auditorium 1

Phyllis Zee, MD (USA)Northwestern University, Feinberg School of Medicine Circadian Disorders and Associated RisksTuesday, October 1, 2013 • 9:00am - 10:00am • Auditorium 1

Pierre-Hervé Luppi, PhD (France)Centre National de la Recherche, ScientifiqueNeurobiology of SleepTuesday, October 1, 2013 • 3:30pm - 4:30pm • Auditorium 1

Demin Han, MD, PhD (China)Chinese Medical Doctor Association OtolaryngologySurgery of Obstructive Sleep ApneaWednesday, October 2, 2013 • 9:00am - 10:00am • Auditorium 1

Mehdi Tafti, PhD (Switzerland)University of LausanneGenetics and Epigenetics of Sleep DisordersWednesday, October 2, 2013 • 3:30pm - 4:30pm • Auditorium 1

Wayne Hening Memorial Lecture

Isabelle Arnulf, MD, PhD (France)Pierre and Marie Curie University, Pitié-Salpêtrière Hospital Neurodegeneration and SleepWednesday, October 2, 2013 • 1:40pm - 2:40pm • Auditorium 1

13

14

Program at a GlanceFriday, September 27, 2013

_____________________________________________________________________________________________________________________5:00pm - 10:00pm On-Site Registration_____________________________________________________________________________________________________________________

Saturday, September 28, 2013_____________________________________________________________________________________________________________________7:00am - 9:00am On-Site Registration

8:00am - 6:45pm International RLS Study Group Annual Meeting I Committee Room 1_____________________________________________________________________________________________________________________8:00am - 5:00pm Course 1: Dental reconfiguration and reconstruction for SDB management _____________________________________________________________________________________________________________________8:00am - 12:00pm Course 3: Medical treatment of SDB – beyond nasal positive pressure_____________________________________________________________________________________________________________________1:00pm - 5:00pm Course 4: Circadian dysfunction in health and disease

Sunday, September 29, 2013

7:00am - 9:00am On-Site Registration

8:00am - 5:00pm Course 5: Advances in the management of pediatric sleep disorders___________________________________________________________________________________________

8:00am - 12:00pm Course 6: Restless legs and motor activation during sleep___________________________________________________________________________________________Course 7: Insomnia disorder: From epidemiology to dissemination of

evidence-based therapeutic approaches_____________________________________________________________________________________________________________________8:30am - 4:30pm Spanish Sleep Society General Meeting I Sercotel Hotel_____________________________________________________________________________________________________________________9:00am - 5:00pm Technologist Meeting I Committee Rooms 1 and 2_____________________________________________________________________________________________________________________1:00pm - 5:00pm: Course 8: Update in sleep medicine technology

___________________________________________________________________________________________Course 9: Sleep and the heart ___________________________________________________________________________________________Course 10: Recording and scoring of movement disorders of sleep and RBD

7:00pm - 8:30pm Opening Ceremony I Palau de les Arts Reina Sofia

Monday, September 30, 2013_____________________________________________________________________________________________________________________7:00am - 9:00am On-Site Registration_____________________________________________________________________________________________________________________8:30am - 9:00am Announcements

9:00am - 10:00am Keynote: Sleep, Death and the Heart Virend Somers I Auditorium 1

10:00am - 11:30am S1: New Diagnostic Technologies for Sleep Disordered Breathing I Auditorium 2___________________________________________________________________________________________S2: Cognitive Behavioral Therapy for Insomnia (CBT-I): Knowledge Transfer

and Treatment Dissemination I Multipurpose Room 1___________________________________________________________________________________________S3: Converging Understanding of the Biology of Restless Legs Syndrome I Auditorium 3___________________________________________________________________________________________S4: The Autonomic Nervous System and Sleep in Human Narcolepsy: Do Patients Have an

Increased Cardiovascular Risk? I Committee Rooms 1 and 2

11:30am - 12:00pm Coffee Break and Exhibition

12:00pm - 1:30pm S5: The Role of Sleep in Emotional Memory Processing and Development or

Prevention of PTSD I Multipurpose Room 1___________________________________________________________________________________________S6: Sleep Disorders and Cancer I Auditorium 2___________________________________________________________________________________________S7: Brain Imaging Studies in Sleep Disorders and Sleep Deprivation I Auditorium 1___________________________________________________________________________________________O-01: Aging and Developmental Issues I Committee Room 1___________________________________________________________________________________________O-02: Sleep Breathing Disorders I Audiorium 3___________________________________________________________________________________________Technologist Program: W1 ADULT PSG Masterclass: Sleep Montage Hook-up;

Sleep Staging and Event Scoring I Committee Rooms 3 and 4_____________________________________________________________________________________________________________________1:40pm - 3:10pm Industry Symposium: Emerging Strategies in Sleep Disorders I Auditorium 1

___________________________________________________________________________________________Industry Symposium: Advances in PAP Therapy I Multipurpose Room 1

15

Program at a Glance

3:10pm - 3:30pm Coffee Break and Exhibition

3:30pm - 4:30pm Keynote: Emerging Treatments for Insomnia Göran Hajak I Auditorium 1_________4:30pm - 5:30pm O-03: Chronobiology & Circadian Disorders I Auditorium 3

___________________________________________________________________________________________O-04: Insomnia Mechanisms I Multipurpose Room 1___________________________________________________________________________________________O-05: Cognition and RBD I Committee Rooms 1 and 2

_____________________________________________________________________________________________________________________5:30pm - 7:00pm S8: Obstructive Sleep Apnea, Motor Vehicles Accidents and Driving

License Regulations I Auditorium 1___________________________________________________________________________________________S9: Neurocognition and Behavior, Sleep Disturbance and Sleep Disordered Breathing I Auditorium 2___________________________________________________________________________________________S10: Identification of the Neuronal Network Regulating the Sleep-waking

Cycle: A Never Ending Story? I Auditorium 3___________________________________________________________________________________________S11: Innovations in Sleep Apnea Management I Multipurpose Room 1___________________________________________________________________________________________S12: Sleep and Circadian Rhythm Abnormalities in Mood Disorders I Committee Rooms 1 and 2___________________________________________________________________________________________Technologist Program: W2 PAED PSG Masterclass: Hook-up; Sleep Staging and Event Scoring;

Top Tips for Compliance I Committee Rooms 3 and 4_____________________________________________________________________________________________________________________7:00pm - 8:00pm DS-M-01: Sleep Apnea and the Risk of Stroke* I Committee Room 1

___________________________________________________________________________________________DS-M-02: Sleep in Traumatic Brain Injury: Current Knowledge and Future Directions*

Committee Room 2___________________________________________________________________________________________DS-M-03: Pharmaco-Sleep: the Assessment of Drug Effects on Human Sleep* I Committee Room 3___________________________________________________________________________________________DS-M-04: Work, School, Sleep, and Occupational Health and Safety in Adolescents and Young

Adults* I Committee Room 4___________________________________________________________________________________________DS-M-05: Improving the Scoring of REM Sleep Without Atonia and of Muscle Activity During

REM Sleep* I Committee Room 5___________________________________________________________________________________________DS-M-06: Is There a Role for Surgery in the Management of Obstructive Sleep Apnea?*

Committee Room 6___________________________________________________________________________________________DS-M-07: How to Assess and Treat Sleep Disorders in Pregnant Women* I Committee Room 7___________________________________________________________________________________________DS-M-08: Periodic Limb Movements under CPAP in Obstructive Sleep Apnea Syndrome*

Committee Room 8___________________________________________________________________________________________DS-M-09: Abordaje del SAHS desde la perspectiva del ORL/Clinical management of OSA:

The ENT viewpoint* I Committee Room 9___________________________________________________________________________________________DS-M-10: Recent Updates in the Diagnosis of Insomnia – DSM5 and ICSD-3: Implications for

Research and Clinical Practice* I Auditorium 3___________________________________________________________________________________________DS-M-11: Movement Disorders and Sleep - A Video Seminar* I Multipurpose Room 1

* Ticket required - purchase at registration desk

8:30pm to 11:00pm Presidents’ Dinner and Reception* I Balneario Las Arenas Resort

Tuesday, October 1, 2013

7:00am - 9:00am On-Site Registration_____________________________________________________________________________________________________________________8:30am - 9:00am Announcements

9:00am - 10:00am Keynote: Circadian Disorders and Associated Risks Phyllis Zee I Auditorium 1

10:00am - 11:30am S13: Sleep, Circadian Rhythms and Brain Health in Aging I Auditorium 2___________________________________________________________________________________________S14: Explaining Differences in Epidemiology of Sleep Disorders Across the World:

The Case of SDB and RLS I Auditorium 3___________________________________________________________________________________________S15: Pregnancy and Sleep I Committee Rooms 1 and 2___________________________________________________________________________________________S16: Interpreting and Evaluating Parasomnias: New Perspectives I Multipurpose Room 1


Program at a Glance

16

Tuesday, October 1, 2013 continued

12:00pm - 1:30pm S17: Novel Insights into Cardiometabolic Mechanisms of OSA I Auditorium 2___________________________________________________________________________________________S18: Those Comorbidities that Invade the Night:Treating Sleep Problems

in Patients with Psychiatric Disorders I Multipurpose Room 1___________________________________________________________________________________________O-06: Parasomnia, Neural Plasticity, and Neurological Disorders Committee Room 1___________________________________________________________________________________________O-07: Sleep Breathing Disorders I Auditorium 3___________________________________________________________________________________________Technologist Program: W3 Performing and Interpreting the MSCT I Committee Rooms 3 and 4

_____________________________________________________________________________________________________________________

1:40pm - 3:10pm Industry Symposium Transcutaneous CO2 Monitoring and its Role in Sleep Medicine

Multipurpose Room 1___________________________________________________________________________________________Industry Symposium: Time to Break the RLS/WED Treatment Paradigm I Auditorium 1


3:30pm - 4:30pm Keynote: Neurobiology of Sleep Pierre-Hervé Luppi I Auditorium 1

4:30pm - 5:30pm O-08: Insomnia Treatment I Multipurpose Room 1___________________________________________________________________________________________O-09: Neurobiology of RLS/PLMS I Auditorium 3___________________________________________________________________________________________O-10: Sleep Breathing Disorders I Committee Rooms 1 and 2

_____________________________________________________________________________________________________________________5:30pm - 7:00pm S19: Pain, Opioids and Sleep Breathing Disorder: An Interaction to Manage I Auditorium 2

___________________________________________________________________________________________S20: Sleep and Glucose Metabolism I Auditorium 3 ___________________________________________________________________________________________S21: Sleep Apnea and The Adipocyte: Trends and Treatments I Multipurpose Room 1___________________________________________________________________________________________Technologist Program W4 CPAP Masterclass: Mask Fitting, Compliance Issues, Titration

Committee Rooms 3 and 4___________________________________________________________________________________________O-12: Narcolepsy and Excessive Daytime Sleepiness I Committee Room 1

_____________________________________________________________________________________________________________________7:00pm - 8:00pm DS-T-01: Psychology and Insomnia* I Committee Room 1

___________________________________________________________________________________________DS-T-02: Sleep Habits and Sleep Environment in Rural Living and Native Communities of

South America* I Committee Room 2___________________________________________________________________________________________DS-T-03: Quality Assurance in Sleep Medicine* I Committee Room 3___________________________________________________________________________________________DS-T-04: Unusual Nocturnal Behavior in Pediatrics -Differentiating Seizures from Non-Epileptic

Events: A Video-Case Discussion* I Committee Room 4___________________________________________________________________________________________DS-T-05: Women Are From Venus and Men Are From Mars* I Committee Room 5___________________________________________________________________________________________DS-T-06: Can We Prevent OSA?* I Committee Room 6___________________________________________________________________________________________DS-T-07: Chronobiology/Circadian Disorders* I Committee Room 7___________________________________________________________________________________________DS-T-08: Sleep Bruxism : Diagnostic and Therapeutic Approaches From a Multidisciplinary

Point of View* I Committee Room 8___________________________________________________________________________________________DS-T-09: Emerging India and Its Sleep Issues* I Committee Room 9___________________________________________________________________________________________DS-T-10: Controversies in RLS with PLMs: Significance, Sleep, CV Risk** I Auditorium 3

*Ticket required - purchase at registration desk **Free symposia - pick up your ticket at registration desk_____________________________________________________________________________________________________________________8:30pm to 9:30pm WASM Member Meeting I Multipurpose Room 1

Wednesday, October 2, 2013

7:00am - 7:00pm On-Site Registration_____________________________________________________________________________________________________________________8:30am - 9:00am Announcements

9:00am - 10:00am Keynote: Surgery of Obstructive Sleep Apnea Demin Han, MD, PhD I Auditorium 1

10:00am - 11:30am S24: The Challenges for Defining Normative Data for Sleep Disordered Breathing Across Lifespan I Auditorium 2

17

Program at a Glance

Wednesday, October 2, 2013 continued

S25: Hypocretin/orexin as a Therapeutic Target for Sleep Disorders I Auditorium 3___________________________________________________________________________________________S26: Spinal Mechanisms in RLS I Committee Rooms 1 and 2___________________________________________________________________________________________S27: Idiopathic Hypersomnia: Past, Present and Future I Multipurpose Room 1


12:00pm - 1:30pm S28: Dental Management of OSA in Adults and Children I Multipurpose Room 1___________________________________________________________________________________________S29: Narcolepsy Update I Auditorium 2___________________________________________________________________________________________S35: Young Investigator Symposium: Sleep and Neurodegeneration I Auditorium 1___________________________________________________________________________________________O-11: Pediatrics SDB I Auditorium 3___________________________________________________________________________________________Technologist Program: W5 REM and Slow Wave Parasomnias: Video and PSG Identification

Committee Rooms 3 and 4_____________________________________________________________________________________________________________________1:40pm - 3:10pm S34: Joint Symposia with WASM and IFCN I Auditorium 2

1:40pm - 2:40pm Hening Memorial Lecture: Neurodegeneration and Sleep Isabelle Arnulf I Auditorium 1


3:30pm - 4:30pm Keynote: Genetics and Epigenetics of Sleep Disorders Mehdi Tafti, PhD I Auditorium 1

4:30pm - 5:30pm O-13: Parasomnia and Psychiatric Disorders I Committee Room 1___________________________________________________________________________________________O-14: RLS/PLMS: Natural Course, Risk Factors and Health I Auditorium 3___________________________________________________________________________________________O-15: Sleep and Health I Multipurpose Room 1

_____________________________________________________________________________________________________________________5:30pm - 7:00pm S30: Using the Dim Light Melatonin Onset (DLMO) to Evaluate Circadian Timing in Clinical

Populations I Multipurpose Room 1___________________________________________________________________________________________S31: Sleep Microstructure, Arousals and Autonomic Functions: New Insights and Clinical

Implications I Auditorium 3___________________________________________________________________________________________S32: Obesity and Sleep Apnea in Children I Auditorium 2___________________________________________________________________________________________S33: Joint Symposia of WASM and SEPAR I Auditorium 1___________________________________________________________________________________________Technologist Program: W6 Actigraphy Masterclass:Equipment, Set up, Research Usage, Clinical

Interpretation I Committee Rooms 3 and 4___________________________________________________________________________________________O-16: Drugs, Technology, and Insufficent Sleep I Committee Room 1

7:00pm - 7:45pm Closing Ceremony I Auditorium 2

Second Floor:- Pre-Congress Courses- Poster Presentations- Discussion Symposia- Technologist Program- Committee Rooms 1-7

First Floor:- Pre-Congress Courses- Symposia- Discussion Symposia- Committee Rooms 8 and 9

Ground Floor:- Exhibitor Booths- Registration- Closing Ceremony- Industry Symposia- Keynote Lectures- Symposia- Discussion Symposia- Co!ee Breaks- WASM Member Lounge- WASM Membership Info- Speaker Ready Room

89

12

6

543

7Posters

Palacio de Congresos Valencia - Floor Plan

18

19

SaturdaySchedule at a Glance • Saturday, September 28, 2013_________________________________________________________________Registration 7:00am - 9:00pm_________________________________________________________________Course 1: Dental reconfiguration and reconstruction for SDB management 8:00am - 5:00pm_________________________________________________________________Course 3: Medical treatment of SDB – beyond nasal positive pressure 8:00am - 12:00pm_________________________________________________________________International RLS Study Group Meeting 9:00am - 6:45pm_________________________________________________________________Course 4: Circadian dysfunction in health and disease 1:00pm - 5:00pm_________________________________________________________________

20

Saturday, September 28, 2013

Course 1: Dental Reconfiguration and Reconstruction forSDB Management8:00am to 5:00pm • Committee Room 6

Chair:Gilles Lavigne (Canada)

Speakers:Raphael Heinzer (Switzerland), Stacey Quo (USA), Marc Blumen (France), Marie Marklund (Sweden),Gilles Lavigne (Canada), Christian Guilleminault (USA), Bernard Fleury (France)

Summary:

is course will provide a comprehensive and integrated management approach of orodental approaches to sleep apneamanagement. Topics will span the normal and abnormal development of the face and dental structures, measurementapproaches including radiology, device biomechanics, devices, rapid maxillary expansion, distraction osteogenesis andrelated procedures, clinical outcomes and the role for a multi-disciplinary management of challenging cases. e coursewill also review the diagnostic and polysomnographic criteria for sleep-disordered-breathing in adults and children,and review the state of the art approaches when using dental devices as treatment of OSA, and results of follow-up.Maxillo-mandibular advancement in teen-agers and adults, and an update on myofunctional therapy will be provided.

Overview on sleep disordered breathing (SDB) and dentistry roleRaphael Heinzer (Switzerland)

Recognition of children and young adult with SDB in dental medicineStacey Quo (USA)

Craniofacial growth and SDB riskMarc Blumen (France)

Orthodontic treatment in children and adult with SDB: indications and risksMarie Marklund (Sweden)

Do SDB and sleep bruxism have a link? A clinical impression or supported by evidencesGilles Lavigne (Canada)

Myofunctional re-education as an interceptive alternative for SDB prevention and managementChristian Guilleminault (USA)

Advances in oral appliances use and misuses: An updateBernard Fleury (France)

Announcement:Course 2 cancelled

21

SA

TU

RD

AY


Course 3: Medical Treatment of SDB – Beyond NasalPositive Pressure8:00am to 12:00pm • Committee Room 8

Chair:Robert Thomas (USA)

Speakers:David Rapoport (USA), Jed Black (USA), Carmen Monasterio Ponsa (Spain), Robert omas (USA)

Summary:e course will discuss options for sleep apnea management outside traditional mask-positive pressure approachesbut not including reconstructive surgery or oral appliances. Topics that should be covered include nasal expiratoryresistance, hypoglossal nerve stimulation, weight loss including bariatric surgery, and gas/pharmacological optionsbased on sleep apnea phenotyping for arousability and chemoreflex instability.

Nasal expiratory positive pressureDavid Rapoport (USA)

Oral pressure (Winx)Jed Black (USA)

Body mass regulation for sleep apnea treatmentCarmen Monasterio Ponsa (Spain)

Gasses and drugsRobert omas (USA)

22

SA

TU

RD

AY


Course 4: Circadian Dysfunction in Health and Disease1:00pm to 5:00pm • Committee Room 4

Co-Chairs:Till Roenneberg (Germany), Phyllis C. Zee (USA)

Speakers:Till Roenneberg (Germany), Phyllis C. Zee (USA), Diane Boivin (Canada), Robert Thomas (USA)

Summary:Following an update on circadian phototransduction, the role of the circadian system in whole-body regulation of coreprocesses (including metabolism, endocrine and cardiovascular regulation) will be discussed. Next, an update on shiftwork and counter measures will be presented, followed by performance in conditions requiring sustained attention andexecutive function (including transportation, health care personnel, and military operations). Methods to assess sleepdebt and prediction of performance deterioration will be discussed.

1:00pm - 1:10pmIntroductionTill Roenneberg (Germany)

1:10pm - 1:40pmRegulation of circadian rhythms: sleep and beyondPhyllis C. Zee (USA)

1:40pm - 2:10pmSleep and circadian regulation of metabolismPhyllis C. Zee (USA)

2:10pm - 2:45pmCircadian rhythm influences on physiology and psychologyDiane Boivin (Canada)

2:45pm - 2:55pmBreak

2:55pm - 3:35pmThe consequences of living against the circadian clockTill Roenneberg (Germany)

3:35pm - 4:15pmCircadian disorders in diseasePhyllis C. Zee (USA)

4:15pm - 4:50pmChallenging circadian rhythm disorder casesRobert Thomas (USA)

4:50pm - 5:00pmPanel discussion and questions

23

SA

TU

RD

AY


International RLS Study Group Annual Meeting8:00am to 6:45pm • Committee Room 1

8:00:am - 9:00amRegistration and networking

9:00am - 9:15amWelcome & introduction

9:15am ‐ 12:15pm Animal models in RLS(each 15 min talk + 5 min discussion)

9:15am Challenge and problems of RLS animal model R. Allen9:35am Natural genetic variation murine iron deficiency model C. Earley9:55am Periodic limb movements in rodents M. Manconi10:15am Drosophila homolog CG1826 (dBTBD9) A. Freeman

10:35am Coffee break

10:55am A11 lesions in rodents A. M. Esteves11:15am Mouse and worm models of RLS: focus on BTBD9 Y. Li11:35am Autonomic nervous system model B. Koo11:55am PLM model: pathways and glutamate mechanism Y. Lai

12:15 Lunch

1:15pm ‐ 2:45pm Wayne Hening YI Awards(each 8 min talk + 3 min discussion)

1:15pm Neurophysiological evaluation of spinal excitability in patients affected by primitiveRestless Legs Syndrome Patrizia Congiu

1:26pm PTPRD Expression regulates sleep consolidation in drosophila Amanda Freeman1:37pm Restless legs syndrome and its association with poor sleep quality, mood disorders,

and one year cardiovascular mortality in patients on chronic dialysis Ali Gholamrezaei1:48pm Reflex testing reveals circadian variation of spinal excitability in restless

legs syndrome patients Samantha Kerr1:59pm Restless leg syndrome in young children with orofacial cleft Marta Moraleda‐Cibrián2:10pm Periodic leg movements in spinal cord injury: Evaluation of arousals and

treatment effect Aaro Salminen2:21pm Multimorbidity and the risk of restless legs syndrome in two prospective

cohort studies Andras Szentkiralyi2:32pm Polysomnographic evaluation of augmentation in patients with restless

legs syndrome Irina Zavalko

2:45pm Are drug holidays needed? C. Earley & C. Trenkwalder

3:15pm Coffee break

3:35pm PLM and apnea S. Fulda

3:55pm The economic cost of RLS. A study in Denmark P. Jennum

4:15pm Long-term studies in RLS: Are active comparators dispensable? R. Allen, DGB, & R.Kohnen

4:45pm Future studies sponsored by the IRLSSG D. Garcia‐Borreguero

5:00pm Final remarks - end of scientific meeting

5:15pm ‐ 6:45pm IRLSSG Business Meeting - open to IRLSSG membership

8:00pm - 8:30pm Reception

8:30pm - 9:30pm Dinner

9:30pm - Presentation of Awards

24

SA

TU

RD

AY

25

SA

TU

RD

AY

SundaySchedule at a Glance • Sunday, September 29, 2013_________________________________________________________________Registration 7:00am - 9:00pm_________________________________________________________________Course 5: Advances in the management of pediatric sleep disorders 8:00am - 5:00pm_________________________________________________________________Course 6: Restless legs and motor activation during sleep 8:00am - 12:00pm_________________________________________________________________Course 7: Insomnia disorder: From epidemiology to dissemination of

evidence-based therapeutic approaches 8:00am - 12:00pm_________________________________________________________________Spanish Sleep Society Meeting 8:30am - 4:30pm_________________________________________________________________Technologist Progam 9:00am - 5:00pm_________________________________________________________________Course 8: Update in sleep medicine technology 1:00pm - 5:00pm_________________________________________________________________Course 9: Sleep and the heart 1:00pm - 5:00pm_________________________________________________________________Course 10: Recording and scoring of movement disorders of sleep and RBD 1:00pm - 5:00pm_________________________________________________________________Opening Ceremony 7:00pm -10:00pm_________________________________________________________________

26

SU

ND

AY


Course 5: Advances in the Management of Pediatric Sleep Disorders8:00am to 5:00pm • Committee Room 8

Co-Chairs:Shelly Weiss (Canada), Daniel Ng (Hong Kong)Speakers:Rosana Cardoso Alves (Brazil), Oliviero Bruni (Italy) Christian Guilleminault (USA); Sanjeev Kothare (USA); Oscar Sans Capdevila (Spain) Daniel Ng (Hong Kong); Shelly Weiss (Canada) Objectives:• Review sleep disordered breathing that occur from neonates to adolescence, and understand their management strategies.• Understand the differences in the interpretation of neonatal vs pediatric vs. adult polysomnography.• Understand the role of pharmacotherapy in the treatment of pediatric insomnia.• Review and update knowledge on pediatric sleep disorders in diverse medical conditions (mental health disorders, epilepsy) • and its impact on neurobehaviorSummary:The course will cover the spectrum of pediatric sleep disorders, with a focus on what is unique in children. Topics willinclude (sleep abnormalities and management in) epilepsy, neuromuscular disorders, developmental disorders, and disordersof attention. Other topics will include the normal development of sleep, sleep apnea including systemic effects and the possiblerole of home testing is resource poor environments. Pediatric aspects of polysomnography will be discussed.8:00am - 8:15amIntroduction

8:15am - 12:00pmPediatric Sleep Disordered Breathing

Polysomnography in Paediatrics: Update on scoring pediatric sleep studiesOscar Sans Capdevila (Spain)Neonatal Sleep Polysomnography and endoscopy: Indications and interpretation strategiesDaniel Ng (Hong Kong)Evaluation of sleep-disordered breathing in children; interpreting data from nasal resistance and flow limitation measuresChristian Guilleminault (USA)Panel: Case discussionsThe panel will present cases related to sleep disordered breathing in pediatrics including review of the limitation of adenotonsillectomy, home vs laboratory investigations, issues related to home ventilation and SDB in children with neuromuscular disorders. Oscar Sans Capdevila (Spain), Daniel Ng (Hong Kong), Christian Guilleminault (USA)

12:00pm - 1:15pmLunch

1:15pm - 5:00pmSleep, Insomnia and Daytime Sleepiness

Treatment of insomnia in typically developing infants and childrenOliviero Bruni (Italy)Treatment of insomnia in children and teenagers with Autism Spectrum Disorders- Behavioural and pharmacologic strategiesShelly Weiss (Canada)Pediatric Sleep and Epilepsy- Update on the evaluation and management of children withnocturnal seizuresSanjeev Kothare (USA)Excessive daytime sleepiness and narcolepsyRosana Cardoso Alves (Brazil)Panel: Case discussionsThe panel will present cases related to insomnia in children with neurologic and mental health disorders, including ADHD, depression, epilepsy, and headaches. Oliviero Bruni (Italy), Shelly Weiss (Canada), Sanjeev Kothare (USA)

Note: Participants who register for this course will have the opportunity (optional) to submit pediatric cases for the panel topresent and discuss.

27

SU

ND

AY


Course 6: Restless Legs and Motor Activation During Sleep8:00am to 12:00pm • Committee Room 6

Chair:Richard P Allen (USA)

Speakers:Diego Garcia Borreguero (Spain), Stephany Fulda (Germany), Raffaele Ferri (Italy),Richard P Allen (USA), Christopher Earley (USA), Arthur Walters (USA)

Objectives:• How and when to use the expanded treatment options for RLS particularly for iron (oral and IV), opioids and drug holidays •How to plan treatments to reduce RLS augmentation risks•How to change or adjust RLS medications•Measurement options for periodic limb movements using physiological recordings or ambulatory leg activity monitoring•Methods to evaluate daytime symptoms of RLS including the use of the multiple suggested immobilization test

Summary:The course will provide a targeted update. Topics covered will include augmentation, new medical options, epidemiologyand diagnostic approaches / criteria including the Suggested Immobilization Test and neuroimaging, and instrumentation.Speakers will review and update the relevant basic science so that recommendations for practice are grounded on the bestcurrent science.

Introduction

Expanded evaluation methods:

Methods to evaluate day time symptomsDiego Garcia Borreguero (Spain)

Measuring periodic leg movements on the polysomnogram: Current standards and problemsStephany Fulda (Germany)

Measuring periodicity of leg movementsRaffaele Ferri (Italy)

Expanded treatment options:

Home activity monitoring of periodic leg movementsRichard P Allen (USA)

Reducing augmentation risks: Long term treatment guidelinesDiego Garcia Borreguero (Spain)

Iron treatments: oral and IV Christopher Earley (USA)

Opioid treatments: Options to considerArthur Walters (USA)

Drug holidaysRichard P Allen, PhD (USA)

Responding to augmentation: Alternate approachesChristopher Earley (USA)

Discussion: Treatment challenges Faculty

28

SU

ND

AY


Course 7: Insomnia Disorder: From Epidemiology to Disseminationof Evidence-Based Therapeutic Approaches8:00am to 12:00pm • Committee Room 3

Chair:Charles Morin (Canada)

Speakers:Yun-Kwok Wing (Hong Kong), Jack Edinger (USA), Ruth Benca (USA), Charles Morin (Canada),Leon Lacks (Australia), Rachel Manber (USA), Colin Espie (UK)

Summary:Insomnia is a common complaint in clinical practice and it can pose a significant challenge both at the diagnostic and therapeuticlevels. This course will present an overview of the epidemiology of insomnia and its burden on mental, physical, and occupationalhealth. It will then summarize recent diagnostic updates and present the most up-to-date evidence on current therapeutic optionsfor the management of insomnia, including cognitive-behavioral, pharmacological, and bright light therapies. Clinical guidelinesfor the management of insomnia comorbid with medical and psychiatric disorders will be discussed, as well as dissemination andpractical treatment implementation issues.

Epidemiology and public health burden of insomniaYun-Kwok Wing (Hong Kong)

Insomnia diagnostic updates: DSM-5 and ICSD-3Jack Edinger (USA)

Neurobiology and pharmacological management of insomniaRuth Benca (USA)

Cognitive behavioral therapies for insomniaCharles Morin (Canada)

Circadian factors and bright light therapy Leon Lacks (Australia)

Clinical management of comorbid insomnia Rachel Manber (USA)

Dissemination and practical implementation issues Colin Espie (UK)

29

SU

ND

AY


Programa Jornada Spanish Sleep Society (SES)8:30am to 4:30pm • Hotel Sercotel Sorolla Palace

8:30am - 8:45amIntroduction

8:45am - 10:00amSesión 1. Comunicaciones OralesModeradores: Miguel Ángel Martínez (Valencia), Irene Cano (Madrid)

A new vibratory postural device for the treatment of positional Obstructive Sleep Apnea (OSA). A pilot study. Joaquin Durán - Cantolla

Circulating FABP4 and subclinical Atherosclerosis in Obstructive Sleep ApneaSyndrome. Raquel Catalá

Objective evaluation of RLS daytime symptoms by means of the Multiple SuggestedImmobilization Test (m-SIT) Domingo Sánchez Ruiz

Narcolepsy and odour: Preliminary Report. Luis Dominguez Ortega

Impact of diagnosis and treatment of Obstructive Sleep Apnea Syndrome (OSAS) withNon-Invasive Ventilation (NIV). Vanessa Ferreira

10:00am - 10:15amPausa Café

10:15am - 11:45amSesión Pósters

Sesión 1.Moderadores: Eduard Esteller (Barcelona), Juan José Poza (San Sebastián)

Sesión 2.Moderadores: Carlos Egea (Vitoria-Gasteiz), Enriqueta Gómez Siurana (Valencia)

11:45am-1:00pmSesión 2. Comunicaciones OralesModeradores: Juan José Ortega (Castellón), Mª José Jurado (Barcelona)

Partial resection of the base of the tongue with harmonic scalpel: A promising aurgicalapproach for sleep apnea.

Oral Appliances in obstructive sleep apnea syndrome: our experience. Mercedes Martín Romero

Metabolomic fingerprinting approach to sleep apnea disorder in human plasma. Teresa Gómez García

Utility of sleep study in children with laryngomalacia. Rogelio Peralta Lepe

Restless legs syndrome in pregnancy. Paula Giménez

1:00pm-2:30pmLunch Simposium: Estado actual y controversias de los trastornos del sueño en los niños yadolescentes: Una visión multidisciplinarModeradores: Oscar Sans (Barcelona), Teresa Canet (Alcoy, Alicante)

Estado actual del diagnóstico y tratamiento de la narcolepsia en niñosy adolescentes Milagros Merino (Madrid)

Estado actual del diagnóstico y tratamiento del SAHS en niños y adolescentes Mª Luz Alonso (Burgos)

Estado actual del diagnóstico y tratamiento del SPI en niños y adolescentes Víctor Soto (Madrid)

Preguntas y discusión

2:30pm-4:30pmAsamblea General de la SES

30


Technologist Program9:00am to 5:00pm • Committee Rooms 1 and 2

Co-Chairs:Simone de Lacy (Spain), Lizzie Hill (UK), Maxine Elbaz (France)

Speakers:Dirk Pevernagie (Belgium), Lizzie Hill (UK), Elena Diaz (Spain), Andrew Morley (UK),Irma van Velzen (e Netherlands), Simone de Lacy (Spain), Sebastiaan Overteem (Belgium), Maxime Elbaz (France),Sarah Keane (Ireland), Montemayor (France), Quera (France),

9:15am - 10:00amKeynote: New diagnostic techniques and the role of sound recording in OSADirk Pevernagie (Belgium)

10:00am - 10:30amAASM scoring manual version 2.0- New rulesLizzie Hill (UK)

10:30am - 11:00amHome versus lab based sleep studiesElena Diaz (Spain)

11:00am - 11:30amCoffee Break

11:30am - 12:00pmFundamental differences between paediatric & adult sleep Andrew Morley (UK)

12:00pm - 12:30pmNocturnal Seizures: presentation in the Sleep LabIrma van Velzen (e Netherlands)

12:30pm - 1:00pmPSG and Medication EffectsSimone de Lacy (Spain)

1:00pm - 2:00pmLunch Break

2:00pm - 2:30pmSleep and Sleep Disorders in Parkinson's DiseaseDr. Sebastiaan Overeem (e Netherlands)

2:30pm - 3:00pmValidation of a new Actigraph MotionWatch versus PolysomnographyMaxime Elbaz (France)

3:00pm - 3:30pmNarcolepsy and H1N1 VaccineSarah Keane (Ireland)

3:30pm - 4:00pmCoffee Break

4:00pm - 4:30pmSleep and AgingDr Montemayor (France)

4:30pm - 5:00pmMelatonin and DepressionDr Quera (France)

31

SU

ND

AY

SU

ND

AY


Course 8: Update in Sleep Medicine Technology1:00pm to 5:00pm • Committee Room 3

Chair:omas Penzel (Germany)

Speakers:Thomas Penzel (Germany), Josep M Montserrat (Spain), Robert Thomas (USA), Ramon Farre (Spain)

Objectives:• Management of sleep disorders with comprehensive sleep centers, sleep centers, dedicated sleep labs, and• sleep medicine practice• Diagnostic tools with cardiorespiratory polysomnography, portable sleep monitoring, single channel systems• for sleep disorders• Innovative internet tools and telemedicine approaches• Signal processing to assess physiology and pathology of sleep• Cardiopulmonary coupling basics and applications• Modes of ventilation and their application

Summary:The course will update participants on cutting edge diagnostic and therapeutic advances, including expandedcompliance / adherence tracking, and ventilation for non-classic sleep-disordered breathing syndromes (adaptiveventilation, volume target pressure ventilation, neuromuscular disorders), and novel sleep tracking devices.

The course will present management basics from the comprehensive sleep center with all possibilities down to dedicated sleeplabs for specific disorders and to sleep physicians outside a sleep center. This includes the diagnostic tools from cardiorespiratorypolysomnography and portable sleep apnea diagnostic methods up to single channel tools for sleep apnea or insomniaquantification. The course will present new internet methods and their use for diagnostic and therapeutic monitoring. This is ofhigh impact when coping with limited economic resources. Cardiopulmonary coupling is a method to investigate stable andunstable sleep. This allows to quantify the impact of sleep disordered breathing as well as to quantify other sleep disorders suchas insomnia. Today new therapeutic modalities of ventilation are presented in order to improve therapy adherence. Someventilation modes mimic physiological breathing. Their application is presented and their impact on therapy adherence as well.

Management of sleep disordered breathing using different diagnostic tools inside andoutside the sleep centerThomas Penzel (Germany)

Innovative internet tools for the diagnosis and therapeutic control of respiratory sleep disordersJosep M Montserrat (Spain)

Cardiopulmonary coupling serves as a marker for unstable sleepRobert Thomas (USA)

Therapeutic advances with new modes of ventilation for respiratory problems during sleepRamon Farre (Spain)

32

33

SU

ND

AY


Course 9: Sleep and the Heart1:00pm to 5:00pm • Committee Room 4

Co-Chairs:Robert omas (USA), Virend Somers (USA)

Speakers:Virend Somers (USA), Jean Louis Pepin (Belgium), Winfried Randerath (Germany)

DescriptionThe course will provide a comprehensive update on hypoxia biology, the interaction of sleep and sleep apnea withcardiovascular and autonomic regulation, including arrhythmogenesis, myocardial function, stroke and vascular dysfunction.

Summary:The interactions of sleep with the cardiovascular system have been of interest to a wide range of clinicians and researches fordecades. If manipulation of sleep can modify cardiovascular risk, the implication for individual and population health arelarge. The bidirectional relationships are now the focus of major multi-center and multi-national clinical trials. This coursewill provide a summary of much of the clinical science in the area, including relationships to hypertension, congestive heartfailure, sympathetic system activity, endothelial dysfunction, cardiac arrhythmias, and treatment of sleep apnea in congestiveheart failure.

Sleep apnea and sleep deprivation - Implications for cardiac and metabolic risk Virend Somers (USA)

Sleep apnea and cardiac arrhythmiasJean Louis Pepin (Belgium)

Sleep apnea and congestive heart failureWinfried Randerath (Germany)

SU

ND

AY

34

SU

ND

AY

35


Course 10: Recording and Scoring of Movement Disorders ofSleep and RBD1:00pm to 5:00pm • Committee Room 5

Chair:Birgit Högl (Austria)

Speakers:Gilles Lavgne (Canada), Federica Provini (Italy), Joan Santamaria (Spain), Birgit Högl (Austria)

Summary:This course deals with practical recording and scoring issues for movement disorders in sleep (specifically bruxism,myoclonus, rhythmic movement disorders, PLM and RBD). How to select appropriate muscles, good montages fordifferent settings (clinical, research, basic, advanced…), how to obtain good records, advantages and disadvantages ofspecific muscles for recording during PSG, how to analyze and quantify. The speakers in this course are experts in theirfield and will give theoretical background as well as practical tips, and time for questions and answers as well as discussion.

Tips and tricks for PSG recording of sleep bruxism and differential DxGilles Lavgne (Canada)

Video and PSG excerpts for recording and scoring of PLM, propriospinal myoclonus, fragmentarymyoclonus and excessive fragmentary myoclonus, sleep starts and rhythmic movement disordersFederica Provini (Italy)

Selection of muscles for recording REM and NREM parasomnias: How to prepare a goodmontage/ advantages and disadvantages of specific muscles with examplesJoan Santamaria (Spain)

Scoring of tonic, phasic and “any” muscle activity in RBD”. Advantages and problems of thedifferent systems of quantification with examplesBirgit Högl (Austria)

SU

ND

AY

36

MondaySchedule at a Glance • Monday, September 30, 2013_________________________________________________________________Registration 7:00am - 9:00pm_________________________________________________________________Announcements 8:30am - 9:00am_________________________________________________________________Keynote 9:00am - 10:00am_________________________________________________________________Symposium S1-4 10:00am - 11:30am_________________________________________________________________Exhibition 11:00am - 5:00pm_________________________________________________________________Coffee Break 11:30am - 12:00pm_________________________________________________________________Symposium S5-7, Technologist Program, Oral Presentations O-1 and O-2 12:00pm - 1:30pm_________________________________________________________________Break 1:30pm - 1:40pm_________________________________________________________________Mundipharma Industry Symposium 1:40pm - 3:10pm_________________________________________________________________Phillips Respironics Industry Symposium 1:40pm - 3:10pm_________________________________________________________________Coffee and Exhibit 3:10pm - 3:30pm_________________________________________________________________Keynote 3:30pm - 4:30pm_________________________________________________________________Posters and Oral Presentations O-3, O-4 and O-5 4:30pm - 5:30pm_________________________________________________________________Symposium S8-12 and Technologist Program 5:30pm - 7:00pm_________________________________________________________________Discussion Symposium • Ticket Required 7:00pm - 8:00pm_________________________________________________________________Presidential Dinner • Ticket Required 8:30pm - 11:00pm_________________________________________________________________

37

MO

ND

AY

Monday, September 30, 2013 9:00am to 10:00am • Auditorium 1

Keynote: Sleep, Death and the Heart

Virend Somers, MD, PhDMayo ClinicUSA

e work of Virend Somers, M.D., Ph.D., at Mayo Clinic in Rochester, Minn.,examines the mechanisms that influence the brain's regulation of the heart and blood vessels in both health and disease. His research includes sleep and itsinteraction with circulatory control, as well as the mechanisms linking obesity to heart disease.

Notes:

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

38

MO

ND

AY


S1: New Diagnostic Technologies for Sleep Disordered Breathing

Chair:Thomas Penzel (Germany)

Speakers:Thomas Penzel (Germany), Robert Thomas (USA), Robert Poirrier (Belgium), Ludger Grote (Sweden),Pierre Escourrou (France), Chen Lin (USA),

Learning Objectives:• New methods for portable diagnosis of sleep apnea – possibilities and limitations• Modern diagnostic methods give new chances to investigate pathophysiology in sleep apnea and cardiovascular consequences

in order to improve predictors for outcome• Therapy compliance monitoring does become a part of diagnostic follow up studies

Target Audience:Sleep physicians who want to learn about new options in diagnostic tools. Sleep physicians who want to see the state ofthe art in technological developments supporting the diagnosis of sleep disordered breathing. Sleep technologist whowant to learn about upcoming developments for the sleep laboratory environment.

Summary:The symposium educates about new technical developments for the diagnosis of sleep disorders. This includeseducation on sleep disordered breathing with consequences for cardiovascular disorders and for sleep fragmentation.One talk is addressing the issues of new technologies in the follow up of compliance with therapy again in patients withsleep disordered breathing. New telemedicine techniques allow a rapid check of patient adherence to therapy withCPAP and other ventilation techniques. In addition to these pathophysiological and technical issues, the managementof sleep centers is addressed. Do we need full sleep centers which cope with all sleep disorders? Do we need specializedsleep centers which focus on respiratory or neurological problems alone? Do we need centers which only performportable sleep studies?

10:00am - 10:00amIntroductionThomas Penzel (Germany)

10:00am - 10:15amCardiopulmonary coupling in the diagnosis of instable sleep and sleep disordered breathingRobert Thomas (USA)

10:15am – 10:30amSagittal movement recording for the detection of sleep disordered breathing and sleep stagesRobert Poirrier (Belgium)

10:30am – 10:45amAutonomic state indicator for the assessment of cardiovascular risk in patients with sleep disorderLudger Grote (Sweden)

10:45am – 11:00amTelemedicine approach to assess CPAP compliancePierre Escourrou (France)

11:00am – 11:15amDifferent activation of autonomic nervous system with flow limitationChen Lin (USA)

11:15am – 11:30amManagement of sleep disordered breathing inside and outside the sleep laboratoryThomas Penzel (Germany)

39

MO

ND

AY

Monday, September 30, 2013 10:00am to 11:30am • Multipurpose Room 1

S2: Cognitive Behavioral Therapy for Insomnia (CBT-I):Knowledge Transfer and Treatment Dissemination

Co-chairs:Charles M. Morin (Canada), Yun Kwok Wing (China)

Speakers:Charles M. Morin (Canada), Yun Kwok Wing (China), Josee Savard (Canada), Rachel Manber (USA),Colin Espie (United Kingdom)

Learning Objectives:• Describe innovative methods to deliver treatment and transfer knowledge• Summarize recent findings on the impact of these treatment delivery models and web-based technologies to

disseminate interventions for insomnia/sleep disturbances

Target Audience:is symposium is likely to be of significant interest for both sleep clinicians providing insomnia treatment andinvestigators conducting clinical trials on insomnia therapies.

Summary:ere is solid evidence that cognitive-behavioral therapy for insomnia (CBT-I) is effective, produces sustained benefitsover time, and is well accepted by patients. An important challenge that remains, however, is to translate this evidenceinto practical applications and to disseminate it to potential users, i.e., individuals with insomnia and health-carepractitioners who work with sleep patients in diverse settings. e main objectives of this symposium are to describeinnovative methods and technologies to disseminate CBT-I and optimize knowledge transfer. Five speakers fromdifferent part of the world will present evidence from recent clinical trials documenting the impact of self-help therapiesusing the Internet and web-based applications, training workshops, and sleep education programs as implemented incommunity, hospital, and school settings.

10:00am - 10:02amIntroductionCharles M. Morin (Canada)

10:02am - 10:19amKnowledge transfer through sleep education among school-aged childrenYun Kwok Wing (China)

10:19am – 10:36amEfficacy of a video-based CBT for insomnia in cancer patientsJosee Savard (Canada), H. Ivers, M-H. Savard, J. Villa, C.M. Morin

10:36am – 10:53amTraining dissemination of CBT-I in veterans administration health care systemRachel Manber (USA)

10:53am - 11:10amA web-based intervention for insomniaColin Espie (United Kingdom)

11:10am - 11:27amInternet-delivered CBT for insomniaCharles Morin, L. Ritterband, F. Thorndike, L. Gonder-Frederick, K. Ingersoll

11:27am – 11:30amQuestion and answerCharles M. Morin (Canada)

40

MO

ND

AY


S3: Converging Understanding of the Biology of Restless Legs Syndrome

Chair:Richard P Allen (USA)

Speakers:Richard P Allen (USA), James R. Connor (USA), Christopher J. Earley (USA), Juliane Winkelmann (USA), Yong-Won Cho (South Korea)

Learning Objectives:• Biological significance of RLS genetics for brain development and iron regulation• Role of hypoxic and related pathways in expression of RLS symptoms• Differing pathways and neurochemical systems for spinal and cortical excitability in RLS• Brain connectivity differences supporting development of RLS symptoms• Possibilities of biologically based developments of new approaches to diagnosis, evaluation and treatment of RLS

Target Audience:Intermediate to advanced clinical and scientific interest in RLS and new diagnostic and treatment considerationsdeveloping from understanding the biology of RLS.

Summary:A wide range in disparate biological features of RLS have each been advanced as the biological basis for RLS, e.g.:peripheral nervous system, spinal mechanisms, dopaminergic systems (A11, nigro-striatal), thalamo-pathways, corticalarousal, pain/sensory systems, glutamatergic activation, hypoxic pathways, iron regulation, genetics. There is now thebeginning of understanding how these various biological features of RLS converge to reveal both underlying biologicaldiatheses for RLS and pathways for expression of the disease. This symposium will present some of the initial findingsthat begin to reveal this complicated biological network for RLS. First, new advances in understanding the biologicalsignificance of RLS genetics reveal pathways for producing both basic iron regulation problems, particularly at theblood-brain-barrier and also basic alterations in development of major brain systems, particularly the nigro-striatalsystem. Second, alternate pathways leading to expression of the disease have been found involving activation of hypoxicand related pathways in peripheral and central tissue that also may relate to RLS genetics and peripheral as well as brainfeatures of RLS. Finally brain connectivity imaging, spectroscopy and recent neurophysiological studies provide aninteresting picture of divergent paths for expression of the disease. These involve altered thalmo-connectivity andpossibly spinal systems with putative somewhat separate pathways and neurochemistry expressing the hyperarousalversus periodic leg movements of RLS. The insights provided by these studies on the biology of RLS impactdevelopments for better diagnosis, evaluation and treatment of RLS.

10:00am - 10:03amIntroductionRichard P Allen (USA)

10:03am - 10:18amMEIS1, iron and RLS: Genetic effects on iron regulation and blood brain barrier in RLSJames R. Connor (USA)

10:18am – 10:33amRLS biological pathways: hypoxic and related pathways in brain and peripheral systemsChristopher J. Earley (USA)

10:33am – 10:48amGenetics and developmental issues in RLS biologyJuliane Winkelmann (USA)

10:48am - 11:03amRLS Cortical/spinal excitability, PLM vs hyperarousal: Iron, dopamine and glutamate Richard P Allen (USA)

11:03am - 11:15amBrain imaging: MRI connectivity, iron and dopamineYong-Won Cho (South Korea)

11:15am - 11:30amQuestion and answerRichard P Allen (USA)

41

MO

ND

AY

Monday, September 30, 2013 10:00am to 11:30am • Committee Rooms 1 and 2

S4: The Autonomic Nervous System and Sleep in HumanNarcolepsy: Do Patients Have an Increased Cardiovascular Risk?

Chair:Pietro Cortelli (Italy)

Speakers:Pietro Cortelli (Italy), Daniela Grimaldi (USA-Italy), Stine Knudsen (Denmark), Yves Dauvilliers (France),Rolf Fronczek (The Netherlands)

Learning Objectives:• Gain insight in what is known about how the autonomic nervous system is affected in hypocretin-deficient human narcolepsy• Learn the results of several recent sleep studies with autonomic measurements in human narcolepsy• Understand the broader impact of hypocretin deficiency in human narcolepsy in relation to possible cardiovascular • risk and obesity

Target Audience:Advanced topic for clinical sleep specialists and basic researchers with a special interest in the autonomic nervous systemeffects of hypocretin deficiency in human narcolepsy.

Summary:Almost all narcolepsy with cataplexy patients lack the neuropeptide hypocretin (orexin). The hypocretin system plays akey role in the complex interaction between sleep and the autonomic nervous system. It is hypothesized that hypocretindeficiency thus affects cardiovascular risk factors in narcolepsy. In this symposium results of several recent studies will bepresented, with a focus on the autonomic nervous system in relation to sleep in human narcolepsy. This includes bloodpressure rhythms and spectral analysis of heart rate variability as a reflection of sympathovagal balance during sleep,which reveals an abnormal sleep-cardiovascular system interaction. Furthermore, recent data indicate a reduced heartrate response to arousals and leg movements during sleep in narcolepsy patients that lack hypocretin. In another study,a higher percentage of ‘non-dipping’ blood pressure profiles (defined as < 10% drop in blood pressure during sleep)was found in drug-free patients with narcolepsy-cataplexy compared to controls without evidence for endothelialdysfunction. Thermoregulation is also controlled by the autonomic nervous system and is altered around sleep onsetand during sleep in human narcolepsy. To conclude, the broader impact of these recent insights will be summarized inrelation to a possible increased cardiovascular risk in human narcolepsy and to the obesity that is characteristic fornarcolepsy.

10:00am - 10:05amIntroductionPietro Cortelli (Italy)

10:05am - 10:25amAbnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy:effects of hypocretinDaniela Grimaldi (USA-Italy)

10:25am – 10:45amAttenuated autonomic response to nighttime arousal and leg movements in human narcolepsyStine Knudsen (Denmark)

10:45am – 11:05amNon-dipping blood pressure profile in narcolepsy with cataplexy Yves Dauvilliers (France)

11:05am - 11:25amRegulation of heart rate, body temperature, metabolism and sleep in human narcolepsyRolf Fronczek (The Netherlands)

11:25am – 11:30amQuestion and answerPietro Cortelli (Italy)

42

MO

ND

AY

Monday, September 30, 2013 12:00pm to 1:30pm • Multipurpose Room 1

S5: The Role of Sleep in Emotional Memory Processing andDevelopment or Prevention of PTSD

Chair:Gina R. Poe (USA)

Speakers:Gina R. Poe (USA), Anne Germain (USA), Maria Corsi-Cabrera (Mexico), Subimal Datta (USA),William Vanderheyden (USA)

Learning Objectives:• Understand the traits of sleep important to processing memories• Learn which sleep traits change after PTSD induction• Observe how sleep normally changes after fear learning and extinction training• Build a comprehensive model of abnormal processing of fearful memories after PTSD• Gain insight as to how the more successful PTSD treatments may work and how reestablishing normal sleep function for

memory processing could recover normal function after PTSD

Target Audience:The content is appropriate for a broad audience familiar with sleep. Presentations will be basic as well as clinical andinclude conceptual models that tie the results together.

Summary:Attendees should be able to identify traits of sleep that change after traumatic events that induce PTSD, and furtherunderstand how such traits are altered during fear conditioning and extinction in those with and without PTSD.Human and basic animal studies will be presented. Mechanistic models and areas of coherence as well as disagreementwill be directly addressed. The symposium will concentrate on the physiological characteristics of sleep that areinfluenced by and influence the adaptive vs. maladaptive sleep processing of traumatic memories.

12:00pm - 12:02pmIntroductionGina R. Poe (USA)

12:02pm - 12:17pmRole of sleep traits in the induction of PTSD, fear conditioning, and fear extinctionGina R. Poe (USA)

12:17pm - 12:34pmBrain imaging findings in combat-exposed Veterans with and without PTSDAnne Germain (USA)

12:34pm - 12:51pmEmotion regulation after sleep deprivation in humansMaria Corsi-Cabrera (Mexico)

12:51pm - 1:08pmRole of REM sleep P-wave activity in fear ex-tinction memorySubimal Datta (USA)

1:08pm - 1:25pmModeling PTSD in the rat: sleep and learning phenotypes William Vanderheyden (USA)

1:25pm – 1:30pmQuestion and answerGina R. Poe (USA)

Technologist Program

12:00pm-1:30pm • Committee Rooms 3 and 4W1 ADULT PSG Masterclass: Sleep Montage Hook-up; Sleep Staging andEvent Scoring

43

MO

ND

AY

Monday, September 30, 2013 12:00pm to 1:30pm • Auditorium 2

S6: Sleep Disorders and Cancer

Co-chairs:Miguel Ángel (Spain), Javier Nieto (USA)

Speakers:Miguel Ángel (Spain), Javier Nieto (USA), Sonia Ancoli-Israel (USA), Ramon Farré (Spain), Francisco Campos-Rodríguez (Spain) Learning Objectives:• Relationship between sleep metabolism, circadian rh ythm and cancer risk • Sleep disturbances and cancer risk (especially sleep duration) • Role of Melatonine and hypnotic treatments in cancer • New discoveries. Intermittent hypoxia and cancer in animal models • New discoveries. Sleep apnea and risk of cancer. Incidence and mortality• The future. New studies needed and the role sleep disorders treatment in cancer

Target Audience:Everyone with interest in sleep disorders.

Summary:The relationship between different aspects of non-apneic sleep disorders, particularly sleep duration and some drugsintake, and cancer has been studied by various authors. Some studies have shown an association between short sleepduration, long sleep duration or prolonged naps and an increased incidence of cancer, particularly breast cancer.Several mechanisms have been postulated as explanations for this association, most notably the increased productionof pro-inflammatory cytokines and the suppression of melatonin secretion, which has been shown to inhibit cancerdevelopment and growth. Moreover, recently three large observational studies from Wisconsin (Nieto J, et al, 1500patients, follow up 22 years, population-based study. Am Respir J Critr Care Med 2012) and Spain (Campos-RodríguezF, et al and Martínez-García MA, et al. Clinical cohort of more than 5,000 patients with suspected OSA with afollow-up 5 years. Am Respir J Crit Care Med 2013 and ATS Congress 2012) have shown a relationship betweensevere sleep apnea (measured by an hypoxemia index) and an increased incidence and mortality from cancer. All thesestudies have been presented in USA and Europe with great interest of the Scientific Community and Press (New YorkTimes, Lancet, Sky news and others). The pathophisiological mechanism proposed to link sleep apnea and cancer isintermittent hypoxia as has been previously observed by Farré et al in an animal model. Some editorials have beenrecently written about it (Redline S in Am Respir J Crit Care Med, Martínez-García MA et al. European RespiratoryJournal). Some studies will begin in 2013 on this topic specially from the Spanish Sleep and Breathing group.

12:00pm - 12:05pmIntroductionMiguel Ángel (Spain)

12:05pm - 12:10pmIntroductionJavier Nieto (USA)

12:10pm - 12:30pmNon-apneic sleep disorders and cancerSonia Ancoli-Israel (USA)

12:30pm - 12:50pmIntermittent hypoxia and cancer. Pathophysiology and studies in animal modelsRamon Farré (Spain)

12:50pm - 1:10pmSleep apnea and risk of cancer incidence and mortalityFrancisco Campos-Rodríguez (Spain)

1:10pm – 1:30pmQuestion and answerMiguel Ángel (Spain) and Javier Nieto (USA)

44

MO

ND

AY


S7: Brain Imaging Studies in Sleep Disorders and Sleep Deprivation

Chair:Seung Bong Hong (South Korea)

Speakers:Seung Bong Hong (South Korea), Luigi Ferini-Strambi (Italy), Eus JW Van Someren (The Netherlands),Michael Chee (Singapore), In-young Yoon (South Korea)

Learning Objectives:• Does OSA cause structural abnormalities in brain and is there a correlation between brain changes and cognitive dysfunction

in OSA patients? • Is brain metabolism and EEG changes reversible by nasal CPAP treatment in OSA patients? • Heterogeneity of insomnia may have impeded progress in our understanding of underlying causes and depending on the

phenotype, remarkably different cerebral mechanisms can underlie seemingly similar subjective sleep complaints • Are there structural changes in brain of narcolepsy patients and the relationship between brain changes and narcolepsy symptoms? • What is the consequence of sleep deprivation in cognitive function and how does fMRI elucidate the effect of sleep

deprivation on brain function?

Target Audience:Sleep physicians, professors, clinical and basic researchers, students.

Summary:The changes of brain function or structures are suspected in various sleep disorders such as OSA, narcolepsy, insomnia and others.Recently both functional and structural abnormalities have been reported in sleep disorders. Neuroimaging such as brain MRI,fMRI, PET, SPECT is a useful research tool for studying brain pathology or dysfunction related to sleep disorders and sleepdeprivation in live human. This symposium will present the results of brain imaging studies in OSA, insomnia, narcolepsy and sleepdeprivation. In OSA, two(#1, 5) speakers will present structural brain abnormalities and their relationship with cognitivedysfunction, and changes of brain glucose metabolism and quantitative EEG after CPAP treatment respectively. The 2nd speakerwill talk about the relationship between brain imaging and different phenotypes of insomnia such as primary insomnia, insomniawith major depression and insomnia with anxiety disorder, and implications for our understanding of insomnia; depending on thephenotype, remarkably different cerebral mechanisms can underlie seemingly similar subjective sleep complaints. Despite evidence ofdisturbances of the hypothalamic hypocretin system in idiopathic narcolepsy patients, a gross inspection of brain MRI is usuallynormal and computer-aided studies of brain MRI revealed conflicting results and there is limited data on possible structural brainchanges that might be associated with idiopathic narcolepsy. So the 3rd speaker will review neuroimaging studies using brain MRIincluding gray and white matter changes and cortical thickness and discuss their relation to the pathogenesis of narcolepsy. Thebrain dysfunctions have been reported in people with sleep deprivation. The 4th speaker will present the techniques and results ofbrain dysfunctions related to sleep deprivation studied by functional MRI (fMRI).

12:00pm - 12:00pmIntroductionSeung Bong Hong (South Korea)

12:00pm - 12:17pmBrain gray/white matter abnormality and cortical thickness changes in narcolepsySeung Bong Hong (South Korea)

12:17pm - 12:34pmStructural brain changes and cognitive dysfunction in OSA patientsLuigi Ferini-Strambi (Italy)

12:34pm - 12:51pmBrain imaging elucidates different insomnia endophenotypesEus JW Van Someren (The Netherlands)

12:51pm - 1:08pmfMRI study on cognitive dysfunction in people with sleep deprivationMichael Chee (Singapore)

1:08pm – 1:25pmBrain metabolism and QEEG changes after CPAP treatment in OSA patientsIn-young Yoon (South Korea)

1:25pm – 1:30pmQuestion and answerSeung Bong Hong (South Korea) 45

MO

ND

AY

Monday, September 30, 2013 12:00pm to 1:30pm • Committee Room 1

O-01: Aging and Developmental Issues

Chair:Oliviero Bruni (Italy)

Two hours of evening light produces significant circadian phase delay shifts in older adultsJeanne F. Duffy (USA)

Mean stress ratings across 6 weeks are related to increased levels of Stage 1 and WASOduring 4 (home) recorded sleep periodsTorbjorn Akerstedt (Sweden)

Sleep complaints and cardio-cerebrovascular diseases in the elderly: a 6-year prospective studyIsabelle Jaussent (France)

To nap or not to nap: evidence on daytime napping and increased 13-year mortalityin a British populationYue Leng (UK)

Age-related changes in sleep pattern and sleep structure and the association to cognitiveperformance; The Metropolit 1953 Danish Male Birth CohortLinda Waller (Denmark)

Sleep quality and arterial stiffness in middle-aged and older womenYoungju Choi (Japan)

46

Monday, September 30, 2013 12:00pm to 1:30pm • Audiorium 3

O-02: Sleep Breathing Disorders

Co-Chairs:Josep Monserrat (Spain), Stuart Quan (USA)

Acute effects of obstructive sleep apnea on autonomic nervous system, arterial stiffness andheart rate in newly diagnosed untreated patientsRen-Jing Huang (Taiwan)

The expression of the Per2 clock gene is up-regulated in non-treated OSAS patients andnormalizes its mRNA levels upon positive pressure treatmentLuis Ferreira Moita (Portugal)

Asthma Predicts 8-Year incidence of obstructive sleep apnea in the Wisconsin sleep cohortErika Hagen (USA)

The association of sleep-disordered breathing with objectively-assessed risk of fallsPaul E. Peppard (USA)

Obstructive sleep apnea in risk for first cardiovascular event and all-cause mortality:A competing risks approachTetyana Kendzerska (Canada)

Survival and adherence to CPAP in the elderlyDaniel López-Padilla (Spain)

47

MO

ND

AY


Emerging Strategies inSleep Disorders

Agenda:

1:40pm - 1:45pmIntroduction amd overviewProfessor Claudia Trenkwalder

1:45pm - 2:05pmThe relation of pain, pain therapy and sleepProfessor Sam Ahmedzai

2:05pm - 2:10pmQuestions & discussion

2:10pm - 2:30pmRLS pathophysiology: the current hypothesisProfessor Arthur Walters


2:35pm - 2:55pmBeyond dopaminergics – is there still achance of a good night’s sleep?Professor Claudia Trenkwalder


3:00pm - 3:10pmSummary and panel discussionProfessor Claudia Trenkwalder

Sponsor:

Monday, September 30, 2013 1:40pm to 3:10pm

Multipurpose Room 1

Advances in PAP Therapy

Agenda:

Co-Chairs:Dr Montserrat (Spain), Dr. Santiago Juarros (Spain)

1:40pm - 2:10pmHow can patient data help you deliverhealthier patientsProf. Escourrou (France)

2:10pm - 2:40pmThe use of Servoventilation in complicatedpatientsDr. Fernanda Troncoso (Spain)

2:40pm - 3:10pmPsychological interventions to improve PAPcomplianceMark Aloia (USA)

Sponsor:

Box Lunch:Box lunch is provided to satellite symposia attendees. Delegates can purchasea lunch ticket for Wednesday prior to noon Tuesday for a cost of 10 € at theregistration desk.

48

MO

ND

AY


Keynote: Emerging Treatments for Insomnia

Göran Hajak, MD, PhDUniversity of Erlangen, Social Foundation BambergGermany

Since his involvement in neuropsychic research began in the late 1980s, Dr. Hajak’sinterests have included the clinical and pathophysiological aspects of affective,emotional, somatoform and sleep disorders, the mechanisms of neuroplasticity andbrain networking, psychopharmacology, and health management. He has beenserving in boards and expert groups of several international institutions such asthe Drug Commission of the German Medical Profession, Federation of Societiesof Biological Psychiatry, German Sleep Society, and Green Cross.

Notes:

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

49

MO

ND

AY

MO

ND

AY


O-03: Chronobiology & Circadian Disorders

Chair:Phyllis Zee (USA)

Sleep disturbances and their relationship with excessive exposure to light at night: The Koreangenome and epidemiology studyYong Seo Koo (South Korea)

Assessing the delayed sleep phase disorder by ambulatory circadian monitoringEduard Estivill (Spain)

Evaluation of circadian gene expression changes in human peripheral blood cells asbiomarkers of circadian disruption in shift workers: Application to studies of breast and prostatecancer chemopreventionHelmut Zarbl (USA)

Circadian activity rhythm disturbances predict mortalityLisette A. Zuurbier (e Netherlands)

50

MO

ND

AY


O-04: Insomnia Mechanisms

Chair:Kai Spiegelhalder (Germany)

Electroencephalographic correlates of on-the-road driving fatigue in untreated insomniac patientsJoy Perrier (Framce)

Insomnia symptoms and subsequent cardiovascular medication: a register-linked follow-up studyamong middle-aged employeesPeija Haaramo (Finland)

Spectral analysis in untreated primary insomniacs: Evidence for cortical hyperarousal andprefrontal hypometabolism during sleepJoy Perrier (France)

Cognitive impairments in individuals with insomnia: Clinical significance and correlatesEmilie Fortier-Brochu (Canada)

51

MO

ND

AY

Monday, September 30, 2013 4:30pm to 5:30pm • Committee Rooms 1 and 2

O-05: Sleep Cognition and RBD

Chair:Luigi Ferini-Strambi (Italy)

Increased TV viewing time is associated with less sleep and more sleep difficulties in a largepopulation-based cohortYue Leng (UK)

Sleep deprivation correlations with risk behaviors in adolescents: Results from a Portuguesenational surveyTeresa Paiva (Portugal)

REM sleep behavior disorder is associated to increased risk of impulse control symptoms inpatients with Parkinson’s diseaseFantini Maria Livia (France)

How should we deal with the possible development into Lewy body diseases from idiopathicREM sleep behavior disorder in the real world clinical practice?Naoko Tachibana (Japan)

52

MO

ND

AY

53

MO

ND

AY

54


S8: Obstructive Sleep Apnea, Motor Vehicles Accidents and DrivingLicense Regulations

is symposium is supported by an unrestricted educational grant from General Directorate for traffic (Dirección de Tráfico).

Chair:Daniel Rodenstein (Belgium), Jean Krieger (France)

Speakers:Daniel Rodenstein (Belgium), Joaquin Teran-Santos (Spain), Maria Segui (Spain), Julia Kremer (Belgium)

Learning Objectives:After a general introduction of the subject under the perspective of the literature available up 2013, the symposium will examinehow different countries are implementing solutions for this issue.

Target Audience:Although not strictly speaking a medical matter, the issue is even more important since most physicians have littleknowledge of the driving license regulations and to their role as physicians in the process of authorizing or limiting orpreventing someone to access to a driving capacity.

Summary:Every sleep specialist dealing with patients will be confronted to the question of motor vehicles driving obligations andrights. This applies specially to obstructive sleep apnea, probably the medical disorder carrying the higher risk formotor vehicle accidents.

5:00pm - 5:35pmIntroductionDaniel Rodenstein (Belgium)

5:35pm - 5:50pmObstructive sleep apnea and motor vehicle accidents: the evidence Joaquin Teran-Santos (Spain)

5:50pm - 6:10pmObstructive sleep apnea and road policy. The Spanish experience Maria Segui (Spain)

6:10pm - 6:25pmObstructive sleep apnea as a risk factor for road safety. In search for recognition Daniel Rodenstein (Belgium)

6:25pm - 6:45pmObstructive sleep apnea and road safety. The EU approach. Julia Kremer (Belgium)

6:45pm – 6:50pmConclusionJoaquin Teran-Santos (Spain)

6:50pm – 7:00pmQuestion and answerDaniel Rodenstein (Belgium)


5:30pm-7:00pm • Committee Rooms 3 and 4W2 PAED PSG Masterclass: Hook-up; Sleep Staging and Event Scoring;Top tips for compliance

MO

ND

AY


S9: Neurocognition and Behavior, Sleep Disturbance and SleepDisordered Breathing

Chair:Christian Guilleminault (USA)

Speakers:Christian Guilleminault (USA), Sarah Biggs (Australia), Yu-shu Huang (Taiwan), Louise O’Brien (USA),Karen Spruyt (USA)

Learning Objectives:There is very little knowledge on what happen following T&A perform for SDB on neurocognition. The symposium willpresent new information on the impact of SDB and snoring in different age groups of children including pre-school and schoolage children. It will also explore the impact of treatment on neurocognition, and the risks associated with currently untreatedmild sleep-disordered breathing on neurocognition and behavior.

Target Audience:Clinician involved in pediatric sleep, researchers involved in sleep disordered research, in psychological and cognitiveoutcome and in assessment of cognitive risks and schooling impact.

Summary:Neurocognition can be impaired in association with sleep disordered breathing. This impairment may impact learningand behavior in children and may lead to behavioral changes. The symposium will present the results of 4-yearlongitudinal data of behavioral and neurocognitive outcomes in children with sleep disordered breathing, comparingthose treated to those untreated in a cohort of Australian children; the results of a study looking at neurocognitivechanges within 6 months post adenotonsillectomy and follow-up of neurocognitive development of children during thefollowing 36 months and the results of longitudinal neurocognitive changes pre and post adenotonsillectomy in acohort of US school-age children and similar neurocognitive evaluation in pre-school and school-age children with cleftpalate, finally presentation of the impact on behavior and neurocognition on pre-school children in New-Zealand.

5:30pm - 5:32pmIntroductionChristian Guilleminault (USA)

5:32pm - 5:52pmSleep-disordered breathing and neurocognitive development: Effect of treating or nottreating SDB-inSarah Biggs (Australia)

5:52pm - 6:12pmA long term (36 months) follow-up study of children post-T&A: neurocognitive changes:effect of ageYu-shu Huang (Taiwan)

6:12pm - 6:32pmFollow-up cohorts of children with OSA and Cleft-palate and SDB: neurocognitive outcomeLouise O’Brien (USA)

6:32pm - 6:52pmObesity sleep disordered breathing and cognition in childrenKaren Spruyt (USA)

6:52pm – 7:00pmQuestion and answerChristian Guilleminault (USA)

55

MO

ND

AY


S10: Identification of the Neuronal Network Regulating theSleep-waking Cycle: A Never Ending Story?

Chair:Pierre Herve Luppi (France)

Speakers:Pierre Herve Luppi (France), Antoine Adamantidis (Belgium), John Peever (Canada), Luis de Lecea (USA),Christelle Peyron (France)

Learning Objectives:This symposium will provide up to date information on the mechanisms and the neuronal network generating thesleep-waking cycle.

Target Audience:The expected audience is a mix of basic and clinical researcher interested to obtain latest hypotheses on the mechanismscontrolling sleep.

Summary:The purpose of this symposium is to provide latest update on the mechanisms at the origin of the sleep-waking cycle.Combination of classical methods with latest advances in genetic manipulation of neurons (optogenetic,pharmacogenetic, transgenic models) have been used to progress in the identification of the neuronal networkresponsible for all sleep-wake stages. In particular, the role in sleep control of the posterior hypothalamus and of thenucleus accumbens will be adressed. Brainstem network controlling REM sleep atonia will also be clarified.

5:30pm - 5:35pmIntroductionPierre Herve Luppi (France)

5:35pm - 5:53pmOptogenetic dissection of hypothalamic sleep-wake circuitsAntoine Adamantidis (Belgium)

5:53pm - 6:11pmThe identification of the REM sleep circuitJohn Peever (Canada)

6:11pm - 6:29pmDifferent flavors of optogenetic awakeningsLuis de Lecea (USA)

6:29pm - 6:47pmThe role of the hypothalamus in REM sleep controlChristelle Peyron (France)

6:47pm – 7:00pmQuestion and answerPierre Herve Luppi (France)

56

MO

ND

AY


S11: Innovations in Sleep Apnea Management

Chair:Meir Kryger (USA)

Speakers:Meir Kryger (USA), David White (USA), Klar Yaggi (USA), Winfried Randerath (Germany)

Learning Objectives:• When CPAP therapy is not acceptable that there are alternative treatments to consider in selected patients• End expiratory airway pressure (EPAP), and oral pressure therapy (OPT) can be useful in selected OSA patients• Hypoglossal nerve stimulation is a potentially promising therapy in OSA• Treatment of OSA may prevent strokes

Target Audience:Clinicians and scientists managing OSA.

Summary:This symposium will review management innovations in the treatment of OSA. The topics to be discussed include newtherapeutic modalities including EPAP, OPT and hypoglossal N stimulation, and whether CPAP can prevent strokes.

IntroductionMeir Kryger (USA)

EPAP therapy in OSAMeir Kryger (USA)

OPT (Oral Pressure Therapy) in OSA David White (USA)

Can CPAP prevent strokes?Klar Yaggi (USA)

Hypoglossal Nerve Stimulation in OSAWinfried Randerath (Germany)

Question and answerMeir Kryger (USA)

57

MO

ND

AY

Monday, September 30, 2013 5:30pm to 7:00pm • Committee Rooms 1 and 2

S12: Sleep and Circadian Rhythm Abnormalities in Mood Disorders

Chair:Ruth Benca (USA)

Speakers:Ruth Benca (USA), Kathleen Ries Merikangas (USA), Ian Hickie (Australia), Tiina Paunio (Finland)

Learning Objectives:• To gain understanding of the current status of research on activity patterns, sleep and circadian rhythms in relation to

mood disorders. • To appreciate the role of genetic and epigenetic mechanisms linking sleep and emotions. • To learn about changes in sleep-related brain plasticity in mood disorders.• To recognize the importance of varied research approaches to identify sleep and circadian targets for treatment

interventions in mood disorders.

Target Audience:This presentation is intended for both clinicians and scientists who are interested in the role of sleep and circadian rhythmdisturbances in mood disorders, including those with backgrounds in sleep and/or psychiatry. The presentations should beaccessible to those with more basic knowledge in the area, but will be of greater interest to the more advanced attendees.

Summary:Abnormalities in the sleep-wake cycle, patterns of physical activity and circadian rhythms are core features of mooddisorders. Moreover, sleep and circadian rhythm disruptions are predictive of the onset of mood disorders and likelycontribute to their progression. This symposium will provide an overview of recent advances in our understanding ofthe relationships between sleep and circadian rhythm abnormalities and mood disorders. Dr. Merikangas will discussfindings from an epidemiologic family study enriched for people with mood disorders, including the relationshipbetween patterns of sleep and activity and mood disorder subtypes as well as ordinal associations between daily moodfluctuations and sleep/activity patterns. Dr. Hickie will review work demonstrating that disrupted circadian function ischaracteristic of young people with emerging mood disorders and is likely to be a key pathophysiological aspect of theseconditions. Dr. Paunio will describe the identification of DNA variants that affect both regulation of sleep and mood,showing that at least some of the genetic variability in regulation of sleep and mood is shared. Finally, Dr. Benca willdiscuss data from high density EEG studies of sleep and waking brain activity in depressed subjects that suggestalterations in brain plasticity mechanisms. Taken together, these findings suggest that an increased focus on objectivemeasures of activity, sleep and circadian rhythms may provide key biomarkers for the onset, course and response totreatment of mood disorders, as well as targets for clinical interventions.

5:30pm - 5:32pmIntroductionRuth Benca (USA)

5:32pm - 5:52pmDaily rhythms of activity, sleep and mood in a family study of affective spectrum disordersKathleen Ries Merikangas (USA)

5:52pm - 6:12pmSleep and circadian rhythm disruption in young people with emerging mood disordersIan Hickie (Australia)

6:12pm - 6:32pmGenetic regulation of sleep and emotionsTiina Paunio (Finland)

6:32pm - 6:52pmHigh-density EEG analysis of sleep in depressionRuth Benca (USA)

6:52pm – 7:00pmQuestion and answerRuth Benca (USA)

58

MO

ND

AY

59

MO

ND

AY


DS-M-01: Sleep Apnea and the Risk of StrokeTicket required - purchase at registration desk

Chair:Antonio Culebras (USA)

Target Audience:Sleep practitioners, neurosomnologists, cardiologists, pulmonary physicians and internists, in practice or in training.

Summary:To review the risk of stroke created by uncontrolled sleep apnea. The discussion will cover systemic hypertension, atrial fibrillationand systemic inflammation as principal facilitators of stroke risk. Management options will be discussed.

60

MO

ND

AY

Monday, September 30, 20137:00pm to 8:00pm • Committee Room 2

DS-M-02: Sleep in Traumatic Brain Injury: Current Knowledge andFuture Directions Ticket required - purchase at registration desk

Co-Chairs:Catherine Duclos (Canada), Tatyana Mollayeva (Canada)Speakers:Peter Meerlo (The Netherlands), Catherine Duclos (Canada), Tatyana Mollayeva (Canada)Learning Objectives:• Have a grasp of the multifactorial etiology of sleep dysfunction post TBI• Recognize the role of the disruption in the neuroanatomical structures which can result in impaired sleep• Understand current techniques to measure sleep after TBI• Establish appropriate assessment of sleep in TBI practice to enhance patient outcomes and reduce treatment errors• Define future directions in the area of sleep post TBITarget Audience:Clinicians and researchers with interest in sleep and TBI. Level of symposium content: Advanced.Summary:Sleep-wake dysfunction is common following Traumatic Brain Injury (TBI), and has intensified many threats post-injury. Thesethreats are not isolated to any particular organ or system; individuals with sleep disruption face increased threats of diminishedfunctioning and recovery in physical, behavioural, cognitive and emotional aspects. The aetiology of sleep-wake dysfunction ispoorly understood and reports on its incidence have also been problematic – some cited a wide range between 21% and 73%.Hidden in the statistics are even more troubling trends, such as one’s ability to sustain purposeful, goal-oriented mental effort tofunction independently after the injury. It is critical to note that sleep dysfunction is a major concern for individuals with TBI,clinicians who attend to persons with TBI, and policyholders who allocate resources to mitigate this health concern. Our discussion will review the available knowledge concerning sleep functioning in the TBI population. Our intent is tosimultaneously educate and increase the audience’s interest and understanding of aetiology of sleep dysfunction post-TBI and tofacilitate a discussion in this critical area, resulting in multidisciplinary efforts (collaboration of sleep and TBI research) addressingthe problem of sleep disruption. The set of presenters in our symposium includes a neuroscientist from the University of Groningenfrom the Netherlands and researchers in the field of sleep after brain injury from University of Toronto and Université de Montréal.Our presentations will cover a range of topics, from understanding the underlying pathophysiological pathways through animalmodels, to issues of identification, assessment and outcomes of sleep in human. The first presentation discusses the underlying neuroanatomy associated with known pathophysiological mechanisms of TBI, andtypes of injuries that lead to a disruption in the neuroanatomical structures that sub serve sleep-wake dysregulation. Thepresentation is intended to emphasize the underlying pathophysiology after experimentally provoked brain injury in animals,supporting that any primary or secondary damage to the areas that coordinate sleep-wake cycle (e.g. suprachiasmatic nucleus(SCN) of the hypothalamus, reticular activating system, pontine nuclei) can be sufficient to cause dysregulation in sleep-wakecycles. More specifically, this presentation will aim to address whether disrupted sleep may influence the course and outcome ofbrain damage. Outline of possible future directions in these areas will follow. The second presentation will discuss circadian rhythm disturbances in the acute phase of moderate to severe TBI, with a particularfocus on how circadian rhythms in the acute phase can provide indications on patient outcome at hospital discharge. The presenterwill raise pertinent question on how sleep disturbances may arise and evolve following TBI in human. Discussion of the futuredirections in this area of research will follow. The third presentation will discuss current methods of measuring sleep in TBI. A notable feature will be coverage oncomprehensive assessment of sleep functioning post-TBI in accordance with the ICSD. Relative indications, advantages,disadvantages and limitations of self-report instruments, evidence on psychometric properties in the TBI population will bepresented. The presentation will conclude with a discussion of the future directions in measuring sleep after TBI, and will provideinformation on the potential of new techniques available in the field. Our sessions will end with a discussion, which will allow for potential formation of international collaborations and networksbetween sleep and TBI researchers.7:00pm - 7:15pmAnimal models for experimental studies on sleep and TBIPeter Meerlo (The Netherlands)7:15pm - 7:25pmThe acute phase of TBI: circadian rhythms and patient outcomeCatherine Duclos (Canada)7:25pm - 7:40pmSleep measures in TBI: issues and opportunitiesTatyana Mollayeva (Canada)

61

MO

ND

AY


DS-M-03: Pharmaco-Sleep: the Assessment of Drug Effects onHuman Sleep Ticket required - purchase at registration desk

Co-Chairs:Sandra Giménez Badia (Spain), Peter Anderer (Austria)

Speakers:Rapahelle Winsky Sommerer (UK), Peter Anderer (Austria), Barry T. Peterson (USA)

Learning Objectives:• Provide support for the design and analysis of pharmaco-sleep studies in human• Assist reseachers using sleep EEG in clinical and basic research, giving specific recommendations, and thereby enabling• standardisation of methodology and facilitating comparability of data across labs• The utility of PSG (and sleep EEG) measures as translatable biomarkers of central pharmacology in the development of drugs • The role of actigraphy in pharmaco-sleep studies• Provide from basic to advance level a multidisciplinary approach to asses drug effects on human sleep

Target Audience:Audience interested in sleep human psychopharmacology, basic level. Researchers and sanitary workers with basic and advanceexperience of design, implementation, analysis and reporting of Human Pharmaco- Sleep Studies trials. Advance researchers usingsleep EEG in clinical research, giving specific recommendations, and thereby enabling standardisation of methodology andfacilitating comparability of data across labs. From basic to advance level provide to all personal working in the sleep field amultidisciplinary and translational evaluation of drug effects on sleep: subjective scales, objective tests, sleep recording tools,clinical, human performance measurement and circadian variations.

Summary:Sleep complaints are very common in our society. Efforts in pharmacological treatment research are therefore constantly increasing.However, evaluating effectiveness of drug treatment on sleep and sleep disorders needs to be accurate and with a multidisciplinaryanalysis approach. In the present symposia, a multidisciplinary but integrated assessment of drug effects on human sleep are presented.1. The International Pharmaco-EEG Society (IPEG) recently presented guidelines summarising the requirements for the recording andcomputerised evaluation of pharmaco-sleep data in man(1). These guidelines provide a set of recommendations enabling thestandardisation of both the experimental conditions and the data processing approaches, thereby promoting a framework aimed atfacilitating the comparison of pharmaco-sleep studies across laboratories, a crucial aspect in the context of drug development programsand the evaluation of the CNS penetration or toxicity of compounds. Ultimately, this standardisation will enable the pooling of datawhich is a requirement for sufficiently powering the validation of novel analytical algorithms and the detection of EEG-based(translatable) biomarkers. [1] Jobert M, Wilson FJ, Roth T, Ruigt GSF, Anderer P, Drinkenburg WHIM, et al.: Guidelines for therecording and evaluation of pharmaco-sleep studies in man - International Pharmaco-EEG Society (IPEG). Neuropsychobiology 2013(in press).. 2. Based on the polysomnographic (PSG) databases recorded in the EU-funded projects SIESTA and SENSATION, weestablished a normative database for sleep macro- and microstructure. The database covers healthy subjects from 20 to 95 years (90males, 99 females), nearly equally distributed in all decades. The meaningful use of this normative data requires an analysis method thatresults in unbiased and reproducible scorings. We will show examples for the usage of the database in sleep medicine (determiningdeviations of patients’ individual sleep characteristics from normative values) and sleep research (assisting in the interpretation of resultsof pharmaco sleep studies). 3. Sleep architecture and sleep EEG measures are useful translatable biomarkers of central pharmacologywith utility in drug development. However interpretation is not always straightforward due to the large number of potential endpointsand hence it can be difficult to make the clear decisions that are essential to the industry. This talk will discuss how preclinical sleep dataand knowledge of translatability can be used to generate robust hypotheses for testing in early clinical studies and hence enable robustdecision-making. 4. Activity-based sleep-wake monitoring using accelerometer-based devices (actigraphy) has become a major tool insleep research and sleep medicine, as a potential alternative to the standard neurophysiological techniques ( polisomnography). Severalreviews have established the use of actigraphy as a reliable and valid assessment method to document sleep-wake patterns, circadianactivity and daytime sedation in pharmaco-sleep studies, not only to evaluate the acute drug effects, but particularly when there is aneed to assess the drug effects on the rest-activity cycle over long time periods. Moreover, it has the advantage of providing objectiveinformation of the repercussion of the drug administration in the patient's natural sleep environment and habits or to ensure thecompliance in drug development. 5. The assessment of drug effects on psychometrics of psychological performance, cognitive functionand memory will be presented. Translational evaluation of these drug effects on sleep by means of different objective tests, skills,physiological and subjective rating scales will be discussed.

Guidelines for pharmaco-sleep studies in manPeter Anderer (Austria)

The importance of objective assessments of home sleep patterns in sleep research and healthcareBarry T. Peterson (USA)

Multidisciplinary and translational evaluation of drugs effects on sleep.Rapahelle Winsky Sommerer (UK)

62

MO

ND

AY


DS-M-04: Work, School, Sleep, and Occupational Health and Safetyin Adolescents and Young Adults

Ticket required - purchase at registration desk

Chair:Luc Laberge (Canada)

Speakers:Luc Laberge (Canada), Frida M. Fischer (Brazil), Christopher P. Landrigan (USA), Lilian R. Teixeira (Brazil)

Learning Objectives:• Describe the consequences of long working hours on sleep, academic performance, social behavior, and substance • abuse of students• Recognize the impact of long work hours and sleep restriction on occupational health and safety of students• Translate and apply recent sleep research findings into practice to promote occupational health and safety risks for physicians • in training• Acknowledge the important role played by sleep physicians and researchers in preventing sleep-related injuries and deaths by • assessment and follow-up of excessive sleepiness in their adolescent and young adult patients

Target Audience:This symposium is intended for occupational health and environmental physicians, primary care physicians, nurses,nurse practitioners, pediatricians, physician assistants, and other healthcare professionals involved in the routinepreventive care of adolescents and young adults.

Summary:Twenty-five years ago, the National Institutes of Health (NIH) targeted adolescents and young adults (ages 12 to 25 years) as apopulation at high risk for problem sleepiness. Today, excessive daytime sleepiness in this age group still constitutes a widespreadproblem and has potential deleterious effects on the individuals’ performance, health, and safety. Over the past three decades, it hasbeen noted that students in many countries have increased the amount of time they dedicate to paid work during the school year.However, sleep curtailment remains an insufficiently acknowledged factor of why employment may prove detrimental to theacademic achievement and occupational health and safety of students who work extensive hours. Also, the downside of studentemployment during the school year has been mainly discussed in terms of the number of hours dedicated to paid work (more than20 hours per week) and its relationship with sleep duration but more rarely in terms of exposure to physical, psychosocial, andorganizational work constraints. This symposium will first present the latest evidence on the relationship between sleep, workcharacteristics, and occupational health and safety in student workers. In addition, this symposium will discuss the necessaryrevisions to medical residents’ workloads and duty hours so to protect patients against fatigue-related errors and to enhance thelearning environment for doctors in training, namely by providing regular opportunities for sleep each day and each week duringresident training.

IntroductionLuc Laberge (Canada)

7:00pm - 7:15pmSocial and work factors on youth employment: impact on sleep, sleepiness and health symptomsFrida M. Fischer (Brazil)

7:15pm - 7:30pmSleep, work-related fatigue and occupational safety in student workersLuc Laberge (Canada)

7:30pm - 7:45pmResident-physicians’ sleep deprivation: effects on occupational and patient safetyChristopher P. Landrigan (USA)

7:45pm - 8:00pmIntervention studies to improve sleep duration and sleepiness among adolescents andyoung adults.Lilian R. Teixeira (Brazil)

63

MO

ND

AY


DS-M-05: Improving the Scoring of REM Sleep Without Atonia andof Muscle Activity During REM Sleep

Ticket required - purchase at registration deskChair:Marco Zucconi (Italy)

Speakers:Raffaele Ferri (Italy), Birgit Högl (Austria)

Learning Objectives:• To show a new validated visual method to better catch phasic muscle activity in different body segments and its• usefulness for diagnosing RBD• To discuss the value of including potential screening and diagnostic criteria such as an automated and/or visual• scoring techniques of tonic/phasic EMG activity during REM sleep in RBD • To apply these new methods in the clinical practice of scoring RBD polysomnography

Target Audience:This proposal is intended for clinicians, fellows, students and PSG technicians involved in patient management andscientists interest in evaluating objectively RBD and their associated features.

Summary:The main polysomnographic feature of RBD, REM sleep without atonia (RWA), needs to be better defined because its currentdescription has no quantitative character. Until now, there has not been a generally accepted consensus on how muscle activityduring REM sleep should be scored, and which muscles or muscle combinations are the most suitable for differentiating betweenRBD and non-RBD subjects. In recent years some methods have been proposed for the analysis of both the EMG activity indifferent muscles and the automatic quantification of the amplitude of the chin EMG signal during REM sleep, with the aim touse them as a markers of REM sleep atonia alteration and, eventually, to support the diagnosis of RBD. The simultaneous EMGrecording of the mentalis, flexor digitorum superficialis and extensor digitorum brevis muscles and the quantitative method (atoniaindex) will be discussed and it will be showed that the new methods are able not only to disclose differences between normalcontrols and patients with RBD, but also between nosologically different groups of patients who seem to present with differenttypes of REM sleep-related motor disturbances.

The usefulness of the Atonia Index for quantifying RSWA in RBD and in different conditionsRaffaele Ferri (Italy)

EMG activity assessment in different muscles to improve the diagnosis of RLSBirgit Högl (Austria)

64

MO

ND

AY


DS-M-06: Is There a Role for Surgery in the Management ofObstructive Sleep Apnea?


Chair:Vijaya Krishnan (India)

Speakers:Vijaya Krishnan (India), Srinivas Kishore (India), Vikas Agrawal (India)

Learning Objectives:• To determine the significance of identifying the level of obstruction and to formulate a rationale approach in the• management of Obstructive Sleep Apnea• To discuss the newer concepts of various surgical modalities available and also to decide - when not to do surgery

Target Audience:ENT Surgeon, Faciomaxillary Surgeon, Chest Physician, Sleep Physician.

Summary:There are various modalities such as drug induced sleep endoscopy, dynamic sleep MRI, Apnoeagraph are available for assessmentof level of obstruction which will help to decide appropriate surgery in properly selected cases for a successful outcome.

7:00pm - 7:05pmIs there a role for Surgery in the Management of OSAS?Vijaya Krishnan (India)

7:05pm - 7:20pmNewer concepts in addressing the palatal level obstructionSrinivas Kishore (India)

7:20pm - 7:35pmNewer concepts in addressing the Tongue base obstructionVikas Agrawal (India)

7:35pm - 7:50pmConclusion Remarks and DiscussionVijaya Krishnan (India)

65

MO

ND

AY


DS-M-07: How to Assess and Treat Sleep Disorders inPregnant Women


Co-Chairs:Rosalia Silvestri (Italy), Mauro Manconi (Switzerland)

Speakers:Rosalia Silvestri (Italy), Jennifer Hensley (USA), Mauro Manconi (Switzerland), Cinzia Castronovo (Italy)

Learning Objectives:• Learn about adverse outcomes of sleep disorders on maternal and fetal health • Learn how to assess sleep disorders in pregnancy across the trimesters• Learn safe and effective treatment options for sleep disorders in pregnancy• Discuss how to prevent and treat sleep disorders in pregnancy according to the latest evidence-based consensus• guidelines in the fields of sleep & obstetrics

Target Audience:Sleep clinicians, gynecologists, pediatricians, nurses, and sleep technicians.

Summary:The outlines and endpoints of the Italian multicenter study on sleep disorders in pregnancy will be presented to open adiscussion on the most recent data concerning the epidemiology and impact of sleep disorders across the differenttrimesters of pregnancy. The different speakers will emphasize the assessment therapy of OSAS, the prognosis andtreatment of RLS/WED in pregnancy according to the new guidelines, and the non-pharmacological approach viacognitive behavioral therapy for insomnia in pregnant women.

A Multicenter Italian Study on sleep disorders in pregnancy: the role of OSAS onmaternal and fetalRosalia Silvestri (Italy)

Prevalence & Epidemiology of WED/RLS in PregnancyJennifer Hensley (USA)

Guidelines on RLS/WED treatment in pregnancyMauro Manconi (Switerland)

A non-pharmacologic approach to insomnia treatment in pregnancy: cognitive-behavioral therapyCinzia Castronovo (Italy)

66

MO

ND

AY


DS-M-08: Periodic Limb Movements under CPAP in ObstructiveSleep Apnea Syndrome


Chair:Gimbada B. Mwenge (Belgium)

Speakers:Gimbada B. Mwenge (Belgium), Daniel Rodenstein (Belgium)

Learning Objectives:• Prevalence of PLM's in patients with severe OSAS• Changes in PLM's in these patients when treated with CPAP.• Effects of these PLM's in the absence of apneas on sleep• Relate the presence and evolution of PLM's to the long-term compliance with CPAP.

Target Audience:Physicians interested in sleep- related movements disorders and in obstructive sleep apnea diagnosis and treatment.

Summary:A large cohort of patients with complaints suggestive of OSAS was prospectively included. PLM's were determined during thediagnostic polysomnography. Patients were habituated to CPAP during 2-3 nights using the Hoffstein-Mateika pressure predictionformula. PLM's were again determined during the treatment polysomnography performed in the same week. PLM's coulddecrease, increase, or remain stable. Patients were followed for one year, and long-term compliance was obtained from the CPAPdevices. these data will be presented and analyzed.

PLM's assessment is time consuming and their added value as a diagnostic or prognostic indicator re unknown in OSAS. If PLM'sin OSAS are simple epiphenomena without influence on sleep quality, symptoms or long-term compliance with CPAP, then theycould be ignored without harm.

67

MO

ND

AY


DS-M-09: Abordaje del SAHS desde la perspectiva delORL/Clinical management of OSA: the ENT viewpoint

Ticket required - purchase at registration deskLanguage: SpanishSupported by Spanish ENT Society

Chair:Eduard Esteller (Spain)

Speakers:Enrique Fernandez Julián (Spain), Eugenio Vicente (Spain), Javier Vila (Spain), Carlos Oconnor (Spain)

Learning Objectives:Last update to ENT surgeons in the diagnosis and treatment of OSAS approach. Revision of the different indications,techniques and results to treat and exanimate airway collapsibility.

Target Audience:Advanced primarily for specialists surgeons dedicated to treat sleep disorders.

Summary:Respiratory disorders are a pathology that requires a multidisciplinary approach. Following that idea, otolaryngologisthas been and must keep fundamental. In this round table, basic guidelines are presented where the ent specialist hasmain relevance, especially in newest surgical and examination techniques to evaluate the upper airway.

7:00pm - 7:15pmSurgical planning after sleep nasoendoscopy versus awake techniques in obstructive sleep apneaEnrique Fernandez Julián (Spain)

7:15pm - 7:30pmHypopharyngeal surgery for OSASEugenio Vicente (Spain)

7:30pm - 7:45pmOther treatments for OSA other than CPAP and Surgery: the mandibular advancement splintsJavier Vila (Spain)

7:45pm - 8:00pmNasal and palatal surgery for OSAS treatment: today's indicationsCarlos Oconnor (Spain)

68

MO

ND

AY


DS-M-10: Recent Updates in the Diagnosis of Insomnia – DSM5 andICSD-3: Implications for Research and Clinical Practice


Co-Chairs:Charles Morin (Canada), Jack Edinger (USA)

Speakers:Colin Espie (United Kingdom), Jack Edinger (USA), Leon Lack (Austrailia), Charles Morin (Canada), Ruth O’Hara (USA), Michael Thorpy (USA), Kai Spiegelhalder (Germany), Eus Van Someren (The Netherlands)

Learning Objectives:• To review recent updates in the diagnosis of insomnia according to DSM-5 and ICSD-3 nosologies.• To discuss the potential implications of these changes on the epidemiology, assessment, and treatment of insomnia

Target Audience:This session is intended both for sleep medicine clinicians and researchers.

Summary:Significant changes have been made to the diagnostic criteria of insomnia in DSM-5 and ICSD-3, including theelimination of the distinction between “Primary” and “Secondary” Insomnia, the dropping of non-restorative sleepfrom the insomnia definition. This session is intended to provide a forum to review these updated diagnostic criteriaand discuss their potential implications for clinical practice and future research. Selected key issues will be addressed bythe panelists and an open discussion with follow with the audience (e.g., are these changes likely to improve casedefinition, recognition and diagnostic accuracy, and promote treatment?).

69

MO

ND

AY


DS-M-11: Movement Disorders and Sleep - A Video SeminarTicket required - purchase at registration desk

Co-Chairs:Friederike Sixel-Döring (Germany), Yves Dauvilliers (France)

Speakers:Alex Iranzo (Spain), Guiseppe Plazzi (Italy), Friederike Sixel-Döring (Germany)

Learning Objectives:• To learn the wide spectrum of motor manifestations occurring in patients with RLS and PLMS (from movements• affecting only the big toe to those affecting the whole body), and how to distinguished them from other abnormal • movements involving the lower limbs (alternating leg movements, hypnic jerks, foot tremor, etc)• To learn the wide motor (punching, kicking, gesticulations, etc) and vocal (yelling, talking, giving a speech, etc)• manifestations occurring in REM sleep. To show that the most common behaviors seen on video are prominent jerks • but may differ according to underlying pathologies.• To learn other unusual movements and behaviors (head banging, hallucinations in sleep, confusional arousals in• dementia, sleep-related eating syndrome) and vocal (stridor, catathrenia, bruxism, snoring) occurring in sleep• To learn the different manifestations of RBD in the setting of Parkinson’s disease that can be captured on video• during polysomnography• To learn how a wide variety of sleep disorders are presented as inserts in several films and cartoons

Target Audience:The sleep specialist, the movement disorder specialist and the general neurologist.

Summary:Movement disorders during sleep are common and include a wide variety of abnormal motor (punching, repetitive legmovements, jumping out of bed, seizures, head banging, etc) and vocal manifestations (shouting, crying, stridor,cathatrenia, etc) . They are usually linked to neurological conditions such as restless legs syndrome, sleepwalking, REMsleep behavior disorder, narcolepsy, epilepsy and neurodegenerative diseases including Parkinson’s disease. They shouldbe recognized by the sleep specialist, the movement disorder specialist and the general neurologist.

7:00pm - 7:12pmThe wide clinical spectrum of RLS and PLMSAlex Iranzo (Spain)

7:12pm - 7:24pmRBD spectrum, sleepwalking and nocturnal epilepsyGuiseppe Plazzi (Italy)

7:24pm - 7:36pmUnusual movements and noises occurring during sleep Alex Iranzo (Spain)

7:36pm - 7:48pmRBD in Parkinson’s DiseaseFriederike Sixel-Döring (Germany)

7:48pm - 8:00pmSleep related movement disorders in cartoons and filmsAlex Iranzo (Spain)

70

TuesdaySchedule at a Glance • Tuesday, October 1, 2013_________________________________________________________________Registration 7:00am - 9:00pm_________________________________________________________________Announcements 8:30am - 9:00am_________________________________________________________________Keynote 9:00am - 10:00am_________________________________________________________________Symposium S13-16 10:00am - 11:30am_________________________________________________________________Exhibition 11:00am - 5:00pm_________________________________________________________________Coffee Break 11:30am - 12:00pm_________________________________________________________________Symposium S17-18, Technologist Program, Oral Presentations O-6 and O-7 12:00pm - 1:30pm_________________________________________________________________Break 1:30pm - 1:40pm_________________________________________________________________UCB Industry Symposium 1:40pm - 3:10pm_________________________________________________________________SenTec Industry Symposium 1:40pm - 3:10pm_________________________________________________________________Coffee and Exhibit 3:10pm - 3:30pm_________________________________________________________________Keynote 3:30pm - 4:30pm_________________________________________________________________Posters and Oral Presentations O-8, O-9 and O-10 4:30pm - 5:30pm_________________________________________________________________Symposium S19-21 and Technologist Program, Oral Presentation O-12 5:30pm - 7:00pm_________________________________________________________________Discussion Symposium 7:00pm - 8:00pm_________________________________________________________________WASM Member Meeting 8:30pm - 9:30pm_________________________________________________________________

71

TU

ESD

AY

Tuesday, October 1, 2013 9:00am to 10:00am • Auditorium 1

Keynote: Circadian Disorders and Associated Risks

Phyllis Zee, MDNorthwestern University, Feinberg School of Medicine USA

Dr. Zee's research has focused on the effects of age on sleep and circadian rhythms, genetic regulation of circadian sleep disorders, and behavioral interventions toimprove sleep and performance. Current NIH-funded research projects include studies to examine the ability of exercise to improve sleep and health in older peoplewith insomnia, phenotypic characterization and genetic analysis of circadian rhythmsleep disorders, relationship between sleep, metabolic and cardiovascular risk and the effects of age on the neural response to sleep loss.

Notes:

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

72

TU

ESD

AY


S13: Sleep, Circadian Rhythms and Brain Health in Aging

Co-chairs:Aleksandar Videnovic (USA), Nadia Gosselin (Canada)

Speakers:Symposium Chairs (USA/Canada), Sonia Ancoli-Israel (USA), Nadia Gosselin (Canada), Aleksandar Videnovic (USA),Alex Iranzo (Spain), Alpar S. Lazar (United Kingdom)

Learning Objectives:• Discuss sleep and circadian dysfunction in Alzheimer's disease.• Understand the impact of sleep disordered breathing on cognition.• Discuss how circadian dysregulation and impaired sleep-wake cycle impact Parkinson's disease.• Understand the interface of RBD and neurogenerration.• Identify sleep and circadian rhythms disturbances in Huntington's disease.

Target Audience:Practitioners, academicians, residents, postdoctoral fellows.

Summary:Sleep dysfunction in neurological diseases remains frequently under-recognized by physicians and under-reported bypatients. Some of the clearest evidence of the bidirectional relationship between sleep and circadian rhythms andexpression of disease is seen in neurodegenerative disorders. This program emphasizes the role of impaired sleep,alertness and circadian rhythmicity in three major neurodegenerative disorders, AD, PD and HD. REM sleep behaviordisorder and its associations with neurodegenerative disorders will be discussed. The program encompasses fields ofneurodegeneration, sleep, and circadian biology, integrating basic science with clinical practice of neurology and sleepmedicine. Greater understanding of the underlying mechanisms of circadian and sleep disturbances has transformativepotential for neurodegenerative disorders and provides new dimension in neurology and sleep medicine.

10:00am - 10:05amIntroductionSymposium Chairs (USA/Canada)

10:05am - 10:20amSleep and circadian disorders and their management in Alzheimer’s diseaseSonia Ancoli-Israel (USA)

10:20am - 10:35amConsequences of obstructive sleep disordered breathing on cognition and brain healthin the elderlyNadia Gosselin (Canada)

10:35am - 10:50amSleep and Circadian Rhythm Dysfunction - Implications for Parkinson’s DiseaseAleksandar Videnovic (USA)

10:50am - 11:05amREM sleep behavior disorder and neurodegenerative diseasesAlex Iranzo (Spain)

11:05am – 11:20amDisruption of Sleep and Circadian Timing in Huntington's DiseaseAlpar S. Lazar (United Kingdom)

11:20am – 11:30amQuestion and answerSymposium Chairs (USA/Canada)

73

TU

ESD

AY


S14: Explaining Differences in Epidemiology of Sleep DisordersAcross the World: The Case of SDB and RLS

Chair:Diego Garcia Borreguero (Spain)

Speakers:Diego Garcia Borreguero (Spain), Manuel Sanchez de la Torre (Spain), Klaus Berger (Germany), Yuichi Inoue (Japan),Juliane Winkelman (USA), Christian Guilleminault (USA)

Learning Objectives:• Relationship between sleep metabolism, circadian rythm and cancer risk• Sleep disturbances and cancer risk (especially sleep duration)• Role of Melatonine and hypnotic treatments in cancer• New discoveries. Intermittent hypoxia and cancer in animal models• New discoveries. Sleep apnea and risk of cancer. Incidence and mortality• The future. New studies needed and the role sleep disorders treatment in cancer

Target Audience:Everyone with interest in sleep disorders.

Summary:There are differences in the rate of sleep disorders throughout the world, and genetics behind these disorders may explainthese differences, genetic and epidemiology are very much linked when considering our understanding of the clinical findings.Two major sleep disorders are considered in the symposium: OSA and RLS. The current understanding of the genetics behindOSA will be presented, and the racial differences in OSA noted in a multi-racial population (Australia) will be outlined.Similarly, prevalence of RLS has been consistently high in western countries; however studies performed in non-Caucasianshave been lower. Our understanding of the genetics behind these disorders may explain some of the discrepancies noteddepending of the racial presentation.

10:00am - 10:05amIntroductionDiego Garcia Borreguero (Spain)

10:05am - 10:20amGenetics of Sleep ApneaManuel Sanchez de la Torre (Spain)

10:20am - 10:35amRacial differences in sleep-disordered breathing specific populationChristian Guilleminault (USA)

10:35am - 10:50amRLS prevalence around the world – numbers, methods, and interpretationsKlaus Berger (Germany)

10:50am - 11:05amRLS epidemiology in Asia: The Japanese perspectiveYuichi Inoue (Japan)

11:05am - 11:20amDifference in ethno-genetics predisposition to RLS across the worldJuliane Winkelman (USA)

11:20am - 11:30amQuestion and answerDiego Garcia Borreguero (Spain)

74

TU

ESD

AY

Tuesday, October 1, 2013 10:00am to 11:30am • Committee Rooms 1 and 2

S15: Pregnancy and Sleep

Chair:Leigh Signal (New Zealand)

Speakers:Louise O’Brien (USA), Mauro Manconi (Switzerland), Maria Sarberg (Sweden), Leigh Signal (New Zealand)

Learning Objectives:• Understand how sleep changes during pregnancy and how these changes impact health, particularly the need for

medical intervention at birth and maternal mental health.• Educate Sleep clinicians and researchers on the need to consider pregnant women with sleep disorders differently than

the general population.• Suggest new field of research on sleep and woman.

Summary:Pregnancy is a period when sleep change and some of the changes may have negative outcome for women andoffspring. An understanding of these changes and to recognize them to prevent as much as possible negative outcome isan important goal. Mother may present significant and dangerous depression that may imacvt well been of both motherand child. Sleep in late pregnancy will have a clear impact in general on the immediat post-partum period. Andpresence or development of well-known sleep disorders such as abnormal breathing during sleep and Restless Leg willimpact both mother and child. The understanding on how fetal development may be affected, and also how motherhealth can be greatly disturb will be presented in this symposium

IntroductionLeigh Signal (New Zealand)

Snoring in pregnancy: Effects on the offspringLouise O’Brien (USA)

Restless legs and pregnancy - when, how and why?Mauro Manconi (Switzerland)

Sleeping problems and post-partum depressionMaria Sarberg (Sweden)

Sleep in late pregnancy and the relationship to maternal healthLeigh Signal (New Zealand)

75

TU

ESD

AY

Tuesday, October 1, 2013 10:00am to 11:30am • Multipurpose Room 1S16: Interpreting and Evaluating Parasomnias: New Perspectives

Chair:Federica Provini (Italy)

Speakers:Federica Provini (Italy), Lino Nobili (Italy), Isabelle Arnulf (France), Thanh Dang-Vu (Canada)

Learning Objectives:To understand that sleep is not simply a quiescent state, but can involve behaviours of varying complexity. Tounderstand that during arousal disorders EEG features of sleep and wakefulness might be simultaneously present indifferent cerebral regions suggesting that sleep depth is not evenly distributed within the brain. To understand thatdreamlike mentation may occasionally exist during arousal disorders, suggesting that a complex mental activity alsotakes place during SWS. To understand how neuroimaging methods might be a useful approach to assess the structuraland functional correlates of sleep impairments enhancing our understanding of the pathophysiological mechanisms ofsleep disorders, including parasomnias. To understand that wake and sleep behaviour and body homeostasis arecontrolled by a neuronal network running from the brainstem to the cerebral cortex and working in a unitary fashionaccording to a caudorostral organization.

Target Audience:Neurologists, Paediatricians, Psychiatrists, Psychologists Level of symposium: advanced.

Summary:Parasomnias are very common, especially among children, but there are many misconceptions about them andneuropathological abnormalities have not been identified for most of the common parasomnias. The study ofparasomnias provides unique opportunities to understand the mechanisms that regulate sleep and wakefulness. In thissymposium we will present recent data obtained using intracerebral electroencephalographic recordings suggesting thatarousal disorders are not a global cerebral phenomenon, but the coexistence of different local states of being. We willpresent the latest data on the complex mental activity taking place during REM and NREM parasomnias and thespecific changes in brain structure or regional activity obtained with functional neuroimaging techniques. Lastly, wewill present data on Agrypnia Excitata (AE), a syndrome characterized by loss of sleep and permanent motor andautonomic hyperactivation, making some general reflections on the composition and function of the cerebral neuronalnetwork generating wake and sleep behaviour and regulating body homeostasis.

10:00am - 10:05amIntroductionFederica Provini (Italy)

10:05am - 10:25amLocal activations in Parasomnias: data from intracerebral recordingsLino Nobili (Italy)

10:25am - 10:45amSleep mentation during NREM and REM parasomniasIsabelle Arnulf (France)

10:45am - 11:05amNeuroimaging of REM and NREM parasomniasThanh Dang-Vu (Canada)

11:05am - 11:20amOneiric stupor and agrypnia excitataFederica Provini (Italy)

11:20am – 11:30amQuestion and answerFederica Provini (Italy)

76

TU

ESD

AY

Tuesday, October 1, 2013 12:00pm to 1:30pm • Committee Room 1

O-06: Parasomnia, Neural Plasticity, and Neurological Disorders

Co-Chairs:Sudhansu Chokroverty (USA), Federica Provini (Italy)

The effect of obstructive sleep apnea on declarative memory consolidationIna Djonlagic (USA)

Screening for sleep dysfunction after traumatic brain InjuryTatyana Mollayeva (Canada)

REM sleep behavior disorder following cerebrovascular stroke : A polysomnographic study in an Egyptian sampleTarek Asaad (Egypt)

Prevalence of nightmares among the general Finnish adult population and veterans of the second world warNils Sandman (Finland)

Sleep enactment behaviors in Parkinson's disease and multiple system atrophy: Beyond REM behavior disorderPietro-Luca Ratti (France)

"I cannot sleep if I don't eat" a dysfunctional beliefs could sustain nocturnal eatingPiergiuseppe Vinai (Italy)


12:00pm-1:30pm • Committee Rooms 3 and 4W3 Performing and Interpreting the MSCT

77

TU

ESD

AY

Tuesday, October 1, 2013 12:00pm to 1:30pm • Auditorium 3

O-07: Sleep Breathing Disorders

Co-Chairs:Joaquin Terán (Spain), Makoto Kikuchi (Japan)

Patients with severe/moderate asthma crisis show abnormal Stanford sleepiness scale scoreCarolina Fransolin (Brazil)

Neuropsychiatric consequences in sleep breathing disordersAntje Buettner-Teleaga (Germany)

A dentist in a sleep medicine specialist team: first results for the treatment of obstructive sleepapnea patients with oral appliancesMarco Zucconi (Italy)

Circulating FABP4 and subclinical atherosclerosis in obstructive sleep apnea syndromeRaquel Català (Spain)

Allergy as a risk factor for sleep disordered breathingLia Oliveira (Portugal)

Safety and efficacy of upper airway stimulation in treatment of obstructive sleep apneaPatrick J Strollo, Jr (USA)

78

TU

ESD

AY


S17: Novel Insights into Cardiometabolic Mechanisms of OSA

Co-chairs:Jan Hedner (Sweden), Brian Kent (Ireland)

Speakers:Jan Hedner (Sweden), Brian Kent (Ireland), Richard Schulz (Germany), Jan Hedner (Sweden),Nikolas Büchner (Germany), Ludger Grote (Sweden)

Learning Objectives:To expand on the epidemiological association between OSA and cardiometabolic disease. To review hypoxic pathwaysthat potentially link OSA with cardiometabolicdisease. To understand and apply appropriate measures of cardiovasculardysfunction in OSA.

Target Audience:Physicians and researchers with an interest in sleep disordered breathing and its links to cardiometabolic disease.Level: Advanced

Summary:This session aims to describe novel insights into the association between sleep disordered breathing and cardiometabolicdisorders. Speakers will address information from large scale epidemiological data bases. Novel mechanisms linkingOSA and cardiovascular and metabolic disease will be presented. Additional topics include new methods and targets tocharacterize cardiovascular disease in OSA.

IntroductionJan Hedner (Sweden)

Cardiometabolic disorders in European sleep apnea patientsBrian Kent (Ireland)

Oxidative stress and cardiometabolic disease in OSARichard Schulz (Germany)

Acid-base balance and carbonic anhydrase activity in OSA and its complicationsJan Hedner (Sweden)

Vascular hemodynamics in OSA - What is appropriate to monitor?Nikolas Büchner (Germany)

Assessment of vascular function by continuous monitoring in OSALudger Grote (Sweden)

Question and answerJan Hedner (Sweden)

79

TU

ESD

AY

Tuesday, October 1, 2013 12:00pm to 1:30pm • Multipurpose Room 1

S18: Those Comorbidities that Invade the Night:Treating Sleep Problems in Patients with Psychiatric Disorders

Chair:Jack D. Edinger (USA)

Speakers:Jack D. Edinger (USA), Colleen E. Carney (Canada), Anne Germain (USA), Daniel Freeman (United Kingdom)

Learning Objectives:• Discuss and demonstrate helpful intervention strategies for managing patients with comorbid depression or nocturnal

panic attacks• Demonstrate how to implement Imagery Rehearsal Therapy for Chronic nightmares• Demonstrate the implementation of graded exposure therapy for CPAP-related anxiety and claustrophobic reactions

Target Audience:Clinicians who wish to learn how to implement a number of useful behavioral sleep medicine interventions with patients thathave complicating comorbidities associated with their sleep problems. Sleep researchers interested in the nature and impact ofmood and anxiety disorders on comorbid sleep problems.

Summary:Patients who present with sleep complaints in association with comorbid anxiety and mood disorders representsignficant challenges to providers charged with their management. Although various behavioral sleep medicine strategieshave been developed for managing the anxiety and mood problems that commonly occur in association with varioussleep disorders, many sleep professionals do not have training or skills in implementing these techniques. Thissymposium will review the evidence for and methods of managing common mood related and anxiety problemspresented by sleep disorders patients. Specific techniques for managing obstacles to adherence with CBT related todepression and noturnal panic attacks will be presented. Methods for dealing with CPAP-related claustrophobia and therecurrent nightmares common in patients with PTSD will be discussed and demonstrated via video vignettes.

12:00pm - 12:02pmIntroductionJack D. Edinger (USA)

12:02pm - 12:22pmGraded Exposure Therapy for Claustrophobic Reactions to CPAP TherapyJack D. Edinger (USA)

12:22pm - 12:42pmManagement of sleep disturbances due to nocturnal panic attacksColleen E. Carney (Canada)

12:42pm - 1:02pmImagery rehearsal therapy for anxiety-provoking dreams and nightmaresAnne Germain (USA)

1:02pm - 1:22pmTargeted CBT for Insomnia Symptoms in SchizophreniaDaniel Freeman (United Kingdom)

1:22pm – 1:30pmQuestion and answerJack D. Edinger (USA)

80

TU

ESD

AY

Box Lunch:Box lunch is provided to satellite symposia attendees. Delegates can purchasea lunch ticket for Wednesday prior to noon Tuesday for a cost of 10 € at theregistration desk.

Tuesday, October 1, 2013 1:40pm to 3:10pm

Auditorium 1

Time to Break the RLS/WEDTreatment Paradigm

Co-Chairs:Diego Garcia Borreguero (Spain), Yves Dauvilliers (France)

Agenda:

An RLS/ WED patient's journey: examining thedaily and long-term disease burden; what mat-ters most and why Luigi Ferini- Strambi (Italy)

RLS/WED treatment guidelines: Rotigotine'sbenefit/ risk ratio Alex Iranzo (Spain)

New Milestones for the PLMs/RLS/ CV risktriad: an evaluation of literature and the EN-CORE trial Claudia Trenkwalder (Germany)

Impact and role of co-morbidities andRLS/ WED David Rye

Sponsor:

Tuesday, October 1, 2013 1:40pm to 3:10pm

Multipurpose Room 1

Transcutaneous CO2 Monitoringand its Role in Sleep Medicine

Agenda:

Principles and evolution of PtcCO2measurementsJan H. Storre (Germany)

Adults with Hypoventilation Syndromes:A North American PerspectivePatrick J Strollo, Jr., MD, FCCP, FAASM USA)

The Importance of noninvasive ventilationmonitoring during sleep. The role of PCO2monitoring Dr. J. Terán Santos, M.D. (Spain)

Sponsor:

81

TU

ESD

AY


Keynote: Neurobiology of Sleep

Pierre-Hervé Luppi, PhDCentre National de la Recherche, ScientifiqueFrance

Sleep researcher since 1983. Specialized in paradoxical (REM) sleep.

Notes:

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

82


O-08: Insomnia Treatment

Chair:Lynda Bélanger (Canada)

Insomnia treatment in the third trimester of pregnancy prevents postpartum depression:A randomized clinical trialMasoud Tahmasian (Iran)

Impact of comorbidity on insomnia treatment response following cognitive-behavior therapy,behavior therapy, and cognitive therapyLynda Bélanger (Canada)

Is insomnia treatment superior to depression treatment for patients with both diagnoses? -Results of a randomized controlled trialKerstin Blom (Sweden)

Cognitive training improves sleep quality and cognitive function among older adults with insomniaIris Haimov (Israel)

_____________________________________________________________________


O-09: Neurobiology of RLS/PLMS

Chair:Yong-Won Cho (Republic of Korea)

Activity and sleep in a mouse model of Parkinson’s diseaseIrina Zavalko (Russia)

Hyperactivity and alterations in iron homeostasis in mu opioid receptor knockout mice:Possible implications for Restless Legs Syndrome/Willis-Ekbom DiseaseMark DeAndrade (USA)

Peripheral hypoxia in patients with restless legs syndromeAaro Salminen (Finland)

PTPRD expression regulates sleep consolidation in drosophilaAmanda Freeman (USA)

83

TU

ESD

AY

Tuesday, October 1, 2013 4:30pm to 5:30pm • Committee Rooms 1 and 2

O-10: Pediatrics Sleep Breathing Disorders

Co-Chairs:Daniel Ng (Hong Kong), Suresh Kotagal (USA)

Child Sleep – The Finnish birth chort study: The effect of maternal sleep during pregnancy on anewborn wellbeing and a mother’s labor experienceOuti Saarenpää-Heikkilä (Finland)

Sleep patterns at 6 months and 4/5 years of age in a Portuguese birth cohortMarta Gonçalves (Portugal)

Sleep onset delay and night awakenings in preschool children: the Generation XXI birth cohortAna Rute Costa (Portugal)

Sleep Cyclic Alternating Pattern (CAP) changes from school-age to adolescence in healthy subjectsPatricio Peirano (Chile)

84

TU

ESD

AY

TU

ESD

AY


S19: Pain, Opioids and Sleep Breathing Disorder -An Interaction to Manage

Co-chairs:Gilles Lavigne (Canada), Raphael Heinzer (Switzerland), Michael T. Smith (USA)

Speakers:Gilles Lavigne (Canada), Giancarlo Vanini (USA), Michael T. Smith (USA), Raphael Heinzer (Switzerland),Christian Guilleminault (USA)

Learning Objectives:• Understand the interaction between pain conditions and sleep breathing.• Understand the perception of pain in presence of sleep breathing disorders.• Understand and estimate the risk of pain management on sleep breathing disorders.• Explore alternative avenues to manage concomitant pain and breathing disorders.

Target Audience:Physicians, dentists, psychologists, nurses and investigators in sleep and pain management and in research.

Summary:Chronic pain is concomitant in many patients with sleep disorders. Pain perception can be modified by the changes inbreathing. Use of opioids, e.g., codeine or morphine, can aggravate breathing disorders. The pain specialist needs tobetter understand such risk, from basic science up to clinical consequences. Alternative in pain management needs tobe discussed. Sleep specialist should be able to guide pain colleagues facing sleep disorders breathing cases.

5:30pm - 5:40pmIntroduction to the interaction between pain and respirationGilles Lavigne (Canada)

5:40pm - 6:00pmNeurochemical control of pain, sleep and breathingGiancarlo Vanini (USA)

6:00pm - 6:20pmSleep disorders and pain perceptionMichael T. Smith (USA)

6:20pm - 6:40pmOpioids and nocturnal breathing disordersRaphael Heinzer (Switzerland)

6:40pm - 6:50pmTake home message on safety and efficient pain relief Christian Guilleminault (USA)

6:50pm – 7:00pmGeneral discussion


5:30pm-7:00pm • Committee Rooms 3 and 4W4 CPAP Masterclass: Mask Fitting, Compliance issues, Titration

85

TU

ESD

AY


S20: Sleep and Glucose Metabolism

Chair:Karine Spiegel (France)

Speakers:Karine Spiegel (France), Luiz Menna-Barreto (Brazil), Rachel Leproult (Belgium), Mark Barone (Brazil)

Learning Objectives:• Understand how sleep loss affects metabolism, leading to type 2 diabetes mellitus;• Understand the association between poor glycemic control and sleep impairments;• Understand rhythmicity as an important component to health.

Target Audience:Researchers who work in the field of sleep restriction, sleep disorders and diabetes; Clinicians, and Health Care Professionalsin general. Although the topic is very specific, the present Symposium will be comprehensible by the Congress audience.

Summary:In this Symposium, the association of diabetes mellitus and sleep impairment will be explored. Some of the most recentfindings concerning how sleep loss favors the development of diabetes and impact glycemic control, and, conversely,how glycemic impairment may affect sleep, will be discussed. The effects of circadian misalignment on glucosemetabolism will also be discussed.

5:30pm - 5:35pmIntroduction with some consideration about the topicKarine Spiegel (France)

5:35pm - 6:00pmInsulin Resistance and Sleep/Wake Cycle, how the impairment of these rhythms lead to diseasesLuiz Menna-Barreto (Brazil)

6:00pm - 6:25pmImpact of sleep loss and circadian misalignment on diabetes riskRachel Leproult (Belgium)

6:25pm - 6:50pmSleep and type 1 diabetes, what is the association?Mark Barone (Brazil)

6:50pm – 7:00pmQuestion and answerKarine Spiegel (France)

86

TU

ESD

AY


S21: Sleep Apnea and The Adipocyte: Trends and Treatments

Chair:Gary S. Richardson (USA)

Speakers:Gary S. Richardson (USA), Joseph M. Ojile (USA), David M. Rapoport (USA)

Learning Objectives:• The participant will become familiar with the physiology of the adipocyte, including central mechanisms controlling

appetite and metabolism• The participant will appreciate the multidirectional relationships among sleep, sleep apnea and obesity—both the

mechanisms linking obesity to sleep pathology and those linking sleep disturbance to obesity• The participant will review and evaluate data regarding CPAP as a therapy that effectively addresses the underlying

obesity factor • The participant will examine and evaluate the current data as a compelling factor in potential changes in treatment for

Sleep Apnea

Target Audience:Physicians in sleep medicine, endocrinology and internal medicine in academic, research and clinical settings. Research andclinical scientists and clinical technologists and medical providers (Advanced Practice Nurses, Physicians Assistants) at anadvanced level.

Summary:The symposium will provide an accessible overview of the multidirectional relationships among sleep, sleep apnea andobesity. Recent advances have substantially enhanced our understanding of the basic physiology of the adipocyte, andof the role of adipose inflammation in the pathogenesis of obesity and insulin resistance. As these mechanisms areelucidated, it also becomes clear that obstructive sleep apnea (OSA), with attendant hypoxia and sympathetic nervoussystem (SNS) activation, represents a singular challenge to the adipocyte, and potently accelerates the indigenousinflammatory response. These data also provide a basic foundation for the observed relationships among OSA andinsulin resistance and the metabolic syndrome, and highlight a second path connecting obesity, inflammation, cytokinesand persistent sleepiness in OSA patients after CPAP therapy. Recent work suggests that adipose remodeling inresponse to OSA may not be reversible with treatment of the hypoxia and sleep disruption. These results provide aperspective for consideration of the growing body of clinical data examining the effects of CPAP therapy on obesitymeasures. Several recent controlled and open trials of CPAP in OSA have produced a mixed picture of the impact ofcurrent OSA therapy on obesity and its consequences. Last, the faculty will consider whether these data should dictatethe consideration of alternate treatment strategies that more directly address the adipose tissue pathology.

5:30pm - 5:35pmIntroductionGary S. Richardson (USA)

5:35pm - 6:00pmThe physiology of sleep, sleep disorders and the adipocyteGary S. Richardson (USA)

6:00pm - 6:25pmDoes CPAP therapy effectively address the underlying obesity factor?Joseph M. Ojile (USA)

6:25pm - 6:50pmDoes available data on the bi-directionality of sleep apnea and obesity support changes in treatment? David M. Rapoport (USA)

6:50pm – 7:00pmQuestion and answerGary S. Richardson (USA)

87


O-12: Narcolepsy and Excessive Daytime Sleepiness

Co-Chairs:Michel Billiard (France), Joan Santamaría (Spain)

What is idiopathic hypersomnia without long sleep? Rethinking the definitions by sleepwake diary dataAndrea Rodenbeck (Germany)

Optogenetic activation of specific neurons to ameliorate symptoms of narcolepsy in micePriyattam Shiromani (USA)

The effects of sodium oxybate treatment on vigilance impairment in narcolepsy – a comparisonbetween in-field and in-laboratory measurementsMojca van Schie (e Netherlands)

EIF3G is associated to narcolepsyAnja Holm (Denmark)

CSF hypocretin level in patients with Kleine-Levin syndromeQinghua Li (China)

88

TU

ESD

AY


DS-T-01: Psychology and InsomniaTicket required - purchase at registration desk

Chair:Wang Weidong (China)

Speakers:Wang Weidong (China), Liu Yanjiao (China), Zhang Haisheng (China)

Learning Objectives:• To know the potential psychopathological factors for insomnia• To get knowledge about an indigenous psychotherapy in China• To get understanding into how to get rid of hypnotic drugs gradually combining with Complementary alternative medicine• To get information about the characteristics of insomnia patients in general hospital in China

Target Audience:Those who are interested in psychological treatment, non-drug therapy, Chinese medical treatment for insomnia.

Summary:In China, a lot of insomnia patients come to Chinese medicine hospital for treatment, as they are worried about theside effects of hypnotic drugs. In addition, we have found that various psychological factors are contributing to gettinginsomnia. We are hoping to share our research and clinical experiences with colleagues from the world. The topics willinvolve following: personality, psychopathology and insomnia; Low Resistance Thought Induction Psychotherapy forinsomnia; Relaxation Therapy in Chinese medicine for insomnia.

7:00pm - 7:15pmSleep regulation technique of low resistance thought induction psychotherapy for insomniaWang Weidong (China)

7:15pm - 7:30pmHow to combine Chinese medical methods into insomnia treatmentLiu Yanjiao (China)

7:30pm - 7:45pmThe latest development of low resistance thought Imprint psychotherapy sleep-regulatingtechnique of insomniaZhang Haisheng (China)

7:45pm - 8:00pmQuestion and answer

89

TU

ESD

AY


DS-T-02: Sleep Habits and Sleep Environment in Rural Living andNative Communities of South AmericaTicket required - purchase at registration desk

Chair:Birgit Högl (Austria)

Speakers:Birgit Högl (Austria), Fernando Louzada (Brazil)

Learning Objectives:• To appreciate cultural differences in sleep habits• To learn about sleep disorders in native communities• To understand the specific facts which have an impact on sleep in these communities

Target Audience:Sleep specialists (neurologists, psychiatrists, psychologists, internal medicine physicians, technicians).

Summary:After attending the symposium participants shall be able to appreciate the specific conditions and circumstancesimpacting sleep habits and sleep health in individuals belonging to native communities in rural areas of South America,to appreciate cultural differences in sleep habits.

90

TU

ESD

AY

TU

ESD

AY


DS-T-03: Quality Assurance in Sleep MedicineTicket required - purchase at registration desk

Chair:Geert Mayer (Germany), Andrea Rodenbeck (Germany)

Speakers:Juergen Fischer (Germany), Andrea Rodenbeck (Germany), Alexander Blau (Germany)

Learning Objectives:• Quality of accreditation• Assessment of process quality of diagnosis and therapy of sleep disorder• Networking as part of assurance quality

Target Audience:Boards of National Sleep Societies and of sleep technologists and officials of Health Authorities.

Summary:Quality of health care is a sufficient, patient-orientated, evidence based and qualified professional process aimingat increasing requested therapy results in individuals as well as in the population in total. In order to improvecontinuously the quality of health care in German sleep labs, the German Sleep Society (DGSM) established anaccreditation process that has been incorporated at the European level. Accreditation is assurance of structural qualityof sleep centers. Sleep that pass the examination are accredited by the DGSM. In a second step external structuredpeer-review quality rating program was initiated, which has become mandatory for DGSM accredited sleep centers in2004. Rating in 2001 and 2011 show that participation increases process quality. The efforts to collect the data fromsleep labs and distribute them to the three reviewers is very time and material consuming. The DGSM thereforeinitiated an electronic database that meets all the European Security requirements to exchange this data. The detailswill be presented and discussed with the audience. The material will be available for other Sleep Societies.

Quality of structure, process, and outcome – first steps and impact on the European levelJuergen Fischer (Germany)

Quality assessment as a mandatory part of re-accreditation – the peer-review programAndrea Rodenbeck (Germany)

SomnoNetz – an online solution Alexander Blau (Germany)

_____________________________________________________________________


DS-T-04: Unusual Nocturnal Behavior in Pediatrics - DifferentiatingSeizures from Non-Epileptic Events: A Video-Case Discussion


Chair:Shelly K. Weiss (Canada)

Speakers:Shelly K. Weiss (Canada), Oliviero Bruni (Italy), Lino Nobili (Italy)

Learning Objectives:• Develop an approach to the evaluation and management of children who present with unusual nocturnal behavior • Apply this knowledge when presented with children who have unusual nocturnal behaviors

Target Audience:Pediatric and adult health professionals who evaluate children with sleep disorders.

Summary:It may be challenging for the clinician to differentiate parasomnias from nocturnal seizures in children. In this interactivesession, which will be entirely case based, pediatric cases will be shown demonstrating different seizure vs non-epilepticdisorders. Each case will generate discussion regarding the evaluation and management of the cases presented.

91

TU

ESD

AY


DS-T-05: Women Are From Venus and Men Are From MarsTicket required - purchase at registration desk

Chair:Nese Dursunoglu (Turkey)

Speaker:Nese Dursunoglu (Turkey), Dursun Dursunoglu (Turkey)

Learning Objectives:Although the greater sleep-apnea prevalence in men has raised the concern that a selection bias for referral and identificationof the diagnosis may favor men, women also come to the clinical interview accompanied by their partner less frequently thanmen. OSAS has also been implicated as an independent risk factor for cardiovascular diseases such as myocardial infarction,hypertension, heart failure, arrhytmias and stroke . In addition, it was shown that especially female patients referred to thesleep clinics, evaluation of metabolic syndrome criteria may play an important role in predicting severe OSA with highsensitivity (86.6%) and negative predictivity (85.7%).

Summary:Women with obstructive sleep apnea (OSA) may be under-diagnosed due to circumstances related to the family lifestyleand socio-cultural factors. Studies have reported that 33-51% of women show a dramatic increase in sleep disturbancein the mid-life years, a time when they enter menopause. Menopause is an established risk factor for SDBPrimary carephysicians should be aware of OSA in women and the importance of referring women for sleep studies when theycomplain of symptoms associated with OSA, even if other non-specific symptoms such as morning headaches arereported. Also, hypothyroidism and depression are accompanied with sleep disorders especially in women.

_____________________________________________________________________


DS-T-06: Can We Prevent OSA?Ticket required - purchase at registration desk

Chair:Makoto Kikuchi (Japan)

Speakers:Tomonori Iwasaki (Japan), Makoto Kikuchi (Japan), Christian Guilleminault (USA)

Learning Objectives:• Sleep Apnea Prevention Orthodontic treatment Adenotonsilectomy Craniofacial growth

Target Audience:All the physician, Dentists, Orthodontists, polysomnographer, the level of symposium content (basic),

Summary:There is no evidence about the prevention of sleep apnea at this moment, however we could have a dream and discussabout the prevention in the cozy atmosphere at Tapas symposium. We could make the airway enlarged by theorthodontic treatment and we could make the airway patency by removing adenoids & Tonsils. These could be theways of prevention of sleep apnea if we know how to grow the craniofacial region.

Tongue posture improvement and pharyngeal airway enlargement as secondary effectsof rapid maxillaryTomonori Iwasaki (Japan)

Jumping the bite for enlarging the airwayMakoto Kikuchi (Japan)

Can we prevent OSA?Christian Guilleminault (USA)

92

TU

ESD

AY


DS-T-07: Chronobiology/Circadian DisordersTicket required - purchase at registration desk

Chair:Luciane Ruiz Carmona Ferreira (Brazil)

Speaker:Luciane Ruiz Carmona Ferreira (Brazil), Milva Maria Figueiredo De Martino (Brazil)

Summary:Introduction:Due to the increasing industrialization of society, the work in shifts is becoming increasingly common, as well as thedevelopment of night work, although with a pronounced negative effect on the workers sleep, performance and health.

Objective:To investigate the patterns of sleep-wake cycle and the circadian rhythmicity of peripheral body temperature, throughmeasures taken at the wrist of nursing students who studies during the day and works on the night shift.

Methods:Longitudinal descriptive study, with a quantitative approach, involving 27 adult subjects, nursing assistants and technicianswho worked in the night shift and were students of undergraduate nursing of a private college in São Paulo State, during thedaytime. The following instruments were used: Identification Form, Morningness Eveningness Questionnaire of Horne andÖstberg, Sleep Diary, for 32 days, divided into school term and school vacations, and a thermistor (Thermochron iButton)on the non-dominant hand wrist to check the temperature of the wrist every 30 minutes.

Results:The adjustment of the temperature data of the wrist to a cosine curve, within a 24-hour period, a significantrhythmicity was verified in 35.3% of subjects in the school term and 93.7% of subjects in the vacation period, apartfrom the existence of different rhythms of the 24 hours such as 12 and 16 hours. There was a statistically significantdifference in the time that the acrophase occurred, when comparing the school term on the days-off and on workingdays (p <0.0001), school vacation on the days-off and working days (p<0.0001) The sleep time during the schoolvacation was higher when the subjects didn’t sleep immediately after work. There was a significant difference whencomparing the sleep time on the vacation period and days off (8:34) and school term and days off (7:24), p<0.0001,and also on vacation on working days (4:19), p=0.0496. Middle Phase of Sleep (MPS) there was a statisticallysignificant difference between the school and vacation periods on working days and days off.

Conclusion:The presence of rhythms different than 24 hours, was observed especially during the school term, and the phase transferof the wrist temperature, according to the period of work/study, with phase opposition on working days whencompared to days off. The greatest spectral power was observed in the 24-hour rhythm, either during school term orvacation, confirming the hypothesis that the region of the wrist shows a well-defined and robust rhythmic expression.The findings reinforce the idea that the study favors the establishment of routine, but has little influence in displacingthe body temperature, wich proved to be strongly influenced by the night shift work. Similar to the acrophase, the MPSshowed great diversity in times of occurrence, but with a phase relation maintained between the rhythms on thedifferent times of study.

93

TU

ESD

AY


DS-T-08: Sleep Bruxism : Diagnostic and Therapeutic ApproachesFrom a Multidisciplinary Point of View


Co-Chairs:Antonio Romero-Garcia (Spain), Gilles Lavigne (Canada)

Speakers:Gilles Lavigne (Canada), Bernard Fleury (France), Guido Maria Macaluso (Italy), Antonio Romero-Garcia (Spain)

Learning Objectives:• To understand and discuss the main etiological factors linked to the presence of sleep bruxism as well as to discuss the • different pathophysiological mechanisms related to awake vs sleep bruxism. • To review and discuss which are the main diagnostic approaches to diagnose the presence of sleep bruxism • To understand that sleep bruxism diagnosis should be multidisciplinary but the criteria for defining it falls into the • field of Sleep Medicine • To discuss the presence of pain in sleep bruxism patient• To review the main therapeutic approaches for the management of bruxism from a multidisciplinary prespective• including the control of risk factors as well as comorbidities, specially those which fall on the field of Sleep Medicine • (i.e. sleep breathing disorders.) Target Audience:Dentists, sleep doctors, psychologists and neurophysiology staff who want to have a more deep knowledge of the lastprogresses in the topic Level: Medium/Advanced.

Summary:Sleep bruxism (SB) is a common sleep- related motor disorder characterized by tooth grinding and clenching. SBdiagnosis is made on history of tooth grinding and confirmed by polysomnographic recording of electromyographic(EMG) RMMA (rhythmic masticatory muscle activity ) episodes in the masseter and temporalis muscles. Thoseepisodes occur in association with sleep arousal and are preceded by physiologic activation of the central nervous andsympathetic cardiac systems. Sleep bruxism has strongly gained the attention of the dental community because of itspathological consequences on the masticatory system This session will provide a comprehensive review of the aetiology,pathophysiology, assessment, and management of SB from a multidisciplinary point of view. This discussion groupsession will be divided in three distinctive parts: PART I: The main etiological theories related to sleep bruxism will bereviewed making special emphasis on the recognition of risk factors an comorbitidies. Among those, we will bediscussing the link among OSA and sleep bruxism. PART II: All the clinical and polysomnographic criteria for thediagnosis of sleep bruxism will be reviewed. Special emphasis will be given to the research diagnostic criteria used insleep labs. The recognition of clinical findings for suspecting bruxism as well as the use of questionnaires will also becovered. PART III: In this part, we will be stating that management of sleep bruxism should be multidisciplinary.Treatment strategies such cognitive behavioural and relaxation techniques, biofeedback, therapies preventing damage ofstomatognathic system structures (occlusal splints), control of risk factors, pharmacological approach, treatment ofcomorbid conditions such OSA etc….will be also reviewed.

Sleep bruxism screening &diagnosis challenges: tools validity and differential of co morbidities.Gilles Lavigne (Canada)

Sleep bruxism and respiratory eventsBernard Fleury (France)

Sleep bruxism and painGuido Maria Macaluso (Italy)

Changing paradigms in the management of sleep bruxismAntonio Romero-Garcia (Spain)

94

TU

ESD

AY


DS-T-09: Emerging India and Its Sleep IssuesTicket required - purchase at registration desk

Chair:Suresh Kumar (India)

Speakers:Preeti Devnani (India), Suresh Kumar (India), Garima Shukla (India)

Learning Objectives:• Epidemiology of OSA and its cardio-cerebrovascular effects• Pediatric sleep disorders and the burden of sleep deprivation• Impact of recognition of the RLS among Indians, on the Indian Sleep Medicine scenario

Target Audience:Colleagues working in adults & pediatric sleep medicine facing similar challenges of an emerging specialty and addressing thepitfalls and progress of sleep medicine in a budding society. Understanding the variation of spectrum of RLS in India.

Summary:Epidemiology of OSA and its cardio-cerebrovascular effectsObstructive sleep apnea (OSA) is a independent risk factor which poses a significant public health problem and itsconsequences are well known. In India the current obesity and diabetes epidemic is bound to increase the prevalenceof OSA as a major public health issue in the coming future. Research on sleep in India will not only have to focuson other sleep disorders but also majorly on cause and effects of OSA and its consequences. There are only a fewcommunity based studies which address the prevalence in India.

Pediatric Sleep Medicine in IndiaThe recognition of the burden of sleep disturbances in the pediatric population in India is a work in progress as iswith several counterparts across the globe. Cross cultural studies in a diverse society as India have shed light on themagnitude of their prevalence and emphasized the impact of cultural, social and co-sleeping factors. Certain behavioralstrategies with emphasis on familial relationships were emphasized in a large multi center project. Pediatric sleep researchalbeit in its infancy is being carried out in ADHD and ASD spectrum population, this preliminary data will be presented.

RLS in IndiaRLS is among the most under-diagnosed sleep disorders worldwide. Unique problems in recognition and timelyinitiation of treatment due to socio-cultural differences in its presentation across populations in India, necessitatesdevelopment of more elaborate diagnostic tools. Few prevalence studies have been published from India, and havereported varying prevalence rates among different populations.

The purpose of this talk will be to summarize the work in the area of RLS conducted in India, and to draw conclusionsregarding unique challenges in diagnosis and management of RLS patients in India.

95

TU

ESD

AY


DS-T-10: Controversies in RLS with PLMs: Significance, Sleep, CV RiskPick up your ticket at registration desk

Chair:David Rye (USA)

Speakers:David Rye (USA), Mauro Manconi (Switzerland), Luigi Ferini-Strambi (Italy), Raffaele Ferri (Italy), Stephany Fulda (Germany), John W. Winkelman (USA)

7:00pm - 7:05pmIntroduction and debate rulesDavid Rye (USA)

7:05pm - 7:25pmPLMs are the source of elevated mortality risk in RLS – Pro speakerMauro Manconi (Switzerland)PLMs are the source of elevated mortality risk in RLS – Con speakerLuigi Ferini-Strambi (Italy)

7:25pm - 7:45pmPLMs are associated with disturbed sleep – Pro speakerRaffaele Ferri (Italy)PLMs are associated with disturbed sleep – Con speakerStephany Fulda (Germany)

7:45pm - 8:05pmTreating PLMs in RLS reduces cardiovascular risk – Pro speakerJohn W. Winkelman (USA)Treating PLMs in RLS reduces cardiovascular risk – Con speakerDavid Rye (USA)

8:00pm - 8:20pmFinal questions and commentsDavid Rye (USA)

Sponsor:

96

WednesdaySchedule at a Glance • Wednesday, October 2, 2013_________________________________________________________________Registration 7:00am - 7:00pm_________________________________________________________________Announcements 8:30am - 9:00am_________________________________________________________________Keynote 9:00am - 10:00am_________________________________________________________________Symposium S24-27 10:00am - 11:30am_________________________________________________________________Exhibition 11:00am - 5:00pm_________________________________________________________________Coffee Break 11:30am - 12:00pm_________________________________________________________________Symposium S28, S29 and S35 Young Investigator Symposium,Technologist Program, Oral Presentation O-11 12:00pm - 1:30pm_________________________________________________________________Break 1:30pm - 1:40pm_________________________________________________________________Isabelle Arnulf (Hening Memorial Lecture) 1:40pm - 2:40pm_________________________________________________________________Symposium 34: A Joint Symposium with the IFCNS 1:40pm - 3:10pm_________________________________________________________________Coffee and Exhibit 3:10pm - 3:30pm_________________________________________________________________Keynote 3:30pm - 4:30pm_________________________________________________________________Posters and Oral Presentations O-13, O-14 and O-15 4:30pm - 5:30pm_________________________________________________________________Symposium S30-32, Technologist Program and Oral Presentation O-16 5:30pm - 7:00pm_________________________________________________________________S33: Joint Symposia of WASM and SEPAR 5:30pm - 7:00pm_________________________________________________________________Closing Ceremony 7:00pm - 7:45pm_________________________________________________________________

97

WED

NESD

AY

Wednesday, October 2, 2013 9:00am to 10:00am • Auditorium 1

Keynote: Surgery of Obstructive Sleep Apnea

Demin Han, MD, PhDChinese Medical Doctor Association OtolaryngologyChina

• President of Beijing Tong-Ren affiliated Hospital of Capital Medical University• Recipient of National Science and Technology Award

Notes:

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

98

WED

NESD

AY


S24: The Challenges for Defining Normative Data for SleepDisordered Breathing Across Lifespan

Chair:Hartmut Schneider (USA)

Speakers:Hartmut Schneider (USA), Brian McGinley (USA), Joseph M. Monserrat (Spain), Ludger Grote (Sweden), Olli Polo (Finland), Thomas Penzel (Germany)

Learning Objectives:• Demonstrate how novel approaches to improve standards for detection and definition of sleep disordered breathing in

clinical and research populations.• Define the challenges of assessing normative data.• Advance sleep field by showing how various age group affect sleep disorders breathing indices

Target Audience:Epidemiologists in Sleep, Physiologists, Pediatricians and adult sleep doctors.

Summary:The standards that have been established for defining sleep disordered breathing have been advanced without a body ofdata defining the range of normal breathing in sleep. New studies have revealed a wide range of normality in sleep andbreathing that varies with age and gender. The problem becomes defining the significant respiratory features and therange that defines abnormality and the clinical significance of this range. This has been complicated by the failure toappreciate the major differences related to age and gender in human sleep.

10:00am - 10:05amIntroductionHartmut Schneider (USA)

10:05am - 10:20amPhysiologic changes of respiratory components across the lifespan: Impact on sleepdisordered breathHartmut Schneider (USA)

10:20am – 10:35amPediatric: advances in criteria for defining sleep disordered breathing Brian McGinley (USA)

10:35am – 10:50amElderly: Problems of defining normality in the older populationJoseph M. Monserrat (Spain)

10:50am - 11:05amDefining sleep disordered breathing in adults, lessons from ESADA.Ludger Grote (Sweden)

11:05am – 11:20amGender differences of sleep disordered breathing Olli Polo (Finland)

11:20am – 11:30amQuestion and answerThomas Penzel (Germany)

99

WED

NESD

AY


S25: Hypocretin/orexin as a Therapeutic Target for Sleep Disorders

Chair:Luis de Lecea (USA)

Speakers:Luis de Lecea (USA), Jyrki Kukkonen (Finland), Takeshi Sakurai (Japan), W. Joseph Herring (USA)

Learning Objectives:• Learn about the basic neuroanatomy and pharmacology of the hypocretin/orexin system • Basic connectivity of orexin neurons with monoaminergic systems • Learn about the differential functions of orexin receptors• Learn about optogenetic methods applied to sleep research • Learn about suvorexant and other therapeutic tools targeting orexin receptors

Target Audience:Specialists in sleep medicine, scientists with an interest in the neurobiology underlying sleep/wake transitions.Intermediate-advanced level.

Summary:This symposium will gather the most current knowledge on the hypocretin/orexin system and the application of orexinreceptorant agonists in the treatment of insomnia and other disorders.

10:00am - 10:02amIntroductionLuis de Lecea (USA)

10:02am - 10:22amHypocretins/orexins as masters regulators of sleep/wake cycle and beyondLuis de Lecea (USA)

10:22am – 10:42amOrexin receptors and signalingJyrki Kukkonen (Finland)

10:42am – 11:02amOrexin systemTakeshi Sakurai (Japan)

11:02am - 11:22amSurvorexant: An orexin receptor antagonist for the treatment of insomniaW. Joseph Herring (USA)

11:22am – 11:30amQuestion and answerLuis de Lecea (USA)

100

WED

NESD

AY

Wednesday, October 2, 2013 10:00am to 11:30am • Committee Rooms 1 and 2

S26: Spinal Mechanisms in RLS

Co-chairs:Walter Paulus (Germany), Stefan Clemens (USA)

Speakers:Walter Paulus (Germany), Federica Provini (Italy), Cornelius Bachmann (Germany), Stefan Clemens (USA), Imad Ghorayeb (France)

Learning Objectives:• Role of dopamine and opioid receptors in the spinal cord • Accessibility of spinal cord function in RLS patients • Augmentation liability in RLS due to spinal specifics • Treatment option by transcutaneously-applied direct current stimulation • How to decide on pharmacotherapy of RLS on the background of spinal specifics

Target Audience:Physicians involved in diagnosis and treatment of the Restless Legs Syndrome.

Summary:Restless Legs Syndrome is a network disorder involving the brain as well as the spinal cord. In this symposium we willaddress both the pathophysiology of the spinal cord as well as treatment oriented aspects. Obviously rodent data differfrom primate data, since the former involve dopaminergic neurotransmission, while the latter address L-dopaergic A11neurones. Differences will be outlined. Aspects such as small fibre neuropathy induced spinal neuron denervation andlack of spinal dopamine transporter will be discussed on the background of reflex studies and therapeutic consequences,in particular with regard to dopaminergic augmentation. Recent data on a beneficial effect of spinal direct currentstimulation will complete the overview on spinal mechanisms in RLS.

10:00am - 10:02amIntroductionStefan Clemens (USA)

10:02am - 10:17amConcepts of Spinal pathophysiology in RLSWalter Paulus (Germany)

10:17am – 10:32amSpinal mechanisms of PLM in RLS patientsFederica Provini (Italy)

10:32am – 10:47amSpinal direct current stimulation in RLSCornelius Bachmann (Germany)

10:47am - 11:02amRodent models of spinal pathophysiologyStefan Clemens (USA)

11:02am – 11:17amPrimate models of spinal pathophysiologyImad Ghorayeb (France)

11:17am – 11:30amQuestion and answerWalter Paulus (Germany)

101

WED

NESD

AY

Wednesday, October 2, 2013 10:00am to 11:30am • Multipurpose Room 1

S27: Idiopathic Hypersomnia: Past, Present and Future

Co-Chairs:Michel Billiard (France), Sona Nevsimalova (Czech Republic)

Speakers:Michel Billiard (France), Karel Sonka (Czech Republic), Seiji Nishino (USA), Sona Nevsimalova (Czech Republic),Timothy Morgenthaler (USA)

Learning Objectives:• To trace the evolution of the concept of idiopathic hypersomnia since its origin• To suggest new limits between the different forms of narcolepsy and idiopathic hypersomnia, based on cluster analysis • To make an update on the role of monoamines, histamine and hypocretin in the pathophysiology of idiopathic

hypersomnia and to suggest new orientations for research• To bring light on the genetics and on the circadian rhythms in idiopathic hypersomnia with and without long sleep time• To propose, based on the largest one-center retrospective review ever published, the most active and the least liable to

side-effects drugs for idiopathic hypersomnia

Target Audience:Mostly clinicians and researchers interested in hypersomnias of central origin, idiopathic hypersomnia and narcolepsy.

Summary:In comparison with narcolepsy and even Kleine-Levin syndrome, idiopathic hypersomnia stands as the least studiedamong hypersomnias of central origin.

10:00am - 10:18amThe concept of idiopathic hypersomnia since its originMichel Billiard (France)

10:18am - 10:36amSpectra of narcolepsy and idiopathic hypersomniaKarel Sonka (Czech Republic)

10:36am – 10:54amNeurochemistry of idiopathic hypersomniaSeiji Nishino (USA)

10:54am – 11:12amGenetic aspects of idiopathic hypersomniaSona Nevsimalova (Czech Republic)

11:12am - 11:30amTreatment of idiopathic hypersomnia: trials and tribulationTimothy Morgenthaler (USA)

102

Wednesday, October 2, 2013 12:00pm to 1:30pm • Auditorium 3

O-11: Pediatrics Sleep Disorder Breathing

Chair:Louise O'Brien (USA)

Lipopolysaccharide-binding protein (LBP) serum levels in children with OSA and obesityLeila Kheirandish-Gozal (USA)

Snoring, sleepiness, inattention, and hyperactivity in preschool and kindergarten children with arepaired cleft palateMarta Moraleda-Cibrian (USA)

Heart rate variability and autonomic modulation in children with obstructive sleep apnea syndromeZhifei XU (China)

The diagnosis and management of clinically significant central sleep apnea in infants with Prader-WillisyndromeIndra Narang (Canada)

Sleep-disordered breathing in children with laryngomalaciaRogelio Peralta Lepe (Spain)

Clinical characteristics of hospitalized heart failure patients with daytime Cheyne-Stokes respirationYasuhiro Tomita (Japan)


12:00pm-1:30pm • Committee Rooms 3 and 4W5 REM and Slow Wave Parasomnias: Video and PSG Identification

103

WED

NESD

AY

WED

NESD

AY

Wednesday, October 2, 201312:00pm to 1:30pm • Multipurpose Room 1

S28: Dental Management of OSA in Adults and Children

Co-chairs:Félix de Carlos Villafranca (Spain), Emilio Macías Escalada (Spain)

Speakers:Félix de Carlos Villafranca (Spain), Christian Guilleminault (USA), Michèle Hervy-Auboiron (France),Bernard Fleury (France)

Learning Objectives:Benefits of Dental Devices and dentofacial orthopedics in the sleep-related breathing disorders

Target Audience:Physicians, Dentists, Pediatricians, Orthodontists interested in treating the syndrome of obstructive sleep apnea in bothchildren and adults.

Summary:The use of intra-oral appliances for the treatment of obstructive problems in the upper airways is not a new concept. Back in 1902,Pierre Robin recommended the use of an appliance of these characteristics (monoblock) in order to achieve functional mandibularadvancement, moving the mandible to a more advanced position. By doing so, he was able to add traction to the tongue andprevent it from falling backwards. Passive manipulation of the lower jaw by means of intra-oral mandibular advancement devices(MAD) involves changes in the morphology and volume of the upper airways. This movement stabilizes and fixes the mandibleand the hyoid bone, preventing posterior rotation of these structures and avoiding occupation of the airway when recumbent.MAD facilitate an increase in volume and permeability of the upper airways. This increase in the upper airways has beendocumented in a large number of studies using different scanning systems and imaging techniques. MAD represent a usefulalternative in patients with chronic snoring and/or obstructive sleep apnoea. They comprise a reasonable alternative with respect toother existing therapies, as they do not involve a permanent change in the individual (as occurs with surgery) and their use can bediscontinued at any time. However, a suitable risk-benefit assessment of the patient must be carried out on an individual level inorder to determine the best therapy in each particular case. Benefits perceived by the patient are confirmed in polysomnographicrecords as: a reduction in the frequency and intensity of snoring, improved oxygen saturation, a reduction in the number of apnoeasand arousals, decreased blood pressure readings and, ultimately, a significant improvement in sleep structure. Obstructive sleepapnoea is a common breathing problem with a complex and poorly understood physiopathology which involves changes in neuralcontrol and in the reflexes of the upper airways. In fact, the coordinate neural regulation of the upper airway muscles is basic tocontrol airway size and resistance. Knowledge of the mechanism of action of these devices and of the facial structures that supportthem represents a different approach to the treatment of obstructive diseases of the upper airway. There still remains an importantoutstanding issue, however, namely that of intervention at an early age. This should be taken into consideration to establish ahypothetical prophylaxis of obstructive sleep disease. The possibility of manipulating maxillomandibular growth by orthopaedicand orthodontic means in children in order to stimulate or inhibit the growth of these structures is of major interest. By doing so,we induce changes in the airways, thus achieving a conformation that is less susceptible to collapse.

IntroductionFélix de Carlos Villafranca (Spain)

Oro-facial growth and pediatric sleep disordered breathingChristian Guilleminault (USA)

Orthopedics and orthodontics treatment of OSA in children and preventionMichèle Hervy-Auboiron (France)

Optimization of oral appliance therapy for sleep-related breathing disordersFélix de Carlos Villafranca (Spain)

Cardiovascular impact in SAOS patients treated with advancement mandibular devicesBernard Fleury (France)

Question and answerFélix de Carlos Villafranca (Spain)

104

WED

NESD

AY

Wednesday, October 2, 201312:00pm to 1:30pm • Auditorium 2

S29: Narcolepsy Update

Part I: Recent Big Data Analysis of Morbidity, Mortality and Societal Burden of Narcolepsy

Part II: Nordic H1N1 Vaccine and Narcolepsy experience: Recent Unexpected Findings

Part I Speakers:Maurice Ohayon (USA), Poul Jennum (Denmark), Jed Black, (USA)

Part I Learning Objectives:• Describe the higher rates of medical comorbidity in patients with narcolepsy relative to the general population of non-• narcolepsy patients treated within the Danish and US healthcare systems. • Quantify the higher rates of healthcare utilization, and associated costs in narcolepsy patients compared with those • without narcolepsy.• Understand the relationship between narcolepsy and mortality risk.

Part I Summary:Part I Summary: While it has long been recognized that narcolepsy can have detrimental impacts on various psychological,medical, and functional facets of life, the broad impact of the disease on both individuals and society has not been, until recently,well quantified using large, population-based samples. The three speakers will present original, population-based research addressingthe burden of illness relating to narcolepsy.

Dr. Ohayon will present findings relating to medical comorbidity and mortality risk associated with narcolepsy in a large cohort of322 well-documented narcolepsy patients within the US population. This cohort is matched with a representative US sample of15,928 individuals.

Dr. Jennum will review his results of an evaluation of 816 narcolepsy patients from the 5.5 million-patient Danish National patientregistry. These data confirm a significant burden of illness and medical comorbidity presence in patients with narcolepsy comparedwith a sample of four-fold, well-matched controls within the registry.

Dr. Black will describe a recent analysis of claims data on 9,312 narcolepsy patients and 46,559 highly-matched controls in the US,which revealed significantly higher rates of comorbid diseases, healthcare service and drug utilization rates, and associated medicalcosts in narcolepsy subjects versus controls. Narcolepsy was also associated with significantly higher rates of short-term disabilityrelated outcomes, including costs.

Combined, these data substantiate the tremendous impact of narcolepsy globally and highlight the importance of ongoing effortsto facilitate earlier diagnosis and timely implementation of effective therapy in patients suffering from the disorder.

Part II Speakers:Markku Partinen (Finland)

Part II Learning Objectives:• Summarize the association of H1N1 vaccination and narcolepsy in Nordic countries and understand the role• that public policy or practices may play in introducing bias in medical practice or scientific discovery.

Part II Summary:Dr. Partinen will provide a general update on the overall pattern of association of H1N1 vaccination and narcolepsyin Nordic countries and review current findings on narcolepsy symptom evolution in children with recent-onsetnarcolepsy. Of particular importance, Dr. Partinen will provide a focused review of the Finnish experience with H1N1vaccination and the presentation of narcolepsy in over 100 Finnish pediatric and adult cases, highlighting the possibilitythat Finnish disability compensation policies may impart a potential source of bias.

105

WED

NESD

AY

Wednesday, October 2, 201312:00pm - 1:30pm • Auditorium 1

S35: Young Investigator Symposium: Sleep and Neurodegeneration

Co-chairs:Carlos H. Schenck (USA), Claudia Trenkwalder (Germany)

Speakers:Carlos H. Schenck (USA), Yo-El Ju (USA), Jason Valerio (Canada), Alia Mansour (Egypt), Preeti Devnani (India),Lena Tholfsen (Norway), Nicholas-Tiberio Economou (Greece), Claudio Liguori (Italy)

Learning Objectives:• To learn about sleep problems associated with neurodegenerative disorders• To learn how idiopathic RBD (iRBD) is a strong risk factor for future parkinsonism• To learn about PET data on cholinergic and striatal dopaminergic dysfunction in iRBD in the context of increased risk

for future neurodegeneration• To become acquainted with an evidence based review of the treatment of RBD• To learn about the correlates of sleep and orexin with cognitive decline in Alzheimer disease (AD).• To become acquainted with how polysomnographic findings can have correlates with mild cognitive impairment and AD

Target Audience:A broad target audience, including clinicians and basic scientists of all levels of training and experience.

Summary:This symposium is dedicated to the recent excellent work of young investigators and those who are new to the area of sleep andneurodegeneration. It covers areas of abnormal sleep in neurodegenerative disorders, focusing on RBD and excessive sleepiness inPD, and their clinical, polysomnographic, and brain imaging correlates. Underlying mechanisms are explored by PET cholinergicand striatal dopaminergic imaging of idiopathic RBD patients, searching for risk factors of future neurodegeneration. An evidencebased review of RBD treatment is presented. In the Introduction, the broad scope of current knowledge on RBD is summarized,and future directions of RBD research are indicated. Research on Alzheimer disease (AD) is presented in regards to the correlatesof sleep and orexin with cognitive decline. Also, correlates of polysomnographic findings are applied across the spectrum ofnormal elderly cognition, mild cognitive impairment, and AD.

Introduction: RBD: Current Knowledge and Future DirectionsCarlos H. Schenck (USA)

Functional brain networks in REM sleep behavior disorderYo-El Ju (USA)

Cholinergic and striatal dopaminergic dysfunction using PET as a risk marker for developing aneurodegenerative disease in patients with idiopathic Rapid Eye Movement sleep behaviour disorderJason Valerio (Canada)

Clinical and Polysomnographic study of RBD in Parkinson’s disease from EgyptAlia Mansour (Egypt)

Treatment of REM Behaviour Disorder- An Evidence Based ReviewPreeti Devnani (India)

Excessive daytime sleepiness in early Parkinson's disease: A five year follow-upLena Tholfsen (Norway)

From normal elderly through Mild Cognitive Impairment (MCI) to Alzheimer’s Disease.A progression based on sleep polysomnographic findingsNicholas-Tiberio Economou (Greece)

Alzheimer disease: sleep, orexin and cognitive declineClaudio Liguori (Italy)

Question and answerCarlos H. Schenck (USA)

106

WED

NESD

AY

Wednesday, October 2, 20131:40pm - 3:10pm• Auditorium 2

Joint Symposium of WASM with the European Chapter of theInternational Federation of Clinical NeurophysiologyS34: REM Sleep: Normal and Abnormal Neurophysiology

Co-chairs:Luis Garcia-Larrea (France), Walter Paulus (Germany)

Speakers:Luis Garcia-Larrea (France), Walter Paulus (Germany), Hélène Bastuji (France), Poul Jennum (Denmark), Marcello Massimini (Italy), Teresa Paiva (Portugal)

Learning Objectives:• To understand physiological mechanisms of brain connectivity during sleep with a focus on REM sleep in humans,

integrating animal and human data• To identify REM sleep using an electronic algorithm for detecting RBD • To analyse brain connectivity during sleep using neurophysiological and imaging techniques• To describe the mechanisms and phenotypes of dreaming in neurological patients

Target Audience:Target audience sleep clinicians, basic researchers and PhD students.

Summary:The Symposium will deal with thalamo-cortical interactions during human sleep with special focus on REM(paradoxical) sleep. It will discuss (a) intracranial data from humans on sensory integration and thalamo-corticalcoupling/decoupling during sleep (H Bastuji, Lyon); (b) the automatic detection of REM sleep in patients withidiopathic REM behaviour disorder (P Jennum, Glostrup) (c) the changes in effective connectivity during humanREM sleep (M Massimini, Milan) and the particularities of REM sleep and dreaming in patients with neurologicaldisorders (T Paiva, Lisbon).

1:40pm - 1:42pmIntroductionLuis Garcia-Larrea (France), Walter Paulus (Germany)

1:42pm – 2:02pmSensory integration and thalamo-cortical coupling/decoupling during sleepHélène Bastuji (France)

2:02pm – 2:22pmAutomatic REM sleep detection associated with idiopathic REM sleep behavior disorderPoul Jennum (Denmark)

2:22pm – 2:42pmCortical reactivity and effective connectivity during REM sleep in humans as revealed byfMRi and EEG Marcello Massimini (Italy)

2:42pm – 3:02pmDreaming in neurological disordersTeresa Paiva (Portugal)

3:02pm - 3:10pmQuestions and answerLuis Garcia-Larrea (France), Walter Paulus (Germany)

107

WED

NESD

AY


Hening Memorial Lecture: Neurogeneration and Sleep

Isabelle Arnulf, MD, PhDPiere and Marie Curit UniversityFrance

Notes:

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________


Keynote: Genetics and Epigenetics of Sleep Disorders

Mehdi Tafti, PhDUniversity of LausanneSwitzerland

Mehdi Tafti received his PhD from the University of Montpellier (France) in 1991after completing his doctoral thesis on sleep regulation in human narcolepsy. Heperformed a postdoctoral fellowship with Dr. Mignot and Dr. Dement and was aResearch Associate at the Department of Psychiatry and Biological Sciences atStanford University. In 1995 he moved to the Department of Psychiatry in Genevawhere he established the first laboratory dedicated to the molecular genetics of sleep and sleep disorders. He joined the Center for Integrative Genomics in September 2004.

Notes:

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

108

Wednesday, October 2, 2013 4:30pm to 5:30pm • Committee Room 1

O-13: Parasomnia and Psychiatric Disorders

Chair:Geert Mayer (Germany)

Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmares, sleepdisturbance and post-traumatic stressM. Monserrat Sanchez Ortuño (Spain)

Can nocturnal sleep disturbances predict non-remission and relapse in patients with majordepressive disorder? A 5-year naturalistic longitudinal studyShirley X. Li (China)

Sleep profile in hypomania : A polysomnographic evaluation in an Egyptian sampleTarek Asaad (Egypt)

Dissociated sleep states in Fibromyalgia: Prevalence and correlationsLigia Ferreira (Portugal)

_____________________________________________________________________


O-14: RLS/PLMS: Natural Course, Risk Factors and Health

Chair:Stephany Fulda (Germany)

Restless leg syndrome in young children with orofacial cleftMarta Moraleda-Cibrian (USA)

The natural history of restless legs syndrome: retrospective data on a clinical sampleMarco Zucconi (Italy)

Patients with periodic limb movements disorder do not differ from patients with another sleepdisorders in terms of nocturnal blood pressureMariusz Sieminski (Portugal)

Disease burden in patients with restless legs syndrome compared with an apnea and a control cohortSolene ieffry (USA)

_____________________________________________________________________

Wednesday, October 2, 2013 4:30pm to 5:30pm • Multipurpose Room 1

O-15: Sleep and Health

Chair:Ferran Barbé (Spain)

Morbidity and mortality in children with obstructive sleep apnea: a controlled national studyPoul Jennum (Denmark)

Sleep structure and cardiometabolic disorders in the general populationJosé Haba-Rubio (Switzerland)

Severity of sleep apnea syndrome is associated with arterial stiffness in elderly populationTae Kim (South Korea)

Orofacial myofunctional evaluation with scores in subjects with OSAGislaine Aparecida Folha (Brazil)

109

WED

NESD

AY

WED

NESD

AY

Wednesday, October 2, 2013 5:30pm to 7:00pm • Multipurpose Room 1

S30: Using the Dim Light Melatonin Onset (DLMO) to EvaluateCircadian Timing in Clinical Populations

Chair:Jeanne Duffy (USA)

Speakers:Jeanne Duffy (USA), Shadab Rahman (USA/Canada), Marcel G. Smits (The Netherlands),Aurelija Jucaite (Lithuania/Sweden), Jung-Hie Lee (Korea)

Learning Objectives:• Sleep regulation by interaction of circadian and sleep-wake homeostatic processes• The dim light melatonin onset (DLMO) as a marker of circadian timing• In-home and laboratory methods for assessing DLMO• Evidence from clinical populations where the DLMO was used to assess circadian timing

Target Audience:Clinicians who treat patients with insomnia and circadian rhythm sleep disorders; circadian rhythm researchers; sleepresearchers who want to understand more about circadian rhythms.

Summary:Circadian Rhythm Sleep Disorders (CRSD) are typically evaluated on the basis of sleep timing, with the assumption that the cause ofthe abnormal sleep timing is an abnormality in the circadian timing system. However, there is evidence that this assumption is nottrue for all CRSD patients. CRSD individuals sleeping at abnormal clock times may be sleeping at normal circadian times, whichwould suggest their behavioral choices of sleep and light-dark exposure are contributing to their sleep timing problems and should bethe focus of treatment. Similarly, individuals sleeping at conventional clock times may be sleeping at abnormal circadian times, whichcould lead to problems with sleep initiation or sleep maintenance; treating such individuals should involve shifting the underlyingcircadian timing without changing sleep timing. Thus, circadian timing information may contribute to addressing several types ofsleeping problems beyond the circadian rhythm disorders, and may guide better treatment choices. In research settings, the dim lightmelatonin onset (DLMO) is a widely-used tool for determining the timing of circadian rhythms. In clinical settings, serial salivasamples are collected in dim light conditions for several hours to be assayed for melatonin levels, and the time of the evening rise inmelatonin (the DLMO) is determined and used as a marker of circadian phase. When the phase is compared with habitual sleeptiming, a phase angle can also be determined. While the phase provides information about the clock time of circadian rhythms, thephase angle provides information about the circadian time of sleep, and can provide insight into whether the individual’s sleep is at atypical or abnormal circadian phase. In this symposium we will describe protocols for assessing DLMO in patient populations andpresent findings from several clinical populations where circadian timing information was used to guide treatment.

5:30pm - 5:45pmIntroduction to symposium: Rationale for direct assessment of circadian rhythms in sleepdisorders patientsJeanne Duffy (USA)

5:45pm - 6:00pmDSPS: Birds of the same feather? Utility of the DLMO test in diagnosing DSPS in aclinical population in CanadaShadab Rahman (USA/Canada)

6:00pm - 6:15pmUsing salivary melatonin measurements in patients with insomnia and possible sleep timingdisorders: Experience with 1,800 patients in the NetherlandsMarcel G. Smits (The Netherlands)

6:15pm - 6:30pmDiurnal melatonin patterns in children: Ready to apply in clinical practice?Aurelija Jucaite (Lithuania/Sweden)

6:30pm – 6:45pmIntegrating DLMO assessments into clinical practice in Korea: Practical considerationsJung-Hie Lee (Republic of Korea)

6:45pm – 7:00pmQuestion and answerJeanne Duffy (USA)

110

WED

NESD

AY


S31: Sleep Microstructure, Arousals and Autonomic Functions: NewInsights and Clinical Implications

Co-Chairs:Liborio Parrino (Italy), Pietro Cortelli (Italy)

Speakers:Liborio Parrino (Italy), Pietro Cortelli (Italy), Eduardo Benarroch (USA), Jussi Toppila (Finland), Andrea Grassi (Italy),Federica Provini (Italy)

Learning Objectives:• To update the relationship between sleep and autonomic regulation. • To evaluate the time relation between arousal events occurring during sleep and autonomic variations• To identify autonomic markers that correlate with sleep microstructure.• To understand the pathophysiological hemodynamic mechanisms associated with unstable sleep• To disclose the harmful impact of high amounts of CAP in sleep disorders, such as Nocturnal Epilepsy, which are

commonly neglected in terms of autonomic risk.

Target Audience:Sleep physicians, Neurologists, Neurophysiologists, Pulmonologists, Cardiologists, Sleep technologists

Summary:There is an intimate relationship between the autonomic nervous system and sleep from an anatomical, physiological, andneurochemical point of view. Recording autonomic parameters during sleep can shed light on the biological price and potentialharmful consequences of sleep disorders. A pivotal role is played by the arousal system which modulates ventilation, cardiovascularcontrol and networks involved in the regulation of motor activities. During non-REM sleep, EEG arousal-related phasic events areorganized in periodic sequences which are associated with oscillatory swings of the autonomic functions. These sequences arerecognized as the cyclic alternating pattern (CAP), which represents the EEG marker of sleep instability. Conditions of reduced sleepquality are characterized by increased amounts of CAP and by a shift in the sympathetic/parasympathetic balance towards asympathetic predominance. CAP-related autonomic alterations have been investigated by means of pulse wave amplitude and heartrate variability in patients with Nocturnal Frontal Lobe Epilepsy, characterized by an impressive increase of CAP. A novel non-invasiveoptical method for monitoring cortical and scalp hemodynamic changes is offered by near-infrared spectroscopy (NIRS), which hasbeen recorded during CAP in healthy subjects and during apnea-related arousals in patients with obstructive sleep apnea syndrome.The proposed symposium will allow presentation of these results and outline perspectives for further research.

5:30pm - 5:34pmIntroductionLiborio Parrino (Italy)

5:34pm - 5:38pmIntroductionPietro Cortelli (Italy)

5:38pm - 5:56pmAnatomo-functional integration between sleep and autonomic nervous systemEduardo Benarroch (USA)

5:56pm - 6:14pmCAP-related cerebral hemodynamic variation measured with near-infrared spectroscopy (NIRS)Jussi Toppila (Finland)

6:14pm – 6:32pmAutonomic nervous system activity during sleep in Nocturnal Frontal Lobe EpilepsyAndrea Grassi (Italy)

6:32pm – 6:50pmAutonomic arousal and motor behaviours during sleepFederica Provini (Italy)

6:50pm – 7:00pmQuestion and answerLiborio Parrino (Italy)

111

WED

NESD

AY


S32: Obesity and Sleep Apnea in Children

Co-chairs:Indra Narang (Canada), David Gozal (USA)

Speakers:David Gozal (USA), Stijn Verhulst (Belgium), Leila Kheirandish-Gozal (USA), Evan Propst (Canada),Indra Narang (Canada)

Learning Objectives:• To understand the current prevalence and anatomical factors associated with obstructive sleep apnea in obese children.• To evaluate the role of the polysomnogram in the diagnosis of paediatric obesity related obstructive sleep apnea. • Outline the current medical options and their pitfalls in the management of obstructive sleep apnea in obese children. • Recognise the adverse consequences of obstructive sleep apnea in obese children and the impact of timely diagnosis and

management of this disorder. • Debate whether tonsillectomy should be a treatment for obstructive sleep apnea in older children. • Discuss advanced surgical techniques for the management of obstructive sleep apnea in obese children.

Target Audience:The proposed scientific symposium is designed to establish a comprehensive and complete review of the most recentevidence based practice of sleep medicine in children with obstructive sleep apnea and obesity. The prevalence andseverity of obesity in children referred to sleep clinics has alarmingly increased in the past 2 decade and is indicative of adramatic increase in the occurrence of obesity-associated morbidities, and more specifically has increased the prevalenceof obstructive sleep apnea. Since both obesity and OSA are two inflammatory disorders, it is not surprising thatinflammatory cascades might be involved in mediating such processes, whether at the pathophysiology of the diseasethemselves or their consequences. Therefore, discussion of novel targeted diagnostic and therapeutic modalities thatmay benefit such high-risk pediatricpopulations

Summary:This symposium is aimed to review the most recent evidence on obesity, its association with obstructive sleep apnea andcardiovascular consequences during childhood. The proposed symposium will begin with review and discussion aboutpathophysiology and risk of OSA in obese children. The next lecture will link pediatric obstructive sleep apnea toinflammatory-pathways and present the evidence of systemic inflammation in OSA and obesity, with emphasis onsimilar and unique signatures. The symposium continues with discussion about changes in endothelial function inchildren with OSA and obesity. Autonomic dysfunction and hypertension will be presented during the 4th lecture andfinally treatment of obese children with OSA will be discussed.

5:30pm - 5:35pmIntroductionDavid Gozal (USA)

5:35pm – 5:55pmPrevalence, anatomical correlates and diagnosis of paediatric obesityStijn Verhulst (Belgium)

5:55pm – 6:15pmSystemic inflammation in OSA and obesityDavid Gozal (USA)

6:15pm – 6:35pmEndothelial function in children with OSA and obesityLeila Kheirandish-Gozal (USA)

6:35pm – 6:55pmAdvanced surgical techniques for the management of obesity related OSA in childrenEvan Propst (Canada)

6:55pm - 7:05pmQuestions and answerIndra Narang (Canada)

112

WED

NESD

AY

113


S33: Joint Symposia of WASM and Sociedad Espanola deNeumologia y Cirugia Toracica (SEPAR)

Co-chairs:Christian Guilleminault (USA), Ferrán Barbé (Spain)

Speakers:Ferrán Barbé (Spain), Manuel Sanchez de la Torre (Spain), Miguel Angel Martinez Garcia (Spain),Alberto Alonso (Spain), Joaquin Duran (Spain), Christian Guilleminault (USA)

Learning Objectives:• To evaluate the role of the different pathogenic pathways in the development of atherosclerosis and cardiovascular disease in

OSA patients• To understand the clinical relevance to identify and treat OSA in subjects with hypertension• To explore the relationship between OSA and pulmonary embolism • To highlight the importance to develop international collaborative clinical trials enrolling thousands of patients

Target Audience:Advanced topic for clinical sleep specialists and basic researchers with a special interest in cardiovascular consequences of OSA

Summary:The intermittent collapse of the upper airway during sleep activates different pathways such as oxidative stress,sympathetic activation, inflammation, hypercoagulability, endothelial dysfunction, and metabolic dysregulation thatpredispose patients with OSA to hypertension and atherosclerosis. OSA is a common cause of systemic hypertensionand should be suspected in hypertensive individuals, especially those with resistant hypertension. Recent data suggestthat OSA could be related to an increase in the incidence of pulmonary hypertension and this association could bebased on the existence of hypercolagulability in OSAS patients. In order to modify clinical guidelines and to highlightthe importance of OSA in the development cardiovascular diseases it is necessary to perform international clinical trials.

5:30pm - 5:35pmIntroductionFerrán Barbé (Spain)

5:35pm – 5:55pmPathogenic bases of cardiovascular consequences in OSA patientsManuel Sanchez de la Torre (Spain)

5:55pm – 6:15pmResistant hypertension and OSAMiguel Angel Martinez Garcia (Spain)

6:15pm – 6:35pmPulmonary embolism and OSAAlberto Alonso (Spain)

6:35pm – 6:55pmThe need of international clinical trials collaboration Joaquin Duran (Spain)

6:55pm - 7:00pmClosing remarksChristian Guilleminault (USA)


5:30pm - 7:00pm • Committee Rooms 3 and 4W6 Actigraphy Masterclass:Equipment, Set up, Research Usage,Clinical interpretation

Wednesday, October 2, 2013 5:30pm to 7:00pm • Committee Room 1

O-16: Drugs, Technology, and Insufficent Sleep

Co-Chairs:Max Hirshkowitz (USA), omas Penzel (Germany)

Endocannabinoids and sleepOscar Prospéro-García (Mexico)

Caffeine withdrawal: Cost or benefit?Leon Lack (Australia)

Sleep extension improves fasting insulin levels in adults who are habitually sleep restrictedRachel Leproult (Belgium)

Fully automated sleep deprivation in rats using air puffsGina Poe (USA)

Gastrointestinal motility and sleep patterns assessed by ambulatory tracking of telemetriccapsules combined with polysomnographyAnneMette Haase (Denmark)

Autoantibodies against distinct neuronal populations in narcoleptic patients – a possible link tovaccine induced autoimmunity?Peter W. Bergman (Sweden)

114

WED

NESD

AY

Poster PresentationsFloor 2 - Multipurpose Room 2

Poster Numbering Guidelines (example: M-A-001)_________________________________________________________________A Aging and Developmental Issues_________________________________________________________________B Behavior, Cognition and Dreaming_________________________________________________________________C Chronobiology/Circadian Disorders_________________________________________________________________E Excessive Daytime Sleepiness (not Narcolepsy)_________________________________________________________________I Insomnia_________________________________________________________________NA Narcolepsy_________________________________________________________________M Memory_________________________________________________________________NP Neural Plasticity_________________________________________________________________NE Neurological Sleep Disorders Affecting Sleep_________________________________________________________________O Other_________________________________________________________________PA Parasomnia_________________________________________________________________PH Pharmacology_________________________________________________________________PS Psychiatric Disorders Affecting Sleep/Wake_________________________________________________________________REM REM Behavior Disorders_________________________________________________________________R Restless Legs Syndrome (RLS) and Movement Disorders_________________________________________________________________S Sleep Breathing Disorders_________________________________________________________________T Technology/Technical_________________________________________________________________YI Young Investigator Award_________________________________________________________________

115

MO

ND

AY

Monday - A - Board #001Presenting Author: Stéphanie Bioulac (France)SLEEPINESS AND DRIVING PERFORMANCE INADULTS WITH ATTENTION DEFICIT HYPERACTIVITYDISORDER (ADHD)Bioulac S, Capelli A, Claret A, Taillard J, Bouvard M, Philip P

Monday - A - Board #002Presenting Author: Ana Allen Gomes (Portugal)DIURNAL TYPE IN CHILDREN: PRELIMINARY RESULTSABOUT THE EUROPEAN PORTUGUESE VERSION OFTHE CCTQDouto D, Allen Gomes A, Pinto De Azevedo M, Clemente V,Carvalho Bos S, Silva C

Monday - A - Board #003Presenting Author: Jr Garmendia Leiza (Spain)INFLUENCE OF INSTITUTIONALIZATION ON THESLEEP PATTERN IN ELDERLY POPULATIONGarmendia Leiza J, Aguilar Garcia M, Andres De Llano J,Martin Martinez D, Casaseca De La Higuera P, Alberola Lopez C

Monday - A - Board #004Presenting Author: Ali Gholamrezaei (Iran)RESTLESS LEGS SYNDROME AND ITS ASSOCIATIONWITH POOR SLEEP QUALITY, MOOD DISORDERS,AND ONE YEAR CARDIOVASCULAR MORTALITY INPATIENTS ON CHRONIC DIALYSISGholamrezaei A, Masoumi M, Mortazavi M, Amra B

Monday - A - Board #005Presenting Author: Alex Hamel (Canada)BED PARTNER AND SLEEP QUALITY IN ELDERLYHamel A, Desjardins S, Loranger J, Lapierre S, Marcoux L

Monday - A - Board #006Presenting Author: Lia Khuchua (Georgia)MULTIPLE SCLEROSIS ASSOCIATED FATIGUE ANDSLEEP DISTURBANCESKiziria M, Chikadze A, Khuchua L, Jibladze M, Tsiskaridze A,Shakarishvili R

Monday - A - Board #007Presenting Author: Mitsuo Kodama (Japan)CRITICAL PERIODIC LIMB MOVEMENT DISORDERFOLLOWED BY CARDIO-PULMONARY ARREST (CPA)TWO MONTHS LATER: A CASE REPORTKodama M

Monday - A - Board #008Presenting Author: Jonathan Loranger (Canada)EVENTS DISTRURBING SLEEP QUALITY AMONG ELDERLYLoranger J, Desjardins S, Hamel A, Lapierre S, Marcoux L

Monday - A - Board #009Presenting Author: John Winkelman (United States)THE EFFECT OF ROTIGOTINE ONNOCTURNAL BLOOD PRESSURE CHANGES ANDPERIODIC LIMB MOVEMENTS OF SLEEP IN PATIENTSWITH IDIOPATHIC RLS: THE ENCORE STUDYGrieger F, Schollmayer E, Moran K, Trenkwalder C

Monday - A - Board #010Presenting Author: Miguel Meira E Cruz (Portugal)SLEEP-RELATED BEHAVIORAL INTERACTIONBETWEEN SCHOOL-AGE SIBLINGS. EVALUATIONWITH CSHQ–PTMeira E Cruz M, Duarte I, Loureiro H, Rodrigo M

Monday - A - Board #011Presenting Author: Plamen Nedev (Bulgaria)SURGICAL MANAGEMENT OF NASAL ALAR RIMAND VALVE COLLAPSENedev P, Milkov M, Iliev G, Iliev G, Benchev R,Vichevamedical Universiti Plovdiv D

Monday - A - Board #012Presenting Author: Paolo Porcacchia (Spain)SLEEP RELATED RHYTHMIC MOVEMENTS ANDPERIODIC LIMB MOVEMENTS IN SCHIZOPHRENIA:A CLINICAL CASE.Porcacchia P, Mora Granizo F, Botebol Benhamou G

Monday - A - Board #013Presenting Author: M. Pujol (Spain)ASSESSMENT OF THE MOVEMENTS IN REM SLEEPBEHAVIOUR DISORDER (RBD) PATIENTS DURINGTHE RAPID OCULAR MOVEMENT IN REM SLEEP.Pujol M, Cruz F, March J, Gispert L, Barbé F

Monday - A - Board #014Presenting Author: Eduardo Valle (Brazil)QUALITY OF LIFE AND SLEEP DISORDERS IN ELDERLYRibeiro Do Valle C, Valle E, Valle L, Alves Fior C

Monday - A - Board #015Presenting Author: Dittoni Serena (Italy)DEVELOPMENT OF A SOFTWARE SYSTEM OF VIDEO-INTEGRATED ANALYSIS MADE FOR THE MOTIONDETECTION AND ANALYSIS OF SLEEP.A Serena D, Michele S, Riccardo M, Mariano P, Catello V,Giacomo D

Monday - A - Board #016Presenting Author: Erik K. St. Louis (United States)DIAGNOSTIC THRESHOLDS FOR QUANTITATIVEREM SLEEP MUSCLE DENSITIES, PHASIC BURSTDURATION, AND REM ATONIA INDEX IN REMSLEEP BEHAVIOR DISORDER WITH CO-MORBIDOBSTRUCTIVE SLEEP APNEASt. Louis E, Mccarter S, Sandness D, Boeve B, Silber M

Monday - A - Board #017Presenting Author: Erik K. St. Louis (United States)PREDICTORS OF INJURY IN REM SLEEP BEHAVIORDISORDERSt. Louis E, Mccarter S, Boswell C, Boeve B, Silber M

Monday - A - Board #018Presenting Author: Nerea Torres Caño (Spain)EVOLUTION OF SAFETY PROFILE OF DIFFERENTTHERAPEUTIC ALTERNATIVES IN RESTLESS LEGSSYNDROME (RLS)Torres Caño N, Giner Bayarri P, Chilet Chilet R, Zalve Plaza G,Blancas Carrasco A, Moliner Ibáñez J

Monday - A - Board #019Presenting Author: Jiahong Zhang And Lu Ning (China)THE RELATIONSHIP BETWEEN PERSONALITYDISORDER AND SLEEP QUALITY IN UNIVERSITYSTUDENTS IN CHINAZhang J, Lu N

Monday - I - Board #020Presenting Author: Yong Won Cho (Republic of Korea)EFFECTS OF PREGABALIN ON PATIENTS WITHHYPNOTIC DEPENDENT INSOMNIACho Y, Moon H, Lee Y, Song M

116

MO

ND

AY

Monday - I - Board #021Presenting Author: Maria Magdalena Dumitru (Romania)SLEEP PROBLEMS IN PATIENTS WITH PARKINSON’SDISEASE IN A HOSPITAL SETTING FROM ROMANIADumitru M

Monday - I - Board #022Presenting Author: Amanda Hellström (Sweden)ASSOCIATIONS BETWEEN SLEEP DISTURBANCESAND LEISURE ACTIVITIES IN LATE-LIFEHellström A, Hellström P, Willman A, Fagerström C

Monday - I - Board #023Presenting Author: Habibolah Khazaie (Iran)TREATMENT OF PARADOXICAL INSOMNIA WITHATYPICAL ANTIPSYCHOTIC DRUGS; A COMPARISONOF OLANZAPINE AND RISPERIDONEKhazaie H, Rezaie L, Darvishi F, Najafi F, Avis K

Monday - I - Board #024Presenting Author: Tae Won Kim (Republic of Korea)CASES OF CHRONIC INSOMNIA PATIENTS TREATEDBY GROUP COGNITIVE BEHAVIORAL THERAPY FORINSOMNIAKim T, Yi M, Joo S, Jeong J, Han J, Hong S

Monday - I - Board #025Presenting Author: Wang Weidong (China)REPETITIVE TRANSCRANIAL MAGNETICSTIMULATION ENHANCES SLEEP QUALITY OFPATIENTS WITH COMORBID MAJOR DEPRESSIVEDISORDER AND INSOMNIALi T, Wang W, Hong L, Lin Y, Wang F

Monday - I - Board #026Presenting Author: Oscar Medina (Venezuela)EFFICACY AND TOLERABILITY OF ZOLPIDEM IN AGROUP OF VENEZUELAN PATIENTS WITH INSOM-NIA UNDERGOING HEMODIALYSISMedina O, Rojas G, Santos E, Moreno C, Paolini M,Sánchez-Mora N

Monday - I - Board #027Presenting Author: Yara Fleury Molen (Brazil)PRE-SLEEP WORRY DECREASE BY ADDING READINGAND GUIDED IMAGERY TO INSOMNIA TREATMENTMolen Y, Santos G, Carvalho L, Prado L, Prado G

Monday - I - Board #028Presenting Author: Laura Palagini (Italy)POOR SLEEP QUALITY IN SYSTEMIC LUPUSERITEMATOSUS: DOES IT DEPEND ON DEPRESSION?Palagini L, Bruno R, Tani C, Gemignani A, Ciapparelli A,Mosca M

Monday - I - Board #029Presenting Author: Sandra Bos (Portugal)INSOMNIA IN POSTPARTUM AND PERCEIVEDINFANT DIFFICULT TEMPERAMENTQuental D, Carvalho Bos S, Marques M, Soares M,Azevedo M, Macedo A

Monday - I - Board #030Presenting Author: Francisco Sánchez-Narváez (Mexico)POLYSOMNOGRAPHIC FEATURES IN THREEINSOMNIA SUBTYPES.Sánchez-Narváez F, De La Orta D, Labra A, Haro R

Monday - I - Board #031Presenting Author: Hiroyuki Sawatari (Japan)LEG THERMAL THERAPY IMPROVED SLEEPSTRUCTURE AND SUBJECTIVE SLEEP QUALITY INCHRONIC HEART FAILURESawatari H, Miyazono M, Nishizaka M, Ando S, Sunagawa K,Chishaki A

Monday - I - Board #032Presenting Author: Manuel Schabus (Austria)NON-PHARMACOLOGICAL TREATMENT OFPRIMARY INSOMNIA USING SENSORIMOTOR-RHYTHM NEUROFEEDBACKSchabus M, Griessenberger H, Heib D, Lechinger J,Hoedlmoser K

Monday - I - Board #033Presenting Author: Arla Stokes And Henry Stokes (Guatemala)PSYCOLOGICAL AND BEHAVIORAL TREATMENTOF PRIMARY AND SECONDARY INSOMNIA INPACIENTS FROM SAN JUAN DE DIOS HOSPITALSLEEP DEPARTMENT OF GUATEMALAStokes A, Stokes H

Monday - I - Board #034Presenting Author: Markus Jansson-Fröjmark (Sweden)PRE-SLEEP AROUSAL, UNHELPFUL BELIEFS ANDMALADAPTIVE SLEEP BEHAVIORS AS MEDIATORS INCOGNITIVE BEHAVIOR THERAPY FOR INSOMNIASunnhed R, Jansson-Fröjmark M

Monday - I - Board #035Presenting Author: Markus Jansson-Fröjmark (Sweden)BEHAVIOR THERAPY SINGLY AND COMBINEDWITH CONSTRUCTIVE WORRY FOR INSOMNIA:COGNITIVE AND BEHAVIORAL PROCESSES ASMEDIATORSSunnhed R, Jansson-Fröjmark M

Monday - I - Board #036Presenting Author: Wei-Dong Wang (China)CLINICAL STUDY ON SLEEP-REGULATINGTECHNIQUE (TIP3-2) COMBINED WITHMEDICATION OF TREATING PRIMARYWang W, Hong L, Lin Y, Wang F, Li T, Wang W, Li G

Monday - I - Board #037Presenting Author: Wei-Dong Wang (China)STUDY ON CLINICAL EFFICACY OF TREATINGPRIMARY INSOMNIA BY WEN DAN NING XIN GRAINWang W, Liu Y, Hong L, Lin Y, Wang F, Wang W, Li G

Monday - I - Board #038Presenting Author: Wang Weidong (China)THE SLEEP-IMPROVING EFFECT OF AN CHINESEINDIGENOUS PSYCHOTHERAPY ON DEPRESSIONASSOCIATED WITH INSOMNIAWang W, Lu X, Hong L, Lin Y, Wang F

Monday - I - Board #039Presenting Author: Irina Zavalko (Russian Federation)EFFECTS OF ANTICIPATION OF A SIGNIFICANTEVENT ON SLEEP DURING LONG-TERM ISOLATIONZavalko I, Rasskazova E, Kovrov G

117

MO

ND

AY

Monday - M - Board #040Presenting Author: Ina Djonlagic (United States)CONSEQUENCES OF REM-PREDOMINANT ANDREM-EXCLUSIVE SLEEP APNEA ON MOTOR MEMORYCONSOLIDATION DURING SLEEPIgue M, Guo M, Malhotra A, Stickgold R, Djonlagic I

Monday - M - Board #041Presenting Author: Kristy Nga Ting Lau (China)HOW MUCH ONE SLEEPS AT NIGHT AFFECTSNAPPING EFFECTS ON EMOTIONAL MEMORYCONSOLIDATIONLau K, Wong M, Lau E

Monday - M - Board #042Presenting Author: Samuel Laventure (Canada)MOTOR MEMORY CONSOLIDATION POTENTIATEDBY EXPOSITION TO A CONDITIONED STIMULUS INSTAGE 2 SLEEPLaventure S, Fogel S, Albouy G, Sévigny-Dupont P, Carrier J,Doyon J

Monday - M - Board #043Presenting Author: Jacky Ho Yin, Wan (Hong Kong)THE EFFECT OF CAFFEINE NAP ON DECLARATIVEAND PROCEDURAL MEMORY IN ELDERLYWan J, Lau E, Lee T

Monday - M - Board #044Presenting Author: Malgorzata Wislowska (Austria)MECHANISMS UNDERLYING DECLARATIVE MEMORYCONSOLIDATION ARE CHANGING WITH AGE -INSIGHT FROM HEALTHY AND DISTURBED SLEEPWislowska M, Heib D, Hoedlmoser K, Griessenberger H,Schabus M

Monday - M - Board #045Presenting Author: Karina A. Zanin (Brazil)EFFECTS OF THE INTERACTION BETWEENZOLPIDEM AND SLEEP DEPRIVATION ON MEMORYIN MICEZanin K, Patti C, Ceccon L, Lopes-Silva L, Poyares D,Frussa-Filho R

Monday - NP - Board #046Presenting Author: Fabio Garcia Garcia (Mexico)SLEEP DEPRIVATION INDUCE MORPHOLOGYCHANGES IN THE HIPPOCAMPUS AND PREFRONTALCORTEX IN YOUNG AND OLD RATSGarcía-García F, Acosta Peña E, Melgarejo Gutierrez M, Flores G

Monday - NE - Board #047Presenting Author: Belia Garcia Parra (Spain)SLEEP QUALITY IN DRUG RESISTANT EPILEPSY PATIENTSAlvarez Guerrico I, Garcia Parra B, Lluis P, Royo I, M Isabel F,Rocamora R

Monday - NE - Board #048Presenting Author: Yan Dong (China)RISK FACTORS ASSOCIATED WITH SLEEP DISTURBANCEFOLLOWING TRAUMATIC BRAIN INJURYDong Y, Sheng P, Tong W, Li Z, Xu D, Hou L

Monday - NE - Board #049Presenting Author: Lobna M Elnabil (Egypt)POLYSOMNOGRAPHIC PICTURE OF MULTIPLESCLEROSIS: CORRELATION WITH MRI FINDINGSElnabil L, Ibrahim E

Monday - NE - Board #050Presenting Author: Isaac Mosquera (Venezuela)SLEEP DISORDERS IN VENEZUELAN FIBROMYALGIAPATIENTS.Isaac M, Franca p, Rafael r, Alonso h, Gabriela P, Maria I L

Monday - NE - Board #051Presenting Author: Edith Lopez Ruiz (Mexico)CHANGES IN SLEEP ARCHITECTURE AFTER TYPE 2DIABETES MELLITUS (T2DM)Lopez Ruiz E, Rivera Garcia A, Ramirez Salado I

Monday - NE - Board #052Presenting Author: Shirin Mollayeva (Canada)FATIGUE IN ONTARIO WORKERS WITH HEADTRAUMA: FREQUENCIES AND CORRELATIONSMollayeva S, Shapiro C, Mollayeva T, Colantonio A

Monday - NE - Board #053Presenting Author: Tatyana Mollayeva (Canada)SELF-REPORT INSTRUMENTS FOR ASSESSING SLEEPDYSFUNCTION IN AN ADULT TRAUMATIC BRAININJURY POPULATION: A SYSTEMATIC REVIEW.Mollayeva T, Kendzerska T, Colantonio A

Monday - NE - Board #054Presenting Author: Cecilia Orellana (Uruguay)CHRONOTYPES IN AN URUGUAYAN POPULATIONAFFECTED BY MULTIPLE SCLEROSISOrellana C, Oheninger C, Gil J, Arbildi M, Martinez F

Monday - NE - Board #055Presenting Author: Michael Saletu (Austria)NOCTURNAL BLOOD PRESSURE REGULATION INSTROKE PATIENTS WITH SLEEP APNEASaletu M, Kotzian S, Schiefer I, Hillberger M, Spatt J

Monday - NE - Board #056Presenting Author: Catherine Wiseman-Hakes (Canada)EXAMINATION OF POLYSOMNOGRAPHY INHOSPITALIZED PATIENTS WITH ACUTE MODERATE-SEVERE TRAUMATIC BRAIN INJURYWiseman-Hakes C, Gaudreault P, Duclos C, Bernard F, CarrierJ, Gosselin N

Monday - NE - Board #057Presenting Author: Pei-Lu Yi (Taiwan)AMYGDALA OPIOID RECEPTORS MEDIATE THEELECTROACUPUNCTURE-INDUCED DETERIORATIONOF SLEEP DISRUPTIONS IN EPILEPSY RATSYi P, Chang F

Monday - O - Board #058Presenting Author: Taís Araújo (Canada)SOCIOCULTURAL VARIATIONS OF SLEEP DIFFICULTIES’COPING STRATEGIES IN COUPLE RELATIONSHIPS INCANADA AND IN BRAZIL.Araújo T, Vallières A, Leanza Y

Monday - O - Board #059Presenting Author: Barýþ Baklan (Turkey)THE CHANGES IN CYCLIC ALTERNATINGPATTERN(CAP) OF EPILEPSY PATIENTSBaklan B

118

MO

ND

AY

Monday - O - Board #060Presenting Author: Cristina Bódalo (Spain)PGO ACTIVITY AFTER CARBACHOL DELIVERY INTHE ORAL AND CAUDAL PONTINE RETICULARNUCLEI: SIMILARITIES AND DIFFERENCES WITHSPONTANEOUS REM SLEEP IN CATS.Bódalo C, Asensio-Gómez L, Rego-García I, De Andrés I

Monday - O - Board #061Presenting Author: Seiji Nishino (Japan)EVALUATIONS OF EFFECTS OF HIGH REBOUND ANDLOW REBOUND MATTRESS PADS ON NOCTURANLSLEEP AND ITS ASSOCIATED PHYSIOLOGYChiba S, Yagi T, Ozone M, Sato M, Nishino S

Monday - O - Board #062Presenting Author: Shih-Chi Chung (Taiwan)THE ASSOCIATION BETWEEN SLEEP AND BODYWEIGHT CHANGES FROM BIRTH TO 3 YEARSChung S, Chu S, Huang Y

Monday - O - Board #063Presenting Author: Helena Azevedo (Portugal)SLEEP QUALITY AND EATING BEHAVIOUR INFEMALE STUDENTSFerreira L, Arruda A, Maia B, Gomes A, Azevedo H,Marques M

Monday - O - Board #064Presenting Author: Emi Hasegawa (Japan)RESTORATION OF OREXIN SIGNALING IN THE DORSALRAPHE AND LOCUS COERULEUS DIFFERNTIALLYAMELIORATE SYMPTOMS OF NARCOLEPTIC MICEHasegawa E, Yanagisawa M, Roth B, Sakurai T, Mieda M

Monday - O - Board #065Presenting Author: Rogie Marie A. Ignacio-Alcantara (Phillipines)THE EFFECT OF CONTINUOUS POSITIVE AIRWAYPRESSURE (CPAP) TREATMENT ON THENEUROCOGNITIVE FUNCTION OF PATIENTS WITHOBSTRUCTIVE SLEEP APNEAIgnacio-Alcantara, Md R, Espiritu-Picar R, Ledesma L

Monday - O - Board #066Presenting Author: Saba Jafarpour (Iran)SLEEP QUALITY AND ASSOCIATED FACTORS INRESIDENTS OF A MAJOR TEACHING HOSPITAL IN IRANJafarpour S, Sadeghniiat-Haghighi K

Monday - O - Board #067Presenting Author: Denise C. Jarrin (Canada)BEYOND SLEEP DURATION: DISTINCT SLEEPDIMENSIONS ARE ASSOCIATED WITH OBESITY INCHILDREN AND ADOLESCENTSJarrin D, Mcgrath J, Drake C

Monday - O - Board #068Presenting Author: Ji Young Kim (Republic of Korea)EFFECT OF BEDSIDE LIGHT ON SLEEP QUALITY ANDBACKGROUND EEG RHYTHMSKim J, Hwang K, Cho J, Koo D, Joo E, Hong S

Monday - O - Board #069Presenting Author: Zhijun Liu (China)SLEEP PROBLEMS AMONG CHINESE PRESCHOOLCHILDREN: PREVALENCE AND ASSOCIATEDFACTORSLiu Z, Wang G, Geng L, Chen R, Tan G, Wang Z

Monday - O - Board #070Presenting Author: Elisa Lopes (Portugal)SLEEP QUALITY IN COLLEGE STUDENTS: A STUDYABOUT THE CONTRIBUTION OF LIFESTYLE,ACADEMIC PERFORMANCE AND GENERALWELL-BEINGLopes E, Milheiro I, Maia A

Monday - O - Board #071Presenting Author: Ning Lu (China)PROACTIVE COPING MODERATES THERELATIONSHIP BETWEEN MEANING OF LIFE ANDSLEEP QUALITY IN UNIVERSITY STUDENTSLu N

Monday - O - Board #072Presenting Author: Sofiya Lypovetska (Ukraine)HEART RATE VARIABILITY, T WAVE ALTERATIONAND PROLONGED QT INTERVAL AS MARKERS OFARRHYTHMOGENESIS IN PATIENTS WITH SLEEPAPNEA SYNDROME AND ARTERIAL HYPERTENSIONLypovetska S

Monday - O - Board #073Presenting Author: Ana Allen Gomes (Portugal)RELIABILITY AND INITIAL VALIDATION OF THEPITTSBURGH SLEEP QUALITY INDEX, EUROPEANPORTUGUESE VERSION: A PRELIMINARY STUDY INA SAMPLE OF HIGHER EDUCATION STUDENTSMarques D, Allen Gomes A, Meiavia A, Salgueiro A, Carlos C,Ribeiro & Dischler J

Monday - O - Board #074Presenting Author: Gisèle Maury (Belgium)MANDIBLE BEHAVIOR DURING WAKEFULNESSAND SLEEP-DISORDERED BREATHING: INTRA- ANDINTER-SCORER VARIABILITY FOR THE VISUALRECOGNITION OF THE MANDIBLE MOVEMENTISOLATED.Maury G, Senny F, Laurent C, Albert A, Laurence S, Robert P

Monday - O - Board #075Presenting Author: Oguz Osman Erdinc (Turkey)THE RELATIONSHIP BETWEEN SLEEP DISORDERSAND EXCESSIVE DAYTIME SLEEPINESS AND ANXIETYIN SEMI RURAL AREAS IN ESKISEHIR, TURKEYMetintas S, Erdinc O, Arikan I, Kalyoncu C

Monday - O - Board #076Presenting Author: Mario Milkov (Bulgaria)INTERNATIONAL SCIENTIFIC COMMUNICATIONS INSLEEP APNEA-RELATED QUALITY OF LIFEMilkov M, Tonchev T, Nedev P, Kirov F, Madjova H

Monday - O - Board #077Presenting Author: Eleida Camargo (Brazil)COMIC STRIPS FOR HEALTH EDUCATION - COMPARATIVE STUDY OF THE EFFECTIVE BETWEENCHILDREN WITH LEARNING DISABILITIES ANDREGULAR SCHOOL PERFORMANCEPereira Camargo E, Bizari Coin Carvalho L, Bizari FernandesPrado L, Fernandes Prado G

Monday - O - Board #078Presenting Author: Fen Ren (China)A TAXOMETRIC ANALYSIS OF THE CHILDREN¡¯SSLEEP HABITS QUESTIONNAIRERen F, Wang G, Wang M, Zhang J

119

MO

ND

AY

Monday - O - Board #079Presenting Author: Yuki Saito (Japan)GABAERGIC TRANSMISSION BY POA NEURONS TOOREXIN NEURONSSaito Y, Tsujino N, Mieda M, Abe M, Sakimura K, Sakurai T

Monday - O - Board #080Presenting Author: Tamar Shochat (Israel)LONGER SLEEP DURATION IS RELATED TO INCREASEDPAIN SENSITIVITY IN HEALTHY YOUNG MENShochat T, Aviram J, Pud D

Monday - O - Board #081Presenting Author: Masoud Tahmasian (Iran)EVALUATION OF SLEEP PROBLEMS IN PREECLAMPTIC,HEALTHY PREGNANTS AND NON-PREGNANTWOMEN IN KERMANSHAH, IRANTahmasian M, Khazaei H, Heidarpour A, Rezaei M,Maroufi A, Ghadami M

Monday - O - Board #082Presenting Author: Stella Maris Valiensi (Argentina)POLYSOMNOGRAPHIC CHARACTERISTICS OF SLEEPIN OLD AGE PATIENTS:Valiensi S, Maggi S, Leon P, Cristiano E, Lucero C

Monday - O - Board #083Presenting Author: Eduardo Valle (Brazil)SLEEP DISORDERS IN CHILDREN –A BRAZILIAN STUDYValle E, Ribeiro Do Valle C, Ribeiro Do Valle L, Reimão R

Monday - O - Board #084Presenting Author: Mehmet Yildiz (Turkey)DISLIPIDEMIA WITH OBSTRUCTIVE SLEEP APNEA(OSAS) IN PATIENTS OVER SIXTY YEARS OLDYildiz M, Keskin G, Karaalioglu B, Tekgul B

Monday - O - Board #085Presenting Author: Xin Yu; Guanghai Wang; Guangxing Xu (China)SLEEP DISORDERS AMONG CHILDREN IN CHINA:A REVIEW OF PULISHED STUDIES IN CHINESELANGUAGEYu X, Wang G, Xu (Corresponding Author) G

Monday - PA - Board #086Presenting Author: Antonio Zadra (Canada)ANALYSIS OF EEG FUNCTIONAL CONNECTIVITYPRIOR TO SOMNAMBULISMDesjardins M, Godbout J, Montplaisir J, Carrier J, Zadra A

Monday - PA - Board #087Presenting Author: Francesca Poli (Italy)SLEEP FORENSIC CASE REPORTSIngravallo F, Poli F, Vignatelli L, Pizza F, Plazzi G

Monday - PA - Board #088Presenting Author: Yoko Komada (Japan)COMPARISON OF CLINICAL FEATURES BETWEENPRIMARY AND SECONDARY SLEEP-RELATED EATINGSYNDROMEKomada Y, Takaesu Y, Nishida S, Sasai T, Furudate N, Inoue Y

Monday - PA - Board #089Presenting Author: Shirley Xin Li (Hong Kong)PREVALENCE AND CORRELATES OF NIGHTMAREDISTURBANCES IN PATIENTS WITH SLEEPDISORDERS OTHER THAN REM-PARASOMNIASLi S, Lam J, Zhang J, Yu M, Wing Y

Monday - PA - Board #090Presenting Author: Martínez Martínez Mª Ángeles (Spain)SLEEP RELATED EATING DISORDER (SRED) ANDNIGHT EATING SYNDROME (NES) : SAME ORDIFFERENT DISORDERS?M Ángeles M, J.A. G, Marta C, Mónica G, Roberto O, Rosario C

Monday - PA - Board #091Presenting Author: Yasunori Oka (Japan)CHILDHOOD NON-REM PARASOMNIA ASSOCIATEDWITH OBSTRUCTIVE SLEEP APNEA: EFFECTIVENESSOF CPAP TREATMENTOka Y, Tokui Y

Monday - PA - Board #092Presenting Author: Antonio Pedrera Mazarro (Spain)NOCTURNAL PAROXYSMAL DYSTONIA (NPD),TWO CASES REPORTPedrera-Mazarro A, Escajadillo-Vargas K, Álvarez-Sánchez J,Cuéllar-Ramos N

Monday - PA - Board #093Presenting Author: Montserrat Pujol (Spain)STUDY OF NECK MYOCLONUS ISOLATED ANDASSOCIATED TO OTHER INVOLUNTARYMOVEMENTS DURING THE SLEEPPujol M, March J, Utgés M, Cruz F, Barbé F

Monday - PA - Board #094Presenting Author: Leticia Soster (Brazil)CLINICAL AND POLYSOMNOGRAPHIC STUDIES ONNOCTURNAL ENURESIS: ARE THERE ANY NEWS?Soster L, Rosana Cardoso A, Simone Nascimento F, AdrienneSuri L, Eliana G, Vera Hermina Kalika K

Monday - PH - Board #095Presenting Author: Mark Eller (United States)EVALUATION OF PHARMACOKINETIC ANDPHARMACODYNAMIC INTERACTIONS OF SODIUMOXYBATE WITH IBUPROFEN: A RANDOMIZED,DOUBLE-BLIND, PLACEBO-CONTROLLED,CROSSOVER STUDYEller M, Skowronski R, Wesnes K, Alvarez-Horine S, Benson B,Black J

Monday - PH - Board #096Presenting Author: Y. Grace Wang (United States)EVALUATION OF DRUG-DRUG INTERACTIONS OFSODIUM OXYBATE WITH DIVALPROEX: RESULTS FROMA PHARMACOKINETIC/PHARMACODYNAMIC STUDYEller M, Wang Y, Wesnes K, Alvarez-Horine S, Benson B,Black J

Monday - PH - Board #097Presenting Author: Keishi Etori (Japan)EFFECTS OF A NEWLY DEVELOPED OREXIN-2RECEPTOR-SELECTIVE ANTAGONIST ON THESLEEP/WAKE STATES IN MICEEtori K, Saito Y, Tsujino N, Sakurai T

Monday - PH - Board #098Presenting Author: P. García-García (Spain)MELATONIN FOR SLEEP DISORDERS:A BIBLIOMETRIC APPROACH DURING THELAST 20 YEARSGarcía-García P, Alamo C, Munoz F

120

MO

ND

AY

Monday - PH - Board #099Presenting Author: Akiko Murakoshi (Japan)FACTORS ASSOCIATED WITH DEVELOPMENT OFBENZODIAZEPINE DEPENDENCE.Murakoshi A, Takausu Y, Komada Y, Ishikawa J, Inoue Y

Monday - PH - Board #100Presenting Author: Basil N Okeahialam (Nigeria)DIURETIC DRUGS BENEFIT PATIENTS WITHHYPERTENSION MORE WITH NIGHT TIME DOSINGOkeahialam B, Ohihoin E, Ajuluchukwu J

Monday - PH - Board #101Presenting Author: Seiji Nishino (United States)EDS IN PARKINSON’S DISEASE: PHARMACOLOGYAND NEW MOUSE MODELSakai N, Yoshida Y, Sato M, Okuro M, Nishino S

Monday - PH - Board #102Presenting Author: Anastasios Bonakis (Greece)URINE DRUG SCREENING IN THE EVALUATION OFPATIENTS WITH EXCESSIVE DAYTIME SLEEPINESSYogendran D, Hettiarachchi G, Bonakis D, Dargan P, WilliamsP, Kosky D

Monday - R - Board #103Presenting Author: Heike Benes (Germany)SLEEP IN RESTLESS LEGS SYNDROME IMPROVESDURING OPIOID TREATMENT - RESULTS FROM ALARGE 1-YEAR MULTI-CENTER TRIALBenes H, Trenkwalder C, Garcia-Borreguero D, Bosse B, HoppM, Kohnen R

Monday - R - Board #104Presenting Author: Eser Bulus (Turkey)PERIODIC LEG MOVEMENTS IN SLEEP BEFORE ANDAFTER CONTINUOUS POSITIVE AIRWAY PRESSURETREATMENT IN PATIENTS WITH OBSTRUCTIVESLEEP APNEABulus E, Benbir G, Karadeniz D

Monday - R - Board #105Presenting Author: Luigi Ferini Strambi (Italy)NEUROCOGNITIVE FUNCTION IN PATIENTS WITHIDIOPATHIC RESTLESS LEGS SYNDROME (IRLS)BEFORE AND AFTER TREATMENT WITHDOPAMINO-AGONISTFerini Strambi L, Marelli S, Galbiati A, Giarolli L, Oldani A,Zucconi M

Monday - R - Board #106Presenting Author: Stephany Fulda (Switzerland)RESPIRATORY-RELATED LEG MOVEMENTS: WHAT ISTHE EVIDENCE BEHIND THE RULES?Fulda S, Zavalko I, Ferri R, Manconi M

Monday - R - Board #107Presenting Author: Suk-Hoon Kang (Republic of Korea)THE PREVALENCE AND IMPACT ON SLEEP OFPERIODIC LIMB MOVEMENTS DURING SLEEP INTHE ELDERLYKang S, Yoon I

Monday - R - Board #108Presenting Author: Elias Georges Karroum (France)TOPOGRAPHICAL CARACTERISATION OF THEPAINFUL RESTLESS LEGS SYNDROMEKarroum E, Leu-Semenescu S, Arnulf I

Monday - R - Board #109Presenting Author: David Kemlink (Czech Republic)RESTLESS LEGS SYNDROME DURING PREGNANCYIN CZECH WOMENKemlink D, Plchova L, Srutkova Z, Pavlickova J, Sonka K,Parizek A

Monday - R - Board #110Presenting Author: Ralf Kohnen (Germany)NO AUGMENTATION DURING OPIOID TREATMENTIN RESTLESS LEGS SYNDROME - RESULTS FROM A 1YEAR LONG-TERM TRIALKohnen R, Bosse B, Hopp M, Winkelmann J, Allen R, Trenkwalder C

Monday - R - Board #111Presenting Author: Michelangelo Maestri (Switzerland)MANAGEMENT OF AUGMENTATION IN RESTLESSLEGS SYNDROME WITH PRAMIPEXOLE EXTENDED-RELEASEMaestri M, Fulda S, Ferini-Strambi L, Zucconi M, Bassetti C,Manconi M

Monday - R - Board #112Presenting Author: Alia Hassan (Egypt)CLINICAL CORRELATES OF PERIODIC LIMBMOVEMENTS IN SLEEP IN PARKINSON’S DISEASEIN EGYPTMansour A, Kamel T, Yaser M, Asaad T, Aref H, Salah N

Monday - R - Board #113Presenting Author: Abolfazl Mozafari (Iran)RELATIONSHIP BETWEEN SNORING WITH SLEEPBEHAVIORAL AND MOVEMENT DISTURBANCE(SBMD) IN CHILDREN 2-12 YEARS OF QOM CITYMozaffari A

Monday - R - Board #114Presenting Author: Ibrahim Oztura (Turkey)SOLEUS MEP-80 RESPONSE LATENCY IN RESTLESSLEGS SYNDROMEParlak O, Oztura I, Baklan B

Monday - R - Board #115Presenting Author: Rosana Cardoso Alves (Brazil)THERAPEUTIC USE OF SAINT JOHN’S WORT INRLS / WILLIS EKBOM’S DISEASEPereira Jr J, Hallinan M, Alves R

Monday - R - Board #116Presenting Author: Lenka Plchová (Czech Republic)VALIDATION OF THE MINIMUM QUESTION SET FORDIAGNOSIS OF THE RESTLESS LEGS SYNDROME INEPIDEMIOLOGY STUDY IN THE POPULATION OFCZECH PREGNANT WOMEN.Plchová L, Šrùtková Z, Pavlíèková J, Paøízek A, Sonka K,Kemlink D

Monday - R - Board #117Presenting Author: J Steven Poceta (United States)MACDONALD CRITCHLEY’S DESCRIPTION OFEKBOM’S SYNDROME IN 1955 WITH A REFERENCETO THOMAS WILLISPoceta J

Monday - R - Board #118Presenting Author: Emmanuelle Pourcher (Canada)RLS PATIENTS CAN ALSO DEVELOP COMPULSIONSON DOPAMINERGIC AGONISTSPourcher E, Bond L

121

MO

ND

AY

Monday - R - Board #119Presenting Author: Aaro Salminen (Finland)PERIODIC LEG MOVEMENTS IN SPINAL CORDINJURY: EVALUATION OF AROUSALS ANDTREATMENT EFFECTSalminen A, Manconi M, Rimpilä V, Luoto T, Ferri R, Polo O

Monday - R - Board #120Presenting Author: Mariusz Sieminski (Poland)PATTERNS OF EEG, BLOOD PRESSURE AND HEARTRATE CHANGES PRECEDING AND FOLLOWINGPERIODIC LIMB MOVEMENTSSieminski M, Pyrzowski J, Partinen M

Monday - R - Board #121Presenting Author: Yurii Sviryaev (Russian Federation)ASSOCIATION BETWEEN PERIODIC LIMBMOVEMENTS AND CO-MORBIDITIES IN HEARTFAILURESviryaev Y, Korostovtseva L, Sazonova Y, Kravchenko S, KonradiA, Shlyakhto E

Monday - R - Board #122Presenting Author: Manami Tanaka (Japan)DOES THE SUGGESTED IMMOBILIZATION TESTPERMIT PREDICTING THE EFFICACY OFDOPAMINERGIC AGONISTS IN THE TREATMENTOF RLS?Tanaka M, Okura M, Taniguchi M, Ohi M

Monday - R - Board #123Presenting Author: Claudia Trenkwalder (Germany)OPIOID TREATMENT IS EFFICACIOUS IN THESHORT- AND LONG-TERM IN PATIENTS WITHSEVERE RESTLESS LEGS SYNDROME AFTER FAILUREOF PREVIOUS MEDICATIONSTrenkwalder C, Benes H, Garcia-Borreguero D, Grote L, HoppM, Kohnen R

Monday - R - Board #124Presenting Author: Eduardo Valle (Brazil)BLOOD PRESSURE MONITORING IN RESTLESS LEGSSYNDROME (WILLIS-EKBOM DISEASE) PATIENTSValle E, Valle M, Valle L, Reimão R

Monday - R - Board #125Presenting Author: Silja Virolainen (Estonia)RESTLESS LEGS SYNDROME- PREVALENCE ANDASSOCIATED FACTORS AMONG UNIVERSITYSTUDENTS IN ESTONIAVirolainen S

Monday - R - Board #126Presenting Author: Arthur S. Walters (United States)RESTLESS LEGS SYNDROME (WILLIS EKBOMDISEASE) AND GROWING PAINS, ARE THEY THESAME THING ?: A SIDE BY SIDE COMPARISON OFTHE DIAGNOSTIC CRITERIA FOR BOTH ANDRECOMMENDATIONS FOR FUTURE RESEARCHWalters A, Gabelia D, Frauscher B

Monday - R - Board #127Presenting Author: Jihui Zhang (China)RESTLESS LEGS SYMPTOMS IN ADOLESCENTS:EPIDEMIOLOGY, HERITABILITY, AND PUBERTALEFFECTSZhang J, Lam S, Li S, Wing Y

Monday - S - Board #128Presenting Author: Anniina Alakuijala (Finland)THE OXFORD SLEEP RESISTANCE TEST (OSLER)IS SENSITIVE IN SHOWING MODIFICATIONS INVIGILANCE WITH CPAP THERAPY IN SLEEP APNEAPATIENTSAlakuijala A, Maasilta P, Bachour A

Monday - S - Board #129Presenting Author: Javier Albares (Spain)VALIDATION OF THE EFFICACY OF AN ANTI-SNORING PILLOWAlbares J, Esteller E, Estivill C, Martinez C, Segarra F, Estivill E

Monday - S - Board #130Presenting Author: María Luz Alonso Alvarez (Spain)RELIABILITY OF HOME RESPIRATORY POLYGRAPHYMONITORING FOR DIAGNOSIS OF SLEEPPANEA/HIPOPNEA SYNDROME IN CHILDRENAlonso-Alvarez M, Terán-Santos J, Cordero-Guevara J,Ordax-Carbajo E, Navazo-Egüia A, Terán Perez J

Monday - S - Board #131Presenting Author: Gislaine Aparecida Folha (Brazil)ANALYSIS OF VALIDITY IN ADULTS OF THEEXPANDED PROTOCOL OF OROFACIALMYOFUNCTIONAL EVALUATION WITH SCORESAparecida Folha G, Cardoso Pereira Valera F, Giovana Borges C,Claudia Maria De F

Monday - S - Board #132Presenting Author: Gislaine Aparecida Folha (Brazil)OROFACIAL MYOFUNCTIONAL EVALUATIONWITH SCORES IN SUBJECTS WITH OBSTRUCTIVESLEEP APNEAAparecida Folha G, Cardoso Pereira Valera F, Dantas Giglio L,Vitaliano Voi Trawizki L, Maria De Felício C

Monday - S - Board #133Presenting Author: Kevin Chan (Australia)IMPACT OF CONTINUOUS POSITIVE AIRWAYPRESSURE (CPAP) ON CHRONIC COUGH INOBSTRUCTIVE SLEEP APNOEA (OSA) – A RANDOMIZED CONTROLLED TRIALChan K, Cossa G, Birring S, Laks L, Ing A

Monday - S - Board #134Presenting Author: Dagoberto Bejarano Ugalde (Spain)ONE NIGHT OF AUTO-CPAP TITRATION WITHOUTPULSE OXIMETRY VERSUS THREE OR FOUR NIGHTSTITRATION.Bejarano Ugalde D, Juarros Martínez S, Disdier Vicente C, DelOlmo Chiches M, Vielba Dueñas D, Ramos Cancelo I

Monday - S - Board #135Presenting Author: Adriano Braga (Brazil)SUCCESS PREDICTORS IN UVULOPALATOPHARYN-GOPLASTIES FOR THE TREATMENT OF OBSTRUC-TIVE SLEEP APNEA SYNDROMEBraga A, Valera F, Eckeli, A, Kupper D, Grechi T, Trawitzky L

Monday - S - Board #136Presenting Author: Letícia Campos (Brazil)POLYSOMNOGRAPHIC ANALYSIS OF OBSTRUCTIVESLEEP APNEA (OSA) IN MIDDLE-AGED ADULTSFOLLOWING PHARYNGEAL FLAP SURGERY FORVELOPHARYNGEAL INSUFFICIENCY TREATMENTCampos L, Sampaio-Teixeira A, Yamashita R, Trindade-SuedamI, Lorenzi-Filho G, Trindade I

122

MO

ND

AY

Monday - S - Board #137Presenting Author: Tracy Carbone (United States)MATERNAL OBSTRUCTIVE SLEEP APNEA ANDADMISSIONS TO THE NEONATAL INTENSIVECARE UNITCarbone T, Violaris A, Cahill K

Monday - S - Board #138Presenting Author: Marina Carrasco (Spain)DRUG-INDUCED SLEEP ENDOSCOPY: A TWODRUG COMPARISON AND SIMULTANEOUSPOLYSOMNOGRAPHY.Carrasco M, Agostini G, Giner P, Rodrigo A, Gómez F, Dalmau J

Monday - S - Board #139Presenting Author: Richard J. Castriotta (United States)HYPOPNEA-DOMINANT SLEEP-DISORDEREDBREATHING IN EXTREME OBESITY.Castriotta R, Mathew R

Monday - S - Board #140Presenting Author: Chia-Chi Chen (Taiwan)USING CYCLIC ALTERNATING PATTERN AS AMARKER FOR CPAP TREATMENT IN PATIENTSWITH OBSTRUCTIVE SLEEP APNEAChen C, Lin C, Lin C, Lo M, Lai C

Monday - S - Board #141Presenting Author: Aleksi Chikadze (Georgia)SLEEP ARCHITECTURE IN PATIENTS WITH SLEEPAPNEA SYNDROME BEFORE CPAP THERAPY ANDAT THE BACKGROUND OF CPAPChikadze A, Khuchua L, Burduladze J, Jibladze M, Chikadze T,Shakarishvili R

Monday - S - Board #142Presenting Author: Camila De Castro Corrêa (Brazil)OROFACIAL MYOLOGY THERAPY: A CASE REPORTOF UPPER AIRWAY RESISTANCE SYNDROMECorrêa C, Megale S, Berretin-Felix G

Monday - S - Board #143Presenting Author: Lusine Dheryan (Armenia)INFLUENCE OF ARTERIAL HYPERTENSION ONRENAL FUNCTION IN PATIENTS WITH OBSTRUCTIVESLEEP APNEA HYPOPNEA SYNDROMEDheryan L, Podosyan G, Matevosyan A, Zelveian P

Monday - S - Board #144Presenting Author: Margarida Dias (Portugal)ECHOCARDIOGRAPHIC FINDINGS IN PATIENTSWITH OBSTRUCTIVE SLEEP APNEADias M, Reis R, Antunes A

Monday - S - Board #145Presenting Author: Swati Dixit (India)A STUDY ON A GENDER BASED COMPARATIVEASSOCIATION BETWEEN DIETARY INTAKE ANDOBSTRUCTIVE SLEEP APNEA SYNDROMEDixit S, Dubey A, Kant S, Tiwari S

Monday - S - Board #146Presenting Author: Abhishek Dubey (India)A STUDY ON ASSOCIATION BETWEEN OBSTRUCTIVESLEEP APNEA SYNDROME (OSAS) AND EPWORTHSLEEPINESS SCORE (ESS), PHYSICAL AND MENTALCOMPONENTS RELATED WITH QUALITY OF LIFE(QOL)Dubey A, Dixit S, Kant S, Tiwari S

Monday - S - Board #147Presenting Author: Eri Eguchi (Japan)ASSOCIATION BETWEEN SUBJECTIVE SLEEPINESSAND SEVERITY OF SLEEP-DISORDERED BREATHINGAMONG TRUCK DRIVERS IN JAPANEguchi E, Tanigawa T, Takahashi M, Sakurai S, Maruyama K

Monday - S - Board #148Presenting Author: Lobna Elnabil (Egypt)EFFECT OF ADENOTONSILLECTOMY ONNOCTURNAL ENURESIS IN CHILDREN WITHOBSTRUCTIVE SLEEP APNEAElnabil L, Helmy H

Monday - S - Board #149Presenting Author: Mostafa Elshazly (Egypt)INSULIN RESISTANCE IN OBSTRUCTIVE SLEEP APNEAElshazly M

Monday - S - Board #150Presenting Author: Jan Hedner (Sweden)ZONISAMIDE REDUCES OBSTRUCTIVE SLEEP APNEA:A RANDOMIZED PLACEBO-CONTROLLED STUDYEskandari D, Zou D, Karimi M, Stenlöf K, Grote L, Hedner J

Monday - S - Board #151Presenting Author: Francsico Javier Segarra Isern (Spain)CORRELATION BETWEEN CLINICAL ANDPOLYSOMNOGRAPHY RESPIRATORY DISORDERS INCHILDREN SLEEPEsteller E, Segarra F, Girabent M, Albares J, Roure N, Estivill E

Monday - S - Board #152Presenting Author: Francisco Javier Segarra Isern (Spain)COGNITIVE AND BEHAVIORAL AFTER ADENOTON-SILLECTOMY IN APNEA SYNDROME OBSTRUCTIVESLEEP CHILDHOODEsteller E, Segarra F, Barceló M, Girabent M, Roure N, Estivill E

Monday - S - Board #153Presenting Author: Jonathan Fernandez Camara (Spain)EFFICACY OF THE MANDIBULAR ADVANCEMENTDEVICE IN PATIENTS WITH SLEEP APNEASYNDROME AND NO TOLERANCE CPAPFernandez Camara J, Mañas Baena E, Gotera Rivera C, BarriosBarreto D, Lazo Meneses P, Esteban Calvo R

Monday - S - Board #154Presenting Author: Jonathan Fernandez Camara (Spain)GENDER DIFFERENCES IN OBSTRUCTIVE SLEEP APNEAFernandez Camara J, Gotera Rivera C, Barrios Barreto D, LazoMeneses P, Mañas Baena E, Esteban Calvo R

Monday - S - Board #155Presenting Author: Shinya Furukawa (Japan)NOCTURNAL INTERMITTENT HYPOXIA AS ANASSOCIATED RISK FACTOR FOR MICROALBUMINURIAIN WOMEN WITH TYPE 2 DIABETES MELLITUSFurukawa S, Eguchi E, Maruyama K, Tanigawa T

Monday - S - Board #156Presenting Author: Katia Gagnon (Canada)MILD COGNITIVE IMPAIRMENT IN OBSTRUCTIVESLEEP APNEAGagnon K, Baril A, DÉCary A, Lafond C, Gagnon J,Gosselin N

123

MO

ND

AY

Monday - S - Board #157Presenting Author: Newton S Faria Junior (Brazil)SLEEP PATTERN IN ADULTS PATIENTS WITHCEREBRAL PALSYGiannasi L, Roberto S, S Faria-Junior N, Oliveira L, Gomes M

Monday - S - Board #158Presenting Author: Enriqueta Gomez- Siurana (Spain)SLEEP DIFFERENCES IN AUTO-ADJUSTABLE CPAPDEVICES AND MANUAL STANDARD CPAP TITRATIONIN A SLEEP LABORATORYGomez-Siurana E, Rubio P, Urdanibia O, Blasco M, Diaz M,Ciopat O

Monday - S - Board #159Presenting Author: Marta Gonçalves (Portugal)THE IMPACT OF BENZODIAZEPINE USE INNOCTURNAL O2 SATURATION OF OSAS PATIENTSGonçalves M, Oliveira A, Leão A, Maia S, Brinca P

Monday - S - Board #160Presenting Author: Christian Guilleminault (United States)SLEEP-DISORDERED-BREATHING IN EHLERS-DANLOS SYNDROME (A GENETIC MODEL OFOBSTRUCTIVE SLEEP APNEA)Guilleminault C, Primeau M, Chiu H, Yuen K, Leger D,Metlaine A

Monday - S - Board #161Presenting Author: Banu Gulbay (Turkey)THE CLINICAL AND POLYSOMNOGRAPHICDIFFERENCES ASSOCIATED WITH HYPERTENSIONIN THE PATIENTS THAT HAVE OSA SYMPTOMS ANDTHE EFFECT OF OSA ON HYPERTENSIONGulbay B, Acican T, Ciftci F, Erdemir Isik M, Onen Z

Monday - S - Board #162Presenting Author: Firoozbakhsh Habibi (Iran)SLEEP DISORDERS IN PATIENTS WITH ASTHMAREFERRING TO GENERAL HOSPITAL OF GACHSARANHabibi F

Monday - S - Board #163Presenting Author: Milada Hobzová (Czech Republic)MULTICENTRIC, EPIDEMIOLOGICAL STUDY OFPREVALENCE OF NEWLY DIAGNOSED SLEEP APNEAIN PATIENTS WITH NOCTURNAL HYPERTENSION(ASSESSED BY 24 HOUR BLOOD PRESSUREMONITORING)Hobzová M, Šonka K, Pretl M, Plačková M , Kolek V

Monday - S - Board #164Presenting Author: Habibolah Khazaie (Iran)PREVALENCE OF SYMPTOMS AND RISK OFOBSTRUCTIVE SLEEP AP- NEA SYNDROME INTHE GENERAL POPULATIONKhazaie H, Najafi F, Rezaie L, Tahmasian M, Sepehry A, Herth F

Monday - S - Board #165Presenting Author: Leila Kheirandis-Gozal (United States)REDUCED NITRIC OXIDE PRODUCTION INMONOCYTES IS ASSOCIATED WITH ABNORMALENDOTHELIAL DYSFUNCITON IN CHILDRENWITH OSA.Kheirandish-Gozal L, Wang Y, Duggan R, Molero Ramirez H,Harshan Vardhan S, Gozal D

Monday - S - Board #166Presenting Author: Dae Lim Koo (Republic of Korea)RESPIRATORY ANALYSIS IN PATIENTS WITHOBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS):MIXED VS. PREDOMINANT OBSTRUCTIVE VS.PURE OBSTRUCTIVEKoo D, Kim D, Kim J, Kim J, Joo E, Hong S

Monday - S - Board #167Presenting Author: Lyudmila Korostovtseva (Russian Federation)OCCURRENCE OF SLEEP DISORDERED BREATHINGIN ACROMEGALYKorostovtseva L, Semenov A, Vaulina D, Kravchenko S, Tsoy U,Sviryaev Y

Monday - S - Board #168Presenting Author: Patricia Lazo Meneses (Spain)ELDERLY PATIENTS AND SLEEP APNEALazo Meneses P, Barrios Barreto D, Mañas Baena E, GoteraRivera C, Jurkojc Mohremberger C, Garcia De Leaniz J

Monday - S - Board #169Presenting Author: Patricia Lazo Meneses (Spain)ARE CURRENTLY ATTENDED PATIENTS IN A UNITOF RESPIRATORY SLEEP DISORDERS DIFFERENTRESPECT THOSE WHO WERE ATTENDED 5 YEARS AGO?Lazo Meneses P, Mañas Baena E, Barrios Barreto D, GoteraRivera C, Jurkojc Mohremberger C, Pedrera Mazarro A

Monday - S - Board #170Presenting Author: Patricia Lazo Meneses (Spain)PULSED PORTABLE OXYGEN CONCENTRATORS DONOT DETECT INSPIRATION WHEN CONNECTED TOBILEVEL VENTILATORS OR CPAPLazo Meneses P, Barrios Barreto D, Gotera Rivera C,Diaz Lobato S, Mayoralas Alises S, Perez Rodriguez E

Monday - S - Board #171Presenting Author: Chuen Peng Lee (Singapore)NON-INVASIVE VENTILATION (NIV) IN OBESITYHYPOVENTILATION SYNDROME (OHS): THESINGAPORE EXPERIENCELee C, Pang P, Tan C

Monday - S - Board #172Presenting Author: Chi-Hang Lee (Singapore)EFFECTS OF INTERACTIONS BETWEEN DIFFERENTCLINICAL PRESENTATIONS OF CORONARY HEARTDISEASE AND TIMING OF POLYSOMNOGRAPHY ONDIAGNOSIS OF OBSTRUCTIVE SLEEP APNEALee C, Hong W, Low T, Tai B, Tan A, Khoo S

Monday - S - Board #173Presenting Author: Byung Jae Yu (Republic of Korea)ANATOMICAL ANALYSIS OF NASAL CAVITY INSTUFFY PATIENT WITH SNORINGLee D, Yu B, Kim J, Yun S, Lee G

Monday - S - Board #174Presenting Author: Radka Stepanova (Czech Republic)CIRCADIAN VARIATION OF MYOCARDIALINFARCTION ONSET IN PATIENTS WITH SLEEP APNEALudka O, Stepanova R, Galkova L, Vyskocilova M, Spinar J,Kara T

124

MO

ND

AY

Monday - S - Board #175Presenting Author: I. M. Madaeva (Russian Federation)ERECTILE DYSFUNCTION IS AN EARLY PREDICTOROF CARDIOVASCULAR DISEASES IN MEN WITHOBSTRUCTIVE SLEEP APNEAMadaeva I, Kolesnikova L

Monday - S - Board #176Presenting Author: Christoph Maier (Germany)RECOGNITION OF SLEEP-RELATED BREATHINGDISORDERS FROM HOLTER-ECGS ¨C A NEW ROBUSTMETHOD SUITABLE FOR CLINICAL SCREENINGAPPLICATIONSMaier C, Wenz H, Dickhaus H

Monday - S - Board #177Presenting Author: Mercedes Martín Romero (Spain)ORAL APPLIANCES IN OBSTRUCTIVE SLEEPAPNEA SYNDROME: OUR EXPERIENCE.Martín Romero M, Reina Marfil N, Ortega Sáenz De Tejada E,Hidalgo Sánchez R, Amecrane N, Hidalgo Sanjuán M

Monday - S - Board #178Presenting Author: Juan F. Masa (Spain)EFFECTIVENESS OF HOME SINGLE-CHANNELNASAL PRESSURE FOR SLEEP APNEA DIAGNOSISMasa J

Monday - S - Board #179Presenting Author: Geert Mayer (Germany)THE COSTS OF SLEEP RELATED BREATHINGDISORDERS: A PROSPECTIVE, REPRESENTATIVESTUDY IN THE GERMAN STATE OF HESSENMayer G, Hessmann P, Reese J, Dodel R, Apelt S, Heitmann J

Monday - S - Board #180Presenting Author: Miguel Meira E Cruz (Portugal)SLEEP BRUXISM AS THE MAIN MANIFESTATION OFSLEEP DISORDERED BREATHING - CASE REPORTMeira E Cruz M, Rebocho S, Drummond M

Monday - S - Board #181Presenting Author: Mario Milkov (Bulgaria)USAGE OF COBLATOR-2 (ARTHROCARE) AND ENTCELON (OLYMPUS) SYSTEMS FOR SOFT PALATEREDUCTION IN HABITUAL SNORING PATIENTSMilkov M, Nedev P, Tonchev T, Kirov F, Madjova H

Monday - S - Board #182Presenting Author: Vahid Mohsenin (United States)HYPERTENSION AND ENDOTHELIAL DYSFUNCTIONIN OBSTRUCTIVE SLEEP APNEA (OSA) - IS ITRELATED TO HYPOXIA?Mohsenin V, Jafari B

Monday - S - Board #183Presenting Author: Tsuguo Nishijima (Japan)SIGNIFICANCE OF PLASMA APOPTOSIS INHIBITOROF MACROPHAGES LEVELS IN PATIENTS WITHOBSTRUCTIVE SLEEP APNEA SYNDROME: A NEWBIOLOGICAL INDICATOR OF SEVERITY ANDTREATMENT RESPONSESNishijima T

Monday - S - Board #184Presenting Author: Özge Oral Tapan (Turkey)EFFECT OF NASAL CPAP THERAPY ON FUNCTIONALRESPIRATORY PARAMETERS AND CARDIOPULMONARYEXERCISE TEST IN OBSTRUCTIVE SLEEP APNEASYNDROMEOral Tapan Ö, Sevinç C, Ýtil B, Öztura Ý, Kayatekin M,Demiral Y

Monday - S - Board #185Presenting Author: Francisco Sánchez-Nárváez (Mexico)NICTURIA AND MORBID OBESITY: PREDICTORSFOR SEVERE AHÍ AND SAO2 DECREASEPalacios A, Sánchez-Narváez F, Labra A, Haro R

Monday - S - Board #186Presenting Author: Hyelim Son (Republic of Korea)ASSOCIATION BETWEEN THE ACTIVITY OF SALIVARYALPHA-AMYLASE AND THE SEVERITY OF PEDIATRICSLEEP DISORDERED BREATHING(SDB)Park C, Son H, Hong H

Monday - S - Board #187Presenting Author: Reyes Haro (Mexico)MORBID OBESITY AND WOMEN AGE ARE RELATEDTO THE OBSTRUCTIVE SLEEP APNEA SYNDROME.Perez J, Sánchez-Narváez F, Labra A, Haro R

Monday - S - Board #188Presenting Author: Joana Pires (Portugal)OSA IN REM AND NREM - INDIVIDUAL SUBJECTIVECOMPLAINTSPires J, Bentes C, Peralta A

Monday - S - Board #189Presenting Author: M. Quera Salva (France)SLEEP DISORDERS AND NEAR-MISS ACCIDENTSAMONG SUMMER LONG-DISTANCE HIGHWAYDRIVERSQuera-Salva M, Barbot F, Hartley S, Sauvagnac R, Machou M,Philip P

Monday - S - Board #190Presenting Author: Andrea Romigi (Italy)SLEEP DISORDERS IN MYOTONIC DYSTROPHY TYPE2: A CONTROLLED POLYSOMNOGRAPHIC STUDYAND SELF-REPORTED QUESTIONNAIRESRomigi A, Albanese M, Placidi F, Izzi f, Marciani m, Massa R

Monday - S - Board #191Presenting Author: Roser Cambrodí (Spain)OBSTRUCTIVE SLEEP APNEA IN A CLINICALSETTING OF EPILEPSY PATIENTS: PREVALENCEAND POLYSOMNOGRAPHIC FEATURES OF 100CONSECUTIVE CASESRoser C, Lorena G, Marta T, Xavier S, Manuel T, Patricia L

Monday - S - Board #192Presenting Author: Sylvie Royant-Parola (France)IMPROVING CPAP USE WITH TELEMONITORINGAND SOCIAL MEDIARoyant-Parola S, Hartley S, Violaine L, Lefevre P, Dagneaux S,Escourrou P

125

MO

ND

AY

Monday - S - Board #193Presenting Author: Ahmad Khajeh Mehrizi (Iran)PREVALENCE AND RISK FACTORS OF THEOBSTRUCTIVE SLEEP APNEA AMONG IRANIANPATIENTS WITH TYPE 2 DIABETES MELLITUSSadeghniiat-Haghighi K, Mohajeri-Tehrani M, Khajeh MehriziA, Fathi F, Saremi-Rasouli F, Larijani B

Monday - S - Board #194Presenting Author: Takeshi Tanigawa (Japan)A CROSS-SECTIONAL STUDY ON THE ASSOCIATIONSOF SLEEP-DISORDERED BREATHING WITHSUBJECTIVE AND OBJECTIVE SLEEPINESS AMONGLOCAL POLICE OFFICERSSaeki A, Tanigawa T, Maruyama K, Eguchi E, Saito I

Monday - S - Board #195Presenting Author: S. Sousa (Portugal)IMPACT OF BARIATRIC SURGERY ON OSAS INOBESE INDIVIDUALSSantos S, Caramujo C, Silva M, Duarte P

Monday - S - Board #196Presenting Author: S. Sousa (Portugal)PREVALENCE OF OSAS IN OBESE INDIVIDUALS.Santos S, Caramujo C, Silva M, Duarte P

Monday - S - Board #197Presenting Author: Sang-Wook Kim (Republic of Korea)PALATAL SENSORY THRESHOLD REFLECTSNOCTURNAL HYPOXEMIA AND AIRWAY OCCLUSIONIN SNORERS AND OBSTRUCTIVE SLEEP APNEAPATIENTSSeoul S, Chang D, Won S, Jeon S, Kim D

Monday - S - Board #198Presenting Author: Garima Shukla (India)SPECTRUM OF SLEEP DISORDERED BREATHINGAMONG PATIENTS WITH MUCOPOLYSACCHARIDOSES:A CLINICO-POLYSOMNOGRAPHIC STUDYShukla G, Gupta A, Gupta N, Kabra M

Monday - S - Board #199Presenting Author: Natalia Strueva (Russian Federation)OBSTRUCTIVE SLEEP APNEA SYNDROME ANDHORMONAL STATUS OF OBESE PATIENTSStrueva N, Poluektov M, Melnithenko G, Saveleva L, Katsya G,Goncharov N

Monday - S - Board #200Presenting Author: Sunchen Sun (China)HERBA SCHIZONEPETAE VERSUS NASAL STEROID:HOW DO THEY AFFECT CPAP PRESSURE ON OSAHSPATIENTS?Sun S, Zhao Y, Qiao J, Ma Y

Monday - S - Board #201Presenting Author: Andreea Coman (Romania)RELATIONSHIP OF ARTERIAL HYPERTENSIONAND OBSTRUCTIVE SLEEP APNEA SYNDROMETodea D, Todor I, Coman A

Monday - S - Board #202Presenting Author: Tsiala Ustyan (Armenia)OBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROMEEXACERBATES THE PULMONARY HYPERTENSION?Ustyan T, Podosyan G, Matevosyan A, Zelveian P

Monday - S - Board #203Presenting Author: Pedro Pileggi Vinha (Brazil)MAXILLARY TRANSVERSE DISTRACTIONOSTEOGENESIS FOR THE TREATMENT OF OSASVinha P, Mello-Filho F, Faria A, Xavier S, Eckeli A

Monday - S - Board #204Presenting Author: Kim Ward (New Zealand)WHAT IS KNOWN ABOUT THE EXPERIENCE OFCPAP FOR OSA FROM THE USERS’ PERSPECTIVE? ASYSTEMATIC INTEGRATIVE LITERATURE REVIEW.Ward K, Gott M, www.Fmhs.Auckland.Ac.Nz/Staff/K.H D

Monday - S - Board #205Presenting Author: Aika Yanai (Japan)INFLUENCE OF APPLICATION OF THE NEW RULEFOR HYPOPNEA IN CARDIAC PATIENTSYanai A

Monday - S - Board #206Presenting Author: Hiroko Tsuda (Japan)SLEEP MEDICINE IN JAPANESE PRE-DOCTORALDENTAL CURRICULUMYoshinori Higuchi H

Monday - S - Board #207Presenting Author: Ph Zelveian (Armenia)INFLUENCE OF NOCTURNAL HYPOXAEMIAON RENAL IMPAIRMENT IN PATIENTS WITHOBSTRUCTIVE SLEEP APNEA-HYPOPNEA SYNDROMEAND ARTERIAL HYPERTENSIONZelveian P, Dheryan L, Matevosyan A, Podosyan G

Monday - S - Board #208Presenting Author: Zhang Xilong (China)EFFICACY OF AUTO-TRILEVEL POSITIVE AIRWAYVENTILATION ON PATIENTS WITH BOTH OBESITYHYPOVENTILATION AND MODERATE TO SEVEREOBSTRUCTIVE SLEEP APNEA SYNDROMESZhang Z

Monday - S - Board #209Presenting Author: Zhang Xilong (China)ADIPONECTIN MAY INHIBIT CHRONICINTERMITTENT HYPOXIA-INDUCED ENDOPLASMICRETICULUM STRESS AND CELL APOPTOSIS INGENIOGLOSSUSZhang Z, Hanpeng H

Monday - SD - Board #210Presenting Author: Fida Tannous (Lebanon)SLEEP PATTERNS AND SLEEP DISORDERS AMONGUNIVERSITY STUDENTS IN LEBANONAssaad S, Tannous F, Costanian C

Monday - SD - Board #211Presenting Author: Raquel Canuto (Brazil)SLEEP DEPRIVATION AND OBESITY IN SHIFTWORKERS IN SOUTHERN BRAZILCanuto R, Anselmo Olinto M, Pattussi M, Henn R, Macagnan J

Monday - SD - Board #212Presenting Author: Garance Dispersyn (France)VALIDATION OF TOTAL SLEEP DEPRIVATIONMODEL IN MICEDispersyn G, Sauvet F, Drogou C, Ciret S, Gallopin T,Chennaoui M

126

MO

ND

AY

Monday - SD - Board #213Presenting Author: Iris Haimov (Israel)THE RELATIONSHIP BETWEEN OBJECTIVELYMEASURED SLEEPINESS AND DRIVING ABILITYHaimov I, Cale M, Shafran Y, Tzischinsky O

Monday - SD - Board #214Presenting Author: Paulo Henriques Filho (Brazil)OBSTRUCTIVE SLEEP APNEA AND P300ABNORMALITIES IN CHILDREN WITH ATTENTIONDEFICITHenriques Filho P, Pratesi R, Gandolfi L, Nobrega Y, Tristao R

Monday - SD - Board #215Presenting Author: Camila Hirotsu (Brazil)THE ROLE OF SLEEP AND SILDENAFIL IN THEPROGRESSION OF CHRONIC KIDNEY DISEASE:A NEW THERAPEUTIC APPROACHHirotsu C, Tufik S, Andersen M

Monday - SD - Board #216Presenting Author: Jee Hyun Kim (Republic of Korea)FAULTY PERCEPTION OF SLEEP STATUS INKOREAN ADOLESCENTSKim J, Han S, Hong S

Monday - SD - Board #217Presenting Author: Jin-Seong Lee (Republic of Korea)EFFECTS OF SLEEP DEPRIVATION ON PAINSENSITIVITY IN HEALTHY SUBJECTSLee J, Kim J, Shin H

Monday - SD - Board #218Presenting Author: Rong Liu (China)ASSOCIATION BETWEEN POOR SLEEP QUALITYAND C-REACTIVE PROTEIN:Liu R, Liu X, Zheng Z, Zee P, Du J

Monday - SD - Board #219Presenting Author: Sally Loomis (United Kingdom)BEHAVIOURAL EVIDENCE THAT MODAFINIL ANDAMPHETAMINE DO NOT PRODUCE EQUIVALENTQUALITIES OF WAKE PROMOTION IN SLEEP-RESTRICTED RATS.Loomis S, Mccarthy A, Edgar D, Tricklebank M, Gilmour G

Monday - SD - Board #220Presenting Author: Andréa Luz (Brazil)DAYTIME WORK AND EVENING CLASSES: REPORTSON SLEEPINESS AMONG YOUNG WORKINGSTUDENTSLuz A, Fischer F

Monday - SD - Board #221Presenting Author: Lia M. Maisuradze (Georgia)A NOVEL EXPERIMENTAL DESIGN TO AVOIDREM SLEEP REBOUNDMaisuradze L, Lortkipanidze N, Oniani N

Monday - SD - Board #222Presenting Author: Canastro Mário (Portugal)PARTIAL SLEEP DEPRIVATION IN PORTUGUESENAVY MILITARIESMário C, Teresa P

Monday - SD - Board #223Presenting Author: Srikant Nannapaneni (United States)SLEEP FRAGMENTATION AND DEPRIVATION INCRITICALLY ILL PATIENTS – IS NOISE A FACTOR?Nannapaneni S, Ramar K, Morgenthaler T, Elmer J, Lee S

Monday - SD - Board #224Presenting Author: Trond Sand (Norway)THE EFFECT OF TWO NIGHTS OF PARTIAL SLEEPRESTRICTION ON OBJECTIVE AND SUBJECTIVE PAINMEASUREMENTSØdegård S, Omland P, Nilsen K, Gravdahl G, Stjern M, Sand T

Monday - SD - Board #225Presenting Author: Ossi Rahkonen (Finland)INSOMNIA SYMPTOMS AND MORTALITYRahkonen O, Haaramo P, Lahelma E, Lallukka T

Monday - SD - Board #226Presenting Author: Alireza Safaiyan (Iran)NIGHT-WORK SHIFTS AND INFLAMMATORY MARKERSSafaeian A

Monday - SD - Board #227Presenting Author: Peter Schwarz (Canada)SLEEP DEPRIVATION IMPAIRS FUNCTIONALMUSCLE RECOVERY FOLLOWING INJURYSchwarz P, Graham W, Li F, Locke M, Peever J

Monday - SD - Board #228Presenting Author: Liliane Teixeira (Brazil)EXPOSURE TO BRIGHT LIGHT DURING EVENINGCLASS HOURS INCREASES SLEEP QUALITY ANDMOOD AMONG WORKING COLLEGE STUDENTS.Teixeira L

Monday - T - Board #229Presenting Author: Tomi Sarkanen (Finland)LONG-TERM SLEEP MEASUREMENT WITH ASMARTPHONE-CONNECTED FLEXIBLE BEDSENSOR STRIPPaalasmaa J, Sarkanen T, Partinen M

Monday - PH - Board #230Presenting Author: Mark Eller (United States)EVALUATION OF DRUG-DRUG INTERACTIONS OFSODIUM OXYBATE WITH DICLOGENAC: RESULTS FROMA PHARMACOKINETIC/PHARMACODYNAMIC STUDYEller M, Skowronski R, Wesnes K, Alvarez-Horine S, Benson B,Black J

Monday - S - Board #231Presenting Author: Pedro Pileggi Vinha (Brazil)IS THERE A RELATIONSHIP BETWEEN THE EXTENTOF MAXILLARY TRANSVERSE DISTRACTION ANDEXPANSION OF THE UPPER AIRWAY?Vinha P, Mello-Filho F, Faria A

Tuesday, October 1, 2013

Tuesday - A - Board #001Presenting Author: María Aguilar Andújar (Spain)PERIODIC LIMB MOVEMENTS DISORDER INPATIENTS WITH SPECIFIC LANGUAGE IMPAIRMENT:AN IMPORTANT CAUSE OF SLEEP DISRUPTIONAguilar-Andújar M, Ramos JimÉNez M, GuerreroSÁNchez M, Menendez C

Tuesday - A - Board #002Presenting Author: María Aguilar Andújar (Spain)SLEEP CHARACTERISTICS IN CHILDREN WITHSPECIFIC LANGUAGE IMPAIRMENT: MACROSTRUCTUREAND MICROSTRUCRURE ANALYSISAguilar-Andújar M, Menéndez De León C, Ramos Sánchez I,Dinca Avarvarei L, Márquez Luque A

127

TU

ESD

AY

Tuesday - A - Board #003Presenting Author: Soheir ElGhonemy (Egypt)SLEEP PATTERNS IN A SAMPLE OF PATIENTSWITH POST-TRAUMATIC DISORDERAssad T, Sadek H, Elghonemy S, Sarag M

Tuesday - A - Board #004Presenting Author: Darwin Vizcarra-Escobar (Peru)QUALITY OF LIFE IS IMPAIRED AMONG OLDERADULTS WITH OBSTRUCTIVE SLEEP APNEAHYPOPNEA SYNDROME DESPITE DISEASE SEVERITYBarbagelata-Aguero F, Vizcarra-Escobar D

Tuesday - A - Board #005Presenting Author: Sandra Carvalho Bos (Portugal)COMPARISON BETWEEN SUBJECTIVE ANDOBJECTIVE ESTIMATIONS OF INFANTS SLEEPCarvalho Bos S, Marques M, Soares M, Amaral A, Azevedo M,Macedo A

Tuesday - A - Board #006Presenting Author: Sandra Carvalho Bos (Portugal)SLEEP PATTERNS IN PORTUGUESE PRESCHOOLAGED CHILDRENCarvalho Bos S, Marques M, Soares M, Amaral A, Azevedo M,Macedo A

Tuesday - A - Board #007Presenting Author: Patrizia Congiu (Italy)NEUROPHYSIOLOGICAL EVALUATION OF SPINALEXCITABILITY IN PATIENTS AFFECTED BY PRIMITIVERESTLESS LEGS SYNDROMECongiu P, Milioli G, Gioi G, Tacconi P, Fantini M,Puligheddu M

Tuesday - A - Board #008Presenting Author: Cintia Fiori (Brazil)HYPOXIA PREDICTS HIGH BLOOD PRESSURE INPATIENTS WITH SEVERE OBSTRUCTIVE SLEEP APNEAFiori C, Martins E, Lopez P, Martinez D

Tuesday - A - Board #009Presenting Author: Iñaki G. De Gurtubay (Spain)PERIODIC LIMB MOVEMENTS ON 713 CONSECUTIVEVIDEO SUPPORTED POLYSOMNOGRAPHY VPSGG.De Gurtubay I, Martin B, Alonso M, Morales G, Cascante J,Eguia V

Tuesday - A - Board #010Presenting Author: Belén Gallego Ariza (Spain)SLEEP QUALITY AND SLEEPINESS REPERCUSSIONON COGNITIVE IMPAIRMENT IN COMMUNITY-DWELLING OLDER MEN AND WOMENGallego-Ariza B, Cabrera-Martos I, Cerón-Lorente L,Flores-Barba M, Torres-Sánchez I, Valenza M

Tuesday - A - Board #011Presenting Author: Belén Gallego Ariza (Spain)IMPACT OF A SUPERVISED MUSCULAR TRAINING ONPERCEIVED QUALITY OF SLEEP AND HEALTH IN APOPULATION WITH KNEE OSTEOARTHRITISGallego-Ariza B, Mateos-Toset S, Cabrera-Martos I,Correa-Toledo A, Badillo-Fontalvo M, Valenza M

Tuesday - A - Board #012Presenting Author: Mariam Gogichadze (Georgia)DEVELOPMENT OF TOLERANCE TO ETHANOL INTHE SLEEP-WAKEFULNESS CYCLEGogichadze M, Nemsadze M, Oniani N, Lortkipanidze N,Khachturovy E, Aladashvili T

Tuesday - A - Board #013Presenting Author: Joke Jaarsma (The Netherlands)DIAGNOSING RESTLESS LEGS SYNDROME:THE PATIENT EXPERIENCEJaarsma J, Sevborn S

Tuesday - A - Board #014Presenting Author: Joke Jaarsma (The Netherlands)SICK LEAVE AND ABSENCE FROM WORK DUE TORESTLESS LEGS SYNDROMEJaarsma J, Sevborn S

Tuesday - A - Board #015Presenting Author: Joke Jaarsma (The Netherlands)DOSING PATTERNS OF DOPAMINE AGONISTS FORRESTLESS LEGSJaarsma J, Sevborn S

Tuesday - A - Board #016Presenting Author: Isabelle Jaussent (France)HYPNOTICS AND MORTALITY IN AN ELDERLYGENERAL POPULATION: A 12-YEAR PROSPECTIVESTUDY.Jaussent I, Ancelin M, Berr C, Besset A, Ritchie K, Dauvilliers Y

Tuesday - A - Board #017Presenting Author: Laura Lillo (Spain)RESTLESS LEGS SYNDROME IN A PATIENT WITHDYSMETABOLIC IRON OVERLOAD SYNDROME ANDABNORMAL IRON DEPOSITS IN BASAL GANGLIAAND SUSBTANTIA NIGRA.Lillo L, Del Castillo A, Morán M, Guzmán De Villoria J,Guillem A, Peraita-Adrados R

Tuesday - A - Board #018Presenting Author: Mauro Manconi (Switzerland)RESPIRATORY-RELATED LEG MOVEMENTS ANDPERIODIC LEG MOVEMENTS DURING SLEEPManconi M, Zavalko I, Bassetti C, Colamartino E, Pons M, Ferri R

Tuesday - A - Board #019Presenting Author: Nicolas Martin (Canada)FUNCTIONAL IMAGING OF NREM RECOVERY SLEEPSLOW WAVES IN YOUNG AND OLDER SUBJECTS :PRELIMINARY RESULTSMartin N, Godbout J, Pouliot P, Doyon J, Maquet P, Carrier J

Tuesday - A - Board #020Presenting Author: Obiabo Yahaya Olugbo (Nigeria)PREVALENCE OF RESTLESS LEGS SYNDROMEAMONG TERTIARY HOSPITAL WORKERS INSOUTH-SOUTH NIGERIA.Obiabo Y

Tuesday - A - Board #021Presenting Author: Roger Godbout (Canada)STAGE 2 SLEEP AND INTELLIGENCE MEASURES INAUTISTIC CHILDRENTessier S, Lambert A, Chevrier É, Scherzer P, Mottron L,Godbout R

Tuesday - B - Board #022Presenting Author: Momoko Kayaba (Japan)DROWSINESS AND LOW ENERGY METABOLISM INTHE FOLLOWING MORNING INDUCED BYNOCTURNAL BLUE LIGHT EXPOSUREKayaba M, Iwayama K, Ogata H, Seya Y, Tokuyama K, Satoh M

128

TU

ESD

AY

Tuesday - B - Board #023Presenting Author: Habibolah Khazaie (Iran)EVALUATION OF DREAM CONTENT AMONGPATIENTS WITH SCHIZOPHRENIA, THEIR SIBLINGS,PATIENTS WITH PSYCHIATRIC DIAGNOSES OTHERTHAN SCHIZOPHRENIA, AND HEALTHY CONTROLKhazaie H, Tahmasian M, Younesi G, Schwebel D, Rezaei M,Rezaie L

Tuesday - B - Board #024Presenting Author: Jessica Lara-Carrasco (Canada)DYSPHORIC DREAMING AND EVENINGNESSDURING THE THIRD TRIMESTER OF PREGNANCYPREDICT ADVERSE DELIVERY OUTCOMESLara-Carrasco J, Simard V, Nielsen T

Tuesday - B - Board #025Presenting Author: Ana Allen Gomes (Portugal)QUALITY OF SLEEP AND QUALITY OF LIFE INHIGHER EDUCATION STUDENTSMeiavia A, Marques D, Allen Gomes A

Tuesday - B - Board #026Presenting Author: Eduardo Valle (Brazil)STRESS AND SLEEP DISORDERS IN TEACHERS – A BRAZILIAN STUDYRibeiro Do Valle L, Ribeiro Do Valle C, Valle E, Malvezzi S,Reimão R

Tuesday - B - Board #027Presenting Author: Ana Paula Rivera Garcia (Mexico)FACIAL MUSCLE CONTRACTIONS DURING REMSLEEP AND ITS ASSOCIATION TO EMOTIONALDREAMED CONTENTRivera Garcia A, Ramirez Salado I, Lopez Ruiz E

Tuesday - B - Board #028Presenting Author: Maria-Raquel G. Silva (Portugal)INADEQUATE SLEEP AND UNHEALTHY FOODHABITS IN PORTUGUESE ADOLESCENTSSilva M, Silva H, Paiva T

Tuesday - B - Board #029Presenting Author: Maria-Raquel G. Silva (Portugal)SLEEP, PRECOMPETITIVE STRESS AND ACHIEVEMENTSIN YOUNG PERFORMANCE ATHLETESSilva M, Paiva T

Tuesday - B - Board #030Presenting Author: Maria-Raquel G. Silva (Portugal)SLEEP, TRAINING VOLUME AND BODYCOMPOSITION IN YOUNG GYMNASTSSilva M, Paiva T

Tuesday - B - Board #031Presenting Author: Maria-Raquel G. Silva (Portugal)SLEEP DURATION AND ENERGY INTAKE IN FEMALEGYMNASTS FROM PREPARATORY TRAINING PERIODTO COMPETITION SEASONSilva M, Paiva T

Tuesday - B - Board #032Presenting Author: Graciela Silva (United States)INCIDENCE AND REMISSION OF SLEEP RELATEDSYMPTOMS IN CHILDREN AND ASSOCIATIONSWITH HEALTH-RELATED QUALITY OF LIFE; A 7-YEARFOLLOW-UP OF THE TUCASA COHORTSilva G, Goodwin J, Archibald K, Vasquez M, Quan S

Tuesday - B - Board #033Presenting Author: Jiahong Zhang (China)A REVIEW OF THE RELATIONSHIP BETWEENSOCIAL, EMOTIONAL AND BEHAVIOURALDIFFICULTIES(SEBD) AND THE SLEEP DISTURBANCE.Zhang J, Lu N, Zhang J

Tuesday - C - Board #034Presenting Author: Mohsin Ali (Canada)CHARACTERIZING SLEEP–WAKE CYCLES OFPRE-HEALTH PROFESSIONAL STUDENTSAli M, Chu R, Nastos S, Whelan S

Tuesday - C - Board #035Presenting Author: R. Robert Auger (United States)CHRONOTYPE DISTRIBUTION IN BIPOLARDISORDER AND MAJOR DEPRESSIVE DISORDERIN AN IN-PATIENT SAMPLE AT A TERTIARYCARE CENTERAuger R, Das P, Cao H, Feeder S, Kashyap R, Frye M

Tuesday - C - Board #036Presenting Author: Tamar Shochat (Israel)PAIN SENSITIVITY IN HEALTHY YOUNG MENIS MODIFIED BY TIME-OF-DAYAviram J, Pud D, Shochat T

Tuesday - C - Board #037Presenting Author: Masoud Bagherian Lemraski (Iran)THE COMPARISON OF SLEEP DISORDERS AMONGSHIFT WORKERS AND NON-SHIFT WORKERS INDOOROD HOSPITALBagherian Lemraski M

Tuesday - C - Board #038Presenting Author: Ahmed Bahammam (Saudi Arabia)INTERMITTENT FASTING DOES NOT INFLUENCETHE CIRCADIAN PATTERN OF MELATONIN WHENCONTROLLING FOR MEALS, LIGHT EXPOSURE ANDSLEEP SCHEDULESBahammam A

Tuesday - C - Board #039Presenting Author: Emmanuelle Bastille-Denis (Canada)THE PRESENCE AND THE NATURE OF DYSFUNCTIONALCOGNITIONS AND THE FOCUS OF ATTENTIONDURING PRE-SLEEP PERIOD IN SHIFT WORKERS.Bastille-Denis E, Roy M, Vallières A

Tuesday - C - Board #040Presenting Author: Emmanuelle Bastille-Denis (Canada)CATASTROPHIZATION PROCESS AND THEMES OFWORRY IN SHIFT WORKERS.Bastille-Denis E, Roy M, Vallières A

Tuesday - C - Board #041Presenting Author: Bjørn Bjorvatn (Norway)A RANDOMIZED CONTROLLED TRIAL OF THEEFFECTS OF BRIGHT LIGHT AND MELATONIN FORDELAYED SLEEP PHASE DISORDERBjorvatn B, Saxvig I, Wilhelmsen-Langeland A, Vedaa Ø,Nordhus I, Pallesen S

Tuesday - C - Board #042Presenting Author: Diane B. Boivin (Canada)CIRCADIAN VARIATION OF HEART RATEVARIABILITY DURING DIFFERENT SLEEP STAGESBoudreau P, Dumont G, Boivin D

129

TU

ESD

AY

Tuesday - C - Board #043Presenting Author: Raquel Canuto (Brazil)ASSOCIATED FACTORS WITH METABOLICSYNDROME IN SHIFT WORKERSCanuto R, Anselmo Olinto M, Pattussi M, Henn R,Macagnan J

Tuesday - C - Board #044Presenting Author: Christian Lavedan (United States)TASIMELTEON TREATMENT ENTRAINS THECIRCADIAN CLOCK AND DEMONSTRATES SIGNIFICANTBENEFIT ON SLEEP AND WAKE PARAMETERS INTOTALLY BLIND INDIVIDUALS WITH NON-24 HOURCIRCADIAN RHYTHMSLockley S, Dressman M, Torres R, Lavedan C, Licamele L,Polymeropoulos M

Tuesday - C - Board #045Presenting Author: María José Martínez Madrid (Spain)INFLUENCE OF SHIFT-WORK SCHEDULE ONCIRCADIAN DISRUPTION IN NURSING STAFFMartínez Madrid M, Rol M, Gómez-García T,Fuentelsaz-Gallego C, Madrid Pérez J

Tuesday - C - Board #046Presenting Author: María José Martínez Madrid (Spain)THE CHALLENGE OF CHRONODISRUPTIONASSESSMENT. THE CASE OF NURSING STAFFSHIFT WORKERSMartínez Madrid M, Campos M, Madrid Pérez J, Rol M,Moreno-Casbas T

Tuesday - C - Board #047Presenting Author: Sofia Isabel Ribeiro Pereira (Brazil)CIRCADIAN AND HOMEOSTATIC PROCESSESINFLUENCE DAYTIME NAP ARCHITECTUREPereira S, Beijamini F, Spada R, Menon F, Clementin J, Louzada F

Tuesday - C - Board #048Presenting Author: Arcady Putilov (Germany)A SIMPLIFIED APPROACH TO MODEL-BASEDANALYSIS OF THE ULTRADIAN SLEEP HOMEOSTASISTHROUGH FITTING TIME COURSES OF ITS EEGINDICATORS OBTAINED ACROSS ROUTINE CLINICALSLEEP LAB RECORDINGS OF ALL-NIGHT SLEEP ANDMULTIPLE 20-MIN NAPPING ATTEMPTSPutilov A

Tuesday - C - Board #049Presenting Author: Milva Maria Figueiredo De Martino (Brazil)CIRCADIAN RHYTHM OF WRIST TEMPERATURE ANDNIGHT SHIFT-WORKRuiz Carmona Ferreira L

Tuesday - C - Board #050Presenting Author: Khosro Sadeghniiat-Haghighi (Iran)EVALUATION OF SLEEP DISORDERS IN FLIGHTCREW AND GROUND STAFF WORKER IN IRANPRIVATE FLIGHT AIRLINESadeghniiat-Haghighi K, Khazaee S, Aminian O, Momeni P

Tuesday - C - Board #051Presenting Author: Khosro Sadeghniiat-Haghighi (Iran)SLEEPINESS, FATIGUE AND ROAD TRAFFIC ACCIDENTSSadeghniiat-Haghighi K, Moradi Nia M, Aminian O,Esmaeeli A

Tuesday - C - Board #052Presenting Author: M.G. Smits (The Netherlands)PERSONALIZED SLEEP MEDICINE APPLIED TOMELATONIN TREATMENT FOR CIRCADIAN RHYTHMSLEEP DISORDERS: CURRENT STATUS AND FUTURESmits M, Keijzer H, Braam W, Vervoort J, Curfs L

Tuesday - E - Board #053Presenting Author: Helena Azevedo (Portugal)SUBJECTIVE DAYTIME SLEEPINESS, EATINGDISTURBANCES AND BODY MASS INDEX IN EMALE STUDENTSArruda A, Marques M, Ferreira L, Maia B, Gomes A, Azevedo M

Tuesday - E - Board #054Presenting Author: Valérie Cochen De Cock (France)HOW TO EVALUATE SLEEPINESS IN PARKINSON’SDISEASE?Cochen De Cock V, Bayard S, Jaussent I, Dauvilliers Y

Tuesday - E - Board #055Presenting Author: Sarah Keane (Ireland)KLEINE LEVIN SYNDROME PRESENTING AFTERHINI VACCINECrowe C, Keane S, Purcell E

Tuesday - E - Board #056Presenting Author: Bomi Kim (Republic of Korea)EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITHEPILEPSY: CONTRIBUTING FACTORS AND IMPACTON QUALITY OF LIFEKim B, No Y, Lee G, Lee S

Tuesday - E - Board #058Presenting Author: Geert Mayer (Germany)MODAFINIL FOR THE TREATMENT OF IDIOPATHICHYPERSOMNIA – RESULTS OF A RANDOMIZED,DOUBLE-BLIND, PLACEBO CONTROLLED STUDYMayer G, Benes H, Young P, Rodenbeck A

Tuesday - E - Board #059Presenting Author: Giuseppe Tropeano (Italy)THE RELATIONSHIP BETWEEN SLEEP DISTURBANCESAND FATIGUE WITH MULTIPLE SCLEROSIS –A CASE REPORTPeverini F, Tropeano G

Tuesday - E - Board #060Presenting Author: Seiji Nishino (United States)SLEEP PHENOTYPE CHARACTERIZATION OFPERIPHERAL AND CENTRAL MOUSE MODELS OFMYOTONIC DYSTROPHYSakai N, Sato M, Charizanis K, Lee K, Swanson M, Nishino S

Tuesday - I - Board #061Presenting Author: Tamar Basishvili (Georgia)INSOMNIA COMPLAINTS AND ASSOCIATEDFACTORS IN GEORGIAN POPULATIONBasishvili T, Eliozishvili M, Lortkipanidze N, Maisuradze L,Darchia N, Espa-Cervena K

Tuesday - I - Board #062Presenting Author: Louise Beattie (United Kingdom)THE GLASGOW NORMAL SLEEP CHECKLIST (GNSC):A RESEARCH TOOL FOR DESCRIBING CONTROL PAR-TICIPANTSBeattie L, Espie C, Biello S

130

TU

ESD

AY

Tuesday - I - Board #063Presenting Author: Kristoffer Bothelius (Sweden)ACCEPTANCE OF INSOMNIABothelius K, Jernelöv S, Kyhle K, Broman J, Gordh T,Fredrikson M

Tuesday - I - Board #064Presenting Author: Ulises Jiménez (Mexico)VALIDITY AND RELIABILITY OF THE MEXICANSCALE OF SLEEP QUALITYFernández K, Ramos M, Marín H, Haro R, Jiménez U

Tuesday - I - Board #065Presenting Author: Pau Giner-Bayarri (Spain)TECHNOLOGICAL INSOMNIA AND ACTIGRAPHYGiner-Bayarri P, Torres-Caño N, Oviedo-Montés T,Quintero-Hernandez K, Mazzillo-Ricaurte A

Tuesday - I - Board #066Presenting Author: Danning He (United States)MULTI-SCALE ENTROPY-BASED MEASURES OFELECTROENCEPHALOGRAM DURING SLEEP ASQUANTITATIVE CRITERIA FOR CHRONIC INSOMNIAHe D, Gamaldo A, Smith M, Allen R, Gamaldo C, Salas R

Tuesday - I - Board #067Presenting Author: Denise C. Jarrin (Canada)DOES VULNERABILITY TO STRESS-RELATEDINSOMNIA PREDICT FUTURE INCIDENT ANDPERSISTENT INSOMNIA AMONG GOOD SLEEPERS?Jarrin D, Chen I, Ivers H, Morin C

Tuesday - I - Board #068Presenting Author: Sooyeon Suh (Republic of Korea)CORTICAL THINNING IN PATIENTS WITHPERSISTENT INSOMNIA AND ITS RELATION WITHINSOMNIA PROGRESSIONKim H, Suh S, Kim H, Cho E, Shin C

Tuesday - I - Board #069Presenting Author: Tak Ho Lam (China)HYPNOSIS FOR INSOMNIA: AN EXAGGERATEDMYTH OR AN UNDERRATED INTERVENTION?Lam T

Tuesday - I - Board #070Presenting Author: Michelangelo Maestri (Switzerland)MACRO AND MICROSTRUCTURE SLEEP CHANGESIN INSOMNIACS WITH HIGH DOSE ABUSE OF BZMaestri M, Ferri R, Bottasini V, Ferini-Strambi L , Manconi M

Tuesday - I - Board #071Presenting Author: Margaret Moline (United States)TREATMENT PATTERNS AMONG THOSE WHOEXPERIENCE MIDDLE-OF-THE-NIGHT AWAKENING(MOTN)Moline M, Brown D, Dibonaventura M, Lorenzo R, Shah D,Ben-Joseph R

Tuesday - I - Board #072Presenting Author: Annika Norell Clarke (Sweden)COGNITIVE BEHAVIOURAL THERAPY FORCOMORBID INSOMNIA AND DEPRESSION:A RANDOMISED, CONTROLLED STUDYNorell-Clarke A, Jansson-Fröjmark M, Tillfors M, Holländare F,Engström I

Tuesday - I - Board #073Presenting Author: Laura Palagini (Italy)METACOGNITION SELECTIVELY DEFINES PRIMARYINSOMNIAPalagini L, Piarulli A, Lai E, Cheli E, Espie C, Gemignani A

Tuesday - I - Board #074Presenting Author: Laura Palagini (Italy)CROSS-SECTIONAL STUDY ON RELATIONSHIPSBETWEEN HYPERTENSION AND INSOMNIAPalagini L, Piarulli A, Bergamasco M, Bruno R, Ghiadoni L,Gemignani A

Tuesday - I - Board #075Presenting Author: Katalin Zsuzsanna Ronai (Hungary)HIGH FREQUENCY SPECTRAL POWER OF SLEEP EEGINCREASES WITH DEPRESSIVE AND INSOMNIASYMPTOMS IN KIDNEY TRANSPLANT RECIPIENTSRonai K, Szentkiralyi A, Alpar L, Mucsi I, Bodizs R, Novak M

Tuesday - I - Board #076Presenting Author: Margaret Moline (United States)SLEEP ARCHITECTURE FOLLOWING TREATMENTOF PATIENTS WITH MIDDLE-OF-THE-NIGHTINSOMNIA WITH BUFFERED SUBLINGUALZOLPIDEM COMPARED TO PLACEBORoth T, Singh N, Steinberg F, Waldron A, Moline M

Tuesday - I - Board #077Presenting Author: Sooyeon Suh (Republic of Korea)SUBNUCLEI ATROPHY IN THE AMYGDALA INPATIENTS WITH PERSISTENT INSOMNIA AND ITSRELATION WITH INSOMNIA PROGRESSION ANDDEPRESSIONSuh S, Kim H, Kim H, Cho E, Shin C

Tuesday - I - Board #078Presenting Author: Katrin Uehli (Switzerland)NOT ALL ARE EQUAL: MODIFIERS OF THE EFFECTOF POOR SLEEP QUALITY ON WORK INJURIESUehli K, Miedinger D, Holsboer-Trachsler E, Schindler C,Kinzli N, Leuppi J

Tuesday - I - Board #079Presenting Author: Tzu - Wen Wang (Taiwan)ENDOGENOUS OPIATES IN THE PARABRACHIALNUCLEUS MEDIATE THE ELECTROACUPUNCTURE -INDUCE SLEEP ACTIVITIES IN RATSWang T

Tuesday - I - Board #080Presenting Author: Zhang Haisheng (China)THE LATEST DEVELOPMENT OF LOW RESISTANCETHOUGHT IMPRINT PSYCHOTHERAPY SLEEP-REGULATING TECHNIQUE OF INSOMNIAWeidong W, Haisheng Z, Hui D

Tuesday - I - Board #081Presenting Author: Rybel Wix Ramos (Spain)HYPERAROUSAL IN INSOMNIAWix Ramos R, De Abreu Arvelo A, Wix Ramos R, PastorGomez J

Tuesday - NA - Board #082Presenting Author: Sophie Bayard (France)EFFORT-BASED DECISION MAKING INNARCOLEPSY-CATAPLEXYBayard S, Cizeau J, Georges M, Dauvilliers Y

131

TU

ESD

AY

Tuesday - NA - Board #083Presenting Author: Pierre-Alois Beitinger (Germany)SUBSIDED INFECTIONS AND AUTOIMMUNE EVENTSIN NARCOLEPSYBeitinger P, Ising M, Kohl G, Steiger A

Tuesday - NA - Board #084Presenting Author: Lawrence Carter (United States)PATIENTS’ JOURNEYS TO A NARCOLEPSY DIAGNOSISCarter L, Acebo C, Kim A

Tuesday - NA - Board #085Presenting Author: Dominguez-Ortega L (Spain)NARCOLEPSY AND ODOUR: PRELIMINARY REPORTDominguez-Ortega D, Diaz Gallego E, Pozo F,García-Armenter C, Serrano-Comino M,Dominguez-Sanchez E

Tuesday - NA - Board #086Presenting Author: Patricia Franco (France)COGNITIVE CHARACTERISTICS OF CHILDRENWITH NARCOLEPSYGuignard-Perret A, Inocente C, Mazza, Phd S, Bayard S,Herbillon V, Franco P

Tuesday - NA - Board #087Presenting Author: Steen Gammeltoft (Denmark)MIRNA PROFILING IN PLASMA FROM PATIENTSWITH SLEEP DISORDERS REVEALS DYSREGULATIONOF MIRNAS IN NARCOLEPSY AND OTHER CENTRALHYPERSOMNIASHolm A, Bang-Berthelsen C, Knudsen S, Kornum B, Jennum P,Gammeltoft S

Tuesday - NA - Board #088Presenting Author: Seung Chul Hong (Republic of Korea)COMPARISONS OF CLINICAL AND POLYSOMNOGRAPHICFINDINGS BETWEEN NARCOLEPSY WITHOUTCATAPLEXY AND IDIOPATHIC HYPERSOMNIAHong S, Kim T, Joo S, Jeong J, Han J

Tuesday - NA - Board #089Presenting Author: Magdalena Krcmarova (Czech Republic)NARCOLEPSY WITH CATAPLEXY AND PARKINSON´SDISEASE - A CASE REPORTKrcmarova M, Dusek P, Kovalska P, Roth B, Sonka K Tuesday - NA - Board #090Presenting Author: Eszter Maurovich Horvat (Germany)HYPOTHALAMO-PITUITARY-ADRENAL AXIS,GLUCOSE METABOLISM AND TNF- IN NARCOLEPSYMaurovich-Horvat E, Keckeis M, Lattová Z, Wetter T, Sonka K,Pollmacher T, Schuld A, Kemlink D

Tuesday - NA - Board #091Presenting Author: Francesca Poli (Italy)INFLUENCE OF CYTOCHROME P450 AND ABCB1GENETIC POLYMORPHISMS ON DRUG EFFICACY INNARCOLEPSY WITH CATAPLEXYPoli F, Moresco M, Riccardi L, Plazzi G, Ingravallo F, Pelotti S

Tuesday - NA - Board #092Presenting Author: Gemma Sansa (Spain)NON-RANDOM TEMPORAL DISTRIBUTION OF SLEEPONSET REM PERIODS IN THE MSLT IN NARCOLEPSYSansa G, Falup-Pecurariu C, Salamero M, Iranzo A, Santamaria J

Tuesday - NA - Board #093Presenting Author: Tomi Sarkanen (Finland)NARCOLEPSY WITH COEXISTING TYPE 1 DIABETES:A CASE REPORTSarkanen T, Huutoniemi A, Partinen M

Tuesday - NA - Board #094Presenting Author: Wisse Van Der Meijden (The Netherlands)TIME- AND STATE-DEPENDENT ANALYSIS OFAUTONOMIC CONTROL IN NARCOLEPSY: HIGHERHEART RATE WITH NORMAL HEART RATE VARIABILITY.Van Der Meijden W, Fronczek R, Reijntjes R, Lammers G,Van Dijk G, Thijs R

Tuesday - NE - Board #095Presenting Author: C Cheng; A Rodriguez (United States)COMPLIANCE WITH NASAL CONTINUOUS POSITIVEAIRWAY PRESSURE (CPAP) IN EPILEPSY ANDOBSTRUCTIVE SLEEP APNEACheng C, Chiang V, Bernbaum M, Koziorynska E, Rodriguez A

Tuesday - NE - Board #096Presenting Author: Catherine Duclos (Canada)ASSOCIATION BETWEEN THE CONSOLIDATION OFTHE REST-ACTIVITY CYCLE AND BRAIN RECOVERYIN THE ACUTE PHASE OF TRAUMATIC BRAIN INJURYDuclos C, Dumont M, De Beaumont L, Wiseman-Hakes C,Bernard F, Gosselin N

Tuesday - NE - Board #097Presenting Author: Tzu-Rung Huang (Taiwan)SLEEP ALTERATIONS IN THE INTERLEUKIN-1 TYPE 1RECEPTOR KNOCKOUT MICE.Huang T

Tuesday - NE - Board #098Presenting Author: Alan Juárez (Spain)SEVERE BRUXISM IN A PATIENT SUFFERINGNASU-HAKOLA DISEASE FOR TEN YEARSJuarez A, Alcaide C, Muñoz F, Montes C

Tuesday - NE - Board #099Presenting Author: Raffaele Manni (Italy)SUBJECTIVE SLEEP QUALITY IN EPILEPSYPATIENTS WITH SLEEP-RELATED SEIZURESManni R, Cremascoli R, Sguazzin C, Terzaghi M

Tuesday - NE - Board #100Presenting Author: Manana Nemsadze (Georgia)THE SIGNS OF DEPRESSION IN “DEPRESSIVE”AND “NON-DEPRESSIVE” RATS - CORRELATIONWITH DENSITY OF µ-RECEPTORS IN THE BRAINSTRUCTURESNemsadze M, Gogichadze M, Datunashvili M, Basishvili T,Shanshiashvili L, Mikeladze D

Tuesday - O - Board #101Presenting Author: Cristina Bódalo (Spain)HISTAMINE INTERACTION WITH THE VENTRALPART OF THE ORAL PONTINE TEGMENTUM: ITSIMPLICATION IN REM SLEEP MODULATIONBódalo C, De Andrés I

Tuesday - O - Board #102Presenting Author: Marta Callejo (Spain)SLEEP, EEG AND BEHAVIORAL RESPONSES AFTERSYSTEMIC ADMINISTRATION OF GABOXADOL INTHE LABORATORY CATCallejo M, Garzón M, De Andrés I

132

TU

ESD

AY

Tuesday - O - Board #103Presenting Author: So-Young Cho (Republic of Korea)RELATIONSHIPS BETWEEN SLEEP AND HEADACHEIN NON-CLINICAL POPULATIONCho S, Yun C, Park S, Chu M

Tuesday - O - Board #104Presenting Author: Ofra Flint-Bretler (Israel)THE EFFECTS OF A PARENTAL INTERVENTIONON ELECTRONIC MEDIA EXPOSURE AND SLEEPPATTERNS IN ADOLESCENTSFlint-Bretler O, Shochat T, Tzischinsky O

Tuesday - O - Board #105Presenting Author: Jimmy Fraigne (Canada)OPTOGENETIC AND PHARMACOGENETIC PROBINGOF RAPID EYE MOVEMENT (REM) SLEEP CIRCUITRYFraigne J, Torontali Z, Adamantidis A, Kim J, Peever J

Tuesday - O - Board #106Presenting Author: Berit Hjelde Hansen (Norway)SELF - AND PARENT REPORTED SLEEP PROBLEMSIN CHILDREN AND YOUTHS WITH EPILEPSY.PRELIMINARY FINDINGS FROM A STUDY IN ATERTIARY EPILEPSY CENTERHansen B, Alfstad K, Van Roy B, Lossius M

Tuesday - O - Board #107Presenting Author: Talma Kushnir (Israel)DO FATHERS SUFFER FROM POSTPARTUM FATIGUE?THE ROLES OF SLEEP QUALITY AND STRESSKushnir T, Israeli-Tedgi S, Urkin J

Tuesday - O - Board #108Presenting Author: Nuria Madureira (Portugal)POLYSOMNOGRAPHIC FINDINGS AND RESPIRATORYMANAGEMENT IN LEIGH SYNDROME ¨C A CASEREPORTMadureira N, Estevao M, Ferreira M, Garcia P, Felix M

Tuesday - O - Board #109Presenting Author: An Mariman (Belgium)INTERRELATIONSHIP OF SLEEP QUALITY WITHFATIGUE, NEUROTICISM AND GLOBAL HEALTH INUNEXPLAINED CHRONIC FATIGUEMariman A, Tobback E, Hanoulle I, Delesie L, Pevernagie D,Vogelaers D

Tuesday - O - Board #110Presenting Author: Helena Cristina Loureiro (Portugal)SLEEP HABITS IN A PEDIATRIC POPULATION OF ASUBURBAN AREA OF LISBONMartins A, Chaves P, Papoila A, Loureiro H

Tuesday - O - Board #111Presenting Author: Koutatsu Maruyama (Japan)UNDERREPORT OF ENERGY INTAKE MODIFIED THEASSOCIATION BETWEEN SLEEP DISTURBANCE ANDOVERWEIGHT AMONG MIDDLE-AGED JAPANESE:TOON HEALTH STUDY.Maruyama K, Tanigawa T, Eguchi E, Sakurai S, Saito I

Tuesday - O - Board #112Presenting Author: Jacqueline Maria Resende Silveira Leite (Brasil)WATSU THERAPY IN THE TREATMENT OF FI-BROMYALGIA SYNDROMEResende Silveira Leite J, Almeida Galdino Alves D, Alves SilvaD, Fernandes Do Prado L, Fernandes Do Prado G, Bizari CoinDe Carvalho L

Tuesday - O - Board #113Presenting Author: Celeste Thirlwell (Canada)A MULTIMODAL APPRAOCH TO TREATINGPATIENTS WITH PSG EVIDENCE OF CYCLINGALTERNATING PATTERN (CAP) AND/OR ALPHAELECTROENCEPHALOGRAPHY PATTERN(ALPHA-EEG): STRATEGIES FOR FIBROMYALGIASYNDROME AND CHRONIC FATIGUE (FMS/CF).Thirlwell C, Anand S, Love D, Janelle L

Tuesday - O - Board #114Presenting Author: Els Tobback (Belgium)POLYSOMNOGRAPHIC AND MSLT DATA IN ALARGE SAMPLE OF PATIENTS WITH UNEXPLAINEDCHRONIC FATIGUE: COMPARISON WITH AREFERENCE SAMPLE AND RELATION WITHSUBJECTIVE SCORESTobback E, Mariman A, Hanoulle I, Delesie L, Vogelaers D,Pevernagie D

Tuesday - O - Board #115Presenting Author: Nevin Fayez Wanis Zaki (Egypt)SLEEP DISORDERS IN A SAMPLE OF EGYPTIANHIGH RISK PREGNANT FEMALESZaki N, Mesbah Y, Shams M

Tuesday - O - Board #116Presenting Author: Zhijun Liu (China)RELIABILITY AND VALIDITY OF CSHQ IN URBANPRESCHOOL-AGED CHILDREN OF MAINLAND CHINALiu Z

Tuesday - S - Board #117Presenting Author: Luis V. F. Oliveira (Brazil)OBSTRUCTIVE SLEEP APNEA AND PULMONARYFUNCTION IN MORBID OBESITY BEFORE ANDAFTER BARIATRIC SURGERY: A RANDOMIZEDCONTROLLED CLINICAL TRIAL.Aguiar I, Santos I, Nacif S, Freitas Junior W, Malheiros C,Oliveira L

Tuesday - S - Board #118Presenting Author: Mohammed Al-Abri (Sultanate Of Oman)CPAP CAN REDUCE BLOOD PRESSURE INSYMPTOMATIC PATIENTS WITH OSASAl-Abri D

Tuesday - S - Board #119Presenting Author: Oguz O Erdinc (Turkey)THE FREQUENCY OF PATIENTS WITHPOLYSOMNOGRAPHIC DIAGNOSIS AS OBSTRUCTIVESLEEP APNEA SYNDROME (OSAS) DURING ONEYEAR IN ESKISEHIR, TURKEYAlisan M, Erdinc O, Metintas S, Tekgol Uzuner G, Fidan H

Tuesday - S - Board #120Presenting Author: Erna Sif Arnardottir (Iceland)THE CLINICAL IMPORTANCE OF OBSTRUCTIVESLEEP APNEA IN ALZHEIMERS DISEASEArnardottir E, Hannesdottir K, Davidsdottir S, ValgardsdottirA, Gislason T, Snaeligidal J

Tuesday - S - Board #121Presenting Author: Daniel Neu (Belgique)COMPLEX SLEEP APNEA DURING CPAP TITRATION:PREVALENCE AND PREDICTIVE FACTORSBalkissou A, Neu D, Pefura-Yone E, Mairesse O, Noseda A

133

TU

ESD

AY

Tuesday - S - Board #122Presenting Author: Jonathan Cámara (Spain)RELATIONSHIP BETWEEN AGE AND DURATIONEVENT NUMBER RESPIRATORY SYNDROME IN PA-TIENTS WITH SLEEP APNEA-HYPOPNEABarrios Barreto D, Gotera Rivera C, Lazo Meneses P, CamaraFernandez J, Esteban Calvo R, Mañas Baena E

Tuesday - S - Board #124Presenting Author: Erla Björnsdóttir (Iceland)SYMPTOMS OF INSOMNIA AMONG OSA PATIENTSBEFORE AND AFTER 2 YEARS OF PAP TREATMENTBjornsdottir E, Janson C, Arnardóttir E, Pack A, Gislason T,Benediktsdottir B

Tuesday - S - Board #125Presenting Author: Laura Cancelo (Spain)CPAP TITRATION: CORRELATION BETWEEN 2DIFFERENT EQUATIONS AND AUTOCPAP.Cancelo L, Hernandez V, Bravo D, Martinez C, Egea C, Duran J

Tuesday - S - Board #126Presenting Author: Emerson Martins (Brazil)SLEEP APNEA AND AGGRESSIVENESSCarissimi A, Caruccio Montanari C, Jihe Kim L, Martins E,Amestoy De Oliveira A, Martinez D

Tuesday - S - Board #127Presenting Author: Luis Vicente Franco De Oliveira (Brazil)SLEEP STUDY AND PULMONARY FUNCTION INMORBIDLY OBESECarvalho Aguiar I, R Santos I, Rodrigues Freitas Junior W,Malheiros C, Franco De Oliveira L

Tuesday - S - Board #128Presenting Author: Luis Vicente Franco De Oliveira (Brazil)VENTILATORY MUSCLE STRENGTH AND QUALITYOF LIFE IN OBESE PATIENTS UNDERGOINGBARIATRIC SURGERY. PRELIMIANRY RESULTS.Carvalho Aguiar I, R Santos I, Rodrigues Freitas Junior W,Malheiros C, Franco De Oliveira L

Tuesday - S - Board #130Presenting Author: Michael P. Chan (United States)CHAN SCORE PREDICTS PRESENCE AND SEVERITYOF SLEEP APNEA AT THE BEDSIDE BEFOREPOLYSOMNOGRAM SLEEP TESTChan M, Chan A, Ly A, Lim N

Tuesday - S - Board #131Presenting Author: Jae Wook Cho (Republic of Korea)SLEEP APNEA AND SEXUAL DYSFUNCTIONCho J, Kim D, Ki Kim K

Tuesday - S - Board #132Presenting Author: Françoise Cornette (Switzerland)PREVALENCE AND PREDICTORS OF SLEEPDISORDERED BREATHING IN PATIENTSUNDERGOING CHRONIC AMBULATORYINTERMITTENT HEMODIALYSISCornette F, Ogna A, Forni V, Burnier M, Heinzer R

Tuesday - S - Board #133Presenting Author: Helio Fernandez (Belgium)ONE YEAR MONITORING OF NOCTURNAL PERIODICBREATHING AT THE ANTARCTIC POLEFernandez H, Pattyn N, Mairesse O, Meeusen R,Mcdonald-Nethercott E, Neyt X

Tuesday - S - Board #134Presenting Author: Marcos Fernández-Barriales (Spain)MANDIBULAR ADVANCEMENT DEVICES AS ANALTERNATIVE TO CONVENTIONAL TREATMENTWITH CPAP IN SELECTED PATIENTS: A HEALTHINTERVENTION ANALYSISFernández-Barriales M, González M, Macías E, Martínez M,De Carlos F, Cobo J

Tuesday - S - Board #135Presenting Author: Alex Ferre (Spain)PRELIMINAR RESULTS OF ORAL APLIANCE DEVICEIN MILD TO MODERATE OBSTRUCTIVE SLEEPAPNEA SYNDROMEFerre A, Vila J, Gallardo E, Perello E, Romero O, Sampol G

Tuesday - S - Board #136Presenting Author: Vanessa Ferreira (Portugal)IMPACT OF DIAGNOSIS AND TREATMENT OFOBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS)WITH NON-INVASIVE VENTILATION (NIV)Ferreira V, Nêveda R, Lombardía E, Pimenta R, Condeço J,Curado H

Tuesday - S - Board #137Presenting Author: Maria Teresa Martins De Araújo (Brazil)ASSOCIATION BETWEEN CLINICAL SIGNS ANDSYMPTOMS RELATED TO SLEEP-DISORDEREDBREATHING IN MOUTH BREATHERSSCHOOLCHILDRENFinck N, Araújo M, Pacheco M

Tuesday - S - Board #138Presenting Author: Gislaine Aparecida Folha (Brazil)ASSESSMENT OF SURFACE EMG SUPRA-HYOIDMUSCLE ACTIVITY IN APNEIC PATIENTS COMPAREDTO HEALTHY SUBJECTS. A PILOT STUDYFolha G, Mapelli A, Cardoso Pereira Valera F, Dantas Giglio L,Vitaliano Voi Trawizki L, Maria De Felício C

Tuesday - S - Board #139Presenting Author: Katia Gagnon (Canada)ARE COGNITIVE DEFICITS OBSERVED INOBSTRUCTIVE SLEEP APNEA ASSOCIATED WITHCOGNITIVE COMPLAINTS?Fortin M, Gagnon K, Baril A, D’Aragon C, Gagnon J, Gosselin N

Tuesday - S - Board #140Presenting Author: Tomokazu Furukawa (Japan)SNORING IS RELATED TO THE ELEVATION OFMORNING BLOOD PRESSUREFurukawa T, Nakano H, Tanahashi T , Yoshihara K, Sudo N

Tuesday - S - Board #141Presenting Author: Belén Gallego Ariza (Spain)SLEEP PATTERN, QUALITY AND SLEEPINESS AMONGPATIENTS WITH EXACERBATION OF CHRONICOBSTRUCTIVE PULMONARY DISEASEGallego-Ariza B, Torres-Sánchez I, Flores-Barba M,Cabrera-Martos I, Correa-Toledo A, Valenza M

Tuesday - S - Board #142Presenting Author: Catarina Gomes (Portugal)SLEEP DISORDERED BREATHING AND GROWTHHORMONE THERAPY IN CHILDREN WITH PRADERWILLI SYNDROMEGomes C, Pereira C, Ferreira R

134

TU

ESD

AY

Tuesday - S - Board #143Presenting Author: David Gozal (United States)OBSTRUCTIVE SLEEP APNEA AND OBESITY AREASSOCIATED WITH REDUCED GPR120 PLASMALEVELS IN CHILDREN.Gozal D, Kheirandish-Gozal L, Carreras A, Khalyfa A, Peris E

Tuesday - S - Board #144Presenting Author: Tomasz Grochowski (Poland)CAN SNORING BE A CAUSE OF AGGRESSIVEBEHAVIOUR IN CHILDREN?Grochowski T, Kukwa W, Ga³±Zka A, Gronkieiwcz Z, KukwaA, Krzeski A

Tuesday - S - Board #145Presenting Author: Keisuke Hosokawa (Finland)SUBJECTIVE SLEEPINESS IS NOT REQUIRED TOADHERE TO CPAP THERAPYHosokawa K, Sariola R, Huhtala H, Polo O

Tuesday - S - Board #146Presenting Author: Kazuya Hosokawa (Japan)A NOVEL TECHNIQUE TO DETECT CARDIACFUNCTION BY ANALYZING AIR-FLOW TOFINGERTIP-OXYGEN LAG TIME ONPOLYSOMNOGRAPHY IN PATIENTS WITH SLEEPDISORDERED BREATHING AND HEART FAILUREHosokawa K, Ando S, Tohyama T, Otsubo H, Nakamura R,Kadokami T

Tuesday - S - Board #147Presenting Author: Poul Jennum (Denmark)ALL-CAUSE MORTALITY OF SLEEP APNOEA WITHAND WITHOUT CPAP TREATMENT IN MALE ANDFEMALE PATIENTS: A CONTROLLED NATIONALSTUDYJennum P

Tuesday - S - Board #148Presenting Author: Poul Jennum (Denmark)MORTALITY OF OBESITY HYPOVENTILATION WITHAND WITHOUT CPAP TREATMENT : A CONTROLLEDNATIONAL STUDYJennum P

Tuesday - S - Board #149Presenting Author: Ana Jimenez Romero (Spain)SLEEP BREATHING DISORDERS AND PERIPHERALARTERIAL DISEASE IN PATIENTS WITH CORONARYARTERY DISEASEJimenez Romero A, Leon Acuña A, Perez Martinez P, OrdoñezDios I, Lopez Miranda J, Jurado Gamez B

Tuesday - S - Board #150Presenting Author: Santiago Juarros (Spain)SEARCH METHODS FOR MONITORING PATIENTSWITH OBSTRUCTIVE SLEEP APNEA TREATEDWITH CPAPJuarros S, Bejarano D, Del Olmo M, Muñoz I, Ramos I, Macias E

Tuesday - S - Board #151Presenting Author: Su Young Jung (Republic of Korea)ANATOMICAL ANALYSES OF MANDIBULARSTRUCTURE USING THREE-DIMENSIONAL FACIALCT FOR EFFECTIVENESS AND PREVENTION OFCOMPLICATIONS IN GENIOGLOSSUS ADVANCEMENTJung S, Shin S, Lee K, Cho J, Kim S

Tuesday - S - Board #152Presenting Author: Mithri R. Junna (United States)INCREASED CORTICAL AROUSAL PROPENSITY INOPIATE USERS WITH COMPLEX SLEEP APNEASYNDROMEJunna M, St. Louis E, Shepard P, Pao W, Somers V,Morgenthaler T

Tuesday - S - Board #153Presenting Author: Hyun Jun Kim (Republic of Korea)HEART RATE VARIABILITY (HRV) IN SLEEP APNEAPATIENTSKim H, Bae J

Tuesday - S - Board #154Presenting Author: Sung Wan Kim (Republic of Korea)CHANGE IN POSITION DEPENDENCY IN NON-RESPONDERS AFTER MULTILEVEL SURGERY FOROBSTRUCTIVE SLEEP APNEAKim S, Jung S

Tuesday - S - Board #155Presenting Author: Michele Romano (Italy)AN ORTHODONTIC-ORTHOGNATHIC CONCEPTUALAPPROACH TO OSAS SURGERY: OUR EXPERIENCEAND RESULTSLaganà F, Rossi D, Romano M, Giannì A

Tuesday - S - Board #156Presenting Author: Michele Romano (Italy)OSTEOTOMYTECHNIQUES A KEY IN OSASTREATMENT: A FIVE YEARS EXPERIENCELaganà F, Rossi D, Romano M, Manconi M, Giannì A

Tuesday - S - Board #157Presenting Author: Julieta Lazarte (Canada)THE EFFECTS OF OSA IN SLEEP, PHYSICALSYMPTOMS, AND MOOD IN PATIENTS WITHCOPD AND ASTHMALazarte J, Ferreira I

Tuesday - S - Board #158Presenting Author: Sung Bu Lee (Republic of Korea)EFFECTS OF SLEEP DISORDERED BREATHINGON QUALITY OF LIFELee S, Chung Y, Jo M

Tuesday - S - Board #159Presenting Author: Isabl Ordonez Dios (Spain)METABOLIC SYNDROME IFLUENCES THE SEVERITYOF SLEEP APNEA SYNDROME: FROM THECORDIOPREV STUDYLeon Acuna A, Ordonez Dios I, Perez Martinez P, JimenezRomero A, Jurado Gamez B, Lopez Miranda J

Tuesday - S - Board #160Presenting Author: Eva Libman (Canada)INSOMNIA SUBTYPES IN SLEEP APNEA:IMPLICATIONS FOR SCREENING AND TREATMENTLibman E, Creti L, Fichten C, Rizzo D, Baltzan M, Bailles S

Tuesday - S - Board #161Presenting Author: Ester López Cadena (Spain)ECHOCARDIOGRAPHY FINDINGS IN A SLEEP APNEAPACIENTS WITH MORBID OBESITYLópez Cadena E, Salord Oleo N, Gasa Galmes M, MonasterioPonsa C, Aponte Torres E, Ruiz Majoral A

135

TU

ESD

AY

Tuesday - S - Board #162Presenting Author: Helena Cristina Loureiro (Portugal)SLEEP DISTURBANCES IN PORTUGUESE ASTHMATICCHILDREN-PRELIMINARY RESULTSLoureiro H, Sokolova A

Tuesday - S - Board #163Presenting Author: Almiro José Machado Júnior (Brasil)MAXILLARY EXPANSION IN CHILDREN WITHOBSTRUCTIVE SLEEP APNEA (OSA): META-ANALYSIS.Machado Júnior A, Zancanella E, Crespo A

Tuesday - S - Board #164Presenting Author: Núria Madureira (Portugal)OBSTRUCTIVE SLEEP APNEA SYNDROME INCHILDREN YOUNGER THAN 2 YEARS OF AGEMadureira N

Tuesday - S - Board #165Presenting Author: Eva Mañas Baena (Spain)NOCTURNAL INTERMITTENT HYPOXEMIA: UTILITYFOR THE EVALUATION OF SEVERITY SLEEP APNEAAND CARDIOVASCULAR COMORBIDITYMañas Baena E, Lazo Meneses P, Fernandez Camara J, EstebanCalvo R, Pedrera Mazarro A, Perez Rodriguez E

Tuesday - S - Board #166Presenting Author: Serguei Marshansky (Canada)IMPACT OF RESPIRATORY EVENTS ASSOCIATEDWITH AUTONOMIC AROUSALS USING TYPE 1 SLEEPLABORATORY AND TYPE 3 AMBULATORY RECORDINGSMarshansky S, Jobin V, Rompré P, Lavigne G, Mayer P

Tuesday - S - Board #167Presenting Author: Juan Antonio Madrid (Spain)CIRCADIAN IMPAIRMENT OF THE WRISTTEMPERATURE RHYTHM IN PATIENTS WITH SLEEPDISORDERED BREATHINGMartinez-Nicolas A, Guaita M, Santamaría J, Montserrat J,Madrid J, Rol A

Tuesday - S - Board #168Presenting Author: Emerson Martins (Brazil)SLEEP APNEA AND SLEEP EFFICIENCY ASPREDICTORS OF SURVIVAL AFTERPOLYSOMNOGRAPHYMartins E, Fiori C, Peukert B, Fagundes M, Martinez D

Tuesday - S - Board #169Presenting Author: Pedro Mayoral Sanz (Spain)THREE-DIMENSIONAL CONE-BEAM COMPUTEDTOMOGRAPHY FOR ASSESSMENT OF AIRWAYCHANGES WITH MANDIBULAR ADVANCE SPLINTMayoral Sanz P, Calvo E

Tuesday - S - Board #170Presenting Author: Pedro Mayoral Sanz (Spain)PREDICTIVE VALUE OF LARYNGOSCOPY WITHREFERENCE TO THE TREATMENT OF OBSTRUCTIVESLEEP APNEA WITH MANDIBULAR ADVANCE DEVICEMayoral Sanz P

Tuesday - S - Board #171Presenting Author: Shawnda A. Morrison (Slovenia)ALTERATIONS IN CENTRAL SLEEP APNOEAFOLLOWING 10-D EXPOSURE TO HYPOXIA:INFLUENCE OF EXERCISEMorrison S, Pangerc A, Eiken O, Mekjavic I, Dolenc-Groselj L

Tuesday - S - Board #172Presenting Author: Nato Darchia (Georgia)EXCESSIVE DAYTIME SLEEPINESS AND THE RISKFOR OBSTRUCTIVE SLEEP APNEA IN GEORGIANPOPULATIONNikoloz O, Datunashvili M, Saxelashvili I, Ibanez V,Espa-Cervena K, Darchia N

Tuesday - S - Board #173Presenting Author: Rosario Ferreira (Portugal)CONGENITAL CENTRAL HYPOVENTILATIONSYNDROME PRESENTING AS PULMONARYHYPERTENSIONNunes T, Ferreira R, Anjos R, Moldovan O, Bandeira T

Tuesday - S - Board #174Presenting Author: Roberto Ocón Quintial (Spain)EVALUATION OF ADENOTONSILLECTOMYOUTCOME FOR OBSTRUCTIVE SLEEP APNEASYNDROME IN CHILDREN, BY PRE ANDPOSTOPERATIVE POLYSOMNOGRAPHY.Ocón Quintial R, Martinez Martinez M, Wu Y, Cabello NajeraM, Gonzalez Martínez M, Molina Osorio J

Tuesday - S - Board #175Presenting Author: Junji Ono (Japan)WE NEED TO PAY SPECIAL ATTENTION ON SLEEPPOSTURES AND HEART DISEASES IN DOWNSYNDROME WITH SLEEP DISORDERED BREATHINGOno J, Sawatari H, Chishaki A, Rahmawati A, Kuroda H,Ando S

Tuesday - S - Board #176Presenting Author: Joaquin Terain (Spain)OSA AND OXIDATIVE STRESS: PRELIMINARYANALYSISOrdax E, Terán-Santos J, Alonso M, Coma M, Peralta R

Tuesday - S - Board #177Presenting Author: Carmen Orte (Spain)THE EFFECTIVENESS OF ADENOTONSILLECTOMYIN CHILDREN WITH OBSTRUCTIVE SLEEP APNEAOrte C, Vicente E, Herrero A, Rodriguez I, De Miguel F

Tuesday - S - Board #178Presenting Author: Sofía Isabel Cieza Ortiz (Spain)RELEVANCE OF HYPOXIA IN SLEEP DISORDEREDBREATHING: DISTINCT CLINICAL, SLEEP, ANDAUTONOMIC FEATURES IN OBSTRUCTIVE SLEEPAPNEA WITH AND WITHOUT HYPOXIAPalma Carazo J, Cieza Ortiz S, Urrestarazu Bolumburu E,Artieda González-Granda J, Alegre Esteban M, Iriarte Franco J

Tuesday - S - Board #179Presenting Author: Wipasinee Phuapradit (Thailand)DETERMINING THE EFFICACY OF TEMPORARYMANDIBULAR ADVANCEMENT SPLINT IN MILD TOMODERATE OBSTRUCTIVE SLEEP APNEA PATIENTSAT BASELINE POLYSOMNOGRAPHY.Phuapradit W, Mahakit P

Tuesday - S - Board #180Presenting Author: Jeimmy Mabel Pinzón Martinez (Spain)APOE GENOTYPE AND OBSTRUCTIVE SLEEP APNEASYNDROME .Pinzón Martinez J, Díaz J, Ortega J, Martinez C, Latorre M,Ruiz P

136

TU

ESD

AY

Tuesday - S - Board #181Presenting Author: Anita Rahmawati (Japan)MAGNETIC RESONANCE IMAGING STUDY OFPERIPHARYNGEAL MUCOSAL INTENSITY INOBSTRUCTIVE SLEEP APNEA PATIENTSRahmawati A, Chishaki A, Nagao M, Adachi K, Nishizaka M,Ando S

Tuesday - S - Board #182Presenting Author: Effat Rasul (United States)OBSTRUCTIVE SLEEP APNEA OUT PATIENTSCREENING STUDYRasul E, Patel A, Khan A

Tuesday - S - Board #183Presenting Author: Jacqueline Maria Resende Silveira Leite (Brasil)ASSESSMENT QUESTIONNAIRE OF CHILDREN WITHSLEEP APNEA (TUCASA): TRANSLATION, CULTURALADAPTATION AND VALIDATIONResende Silveira Leite J, Ruotolo Ferreira V, Fernandes DoPrado L, Fernandes Do Prado G, Bizari Coin De Carvalho L

Tuesday - S - Board #184Presenting Author: Ville Rimpilä (Finland)TRANSCUTANEOUS CARBON DIOXIDE DURINGEPISODES OF APNEA AND UPPER AIRWAY FLOW-LIMITATIONRimpilä V, Saaresranta T, Hosokawa K, Huhtala H, Polo O

Tuesday - S - Board #185Presenting Author: Duarte Ari Diogo Rocha (Portugal)COMPARISON OF THE CLINICAL ANDPOLYSOMNOGRAPHIC FINDINGS IN OSAPATIENTS VS REM SDBRocha D, Matos E, Ferreira A, Calvo M

Tuesday - S - Board #186Presenting Author: Jimena Rugeles-Plata (Spain)POLYSOMNOGRAPHY (PSG) CORRELATION INPATIENTS WITH MODERATE – SEVERE OSAS ATTHE TIME OF DIAGNOSIS AND AFTER TREATMENTWITH CPAP.Rugeles-Plata J, Espín-Giménez C, Guaba-Camilo M,Fernandez-Caballos A, Ferrandis-Ballester F

Tuesday - S - Board #187Presenting Author: Muventhiran Ruthranesan (Malaysia)PREVALENCE, CLINICAL SIGNIFICANCE, ANDPREDICTORS FOR SLEEP-RELATEDHYPOVENTILATION AMONG OBESE ASIANSWITH OBSTRUCTIVE SLEEP APNEA SYNDROMERuthranesan M, Chirakalwasan N

Tuesday - S - Board #188Presenting Author: Lirios Sacristán Bou (Spain)APPLICABILITY OF THE EPWORTH SLEEPINESSSCALE TO FIBROMYALGIC WOMEN WITH SLEEPAPNEA-HYPOPNEA SYNDROME.Sacristán Bou L, Peña Blas F, Hernández Blasco L,Pascual Lledó F, Martín Serrano C

Tuesday - S - Board #189Presenting Author: Rute Sampaio (Portugal)A NEW CHARACTERIZATION OF ADHERENCEPATTERNS TO AUTO-ADJUSTING POSITIVE AIRWAYPRESSURE IN SEVERE OBSTRUCTIVE SLEEP APNEASYNDROME: CLINICAL AND PSYCHOLOGICALDETERMINANTSSampaio R, Pereira M, Winck J

Tuesday - S - Board #190Presenting Author: Ken Satoh (Japan)SCREENING OF SLEEP APNEA SYNDROME DURINGA FULL MEDICAL CHECKUP: A COMPARISONBETWEEN AN OPTICAL FIBER-TYPE SLEEP APNEASENSOR AND AN OVERNIGHT PULSE OXIMETRYSatoh K, Mitachi S

Tuesday - S - Board #191Presenting Author: Hiroyuki Sawatari (Japan)SLEEP-DISORDERED BREATHING IN ADULTSWITH DOWN SYNDROME: A CROSS CULTURALCOMPARISONSawatari H, Hill E, Nishizaka M, Chishaki A, Riha R, Ando S

Tuesday - S - Board #192Presenting Author: Mariusz Sieminski (Poland)AMPLITUDES OF BLOOD PRESSURE AND HEARTRATE DURING OBSTRUCTIVE APNEAS ARE RELATEDTO DURATION OF APNEA AND TO DESATURATION.Sieminski M, Partinen M

Tuesday - S - Board #193Presenting Author: Guilherme Silva Julian (Brazil)EVALUATION OF THE EXPRESSION OF PIGMENTEPITELIUM DERIVED FACTOR (PEDF) IN CHRONICINTERMITTENT HYPOXIA: VALIDATION ANDCHOICE FOR BEST HOUSEKEEPING GENES INTHE MODELSilva Julian G, Watanabe De Oliveira R, Cini Perry J, Tufik S,Visniauskas B, Ribeiro Chagas J

Tuesday - S - Board #194Presenting Author: Kiril Terziyski (Bulgaria)RESPONSE TO HYPOXIC PROVOCATION INPATIENTS WITH CHRONIC HEART FAILURE AND ITSPREDICTIVE VALUE FOR CENTRAL SLEEP APNEATerziyski K, Draganova A, Aliman O, Ilchev I, Hristova A,Kostianev S

Tuesday - S - Board #195Presenting Author: M. Fernanda Troncoso Acevedo (Spain)METABOLOMIC FINGERPRINTING APPROACH TOSLEEP APNEA DISORDER IN HUMAN PLASMATroncoso Acevedo M, Gómez García T, Ferrarini A, Ruperez F,Garcia A, Gonzalez Mangado N

Tuesday - S - Board #196Presenting Author: Orna Tzischinsky (Israel)DEVELOPING AND VALIDATING A QUESTIONNAIRETO SCREEN COMMERCIAL DRIVER’S LICENSEAPPLICANTS FOR SLEEP-DISORDERED BREATHINGTzischinsky O, Epstein R, Pillar G

Tuesday - S - Board #197Presenting Author: Heisl Vaher (Estonia)MEASURING ATTENTION DEFICIT WITH DASS TESTIN CHILDREN WITH OBSTRUCTIVE SLEEP APNEAVaher H, Vaikjärv R, Veldi M, Kasenõmm P, Vasar V

Tuesday - S - Board #198Presenting Author: Darwin Vizcarra-Escobar (Peru)QUALITY OF LIFE IMPAIRMENT. A REASON FORRETHINK THE IMPORTANCE OF UPPER AIRWAYRESISTANCE SYNDROME.Vizcarra-Escobar D, Barbagelata-Aguero F

137

TU

ESD

AY

Tuesday - S - Board #199Presenting Author: Renato Watanabe De Oliveira (Brasil)EVALUATION OF THE EFFECT OF HYPOXIA ON THEEXPRESSION AND ACTIVITY OF NEPRILYSIN (EC3.4.24.11), A PROTEASE INVOLVED ON ALZHEIMER’SDISEASE.Watanabe De Oliveira R, Silva Julian G, Cini Perry J, Tufik S,Visniauskas B, Ribeiro Chagas J

Tuesday - S - Board #200Presenting Author: Chikara Yoshimura (Japan)CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPYDECREASES PLASMA GLUCOSE LEVELS AFTER THEGLUCOSE LOAD EVEN IN NON-DIABETIC PATIENTSWITH OBSTRUCTIVE SLEEP APNEAYoshimura C, Tamura A, Kawano Y, Watanabe T, Ando S

Tuesday - T - Board #201Presenting Author: Maryam Al Hooti (Sultanate Of Oman)CPAP ACCEPTANCE AND COMPLIANCE IN SLEEPAPNEA PATIENTS IN OMANAl Hooti M, Jaju D, Abri M

Tuesday - T - Board #202Presenting Author: Thuraya Hamed Rashed Al Zuheibi (Sultanate Of Oman)EFFECTS OF THREE MODES OF RESPIRONICS AUTOCPAP MACHINES IN PATIENTS WITH OSAHSAl Zuheibi, T, Al Abri M

Tuesday - T - Board #203Presenting Author: Maksim Alekhin (Russian Federation)EVALUATION OF SLEEP DISORDERED BREATHINGUSING NON-CONTACT REMOTE BIO- RADIOLOCATIONMETHODAlekhin M, Anishchenko L, Zhuravlev A, Ivashov S,Korostovtseva L, Sviryaev Y

Tuesday - T - Board #204Presenting Author: Willy C.M. Arends-Derks (The Netherlands)MEDICAL TECHNOLOGY ASSESSMENT OFPOLYSOMNOGRAPHY, TYPE 2: FULL PSG ATHOME - NIGHT TO NIGHT VARIABILITY IN APNEAHYPOPNEA INDEX (AHI) AND PERIODIC LIMBMOVEMENT INDEX (PLMI).Arends-Derks W, Horst-Haverkamp M, Schreuder K,Rohling L, De Weerd A

Tuesday - T - Board #205Presenting Author: Erna Sif Arnardottir (Iceland)HOW TO MEASURE SNORING?Arnardottir E, Sigurgunnarsdottir M, Sigurdsson G,Saevarsson G, Hoskuldsson S, Gislason T

Tuesday - T - Board #206Presenting Author: Anna Bagué (Spain)REVIEW OF GENIOGLOSSUS MUSCLE ELECTRICALSTIMULATION EFECTIVENESS FOR THE TREATMENTOF OBSTRUCTIVE SLEEP APNEA-HIPOPNEA (OSAHS)Bagué A, Esteller E

Tuesday - T - Board #207Presenting Author: Patricia Souza Bastos (Brazil)ANALYSIS OF MEAN TRANSCUTANEOUS CARBONDIOXIDE TENSION DURING POLYSOMNOGRAPHICEXTENDED MONITORING IN SARAH NETWORKHOSPITAL PATIENTS.Bastos P, Pinnola G, De Oliveira S

Tuesday - T - Board #208Presenting Author: Caroline U. Blankvoort (The Netherlands)MEDICAL TECHNOLOGY ASSESSMENT OFPOLYSOMNOGRAPHY, TYPE 2: FULL PSG AT HOME –HOW OFTEN DO TECHNICAL FAILURES OCCUR?Blankvoort C, Steinebach H, Warnaar I, Rohling L, De Weerd A

Tuesday - T - Board #209Presenting Author: Agnes M J Bon (The Netherlands)MEDICAL TECHNOLOGY ASSESSMENT OFPOLYSOMNOGRAPHY, TYPE 2: FULL PSG AT HOME.DETECTION OF NAPS AND THEIR CLINICALCORRELATES.Bon A, Bossche R, Mattern-Coren E, De Weerd A

Tuesday - T - Board #210Presenting Author: Maria Angeles Bonmati-Carrion (Spain)AN INNOVATIVE METHOD FOR EVALUATINGACTIVITY REST PATTERN BASED ON POSITIONCHANGESBonmati-Carrion M, Middleton B, Revell V, Skene D, Rol A,Madrid J

Tuesday - T - Board #211Presenting Author: Camila De Castro Corrêa (Brazil)ELECTRONIC TUTOR ABOUT OBSTRUCTIVESLEEP APNEA SYNDROME: DEVELOPMENT ANDEVALUATION OF A HEALTH COLLABORATIVENETWORKCorrêa C, Berretin-Felix G, Fukushiro A, Blasca W

Tuesday - T - Board #212Presenting Author: Alexandre Domingues (Portugal)SLEEP PARAMETER ESTIMATION FROMPORTABLE DATADomingues A, Paiva T, Sanches J

Tuesday - T - Board #213Presenting Author: Alex Ferre (Spain)CARDIORESPIRATORY POLYGRAPHY DIAGNOSTICACCURACY IN MILD TO MODERATE OBSTRUCTIVESLEEP APNEA HYPOPNEA SYNDROME (OSAHS)Ferre A, Rahnama K, Vila J, Cambrodi R, Jurado M, Romero O

Tuesday - T - Board #214Presenting Author: Ana Ferreira (Portugal)POSITIONAL SLEEP APNEA THERAPY – OUR EXPERIENCEFerreira A, Vale A, Rocha D, Matos E, Calvo T

Tuesday - T - Board #215Presenting Author: Laree Fordyce (Canada)CPAP COMPLIANCE – THE FIRST YEAR AND BEYONDFordyce L, Siemens A, Rousseau R, Becerra E

Tuesday - T - Board #216Presenting Author: Teresa Gómez García (Spain)UTILITY OF PULSE TRANSIT TIME IN THEDETECTION OF HIGH BLOOD PRESSURE INPATIENTS ADMITTED IN A SLEEP UNIT.Gómez García T, Acevedo M, Camacho G, Gonzalez M,Sanabria J, Mangado N

138

TU

ESD

AY

Tuesday - T - Board #217Presenting Author: Patricia Lazo Meneses (Spain)RELATIONSHIP BETWEEN THE WRONG REASONSFOR CLINICAL AND CHANGE CONTROL PRESSUREADJUSTMENT RESULTING WITH THERAPEUTICAUTOCPAPJurkojc Mohremberger C, Lazo Meneses P, Barrios Barreto D,Manasbaena E, Garcia De Leaniz J, Esteban Calvo R

Tuesday - T - Board #218Presenting Author: Yan Ma (China)A NEW APPROACH TO SLEEP STUDY: DOES HEARTTELL US A LOT?Ma Y, Sun S

Tuesday - T - Board #219Presenting Author: J R Garmendia Leiza (Spain)UTILITY OF THE STATISTICAL AND NONLINEARANALYSIS FOR THE ACTIGRAPHIC SLEEP PATTERNCHARACTERIZATIONMartin Martinez D, Casaseca De La Higuera P, Alberola LopezC, Garmendia Leiza J, Andres De Llano J, Alberola Lopez S

Tuesday - T - Board #220Presenting Author: Maxime Elbaz (France)PERFORMANCE ASSESSMENT OF A MEDICAL DEVICEFOR HOME MONITORING OF CPAP TREATMENT INPATIENTS WITH OBSTRUCTIVE SLEEP APNOEASYNDROMEElbaz M, Joelle T, Amelie C, Benoit P, Claude W, Damien L

Tuesday - T - Board #221Presenting Author: Jussi Nupponen (Finland)ASSESSMENT OF THE RELIABILITY OF THENOCTURNAL TCCO2 SIGNALS WITH TREND LINESNupponen J, Rimpilä V, Salminen A, Polo O

Tuesday - T - Board #222Presenting Author: Kristin Anna Olafsdottir (Iceland)DIFFERENCE BETWEEN AUTOMATIC AND MANUALANALYSIS OF RESPIRATORY EVENTS IN SLEEPSTUDIESOlafsdottir K, Sigurdardottir S, Gislason T, Johannesdottir O,Hilmarsson O, Arnardottir E

Tuesday - T - Board #223Presenting Author: Beatriz Rodriguez (Spain)AMBULATORY CIRCADIAN MONITORING (ACM),A COMPLEMENTARY TOOL IN SLEEP MEDICINERodriguez-Morilla B, Campos Martínez M, Paniagua Soto J,Estivilldomènech C, Rol De Lama M, Madrid Pérez J

Tuesday - T - Board #224Presenting Author: Lisette C. Rohling (The Netherlands)MEDICAL TECHNOLOGY ASSESSMENT OFPOLYSOMNOGRAPHY, TYPE 2: FULL PSG AT HOME –DIFFERENCE OF TWO UNATTENDED PSG AT HOMESYSTEMS.Rohling L, Blankvoort C, Mattern-Coren E, De Weerd A

Tuesday - T - Board #225Presenting Author: Janet Scheper (The Netherlands)MEDICAL TECHNOLOGY ASSESSMENT OFPOLYSOMNOGRAPHY, TYPE 2: FULL PSG AT HOME.Scheper J, Bossche R, Jansen N, Rohling L, De Weerd A

Tuesday - T - Board #226Presenting Author: Eus J.W. Van Someren (The Netherlands)AFFORDABLE SLEEP ESTIMATES USINGMICRO-ELECTRO-MECHANICAL-SYSTEMS(MEMS) ACCELEROMETRYTe Lindert B, Van Someren E

Tuesday - T - Board #227Presenting Author: Olalla Urdanibia (Spain)EEG NEWBORN 60 MIN VS. 30 MINUrdanibia O, Otsubo H, Diaz M, Ciopat O, Blasco M,Gómez E

Tuesday - T - Board #228Presenting Author: Timothy Morgenthaler (United States)THERE IS NO MEANINGFUL DIFFERENCE IN THERESPIRATORY EVENT INDEX CALCULATED USINGTHE ACTIGRAPH ESTIMATED SLEEP TIME VERSUSTOTAL RECORDING TIMEWittine L, Olson E, Morgenthaler T

Tuesday - T - Board #229Presenting Author: Ding Zou (Sweden)ASSOCIATION OF Â-ADRENERGIC RECEPTORPOLYMORPHISMS AND NOCTURNALCARDIOPULMONARY COUPLING IN THE SKARASLEEP COHORTZou D, Grote L, Bengtsson Boström K, Eder D, Lindblad U,Hedener J

Tuesday - B - Board #230Presenting Author: Joseph De Koninck (Canada)GENDER DIFFERENCES IN THE DREAMS OFCANADIAN ADOLESCENTSDale A, Wong C, De Koninck J

Tuesday - O - Board #231Presenting Author: Talyta Cortez Grippe (Brazil)EXACERBATED PHAGOCYTOSIS AND SLEEPAPNEA SYNDROMEGrippe T, Afflalo M, Gaio E, Couto S, Goncalves S, MesquitaW, Muniz-Junqueira M

Wednesday, October 2, 2013

Wednesday - A - Board #001Presenting Author: Cristina Alcaide (Spain)PARTIAL CONTINUOUS EPILEPSY AS THE INITIALCONDITION OF A PATIENT DIAGNOSED WITHCREUTZFELDT-JAKOB DISEASEAlcaide C, Juarez A, Marina L, Montes C

Wednesday - A - Board #002Presenting Author: Ximena Alvarado (Bolivia)PREVALENCE OF RESTLESS LEGS SYNDROMESECONDARY TO HEMODIALYSIS UNIT CLINICASHOSPITALAlvarado X

Wednesday - A - Board #003Presenting Author: Geetika Bajpai (India)VALIDATION OF A MODIFIED HINDI VERSIONOF THE EPWORTH SLEEPINESS SCALE IN A NORTHINDIAN POPULATIONBajpai G, Shukla G, Pandey R, Gupta A, Goyal V,Madhuri Behari A

139

WED

NESD

AY

Wednesday - A - Board #004Presenting Author: Rubén V. Rial (Spain)MELATONIN REVERTS SIGNS OF AGING IN THESLEEP OF RATSBarceló P, Akaârir M, Fiol De Roque M, Vallés G

Wednesday - A - Board #005Presenting Author: Eus J.W. Van Someren (The Netherlands)THE SLEEP REGISTRY. AN INTERNATIONAL ONLINESURVEY AND COGNITIVE TEST ASSESSMENT TOOLAND DATABASE FOR MULTIVARIATE SLEEP ANDINSOMNIA PHENOTYPINGBenjamins J, Migliorati F, Dekker K, Wassing R, Moens S, VanSomeren E, Hartescu L, Itzhacki J, Pinto T, Tesler N, Perrier J,Garbazza C, Jarkiewicz M

Wednesday - A - Board #006Presenting Author: Anastasios Bonakis (Greece)SLEEP IN FRONTOTEMPORAL DEMENTIA ISEQUALLY OR POSSIBLY MORE DISRUPTED WHENCOMPARED TO THAT IN ALZHEIMER’S DISEASE.Bonakis A, Economou N, Paparrgopoulos T, Di Coscio E,Bonanni E, Papageorgiou S

Wednesday - A - Board #007Presenting Author: Luca Carnicelli (Italy)DISRUPTION OF SLEEP-WAKE CONTINUUM INDEMENTIA AND MILD COGNITIVE IMPAIRMENT:MACROSTRUCTURAL AND MICROSTRUCTURALFINDINGSCarnicelli L, Maestri M, Economou N, Paparrigopoulos T,Tognoni G, Bonanni E

Wednesday - A - Board #008Presenting Author: Andrea Crespo Sedano (Spain)NONLINEAR ANALYSIS OF HEART RATE VARIABILITYIN PATIENTS WITH SLEEP APNEA HYPOPNEASYNDROME (SAHS). A SEVERITY STUDY.Crespo A, Del Campo F, Gómez J, Álvarez D, Marcos J, Hornero R

Wednesday - A - Board #009Presenting Author: Andrea Crespo Sedano (Spain)ASSOCIATION BETWEEN APOLIPOPROTEIN E GENEPOLYMORPHISM AND HYPERTENSION INOBSTRUCTIVE SLEEP APNEA SYNDROME PATIENTS.Crespo A, Del Campo F, De Frutos J, Arroyo A, Ruiz T, Alonso M

Wednesday - A - Board #010Presenting Author: Rafael Del Río Villegas (Spain)EFFECTS OF TREATMENT WITH LITHIUM IN A CASEOF KLEINE-LEVIN WITHOUT COMPULSIVE EATINGDel Río R, Bravo-Ortiz M

Wednesday - A - Board #011Presenting Author: M.C. Nicolau (Spain)BRIGHT LIGHT EXPOSURE IMPROVES THE SLEEP-WAKE RHYTHM IN INSTITUTIONALIZED ELDERFiol De Roque M, Rubiño J, Ottmann D, Muñoz S, Nicolau M

Wednesday - A - Board #012Presenting Author: Paula Giménez Rodríguez (Spain)RESTLESS LEGS SYNDROME IN PREGNANCYGiménez P, Canet T, Adsuar E

Wednesday - A - Board #013Presenting Author: Paula Giménez Rodríguez (Spain)RESTLESS LEGS DURING PREGNANCY: THE ROLEOF FERRITINGiménez P, Canet T, Emma A

Wednesday - A - Board #015Presenting Author: Monica L. Andersen (Brazil)INFLUENCE OF METHAMPHETAMINE SELF-ADMINISTRATION ON SLEEP IN RHESUS MONKEYSUSING ACTIGRAPHYL. Andersen M

Wednesday - A - Board #016Presenting Author: Neli Maglakelidze (Georgia)SERIAL ELECTRICAL STIMULATIONS OFHYPOTHALAMIC OREXIN-CONTAINING NEURONALREGIONS LEAD TO ELEVATION OF CSF OREXINACONCENTRATION AND FASTEN THE RECOVERYOF SLEEP-WAKEFULNESS CYCLE FROMEXPERIMENTALLY INDUCED COMATOSE STATEMaglakelidze N, Chkhartishvili E, Dzadzamia S, Chijavadze E,Babilodze M, Nachkebia N

Wednesday - A - Board #017Presenting Author: Martínez - Martínez M.A. (Spain)PROPIOSPINAL MYOCLONUS AT SLEEP ONSET (PSM)AFTER SPINAL ANESTHESIA IN A PATIENT WITHRESTLESS LEGS SYNDROME (RLS) AND PERIODICLIMB MOVEMENTS DURING SLEEP (PLMS): A CASEREPORT.Maria Ángeles M, Roberto O, Mónica G, Jessica Guadalupe M,Andrés G, José Luis M

Wednesday - A - Board #018Presenting Author: Olga Mchedlidze (Georgia)SERIAL ELECTRICAL STIMULATIONS OFHYPOTHALAMIC OREXIN-CONTAINING NEURONALREGIONS LEAD TO ELEVATION OF CSF OREXINACONCENTRATION, SHORTEN ANESTHESIA TIMEAND FASTEN RECOVERY OF NORMAL SLEEP CYCLESFROM DEEP ANESTHESIA INDUCED SLEEPMchedlidze O, Chkhartishvili E, Maglakelidze N, Tsomaia V,Rogava N, Nachkebia N

Wednesday - A - Board #019Presenting Author: Merino-Andreu Mila (Spain)POLISOMNOGRAPHIC PHENOTYPE IS LINKED WITHGENETIC FINDINGS IN PRADER-WILLI SYNDROMEMila M, Aguilera Vergara M, Martínez-Bermejo A,Quero-Jiménez J

Wednesday - A - Board #020Presenting Author: Nargizi Nachkebia (Georgia)MALFUNCTIONING OF BRAIN MUSCARINICCHOLINERGIC SYSTEM IN THE PERIOD OF EARLYPOSTNATAL DEVELOPMENT LEADS TO BEHAVIORALAND SLEEP DISTURBANCES IN ADULT AGE RATSAND CHANGES IN DENSITY OF M2/M4 MUSCARINICRECEPTORSNachkebia N, Chkhartishvili E, Mchedlidze O, Dzadzamia S,Maglakelidze N, Chijavadze E

Wednesday - A - Board #021Presenting Author: Teresa Rebelo-Pinto (Portugal)HEADACHES, SLEEP AND ACADEMIC SUCCESS INADOLESCENTSRebelo-Pinto T, Carneiro-Pinto J, Rebelo-Pinto H, Paiva T

Wednesday - A - Board #022Presenting Author: Patricio Peirano (Chile)ASSOCIATION BETWEEN THE AMOUNT OF DAYTIMESLEEP VARIABILITY AND COGNITIVE FLEXIBILITY INOLDER ADULTSReyes S, Algarín C, Bunout D, Peirano P

140

WED

NESD

AY

Wednesday - A - Board #023Presenting Author: Outi Saarenpää-Heikkilä (Finland)CHILD SLEEP – THE FINNISH BIRTH COHORT STUDYSaarenpää-Heikkilä O, Paavonen J, Himanen S, Kylliäinen A,Pölkki P, Paunio T

Wednesday - A - Board #024Presenting Author: Alan Luiz Eckeli (Brazil)OBSTRUCTIVE SLEEP APNEA SYNDROME INPARKINSON’S DISEASE: PRELIMINARY RESULTSSobreira Neto M, Pereira M, Sobreira E, França Fernandes R,Tumas V, Eckeli A

Wednesday - A - Board #025Presenting Author: William Vanderheyden (United States)INCREASE IN REM SLEEP FOLLOWING TRAUMAEXPOSUREVanderheyden W, Urpa L, Poe G

Wednesday - A - Board #026Presenting Author: Ryuichiro Yamamoto (Japan)THE RELATIONSHIPS BETWEEN SLEEPDISTURBANCE AMONG ELEMENTARY SCHOOLCHILDREN AND LIFESTYLES OF THEIR FAMILYYamamoto R, Maruyama M, Hojo R, Inaga M, Nagashima Y,Sugimori N

Wednesday - B - Board #027Presenting Author: Torbjorn Akerstedt (Sweden)REPEATED SLEEPINESS RATINGS THROUGHOUTTHE DAY – A NORMATIVE FIELD STUDY IN 800INDIVIDUALS ACROSS ONE WORKING WEEKAkerstedt T, Kecklund G, Hallvig D

Wednesday - B - Board #028Presenting Author: Juan Carrillo (Chile)ALERT LEVEL ASSESSMENT ASSOCIATED WITHAGE AND RECENT SLEEP IN MINING WORKERSAnabalon H, Masalán P, Carrillo J, Berrizbeitia A,Anabalon C, Bravo M

Wednesday - B - Board #029Presenting Author: Laura Cerón-Lorente (Spain)REPERCUSSION OF SLEEP QUALITY AND DAYTIMESLEEPINESS ON POSTURAL STEADINESS INMENOPAUSAL WOMENCerón-Lorente L, Gallego-Ariza B, Cabrera-Martos I,Badillo-Fontalvo M, Mateos-Toset S, Valenza M

Wednesday - B - Board #031Presenting Author: Vanessa R Ferreira (Brazil)PSYCHOMOTOR ASSESSMENT IN SLEEP BREATHINGDISORDER CHILDREN – PILOT STUDYFerreira V, Leite J, Prado L, Prado G, Carvalho L

Wednesday - B - Board #032Presenting Author: Elena Rueda (Spain)TITLE EFFECT OF MULTICOMPONENT COGNITIVEBEHAVIORAL THERAPY IN A SAMPLE OF CHRONICINSOMNIACS IN HYPNOTIC TREATMENT.Guallar Ballester J, Agusti Visiedo J, Baguena Puigcerver M,Rueda Ravasco E, Ortega Albás J

Wednesday - B - Board #033Presenting Author: Kerstin Hoedlmoser (Austria)SLEEP TO BOOST (RE-)LEARNING A FINE-MOTOR SKILLHoedlmoser K, Petzka M, Birklbauer J, Gruber G, Benjamins J,Van Someren E

Wednesday - B - Board #034Presenting Author: Janne Grønli (Norway)EFFECTS OF SOCIAL DEFEAT ON SLEEP ANDBEHAVIOR: IMPORTANCE OF THECONFRONTATIONAL BEHAVIORKinn Rød A, Murison R, Mrdalj J, Milde A, Jellestad F, Grønli J

Wednesday - B - Board #035Presenting Author: Shun Nakajima (Japan)RELATIONSHIP AMONG NIGHTMARE, INSOMNIAAND DEPRESSION AMONG RESIDENTS IN JAPANESERURAL COMMUNITYNakajima S, Yuichi I, Okajima I, Taeko S, Komada Y, Nomura T

Wednesday - B - Board #036Presenting Author: Amelia Piquer (Spain)COMPARISON BETWEEN THE OBJECTIVELYMEASURED AND THE SUBJECTIVE SLEEP IN AGROUP OF PATIENTSPiquer A, Cutillas A, Perales P, Besa G, Goyo D, Gomez Siurana E

Wednesday - B - Board #037Presenting Author: Iñigo Saez-Uribarri (Spain)MORE COMPLEX DREAMS WITH EMOTIONS ORAGGRESSIONS ARE ASSOCIATED WITH LONGERREPORTSSaez-Uribarri I

Wednesday - B - Board #038Presenting Author: Iñigo Saez-Uribarri (Spain)RECALLING YOUR DREAMS WON’T MAKE YOUNERVOUS IN THE MORNING.Saez-Uribarri I

Wednesday - B - Board #039Presenting Author: Oliver Todd (Germany)POOR SLEEP- AN EARLY SIGN OF INCIPIENTDELIRIUM, OR A RISK FACTOR IN ITSELF?A CLINICAL OBSERVATIONAL STUDY.Todd O

Wednesday - B - Board #040Presenting Author: Mark Lawrence Wong (China)REVERSING DECLINE OF HIGHER ORDECOGNITIVE FUNCTIONS DURING THE DAY WITHA NAPWong M, Lau K, Lau E

Wednesday - C - Board #041Presenting Author: Rubén V. Rial (Spain)THE GLYCEMIC INDEX OF A MID MORNING SNACKMODIFIES THE BODY TEMPERATURE RHYTHMBelzunce J, Noguera C, Gené L, Rial R

Wednesday - C - Board #042Presenting Author: Juan Antonio Madrid (Spain)NON DIPPING BLOOD PRESSURE PATTERN ISRELATED TO AN INCREASE IN DAYTIME DISTALSKIN TEMPERATUREBlazquez A, Martinez-Nicolas A, Rol A, Antonio J

Wednesday - C - Board #043Presenting Author: Juan Antonio Madrid (Spain)ASSOCIATION BETWEEN THE IMPAIRMENT OF SKINTEMPERATURE RHYTHM AND HYPERTENSIONBlazquez A, Martinez-Nicolas A, Rol A, Antonio J

141

WED

NESD

AY

Wednesday - C - Board #044Presenting Author: Maria Angeles Bonmati-Carrion (Spain)AMBULATORY MONITORING IN HUMANS: A NEWMETHOD TO OBJECTIVELY ASSESS CIRCADIANPHASE AS COMPARED WITH DIM LIGHTMELATONIN ONSET (DLMO)Bonmati-Carrion M, Middleton B, Revell V, Skene D, Rol A,Madrid J

Wednesday - C - Board #045Presenting Author: Juan Carrillo (Chile)ANXIETY AND DEPRESSION ASSOCIATED WITHSLEEP DISTURBANCES IN SHIFT WORKERSCarrillo J, Becerra M

Wednesday - C - Board #046Presenting Author: Juan Carrillo (Chile)HYPERTENSION AND ITS ASSOCIATION WITH SHIFTWORK, SLEEP-DISORDERED BREATHING AND PLACEIN THE ORGANIZATIONAL HIERARCHYCarrillo J, Bastias I, Contreras P, Mistretta D, Vargas C

Wednesday - C - Board #047Presenting Author: Katarina Danielsson (Sweden)COGNITIVE BEHAVIOUR THERAPY: AN ADDITIVETREATMENT IN DELAYED SLEEP PHASE DISORDER.Danielsson K, Jansson-Fröjmark M, Broman J, Markström A

Wednesday - C - Board #048Presenting Author: Diane B. Boivin (Canada)THE CIRCADIAN RHYTHM OF BLOOD PRESSURE ISMASKED BY POSTURAL CHANGESHsein Yeh W, Boudreau P, Dumont G, Boivin D

Wednesday - C - Board #049Presenting Author: Manon Lamy (Canada)SLEEP DIARIES FOR SHIFT WORKERSLamy M, Bastille-Denis E, Vallières A

Wednesday - C - Board #050Presenting Author: Cristina Martínez Null (Spain)SOCIAL JETLAG MORE THAN THE EVENINGCROTOTYPE IS THE MAIN CAUSE OF CHRONICSLEEP PRIVATION IN TEEN PEOPLEMartínez Null C, López Picado A, Egea Santaolalla C, ManjónCaballero J, Izaguirre Martínez I, De Andrés Eciolaza J

Wednesday - C - Board #051Presenting Author: Juan Antonio Madrid (Spain)DAY-NIGHT CONTRAST AS SOURCE OF HEALTHFOR HUMANSMartinez-Nicolas A, Madrid J, Rol A

Wednesday - C - Board #052Presenting Author: Leon Lack (Australia)PERIOD LENGTHS OF TEMPERATURE ANDMELATONIN CIRCADIAN RHYTHMS IN DELAYEDSLEEP PHASE DISORDERMicic G, Lack L, Lovato N, Burgess H, Ferguson S

Wednesday - C - Board #053Presenting Author: Inmaculada Pitarch Castellano (Spain)SLEEPING DISORDERS RELATED WITH ALTERATIONSOF MELATONINE SECRETION CIRCADIAN RHYTHMPitarch Castellano I, Puertas Cuesta F, Perez Pitarch A

Wednesday - C - Board #054Presenting Author: Inmaculada Pitarch Castellano (Spain)SALIVARY DETERMINATION OF DIM LIGHTMELATONIN ONSET AS A TOOL IN ATTENTIONDEFICIT HYPERACTIVITY DISORDER DIAGNOSISPitarch Castellano I, Puertas Cuesta F, Perez Pitarch A

Wednesday - C - Board #055Presenting Author: Tamar Shochat (Israel)HEMOSTATIC MARKERS IN SHIFT WORKINGFEMALE NURSESSaharov G, Nadir Y, Zoran I, Keren A, Brenner B, Shochat T

Wednesday - C - Board #056Presenting Author: Marta Segura Aroca (Spain)SLEEP QUALITY OF NURSES WORKING IN SIXHOSPITALS OF THE SPANISH NATIONALHEALTH SYSTEMSegura Aroca M, Gómez García T, Lopez Iborra M,Alonso Poncelas E, Santos Serrano R, Domenech López X

Wednesday - C - Board #057Presenting Author: Tamar Shochat (Israel)THE EFFECTS OF A SCHEDULED NAP DURING THENIGHTSHIFT ON PERFORMANCE, SLEEPINESS ANDVIGOR IN NURSESShochat T, Zion N

Wednesday - C - Board #058Presenting Author: Ana Viegas (Portugal)MELATONIN IN PATIENTS WITH DELAYED SLEEPPHASE DISORDERViegas A, Rebocho S, Paiva T

Wednesday - E - Board #059Presenting Author: Marc Guaita (Spain)DAYTIME PERIPHERAL TEMPERATURE CHANGESDURING MWT AND MSLTGuaita M, Martinez A, Madrid J, Rol M, Salamero M,Santamaria J

Wednesday - E - Board #060Presenting Author: Marc Guaita (Spain)HEART RATE VARIABILITY DURING THE MSLT ANDMWT IN PATIENTS WITH AND WITHOUT EXCESSIVEDAYTIME SLEEPINESSGuaita M, Umberto M, Montserrat V, Caminal P, Salamero M, Santamaria J

Wednesday - E - Board #061Presenting Author: Stefan Mihaicuta (Romania)LOWER LEVELS OF EPWORTH SLEEPINESS SCOREPREDICTS SLEEP APNEA SYNDROME IN A SLEEPLABORATORYMihaicuta S, Paralescu S, Toth I

Wednesday - E - Board #062Presenting Author: María Ruzafa (Spain)CHRONOTYPE AND DAYTIME SLEEPINESS INNURSES WORKING IN SIX HOSPITALS OF THESPANISH NATIONAL HEALTH SYSTEMRuzafa Martíneza M, Moreno Casbas T, Serrano Pinto A,González- María E, Heredia Reina M, Otero Fernández A

142

WED

NESD

AY

Wednesday - E - Board #063Presenting Author: Karel Schreuder (The Netherlands)PROLONGED DAYTIME DISSOCIATIVE NREM3 SLEEPSTATE IN HYPERSOMNOLENCE WITH KLEINE LEVINSYMPTOMATOLOGY, A CASE REPORT.Schreuder K, Sie J, De Vries X, Hoekema A, Finnema K,De Weerd A

Wednesday - E - Board #064Presenting Author: Tokusei Tanahashi (Japan)CHANGES IN SUBJECTIVE EXCESSIVE DAYTIMESLEEPINESS AFTER THE GREAT EAST JAPANEARTHQUAKETanahashi T, Furukawa T, Hirayama K, Nakano H, Sudo N

Wednesday - I - Board #065Presenting Author: Ainhoa Alvarez Ruiz De Larrinaga (Spain)TRAZODONE AS CO-TREATMENT FOR INSOMNIACPATIENTSAlvarez Ruiz-Larrinaga A, Majón Caballero J, López Picado A,Mendaza Ortiz M, Egea Santaolalla C, Duran-Cantolla J

Wednesday - I - Board #066Presenting Author: Francesca Canellas (Spain)INSOMNIA GROUP THERAPYBelber M, De La Fuente L, Canellas F

Wednesday - I - Board #067Presenting Author: Rafael Del Rio Villegas (Spain)PERSONALITY AND SEVERITY OF PRIMARYINSOMNIABravo-Ortiz M, Valverde C, Herrero E, Melero J, Naranjo M,Del Rio R

Wednesday - I - Board #068Presenting Author: Oliviero Bruni (Italy)TOWARD A CLINICAL AND THERAPEUTICCLASSIFICATION OF INSOMNIA OF CHILDHOODBruni O, Elisabetta A, Marco A, Assia R, Claudia D, Raffaele F

Wednesday - I - Board #069Presenting Author: Vanda Clemente (Portugal)COIMBRA SLEEP ACTIVATION SCALE (C-SAS):PSYCHOMETRIC PROPERTIES IN INSOMNIACSClemente V, Almeida J, Martins I, Allen Gomes A, MoutinhoDos Santos J

Wednesday - I - Board #070Presenting Author: M. Montserrat (Spain)CAN CBT FOR INSOMNIA ALSO IMPROVE PAINSENSITIVITY IN FIBROMYALGIA PATIENTS?: RESULTSFROM A RANDOMIZED CLINICAL TRIALEdinger J, Sanchez Ortuño M, Stechuchak K, Coffman C,Krystal A

Wednesday - I - Board #071Presenting Author: Kunihiro Futemma (Japan)THE IMPACT OF HYPNOTICS USAGE ON DAYTIMEFUNCTION AND ASSOCIATED FACTOR FOR THEUSAGE IN SHIFTWORK NURSES.Futemma K, Murakoshi A, Takaesu Y, Asaoka S, Komada Y,Inoue Y

Wednesday - I - Board #072Presenting Author: Sanjive Jain (Canada)INTRODUCING INSOMNIA MEDITATION THERAPY:A NOVEL BEHAVIOURAL INTERVENTION FORINSOMNIAJain S, Shapiro G

Wednesday - I - Board #073Presenting Author: Aggeliki Konsta (Greece)STRESS MANAGEMENT TECHNIQUES IN PRIMARYINSOMNIA: A RANDOMIZED CONTROLLED TRIALKonsta A, Dikeos D, Bonakis A, Economou N, Chrousos G,Darviri C

Wednesday - I - Board #074Presenting Author: Diego Mazzotti (Brazil)INSOMNIA AND MORTALITY AMONG OLDERPEOPLE IN FIVE LATIN AMERICAN COUNTRIES:A POPULATION BASED COHORT STUDYMazzotti D, Garbuio S, Ferri M, Tufik S, Ferri C

Wednesday - I - Board #075Presenting Author: Merino-Andreu Mila (Spain)EVALUATION OF ORAL IRON SUPPLEMENTATIONIN PEDIATRIC MAINTENANCE INSOMNIAMila M, Cecilia A, Gracia A, Antonio M, Oscar T, Patricio P

Wednesday - I - Board #076Presenting Author: Jesus Moo Estrella (Mexico)TYPES OF INSOMNIA AND PHYSICAL ACTIVITYIN COLLEGE STUDENTSMoo Estrella J, Rosado Narvaez C, Yañez Loría A,Valencia Flores M

Wednesday - I - Board #077Presenting Author: Markku Partinen (Finland)SLEEP DIFFICULTIES IN PARKINSON´S DISEASEPartinen M, Ylikoski a, Martikainen K

Wednesday - I - Board #078Presenting Author: Campolo Benedetta (Italy)SLEEP AND PULMONARY INTENSIVE CARE:INSOMNIA AND THE PARADOX OFRoccia F, Campolo B, Gallelli L

Wednesday - I - Board #079Presenting Author: Eus J.W. Van Someren (The Netherlands)DIFFERENTIAL BRAIN STRUCTURAL CORRELATESOF INSOMNIA IN DEPRESSION VS. ANXIETYStoffers D, Van Tol M, Penninx B, Veltman D, Van Der Wee N,Van Someren E

Wednesday - I - Board #080Presenting Author: Vladimir Svetnik (United States)COMPARISON OF EEG POWER SPECTRA BETWEENPATIENTS WITH PRIMARY INSOMNIA AND GOODSLEEPER CONTROLS, ACCOUNTING FOR THEEFFECTS OF AGE, GENDER, AND SLEEP PERIOD,USING A LARGE COMPILATION OF PSG RECORDINGSFROM THREE CLINICAL TRIALS.Svetnik V, Snyder E, Ivgy-May N, Ma J, Tao P, Herring W

Wednesday - I - Board #081Presenting Author: Dora Zalai (Canada)THE SILENCE OF SLEEP DISORDERS. HIGHPREVALANCE OF INSOMNIA AND OBSTRUCTIVESLEEP APNEA SYMPTOMS IN CHRONIC HEPATITISC INFECTIONZalai D, Mcshane K, Sherman M, Fornadi K, Shapiro C,Carney C

143

WED

NESD

AY

Wednesday - I - Board #082Presenting Author: Dora Zalai (Canada)ARE YOU CONCERNED ABOUT YOUR FATIGUE?FATIGUE PERCEPTIONS MEDIATE THERELATIONSHIP BETWEEN INSOMNIA AND FATIGUERELATED FUNCTIONAL IMPAIRMENT IN CHRONICHEPATITIS C INFECTIONZalai D, Mcshane K, Sherman M, Fornadi K, Shapiro C,Carney C

Wednesday - NA - Board #083Presenting Author: Maria Albanese (Italy)CSF BETA-AMYLOID LEVELS ARE ALTERED INNARCOLEPSY: A LINK WITH THE INFLAMMATORYHYPOTHESIS?Albanese M, Liguori C, Placidi F, Izzi F, Marciani M, Romigi A

Wednesday - NA - Board #084Presenting Author: Ximena Alvarado (Bolivia)CASE REPORTAlvarado X

Wednesday - NA - Board #085Presenting Author: Yves Dauvilliers (France)EFFECT OF SODIUM OXYBATE (SXB), MODAFINILAND COMBINATION ON DISRUPTED NIGHTTIMESLEEP IN NARCOLEPSYDauvilliers Y, Roth T, Guinta D, Alvarez-Horine S, Dynin E,Black J

Wednesday - NA - Board #086Presenting Author: Claire E.H.M. Donjacour (The Netherlands)ENERGY EXPENDITURE IN NARCOLEPSY PATIENTSAND CONTROLSDonjacour C, Schoffelen P, Overeem S, Lammers G, Pijl H,Westerterp K

Wednesday - NA - Board #087Presenting Author: Patricia Franco (France)CHARACTERISTICS OF NARCOLEPSY ACCORDINGTO THE AGE OF DIAGNOSISInocente C, Lecendreux M, Dauvilliers, Md, Phd Y, Drouot X,Arnulf I, Franco P

Wednesday - NA - Board #088Presenting Author: Masako Kohsaka (Japan)TWENTY-FOUR-HOUR SLEEP-WAKE MONITORINGIN NARCOLEPSY: COMPARISON WITH MSLTKohsaka M, Fukuda N

Wednesday - NA - Board #089Presenting Author: Jesús Paniagua Soto (Spain)MULTIPLE SLEEP LATENCY TEST IN PATIENTS WITHSUSPECTED NARCOLEPSY. REVIEW OF 45 CASES.Paniagua-Soto J, Ruiz-García J, Iznaola-Muñoz M, Ruiz-Serrano L

Wednesday - NA - Board #090Presenting Author: Thomas Roth (United States)EFFECT OF SODIUM OXYBATE ON SLEEP STAGESHIFTS AND SLEEP QUALITY IN PATIENTS WITHNARCOLEPSYRoth T, Dauvilliers Y, Guinta D, Alvarez-Horine S, Dynin E,Black J

Wednesday - NA - Board #091Presenting Author: John Peever (Canada)PHARMACOGENETIC INHIBITION OF THESUBCOERULEUS REGION INFLUENCES REM SLEEPAND CATAPLEXY IN NARCOLEPTIC MICE.Sanghera K, Kim J, Peever J

Wednesday - NA - Board #092Presenting Author: Tomi Sarkanen (Finland)SYMPTOMS OF NARCOLEPSY IN RELATION TOPANDEMRIX VACCINATION AND CSF-HYPOCRETIN-1LEVELSSarkanen T, Huutoniemi A, Partinen M

Wednesday - NA - Board #093Presenting Author: M Berta Silva (Portugal)PREDICTIVE POWER OF HLA-DQB1* TO IDENTIFYNARCOLEPTIC PATIENTSSilva M, Lopes J, Carvalho C, Cunha D, Pinho Costa P,Martins-Da-Silva A

Wednesday - NA - Board #094Presenting Author: Ana Viegas (Portugal)LOW HLA DQB1 0602 IN PORTUGUESENARCOLEPTICSViegas A, Rebocho S, Paiva T, David A

Wednesday - NE - Board #095Presenting Author: Amaury José Asencio Guerra (Spain)FATAL FAMILIAL INSOMNIA (FFI) IN BASQUECOUNTRY. CLINICAL MANIFESTATIONS,POLYSOMNOGRAPHIC PATTERNS ANDPATHOLOGIC FINDINGS IN THREE CASES.Asencio Guerra A, Alvarez Ruiz De Larrinaga A,Egea Santaolalla C, Durán Cantolla J, Alvarez Vadillo E,Julián Villaverde F

Wednesday - NE - Board #096Presenting Author: Eter Chijavadze (Georgia)EFFECT OF INDUCED HYPOGLYCEMIA ONSLEEP-WAKING CYCLE IN RATSChijavadze E, Babilodze M, Mchedlidze O, Chkhartishvili E,Nachkebia N

Wednesday - NE - Board #097Presenting Author: Alex Ferre (Spain)POLISOMNOGRAPHYC RESULTS IN CHIARIMALFORMATION TYPE IFerre A, Poca M, De La Calzada M, Moncho D, Romero O,Sahuquillo J

Wednesday - NE - Board #098Presenting Author: Alex Ferre (Spain)SLEEP RELATED BREATHING DISORDERS (SRBD)IN PATIENTS WITH CHIARI TYPE I MALFORMATIONBEFORE AND AFTER POSTERIOR FOSSADECOMPRESSIONFerre A, Poca M, De La Calzada M, Moncho D, Romero O,Sahuquillo J

Wednesday - NE - Board #099Presenting Author: Masaya Segawa (Japan)FAILURE IN RESTRICTING ATONIA IN REM STAGECAUSED DYSFUNCTION OF THE DOPAMINENEURON IN CHILDHOODSegawa M

144

WED

NESD

AY

Wednesday - O - Board #100Presenting Author: Alison Bentley (South Africa)THE EFFECT ON SLEEP INERTIA ON PAINPERCEPTION DEPENDS ON THE TYPE OF PAINBenjamin D, Inkley R, Bentley A

Wednesday - O - Board #101Presenting Author: Isabel Caballero-Martinez (Spain)SLEEP DISORDERS IN PATIENTS WITH EPILEPSYCaballero-Martinez M, Caballero-Martinez M,Vazquez-Rodriguez R, Martinez-Agredano P, Arenas-Cabrera C,Jimenez-Hernandez M

Wednesday - O - Board #102Presenting Author: Caballero-Martinez (Spain)PAROXYSMAL MOTOR DISORDERS OF SLEEPMISDIAGNOSED AS EPILEPSYCaballero-Martinez M, Caballero-Martinez M,Martinez-Agredano P, Arenas-Cabrera C, Vazquez-Rodriguez R,Jimenez-Hernandez M

Wednesday - O - Board #103Presenting Author: Suzana V. Schönwald (Brazil)PRIMARY SLEEP DISORDER CATEGORIZATION INTOCLINICAL PRACTICE: A PILOT STUDY WITH THEPRIMSC CODING SYSTEMCarvalho D, Margis R, Schuh A, Gerhardt G, Rieder C,Schönwald S

Wednesday - O - Board #104Presenting Author: Laura Cerón-Lorente (Spain)SLEEP DISTURBANCES AND MANUAL DEXTERITYIN FIBROMYALGIACerón-Lorente L, Badillo-Fontalvo M, Cabrera-Martos I,Torres-Sánchez I, Gallego-Ariza B, Valenza M

Wednesday - O - Board #105Presenting Author: Gregory Collet (Belgium)SLEEP DURING AN ANTARCTIC OVERWINTERING:COMPARING AN ALTITUDE BASE AND A COASTALSTATIONCollet G, Mairesse O, Mcdonald-Nethercott E, Ducrot Y,Meeusen R, Pattyn N

Wednesday - O - Board #106Presenting Author: Laura Creti (Canada)EFFECTS OF SLEEP DISTURBANCE IN THEPOSTPARTUM: ARE NEW MOTHERS AN EXCEPTIONTO THE RULE?Creti L, Rizzo D, Fichten C, Bailes S , Libman E

Wednesday - O - Board #107Presenting Author: Antonio Pedrera Mazarro (Spain)THE PENELOPE SYNDROME NOT ALWAYS MEANSBAD PROGNOSISCuéllar-Ramos N, Cortés-Jiménez V, Álvarez-Sánchez J,Pedrera-Mazarro A

Wednesday - O - Board #108Presenting Author: Manuel De Entrambasaguas (Spain)INSOMNIA AND DEATH OF MARILYN MONROEDe Entrambasaguas M

Wednesday - O - Board #109Presenting Author: Sara Cabrera García-Armenter (Spain)INCIDENCE OF SLEEP DISORDERS IN A SIMPLE OFDOWN SYNDROME PATIENTS.Dominguez Ortega L, Cabrera García-Armenter S, Díaz GállegoE, Serrano Comino M

Wednesday - O - Board #110Presenting Author: Jack D. Edinger (United States)A COLLABORATIVE CARE MODEL FOR IMPROVINGSLEEP DISORDERS MANAGEMENT IN PRIMARY CARE.Edinger J, Grubber J, Ulmer C, Zervakis J, Olsen M

Wednesday - O - Board #111Presenting Author: Lamia Afifi (Egypt)SLEEP DISORDERS IN CHRONIC RENAL FAILUREPATIENTSEltawdy M, Rabah A, Nada M, Refaat R, Afifi L

Wednesday - O - Board #112Presenting Author: Lígia Ferreira (Portugal)CYCLIC ALTERNATING PATTERN IN CONGENITALDEAF - QUANTITATIVE AND TOPOGRAPHICANALYSISFerreira L, Paiva T

Wednesday - O - Board #113Presenting Author: Catarina Ferreira (Portugal)MANDIBULAR ADVANCEMENT SPLINT FOR THETREATMENT OF OBSTRUCTIVE SLEEP APNEAFerreira C, Teixeira F, Vaz Rodrigues L, Carvalho F, MoutinhoDos Santos J

Wednesday - O - Board #114Presenting Author: Katia Gagnon (Canada)ARE SLEEP COMPLAINTS FOLLOWING MILDTRAUMATIC BRAIN INJURY ASSOCIATED WITHCHANGES IN THE CHARACTERISTICS OF SLEEPSLOW WAVES?Gagnon K, Khoury S, Carrier J, Montplaisir J, Lavigne G,Gosselin N

Wednesday - O - Board #115Presenting Author: Belén Gallego Ariza (Spain)AN 8-WEEKS EXERCISE MUSCLE TRAININGIMPROVES SUBJECTIVE FATIGUE AND QUALITYOF SLEEP IN PARKINSON DISEASE’S PATIENTSGallego-Ariza B, Cabrera-Martos I, Correa-Toledo A,Mateos-Toset S, Flores-Barba M, Valenza M

Wednesday - O - Board #116Presenting Author: Ali Gholamrezaei (Iran)SLEEP QUALITY IN WOMEN WITH SYSTEMICLUPUS ERYTHEMATOSUSGholamrezaei A, Hosseini N, Sayed Bonakdar Z

Wednesday - O - Board #117Presenting Author: Sandra Giménez Badia (Spain)SLEEP QUALITY IN INTENSIVE CARE UNITGiménez Badia S, Batet S, Italiano S, Roche-Campo F,Antonijoan R

Wednesday - O - Board #118Presenting Author: Ana Allen Gomes (Portugal)BRIEF INSOMNIA AND QUALITY OF SLEEP SCALE(BIQSS): RELIABILITY AND VALIDITY IN HIGHEREDUCATION STUDENTSGomes A, Marques D, Tavares J, Azevedo M

Wednesday - O - Board #119Presenting Author: Jean-Philippe Gouin (Canada)HEART RATE VARIABILITY PREDICTS SLEEPEFFICIENCYGouin J, Wenzel K, Deschenes S, Dang-Vu T

145

WED

NESD

AY

Wednesday - O - Board #120Presenting Author: Nadia Tobback (Switzerland)EFFECTS OF REAL VS SIMULATED ALTITUDE ONSLEEP AND SLEEP DISORDERED BREATHINGHeinzer R, Saugy J, Tobback N, Rupp T, Haba-Rubio J, Millet G

Wednesday - O - Board #121Presenting Author: Rosa Martins (Portugal)IS THERE A CORRELATION BETWEEN CLINICALFACTORS AND NOCTURNAL OXIMETRY IN CYSTICFIBROSIS CHILDREN?Martins R, Silva A, Mexia S, Asseiceira I, Pereira L, Ferreira R

Wednesday - O - Board #122Presenting Author: A Martins Da Silva (Portugal)SLEEP DISORDERS DIAGNOSIS BY GENETICASSESSMENTMartins-Da-Silva A, Ramalheira J, Silva L, Cunha D, Brás S,Carvalho C

Wednesday - O - Board #123Presenting Author: Rie Miyata (Japan)DAILY ALTERATION OF MELATONIN AND OXIDATIVESTRESS MARKERS IN DEVELOPMENTAL DISORDERSMiyata R, Tanuma N, Hayashi M, Kohyama J

Wednesday - O - Board #124Presenting Author: Stella Maris Valiensi (Argentina)INFLUENCE OF THE OBSTRUCTIVE SLEEP APNEATREATMENT IN THE GLAUCOMA CONTROLMoussalli M, Bekerman J, Cuello Oderiz C, Valiensi S

Wednesday - O - Board #125Presenting Author: Bikemgül Özkara (Turkey)THE APPLICATION OF CONTINUOUS POSITIVEAIRWAY PRESSURE IN ASSOCIATION WITHOBSTRUCTIVE SLEEP APNEA SYNDROME ANDSUBCONJUNCTIVAL HEMORRHAGE DUE TOHYPERTENSIVE ATTACKS: CASE REPORTSÖzkara B, Þevketbeyoðlu H, Taþ D

Wednesday - O - Board #126Presenting Author: Jesús Paniagua Soto (Spain)CHILDREN SLEEP CLINIC IN CLINICALNEUROPHYSIOLOGY SERVICE IN VIRGEN DE LASNIEVES HOSPITAL IN GRANADA (SPAIN)Paniagua-Soto J, Iznaola-Muñoz M, Ruiz-García J, Ruiz-Serrano L

Wednesday - O - Board #127Presenting Author: Silvia Pucci (Portugal)THE ROLE OF PSYCHOLOGICAL MORBIDITY ONSLEEP QUALITY AND LIFESTYLE IN ADOLESCENTSPucci S, Graça Pereira M

Wednesday - O - Board #128Presenting Author: Tim Weysen (The Netherlands)CREATING A SLEEP-PERMISSIVE CONDITIONUSING BED WARMINGWeysen T, Møst E, Raymann R

Wednesday - O - Board #129Presenting Author: Zohreh Yazdi (Iran)ASSESSING THE KNOWLEDGE AND ATTITUDEGENERAL PHYSICIAN ABOUT SLEEP MEDICINE INQAZVIN, IRANYazdi z, Jalilolghadr S, Rezaiean S

Wednesday - PS - Board #130Presenting Author: Maha Abou-Khadra (Egypt)SLEEP, SYMPTOM-RATINGS AND SERUM FERRITINLEVELS IN CHILDREN WITH ADHDAbou-Khadra M, Amin O, Shaker O, Rabah T

Wednesday - PS - Board #131Presenting Author: Pasquale Alvaro (Australia)INSOMNIA, DEPRESSION AND SUBTYPES OFANXIETY: DOES CHRONOTYPE UNIQUELY MEDIATETHESE RELATIONSHIPS DURING ADOLESCENCE?Alvaro P, Roberts R, Harris J

Wednesday - PS - Board #132Presenting Author: Maha Abou-Khadra (Egypt)SLEEP PATTERNS AND PROBLEMS AMONGEGYPTIAN CHILDREN WITH ADHD: THE IMPACTOF SYMPTOMS SEVERITY AND SUBTYPESAmin O, Abou-Khadra M

Wednesday - PS - Board #133Presenting Author: Samya Ashour (Egypt)SLEEP DISTURBANCES IN CHILDREN WITHATTENTION DEFICITAshou Helal S

Wednesday - PS - Board #134Presenting Author: Roger Godbout (Canada)IS CORTISOL ASSOCIATED WITH POOR SLEEP INAUTISM? A LABORATORY STUDY IN HIGHFUNCTIONING ADULTS.Chicoine M, Limoges É, Chevrier É, Lupien S, Mottron L,Godbout R

Wednesday - PS - Board #135Presenting Author: Mónica Díaz Román (Spain)SLEEP AND ADHDCiopat O, Díaz Román M, Urdanibia Centelles O,Rubio Sánchez P, Gomez Siurana E, Goyo Ibarra D

Wednesday - PS - Board #136Presenting Author: Xavier Estrada Prat (Spain)SLEEP ARCHITECTURE DISTURBANCES INCHILDREN WITH BIPOLAR DISORDER VERSUSATTENTION DEFICIT AND HYPERACTIVITYDISORDER: A PILOT STUDYEstrada Prat X, Alvarez Guerrico I, Principe A, Batlle Vila S,Martín López L, Duñó Ambrós L

Wednesday - PS - Board #137Presenting Author: Iris Haimov (Israel)THE EFFECTS OF ACUPUNCTURE TREATMENTON SLEEP QUALITY AND ON EMOTIONALMEASURES AMONG INDIVIDUALS LIVING WITHSCHIZOPHRENIAHaimov I, Bloch B, Vadas L, Ravid S, Kremer I, Reshef A

Wednesday - PS - Board #138Presenting Author: Jesus Escribá-Alepuz (Spain)SLEEP HABITS AND SLEEP DISORDERS IN CHILDRENWITH ATTENTION DEFICIT-HYPERACTIVITYDISORDER. INFLUENCE OF TREATMENT. AMULTICENTER STUDYJesus E, Soria-Bretones C, Pau G, Alberto D, Teresa O,M. Ángeles G

146

WED

NESD

AY

Wednesday - PS - Board #139Presenting Author: Deependra Kumar (Germany)CAV1.2 CALCIUM CHANNEL IS INVOLVED IN THECIRCADIAN REGULATION OF SLEEPKumar D, Dedic N, Flachskamm C, Deussing J, Kimura M

Wednesday - PS - Board #140Presenting Author: Roger Godbout (Canada)SLEEP IN CHILDREN WITH HIGH FUNCTIONINGAUTISM: POLYSOMNOGRAPHY, QUESTIONNAIRESAND DIARIES IN A NON-COMPLAINING SAMPLE.Lambert A, Tessier S, Chevrier É, Scherzer P, Mottron L,Godbout R

Wednesday - PS - Board #141Presenting Author: Roger Godbout (Canada)WAKE EEG COHERENCE BEFORE AND AFTER SLEEPIN ADULTS WITH AUTISM: DECREASED MORNINGFRONTAL CONNECTIVITY.Léveillé C, Bolduc C, Limoges É, Chevrier É, Mottron L,Godbout R

Wednesday - PS - Board #142Presenting Author: Maria-Cecilia Lopes (Brazil)SLEEP COMPLAINT AS A BIOMARKER OF BIPOLARDISORDER IN CHILDREN AND ADOLESCENTLopes M

Wednesday - PS - Board #143Presenting Author: Maria-Cecilia Lopes (Brazil)THE RELATIONSHIP BETWEEN SLEEP COMPLAINTSAND SUICIDAL BEHAVIOUR IN A MILD TO SEVEREDEPRESSED SAMPLE OF CHILDREN AND ADOLESCENTSLopes M

Wednesday - PS - Board #144Presenting Author: Azad Maroufi (Iran)COMPARISON OF FREQUENCY OF SLEEP DISORDERSIN MMT VOLUNTEERS AND OPIUM DEPENDANTPATIENTSMaroufi A, Khazaie H

Wednesday - PS - Board #145Presenting Author: María Natalia Pereira (Spain)SLEEP AND MOOD DISORDERS IN EPILEPSYPereira M, Zuccolo L, Cieza Ortiz S, Urrestarazu Bolumburu E,Iriarte Franco J

Wednesday - PS - Board #146Presenting Author: Olivier Potvin (Canada)SUBJECTIVE SLEEP CHARACTERISTICS ASSOCIATEDWITH ANXIETY AND DEPRESSION IN OLDERADULTS: A POPULATION-BASED STUDYPotvin O, Lorrain D, Belleville G, Grenier S, Préville M

Wednesday - PS - Board #147Presenting Author: Guanghai Wang (China)SLEEP DISUTBANCES AND EMOTIONAL/BEHAVIORALPROBLEMS AMONG CHINESE SCHOOL-AGEDCHILDREN: PREVALENCE AND ASSCOAITONWang G, Xu G, Lu N, Ren F, Geng L, Sun Y

Wednesday - REM - Board #148Presenting Author: Susumu Abe (Japan)SLEEP BRUXISM AND MASSETER MUSCLE ACTIVITYDURING REM SLEEP OF REM SLEEP BEHAVIORDISORDER PATIENTS: A CASE CONTROL STUDYAbe S, Gagnon J, Montplaisir J, Rompré P, Kawano F, Lavigne G

Wednesday - REM - Board #149Presenting Author: Alan Eckeli (Brazil)REM SLEEP BEHAVIORAL DISORDER INPARKINSON`S DISEASE: PRELIMINARY RESULTSEckeli A, Sobreira Neto M, Sobreira E, Chagas M, Tumas V,França Fernandes R

Wednesday - REM - Board #150Presenting Author: Arturo Garay (Argentina)ANALYSIS OF CICLIC ALTERNATING PATTERNS INAGRYPNIA EXCITATA (AE): INSIGHTS FROM A CASEOF LIMBIC AUTOINMUNE ENCEPHALOPATHY(AE-LAE)Garay A, Blanco S

Wednesday - REM - Board #151Presenting Author: Katie Hancock (United States)PILOT QUANTITATIVE ANALYSES OF REM SLEEPWITHOUT ATONIA IN CHILDREN ANDADOLESCENTS WITH REM SLEEP BEHAVIORDISORDERHancock K, Mccarter S, St. Louis E, Kotagal S, Lloyd R, Boeve B

Wednesday - REM - Board #152Presenting Author: Poul Jennum (Denmark)PARKINSONISM AS AN OUTLIER DETECTIONPROBLEMKempfner J, Jennum P

Wednesday - REM - Board #153Presenting Author: Daniele Lo Cocco (Italy)REM SLEEP BEHAVIOR DISORDER AND PERIODICLEG MOVEMENTS IN SLEEP IN PATIENTS WITHAMYOTROPHIC LATERAL SCLEROSISLo Cocco D, Mattaliano P, Gioi G, Congiu P, Fantini M,Puligheddu M

Wednesday - REM - Board #154Presenting Author: Masayuki Miyamoto (Japan)STRIATAL DOPAMINE TRANSPORTER IMAGING(FMT-PET) IN PATIENTS WITH IDIOPATHIC RAPIDEYE MOVEMENT SLEEP BEHAVIOR DISORDER- A CROSS-SECTIONAL STUDYMiyamoto M, Miyamoto T, Hirata K

Wednesday - REM - Board #155Presenting Author: Shady Rahayel (Canada)PATTERNS OF CORTICAL THINNING IN IDIOPATHICRAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDERRahayel S, Montplaisir J, Monchi O, Bedetti C, Postuma R,Gagnon J

Wednesday - REM - Board #156Presenting Author: Friederike Sixel-Döring (Germany)REM SLEEP BEHAVIOR DISORDER IS ABSENT IN DENOVO PARKINSON DISEASE PATIENTS WITH PARKINMUTATIONS: A REPORT FROM THE DENOPACOHORTSixel-Döring F, Lohmann K, Klein C, Mollenhauer B,Trenkwalder C

Wednesday - REM - Board #157Presenting Author: Friederike Sixel-Döring (Germany)REM SLEEP BEHAVIORAL EVENTS (RBE): A NEWMARKER FOR NEURODEGENERATION IN EARLYPARKINSON’S DISEASE?Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C

147

WED

NESD

AY

Wednesday - REM - Board #158Presenting Author: Koh-Ichiro Taniguchi (Japan)HOW DO NEUROLOGICAL AND PSYCHIATRIC SIGNSAND SYMPTOMS WHICH ARE INDICATIVE OF LEWYBODY DISEASE APPEAR IN APPARENT IDIOPATHICREM SLEEP BEHAVIOR DISORDER? – A DESCRIPTIVESTUDY IN THE CLINICAL SETTINGTaniguchi K, Oguri T, Sugiyama H, Hamano T, Tachibana N

Wednesday - REM - Board #159Presenting Author: Ari Ylikoski (Finland)PARASOMNIAS IN PARKINSON´S DISEASEYlikoski A, Martikainen K, Partinen M

Wednesday - REM - Board #160Presenting Author: Marielle Zoetmulder (Denmark)INCREASED MOTOR ACTIVITY DURING REMSLEEP IS LINKED WITH DOPAMINE FUNCTIONIN IDIOPATHIC REM SLEEP BEHAVIOUR DISORDERAND PARKINSON’S DISEASEZoetmulder M, Nikolic M, Biernat H, Korbo L, Friberg L,Jennum P

Wednesday - R - Board #161Presenting Author: Salma Batool-Anwar (United States)LIFESTYLE FACTORS AND RISK OF RESTLESS LEGSSYNDROME: PROSPECTIVE COHORT STUDYBatool-Anwar S, Li Y, De Vito K, Winkelman J, Malhotra A,Gao X

Wednesday - R - Board #162Presenting Author: Karla Carlos (Brazil)PHYSICIANS WITH RESTLESS LEGS SYNDROME AREMORE LIKELY TO FAIL IN THE WRITTEN TEST TOGET IN THE RESIDENCY PROGRAM IN BRAZIL.Carlos K, Carvalho L, Prado A, Prado L, Prado G

Wednesday - R - Board #164Presenting Author: Cristian Falup-Pecurariu (Romania)PREVALENCE OF RESTLESS LEGS SYNDROME INCHRONIC LIVER DISEASES CASE-CONTROL STUDYFalup-Pecurariu C, Coman F, Moraru G, Alexandru R

Wednesday - R - Board #165Presenting Author: Cristian Falup-Pecurariu (Romania)HIGH PREVALENCE OF RESTLESS LEGS SYNDROMEIN SYSTEMIC LUPUS ERYTHEMATOSUSFalup-Pecurariu C, Duca L, Moarcas M

Wednesday - R - Board #166Presenting Author: Fernando Prieto (Spain)TREATMENT OF RESTLESS LEGS SYNDROME WITHLACOSAMIDE. REPORT OF EIGHT CASESPrieto F, Saus R, Puertas FJ

Wednesday - R - Board #167Presenting Author: David Gabelia (Austria)ASSESSMENT OF FRAGMENTARY MYOCLONUS INHEALTHY SLEEPERSGabelia D, Mitterling T, Bregler D, Ehrmann L, Högl B,Frauscher B

Wednesday - R - Board #168Presenting Author: José Haba-Rubio (Switzerland)ANTIDEPRESSANTS AND RLS/PLMS IN THEGENERAL POPULATIONHaba-Rubio J, Marques-Vidal P, Andries D, Tobback N, TaftiM, Heinzer R

Wednesday - R - Board #169Presenting Author: Jesús Paniagua Soto (Spain)CLINICAL CASE: TEN- YEAR -OLD GIRL WITHIMPOSSIBILITY TO WAKE UPPaniagua -Soto J, Ruiz L, Iznaola C, Ruiz J

Wednesday - R - Board #170Presenting Author: Sofia Kasradze (Georgia)SLEEP-RELATED PROBLEMS AND RESTLESS LEGSSYNDROME IN THE CHILDREN WITH LEARNINGAND DEVELOPMENTAL DISORDERSKasradze S, Ediberidze T, Alkhidze M, Maisuradze L

Wednesday - R - Board #171Presenting Author: Carmen Montes (Spain)FACIOMANDIBULAR MYOCLONUS DURING SLEEP:VIDEO-EEG RECORDING RULE OUT EPILEPSY AS ACAUSE OF NOCTURNAL TONGUE BITINGMontes C, Alcaide C, Juarez A, Segundo J, Cabeza C

Wednesday - R - Board #172Presenting Author: Pablo A. Ruiz-Elena (Spain)ROTIGOTINE USE IN LONG-TERM TREATMENTOF RESTLESS LEGS SYNDROME: EXPERIENCE INGENERAL UNIVERSITY HOSPITAL OF CASTELLON.Ruiz-Elena P, Pinzon-Martinez J, Gomis-Devesa A,Barreda-Altaba I, Ortega-Albas J, Estarelles-Marco M

Wednesday - R - Board #173Presenting Author: Domingo Sanchez Ruiz (Spain)OBJECTIVE EVALUATION OF RLS DAYTIMESYMPTOMS BY MEANS OF THE MULTIPLESUGGESTED IMMOBILIZATION TEST (M-SIT)Sanchez Ruiz D, Garcia Borreguero D

Wednesday - R - Board #174Presenting Author: Taeko Sasai-Sakuma (Japan)CHANGE IN HEART RATE VARIABILITY PRECEDESTHE OCCURRENCE OF PERIODIC LEG MOVEMENTSDURING SLEEP: AN OBSERVATIONAL STUDYSasai-Sakuma T, Matsuura M, Inoue Y

Wednesday - R - Board #175Presenting Author: Denise Sharon (United States)RLS AROUND THE GLOBE: DIAGNOSIS ANDEPIDEMIOLOGYSharon D, Shamsnia M, Mack C

Wednesday - R - Board #176Presenting Author: Carmen Soria-Bretones (Spain)RESTLESS LEGS SYNDROME IN ATTENTIONDEFICIT-HIPERACTIVITY DISORDER: WHAT ABOUTTHE ROLE OF TREATMENT? A MULTICENTER STUDYSoria-Bretones C, Escribá-Alepuz J, Giner-Bayarri P,Hernández-Muelas S, Oviedo-Montés T, García-Jiménez M

Wednesday - R - Board #177Presenting Author: Andras Szentkiralyi (Germany)MULTIMORBIDITY AND THE RISK OF RESTLESS LEGSSYNDROME IN TWO PROSPECTIVE COHORT STUDIESSzentkiralyi A, Völzke H, Hoffmann W, Trenkwalder C, Berger K

Wednesday - R - Board #178Presenting Author: Magdalena Szklarek (Poland)THE IMPACT OF THE USE OF AMALGAMS IN THEDENTITION ON THE APPEARANCE OF THESYMPTOMS OF RESTLESS LEGS SYNDROMEDEVELOPED BY OLDER PEOPLE.Szklarek M, Kostka T

148

WED

NESD

AY

Wednesday - R - Board #179Presenting Author: Irina Zavalko (Russian Federation)POLYSOMNOGRAPHIC EVALUATION OFAUGMENTATION IN PATIENTS WITH RESTLESSLEGS SYNDROMEZavalko I, Maestri M, Ferini-Strambi L, Marelli S , Manconi M

Wednesday - S - Board #180Presenting Author: Andrée-Ann Baril (Canada)REDUCTION IN REGIONAL CEREBRAL BLOODFLOW IN OBSTRUCTIVE SLEEP APNEA DURINGWAKEFULNESS: A HIGH-RESOLUTION SPECT STUDYBaril A, Gagnon K, Montplaisir J, Soucy J, Gagnon J, Gosselin N

Wednesday - S - Board #181Presenting Author: Matthias Boentert (Germany)SLEEP QUALITY AND SLEEP-RELATED SYMPTOMS INPOMPE DISEASEBoentert M, Karabul N, Wenninger S, Schoser B, Mengel E, Young P

Wednesday - S - Board #182Presenting Author: Joan Brunso Casellas (Spain)OSTEOTOMY GUIDES AND CUSTOMISEDOSTEOSYNTHESIS PLAQUES MADE WITH CAD-CAMAND RAPID PROTOTYPING TECHNOLOGY IN THESKELETAL SURGICAL TREATMENT OF SEVERE OSABrunso J, Amilibia J, Cabriada V, Municio J, Gimeno J,Santamaria J

Wednesday - S - Board #183Presenting Author: Teresa Canet (Spain)DETECTING SLEEP RESPIRATORY DISTURBANCESIN PREGNACYCanet T, Gimenez P

Wednesday - S - Board #184Presenting Author: Antonio Q. Chan (United States)MECHANISM OF SUDDEN CARDIAC DEATH INOBSTRUCTIVE SLEEP APNEA, REVISITEDChan A, Antonio N

Wednesday - S - Board #185Presenting Author: Ennio A. Vivaldi (Chile)A NEW RESPIRATORY DISTURBANCE VARIABLE (RDV)BASED ON THE ENVELOPE ANALYSIS OF THEAIRFLOW SIGNAL AND ITS RELATIONSHIP TO AHIDíaz J, Arancibia J, Bassi A, Vivaldi E

Wednesday - S - Board #186Presenting Author: Joaquin Duran-Cantolla (Spain)A NEW VIBRATORY POSTURAL DEVICE FOR THETREATMENT OF POSITIONAL OBSTRUCTIVE SLEEPAPNEA (OSA). A PILOT STUDYDuran-Cantolla J, Barbe F, Rigau J, Oreja D, Martinez-Null C,Egea Santaolalla C

Wednesday - S - Board #187Presenting Author: Kelly Escajadillo Vargas (Spain)THE ROLE OF CENTRAL SLEEP APNEA IN ASSESSINGINFANTS WITH APPARENT LIFE-THREATENING EVENTEscajadillo-Vargas K, Cuéllar-Ramos N, Pedera-Mazarro A,Buenache-Espartosa R, Villadóniga-Zambrano M,Lamas-Ferreiro A

Wednesday - S - Board #188Presenting Author: Luis Vicente Franco De Oliveira (Brazil)SLEEP STUDY ON PATIENTS WITH NON-CYSTICFIBROSIS BRONCHIECTASIS: A PILOT STUDYFaria Júnior N, Santos I, Pasqual R, Leitão Filho F, Jardim J, Oliveira L

Wednesday - S - Board #189Presenting Author: Catarina Ferreira (Portugal)HOW SLEEP STUDIES ARE IMPORTANT TO INITIATENONINVASIVE VENTILATION IN DUCHENNEMUSCULAR DYSTROPHYFerreira C, Martins V, Lopes G, Madureira N, Moita J

Wednesday - S - Board #190Presenting Author: Jonathan Camara (Spain)COMORBIDITY AND GENDER IN PATIENTS WITHSLEEP APNEA-HYPOPNEA SYNDROME REQUIRINGPERFORMANCE OF AUTOCPAPGotera Rivera C, Barrios Barreto D, Lazo Meneses P, MañasBaena E, Jurkojc C, Camara J

Wednesday - S - Board #191Presenting Author: José Haba-Rubio (Switzerland)PREVALENCE AND CHARACTERISTICS OF SLEEPDISORDERED BREATHING IN PRE- ANDPOST-MENOPAUSAL WOMENHaba-Rubio J, Vat S, Andries D, Tobback N, Tafti M,Heinzer R

Wednesday - S - Board #192Presenting Author: Ali Gholamrezaei (Iran)P-WAVE DURATION AND DISPERSION IN HOLTERELECTROCARDIOGRAPHY OF PATIENTS WITHOBSTRUCTIVE SLEEP APNEAHashemi Jazi M, Amra B, Yazdchi M, Jahangiri M, Tabesh F,Gholamrezaei A

Wednesday - S - Board #193Presenting Author: M. Blanca Hoyo (Spain)SLEEP APNEA AND/OR OHS IN MORBID OBESITY:ANALYSIS OF GENDER DIFFERENCESHoyo M, Lopez E, Ibañez M

Wednesday - S - Board #194Presenting Author: Poul Jennum (Denmark)USAGE OF PSYCHOTROPIC MEDICATION INOBSTRUCTIVE SLEEP APNEA: A CONTROLLEDNATIONAL STUDYJennum P

Wednesday - S - Board #195Presenting Author: María José Jurado (Spain)ASSESSMENT OF NONINVASIVE PACO2 ANDNASAL-CANNULA PRESSURE TRANSDUCER DURINGPOLYSOMNOGRAPHY IN CHILDREN YOUNGERTHAN 3 YEARS WITH OSAS.Jurado M, Sampol G, Romero O

Wednesday - S - Board #196Presenting Author: Yan Ma (China)DETECTING PEDIATRIC SLEEP APNEA:CONSISTENCY ON CARDIOPULMONARYCOUPLING AND OXIMETRY MEASUREMENTMa Y, Yeh J, Sun S, Qiao J, Peng C

Wednesday - S - Board #197Presenting Author: Cristina Martínez Null (Spain)PREVALENCE OF SLEEP APNEA-HYPOPNEASYNDROME (SAHS) AMONG A BRUXISMPOPULATION. PRELIMINARY DATA.Martínez Null C, Anitua Aldecoa E, Durán Carro J, Aguirre J,Durán Cantolla J

149

WED

NESD

AY

Wednesday - S - Board #198Presenting Author: Aida Matevosyan (Armenia)DIAGNOSTIC VALUE OF BERLIN QUESTIONNAIRE ASA SCREENING TOOL FOR OBSTRUCTIVE SLEEPAPNEA-HYPOPNEA SYNDROMEMatevosyan A, Podosyan G, Khandanyan G, Shukuryan A

Wednesday - S - Board #199Presenting Author: Stefan Mihaicuta (Romania)OBESITY STRATIFICATION AS A PREDICTOR FORSLEEP APNEA SYNDROMEMihaicuta S, Frent S, Deleanu O

Wednesday - S - Board #200Presenting Author: Susana Mota-Casals (Spain)HOSPITAL SLEEP UNIT AND PRIMARY CARECOLLABORATION IN DIAGNOSIS OF RESPIRATORYSLEEP DISEASES: ASSESSMENT OF A SIX-YEAREXPERIENCEMota-Casals S, Obrador-Lagares A, Eizaguirre Antón S,Haro-Estarriol M

Wednesday - S - Board #201Presenting Author: Paula Contreras (Chile)SLEEP BREATHING DISORDERS SCREENING INCHILEAN MINERSSantin J, Moya P, Contreras P, Pincheira E

Wednesday - S - Board #202Presenting Author: Hyojung Nam (Republic of Korea)ANALYSIS OF AGE EFFECT TO DETERMINE OPTIMALNASAL PRESSURE IN KOREAN PATIENTS WITHOBSTRUCTIVE SLEEP APNEANam H, Shin W, Yoo R, Sung M, Cho H, Shon Y

Wednesday - S - Board #203Presenting Author: Ana Jimenez Romero (Spain)IMPORTANCE OF CPAP SCHOOL. IMPROVINGTREATMENT ADHERENCE?Ordonez Dios I, Jimenez Romero A, Garcia Amores M, VillarPastor B, Feu Collado N, Jurado Gamez B

Wednesday - S - Board #204Presenting Author: Rogelio Peralta Lepe (Spain)UTILITY OF SLEEP STUDY IN CHILDREN WITHLARYNGOMALACIAPeralta Lepe R, Castaño De Las Pozas G, Alonso Álvarez M,Cordero Guevara J, Ordax Carbajo E, Terán Santos J

Wednesday - S - Board #205Presenting Author: N. Pelletier-Fleury (France)THE EFFECTIVENESS OF A COMMUNITYPHARMACIST-LED INTERVENTION TO IMPROVESCREENING FOR SLEEP APNEA IN PRIMARY CARE –A COHORT STUDYPerraudin C

Wednesday - S - Board #206Presenting Author: Juan Antonio Piña Fernandez (Spain)IS THERE A CORRELATION BETWEEN OF THEEPWORTH SLEEPINESS SCALE AND THE CPAPADHERENCE ?Piña Fernandez J, Mochon Doña A, Cuellar Raya P,Cebrian Gallardo J

Wednesday - S - Board #207Presenting Author: Juan Antonio Piña Fernandez (Spain)THE OSA PATIENT IN A SPECIFIC SLEEP NURSEDEPARTMENTPiña Fernandez J, Mochon Doña A, Cuellar Raya P, CebrianGallardo J

Wednesday - S - Board #208Presenting Author: Juan Antonio Piña Fernandez (Spain)IMPORTANCE OF NURSE INTERVENTION IN THEADAPTATION OF PATIENT TREATED WITH CPAPPiña Fernandez J, Mochon Doña a, Cuellar Raya p, CebrianGallardo J

Wednesday - S - Board #209Presenting Author: Lucila Prado (Brazil)OBSTRUCTIVE SLEEP APNEA AND SNORETREATMENT WITH TONGUE STABILIZER DEVICE:RANDOMIZED CLINICAL TRIAL, PRELIMINARY DATAPrado L, Jung A, Prado A, Carlos K, Carvalho L, Prado G

Wednesday - S - Board #210Presenting Author: Leon Rosenthal (United States)THE IMPACT OF SLEEP POSITION PREFERENCEON SUPINE SLEEP DURING OVERNIGHTPOLYSOMNOGRAPHYRosenthal L, Rosenthal A

Wednesday - S - Board #211Presenting Author: M. Montserrat And Sanchez Ortuno (Spain)INTERVENTIONS TO IMPROVE ADHERENCE TO PAPIN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA:DOES THE PATIENT’S PERSONALITY MATTER?Sanchez Ortuno M, Lee-Chiong T, Goelz K, Harrington J,Edinger J, Aloia M

Wednesday - S - Board #212Presenting Author: Colin Shapiro (Canada)THAT’S ONE SMALL BOOK FOR A MAN, ONE GIANTLEAP FOR CPAP COMPLIANCE. ASSOCIATIONBETWEEN PATIENT EDUCATION AND CPAPCOMLIANCE IN AN URBAN AND A RURAL SETTINGIN CANADA.Shapiro C, Zalai D

Wednesday - S - Board #213Presenting Author: Milan Sova (Czech Republic)THE INFLUENCE OF CONTINUOUS POSITIVEAIRWAY PRESSURE THERAPY ON PREVALENCE OFMASKED HYPERTENSION IN PATIENTS WITHOBSTRUCTIVE SLEEP APNEASova M, Sovova E, Hobzova M, Kamasova M, Kolek V

Wednesday - S - Board #214Presenting Author: Milan Sova (Czech Republic)ANALYSIS OF PHARMACOTHERAPY ANDCOMPENSATION OF ARTERIAL HYPERTENSIONIN PATIENTS WITH OBSTRUCTIVE SLEEP APNEASova M, Sovova E, Hobzova M, Kamasova M, Kolek V

Wednesday - S - Board #215Presenting Author: Yoshikazu Tkakaesu (Japan)IS ORAL APPLIANCE AS EFFICACIOUS AS NCPAPIN PATIENTS WITH POSITIONAL-DEPENDENTOBSTRUCTIVE SLEEP APNEA?Takaesu Y, Tsuiki S, Kobayashi M, Komada Y, Inoue Y

150

WED

NESD

AY

Wednesday - S - Board #216Presenting Author: Aneliya Draganova (Bulgaria)PREVALENCE OF CENTRAL SLEEP APNEA AMONGHEART FAILURE PATIENTS WITH PRESERVEDEJECTION FRACTIONTerziyski K, Draganova A, Aliman O, Ilchev I, Hristova A,Kostianev S

Wednesday - S - Board #217Presenting Author: Orna Tzischinsky (Israel)FACTORS AFFECTING THE INTENTION ANDDECISION TO BE TREATED FORTzischinsky O, Shahrabani S, Givati G, Dagan Y

Wednesday - S - Board #218Presenting Author: Jorge Vale (Portugal)CHIARI MALFORMATION AND CENTRAL SLEEPAPNEA: SUCCESSFUL THERAPY WITH ADAPTIVEPRESSURE SUPPORT SERVO-VENTILATION.Vale J, Silva E, Gil I, Sanchez A, Marques C, Simões Torres A

Wednesday - S - Board #219Presenting Author: Jorge Vale (Portugal)THE IMPACT OF OBSTRUCTIVE SLEEP APNEAIN DIABETES MELLITUSVale J, Manuel P, Oliveira A, Gil I, Nascimento E, Sanchez A

Wednesday - S - Board #220Presenting Author: Matilde Valencia-Flores (Mexico)STOP-BANG QUESTIONNAIRE IS A GOOD TEST INDISCRIMINATING OSA IN OBESE WOMEN BUT NOIN MENValencia-Flores M, Santiago-Ayala V, Resendiz-García M,Castaño-Meneses V, Mendoza-Pacheco A, García-Ramos G

Wednesday - S - Board #221Presenting Author: Sopharat Vat (Switzerland)PREVALENCE OF THE UPPER AIRWAY RESISTANCESYNDROME IN THE GENERAL POPULATIONVat S, Haba-Rubio J, Andries D, Tobback N, Tafti M, Heinzer R

Wednesday - S - Board #222Presenting Author: Sopharat Vat (Switzerland)SCREENING FOR SLEEP-DISORDERED BREATHINGIN THE GENERAL POPULATION: PREDICTIVEPERFORMANCE OF FOUR QUESTIONNAIRESVat S, Haba-Rubio J, Andries D, Tobback N, Tafti M, Heinzer R

Wednesday - S - Board #223Presenting Author: Javier Vila (Spain)PARTIAL RESECTION OF THE BASE OF THE TONGUEWITH HARMONIC SCALPEL: A PROMISING SURGICALAPPROACH FOR SLEEP APNEA.Vila J

Wednesday - S - Board #224Presenting Author: William Wohlgemuth (United States)CPAP ADHERENCE AS A MEDIATOR BETWEENCO-MORBID INSOMNIA, OSA AND SUBJECTIVEDAYTIME SLEEPINESSWohlgemuth W, Wallace D, Tetali P

Wednesday - S - Board #225Presenting Author: Tomás Zamora (Spain)STUDY OF THERMAL PROPERTIES, TOXICITYEMISSIONS AND REBREATHING AVOIDANCE ASEXOGENOUS STRESSORS OF SUDDEN INFANTDEAD SYNDROME IN BABY MATTRESSES. DESIGNRECOMMENDATIONSZamora T, Pin G, Barberá V, Morell M, Aznar M, Huertas P

Wednesday - YI - Board #226Presenting Author: Maria Jose Elso Tinoco (Chile)CHARACTERIZATION OF SLEEP DISORDERS ONPATIENTS WITH PARKINSON´S DISEASE IN CHILEElso Tinoco M, Zenteno Araos F, Zenteno Araos D, Avello R,Mery Canales V

Wednesday - YI - Board #227Presenting Author: Shirley X. Li (China)FACTORS ASSOCIATED WITH TREATMENTRESPONSES IN PATIENTS WITH REM SLEEPBEHAVIOR DISORDERLi S, Lam S, Zhang J, Yu M, Wing Y

Wednesday - YI - Board #228Presenting Author: Elaheh Solemannejad (Canada)HYPODOPAMINERGIC MICE HAVE A SLEEPPHENOTYPE THAT RESEMBLES HUMANPARKINSON’S DISEASESoleimannejad E, Burgess C, Salahpour A, Peever J

Wednesday - A - Board #229Presenting Author: Viara Mileva (The Netherlands)MOTHER-CHILD BED-SHARING ASSOCIATEDWITH MORE WHEEZING IN EARLY CHILDHOODLuijk M, Mileva-Seitz V, Sonnenschein - Van Der Voort A, VanIjzendoorn M, De Jongste J, Duijts L

151

152

Sponsorsand Exhibitors

153

154

Exhibitor Floor Plan

Mundipharma International Limited www.mundipharma.comMundipharma is one of the Purdue/Mundipharma/Nappindependent associated companies - privately ownedcompanies and joint ventures covering the world'spharmaceutical markets. e companies worldwide arededicated to bringing to patients with severe anddebilitating diseases the benefits of novel treatmentoptions in fields such as severe pain, rheumatoid arthritis,haemato-oncology and respiratory disease.

UCBwww.ucb.comUCB, Brussels, Belgium is a global biopharmaceuticalcompany focused on the discovery and development ofinnovative medicines and solutions to transform the livesof people living with severe diseases of the immunesystem or of the central nervous system.

Our Sponsorsis activity is supported in part by educational grants from the following companies in accordance with ACCME Standards.

155

BRONZE SPONSORS

Jazz Pharmaceuticals www.jazzpharma.comJazz Pharmaceuticals is a specialty biopharmaceutical company that identifies, develops and commercializes products to meetunmet patient needs in narcolepsy, oncology, pain and psychiatry. Our US products in these areas include: Xyrem® (sodiumoxybate), Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide), Luvox CR® (fluvoxamine maleate), and FazaClo®(clozapine, USP).

Philips Respironics www.philips.com/RespironicsFor more than three decades, Philips Respironics has been a leading global provider of innovative solutions for thesleep and respiratory markets. Its products help manage a broad spectrum of sleep-disordered breathing, chronicobstructive pulmonary disease, asthma, and restrictive lung disorders. Philips Respironics has made a commitment toalign with clinicians and provide integrated solutions that lead to better sleep and breathing, healthier living, andhealthier practices. For more information, visit our website www.philips.com/Respironics.

ResMed www.resmed.comResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatmentand management of respiratory disorders, with a focus on sleep-disordered breathing. ResMed is dedicated to developinginnovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patientsand healthcare professionals of the potentially serious health consequences of untreated SDB.

SILVER SPONSORS

ActiGraphwww.actigraphcorp.comActiGraph is a leading provider of actigraphy monitoringhardware and software solutions for the global scientificcommunity. ActiGraph’s innovative suite of wireless actigraphymonitors are among the most widely used and extensivelyvalidated devices of their kind, delivering objective and reliable24 hour sleep/wake and daily activity data to customers in over70 countries.

AESPIwww.aespi.nete Spanish Restless Legs Association, AESPI, was founded in2004 and is registered as # 584249 in the national registry ofassociations. We have several publications, a book, "e Devilat Wakes Me Up When I Sleep," and a weekly magazine, aswell as a digital magazine which comes out every two monthsand a web site, www.aespi.net.

Cadwellwww.cadwell.comCadwell has developed useful and innovative devices forphysiatrists, neurologists, neurophysiologists and technologistswho want the best devices to provide superior patient care since1979. Products include the Cascade family for IONM, theEasy family for all types of EEG and PSG and the Sierra familyfor EMG, NCV and clinical EP.

CamNtech Ltdwww.camntech.comCamNtech are leaders in the development of innovativeminiature physiological recorders. CamNtech has considerableexperience and a proven track record in the field of ambulatorymonitoring devices. CamNtech has a range of products thatrecord Heart rate, HRV, ECG, EEG, EMG and PhysicalActivity with a multitude of application areas.

Compumedics Ltdwww.compumedics.comCompumedics, an Australian company founded in 1987, is aglobal leader in technological solutions for sleep diagnostics,neurodiagnostics and cardiology. Compumedics offers acomprehensive range of innovative solutions for in-lab,ambulatory, home and research applications including world'sfirst such as the High-Definition GraelHD and the Bluetooth-enabled PSG-Anywhere SomtéPSG

Dymedix Diagnosticswww.dymedix.comDymedix Diagnostics offers disposable sensors and reusablesensors for sleep disorder diagnostic testing. e advancedtechnology in our Airflow Sensors and Respiratory EffortSensors provides accurate data, reliability, and ease of use.Neonate, Pediatric, and Adult Sensors are compatible on mostPSG systems and home testing devices.

Commercial Companies and Exhibitors

156

Elsevierwww.elsevier.comELSEVIER is a leading publisher of health sciencepublications, advancing medicine by delivering superiorreference information & decision support tools to doctors,nurses, health practitioners & students. Elsevier has a selectionof leading Neurology journals on display. Visit our stand andcollect your free sample copy.

European Alliance for Restless Legs Syndromewww.earls.euEARLS is a non-profit Alliance of National PatientOrganizations from various European countries that willengage in activities which contribute to greater awareness ofRestless Legs Syndrome in the broadest sense. EARLS will raiseimportant issues at a European level common to all members.

GENEActivwww.geneactiv.co.uk e GENEActiv range of wrist-worn, raw data accelerometersare designed for objectively measuring activities within free-living and clinical research. Along with standard sleepactigraphy outputs, the raw data format allows further analysispossibilities. GENEActiv has been proven in both small scalestudies and large international cohorts of over 10,000 subjects.

Inspire Medical Systems, Inc.www.inspiresleep.comInspire Medical Systems Inc. is the leading developer ofinnovative, implantable neurostimulation systems to treatObstructive Sleep Apnea. Utilizing technologies from the fieldsof cardiac pacing and neurostimulation, Inspire has developedan Upper Airway Stimulation therapy, designed to improvesleep and enrich the lives of people suffering from sleep apnea.

International RLS Study Groupwww.irlssg.orge International Restless Legs Syndrome Study Group(IRLSSG) is an organization of professionals committed toadvancing basic and clinical research on Restless LegsSyndrome (RLS). eir mission includes the cooperativeplanning, implementation, analysis, and reporting of multi-center studies with an international emphasis.

JUSTE S.A.Q.Fwww.juste.esJUSTE, S.A.Q.F. is a family-owned Spanish company activelyengaged in researching, developing and distributingpharmaceutical products and API’s for pharmaceuticalspecialties. In addition, we develop and manufacturepharmaceutical products and food supplements in soft gelatinecapsules. JUSTE is present in Central America and theCaribbean through the affiliated companies of JusteInternacional, and in several countries all over the worldthrough distributors.


157

Narcolepsy Networkwww.narcolepsynetwork.orgNarcolepsy Network is a national patient support organizationfor people with narcolepsy, their families, friends and treatingprofessionals. e organization's goals include raising awarenessof narcolepsy, advocating for all people with narcolepsy,providing education and supporting research.

Natus Medical Incorporatedwww.natus.comNatus is a leading provider of healthcare products used for thescreening, detection, treatment, monitoring and tracking ofcommon medical ailments in newborn care, neurologicaldysfunction, epilepsy, sleep disorders, and balance and mobilitydisorders. Product offerings include computerizedneurodiagnostic systems, polysomnography and softwaresystems for managing and tracking disorders and diseases forpublic health laboratories.

NightBalance B.V.www.nightbalance.come NightBalance Sleep Position Trainer (SPT) is a newmedical aid for the treatment of Positional Obstructive SleepApnea. e SPT trains patients effectively and comfortably notto sleep in supine position through gentle vibrations. e SPTis tested over more than 25.000 nights in clinical research.

Nomicswww.nomics.beA surrogate for oesophageal pressure and recognition ofbreathing effort. Nomics marketed the Jawac (for Jaw Activity),a new sensor that revolutionizes the diagnosis of sleep-disordered breathing both for children and adults. Bymeasuring mandibular movements during sleep, the Jawacsensor offers a powerful and simple solution to assess breathingefforts during sleep.

Nox Medical ehfwww.noxmedical.comNox Medical is a leading provider of Sleep Diagnostics systems.By introducing the NOX T3 and now the Nox A1, Nox Medicalhas created a breakthrough in the portable sleep diagnosticsmarket. Behind the revolutionary design and wireless solution aredecades of clinical and engineering excellence.

OrthoApneawww.orthoapnea.comOrthoApnea, S. L. is a Spanish manufacturer of oral devicesfor the treatment of sleep apnea and snoring. e patentedOrthoApnea appliance stands out among other solutions forthe improved effectiveness and patient comfort. OrthoApneais currently present in over 25 countries through its networkof international collaborators.

Oxigen Salud S.A.www.oxigensalud.comOXIGEN salud es una empresa familiar que desarrolla laasistencia domiciliaria en el ámbito de las terapias respiratoriassuministrando, de manera innovadora, productos y servicios queaporten un valor mayor a los pacientes. Queremos dar el mejorservicio a cada paciente al mejor precio para nuestros clientes.


158

Salimetrics www.salimetrics.comExciting times at Salimetrics, World Leader in SalivaryBioscience. Our continuing success reflects the increasing useof our Assays for measuring Biomarkers in Saliva. Our CortisolAssay proven to be the “Best Commercially Available” Our newSalivary Melatonin Assay e Most Time Efficient, Precise andEasiest to use Assay Protocol aiding studies such as SleepRegulation, Insomnia, Sleep Wake Cycle.

SenTec AGwww.sentec.chSenTec is a Swiss manufacturer of a non-invasive patientmonitoring system (SDMS) providing transcutaneouscapnometry (tcPCO2) and SpO2/PR in real time. e SDMSreliably reflects patient ventilation and oxygenation from spot-check to long time (overnight) measurements and features anassociated remote monitoring system called V-CareNeT™.Please visit http://jiddet.net/sleep_sentec for Sleep-Studies.

Seven Dreamers Laboratorieswww.sevendreamers.comSeven Dreamers Laboratories is a R&D focused medical devicemanufacturer, which performs research and development ofmedical devices for worldwide markets. Following our motto,“Pursuing a better life with wisdom through innovativetechnology", we have developed a new device for OSAS. Pleasecome by our booth to see the NaStent.

Sleep Multimedia, Incwww.sleepmultimedia.comSleepMultiMedia is a computerized textbook of sleep medicinewith text, sound, graphics, animation, and video. Updatedannually, the program covers sleep research, sleep physiology, andclinical sleep medicine, including orofacial management of sleepapnea. SleepMultiMedia features over 5,000 Abstracts, 135CME credits, extensive information on polysomnography, anupdated sleep center policy and procedure manual, and printableinteractive patient care programs in Spanish and English.

Sleepvirtualwww.sleepvirtual.comSleepvirtual/Neurovirtual USA Inc., develops/marketsneurological devices to hospitals and clinics worldwide. Weoffer solutions for EEG, and PSG monitoring. Our missionis to improve our customers’ quality of service and theirpatients’ quality of life with superior products and responsivecustomer support.

The Society for Worldwide Medical Exchangewww.worldwidemedicalexchange.orge Society for Worldwide Medical Exchange (SWME) is aninternational non-profit organization uniting doctors aroundthe world to advance global health through medical education.Recognizing health as a fundamental human right, we work tostrengthen health care delivery by breaking down barriers toquality medical education.


159

SOMNOmedics GmbHwww.somnomedics.euSOMNOmedics manufactures, distributes and servicesproducts dedicated to sleep diagnostics. SOMNOmedicsdevices are small, light-weight, highly-reliable and patient-worn. e SOMNOtouch is the smallest respiratory screeneravailable and can also be used for ambulatory sleep testing.Our wireless solution allows patients data to be observed fromany environment.

Spanish Sleep Societywww.ses.org.ese Spanish Society on Sleep Medicine is the highest exponentfor the development of the investigation and impulse of SleepMedicine in Spain. As a Scientific Society, it gathers more than300 professionals and investigators of different tracks:medicine, psychology, biology, nursing and technologists ofpolysomnography. Every year the Society organizes its NationalCongress, where professionals can find a platform fordiscussion and can update their knowledge experiences.

Valkee Oywww.valkee.comValkee Bright Light Headset is a personal med-tech product,based on the positive health effects of regular and adequatelight. Valkee substitutes mood-elevating effects of the sunwhen enough ambient light is not available, by channelingbright light directly to photosensitive regions of the brainthrough the ear canal. Valkee’s bright light affects hormonalactivity, similar to what sunlight does, and as a result increasesenergy during winter days and acts as a preventative andtreatment of mood swings.

VitalAirewww.vitalaire.esVitalAire is part of Air Liquide group, the world leader in gasesfor industry, health and the environment (present in 80 countrieswith close to 50,000 employees) VitalAire, provides homecare,enabling patients to enjoy better quality of life. VitalAire is oneof the more innovative companies in the homecare, for morethan 20 years VitalAire is contributing to facilitate treatment athome. A dedicated team of more than 10,000 employeesworldwide supplies more than 7,500 hospitals and clinics andserves more than one million patients at home.

World Association of Sleep Medicinewww.wasmonline.orgWASM’s mission is to advance sleep health worldwide. WASMfulfills this mission by promoting and encouraging education,research, and patient care. Our 5th World Congress on SleepMedicine in Valencia, Spain will bring together sleep cliniciansand researchers to discuss advances made in sleep research andclinical knowledge.

Weinmannwww.weinmann.deWeinmann – partner for life. We develop, produce and marketdiagnostic and therapeutic system solutions. Reliability and thebest possible quality is our promise. We create innovative,economical and customized products for valid diagnoses and abroad therapy spectrum for the benefit of patient, doctor andcost carrier


160

The Willis-Ekbom Disease (WED) Foundationwillis-ekbom.orge Willis-Ekbom Disease (WED) Foundation (formerly theRestless Legs Syndrome Foundation is a non-profit patientorganization providing the latest information about RLS. egoals of the Foundation are to increase awareness, improvetreatments, and through research, find a cure for RLS -- aneurological disease severely affecting millions of individuals.

Wisepress Medical Bookshopwww.wisepress.comWisepress are Europe’s principal conference bookseller. Weexhibit the leading books, sample journals and digital contentrelevant to this meeting. Books may be purchased at the booth,and we offer a postal service. Visit our online bookshop forspecial offers and follow us on Twitter for the latest news@WisepressBooks.

World Sleep Daywww.worldsleepday.orgWorld Sleep Day is an annual event, intended to be acelebration of sleep and a call to action on important issuesrelated to sleep, including medicine, education, social aspectsand driving. It is organized by the World Sleep Day Committeeof the World Association of Sleep Medicine (WASM) and aimsto lessen the burden of sleep problems on society through betterprevention and management of sleep disorders.


161

Notes:_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

Membership Information�e goal of WASM is to advance knowledge about sleep and sleep disorders among health care personnel and among the public worldwide. By establishing international exchanges among physicians, psychologists, nurses, technologists, and other medical personnel interested in the sleep �eld, and sharing insights and information with basic researchers, the �eld of sleep medicine is an advance for all populations. Increasing knowledge about sleep medicine will have a bene�cial impact on the quality of life of individuals around the world. Individuals who are sleep health professionals are encouraged to become members. Membership bene�ts include:

1. $125 discount on WASM congress.2. Sleep Medicine journal (online access for all memberships, print copy for Full membership)3. Voting rights at biennial meeting.4. Eligible for committee participation.5. Knowledge that you �nancially support the work of WASM.

Step A – Demographic Information

_________________________ _________________________First Name Last Name

_________________________ _________________________ MD/PhD/Technician/Other Specialty

Gender: M F

Email: _________________________________

Address _________________________________

Hospital _________________________________

Street _________________________________

City _________________________________

State _________________________________

Zip _________________________________ Country _________________________________

Phone _________________________________

Fax _________________________________

Step B – Membership Type______ Full 2 year membership 2014-2015 (US$250)______ 2 year membership 2014-2015 (US$100)______ Full 1 year membership 2014 (US$135)______ 1 year membership 2014 (US$55)______ Student membership 2014 (US$25)

Step C – Credit Card Payment Details

Card Holder Name: __________________________

Street: _____________________________________

City: ______________________________________

Country: ___________________________________

Zip Code: __________________________________

Amount in US $: ____________________________

VISA or MasterCard Number:

___________________________________________

Expiration Month and Year (MM /YY): __________

3 digit Veri�cation Number: ___________________

Signature: __________________________________

Step D – Send Information to WASM

Online: www.wasmonline.org

Mail: World Association of Sleep Medicine 3270 19th Street NW, Suite 109 Rochester, MN 55901

Phone: +1-507-316-0084Fax: +1-877-659-0760Email: [email protected]

Please allow one week for your membership to be processed. An email will be sent providing access to the membership website.

Stop by our booth for details! Booth #2

World Association of Sleep Medicine Foundation3270 19th St. NW • Suite 109Rochester, MN 55901 USAT: 507.316.0084 • [email protected]

www.wasmcongress.com

Symposium Submission Deadline:

June 30, 2014

Documents

WASM 2013 Valencia Final Program 1